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ABSTRACT 
Nucleotides have been routinely supplemented to infant formulas due to 
the important roles they play in metabolism and to replicate the higher 
concentrations typically found in human milk.  A method utilising anion 
exchange solid-phase extraction clean-up and liquid chromatography was 
developed for the rapid, routine determination of supplemented cytidine 
5′-monophosphate, uridine 5′-monophosphate, inosine 5′-monophosphate, 
guanosine 5′-monophosphate, and adenosine 5′-monophosphate in bovine 
milk-based infant formula.  Chromatographic analyses were performed 
using a C18 stationary phase with gradient elution, UV detection, and 
quantitation by an internal standard technique.  A single-laboratory 
validation was performed, with recoveries of 92–101% and repeatability of 
1.0–2.3%.  An extension study demonstrated the expansion in scope to a 
wider range of different infant formula products including milk protein and 
hydrolysate-based products, low and high fat products, soy protein-based 
and elemental products, adult nutritional and infant formulations, in both 
ready-to-feed and powder forms. 
The development of a method to measure the total potentially available 
nucleosides (TPAN) in human milk has made an important contribution to 
further understanding the distribution of nucleosides and nucleotides.  This 
method was applied in a lactation study of bovine milk with colostrum and 
milk samples collected from two herds over the course of the first month 
post-partum, pooled within each herd by stage of lactation and the TPAN 
concentrations were determined.  Sample analysis consisted of parallel 
enzymatic treatments, phenylboronate affinity gel extraction, and liquid 
chromatography to quantify contributions of nucleosides, monomeric 
nucleotides, nucleotide adducts, and polymeric nucleotides to the 
nutritionally available nucleoside pool.  Bovine colostrum contained high 
levels of nucleosides and monomeric nucleotides, which rapidly decreased 
as lactation progressed into transitional milk.  Mature milk was relatively 
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consistent in nucleoside and monomeric nucleotide concentrations from 
approximately the tenth day post-partum.  Differences in concentrations 
between summer-milk and winter-milk herds were largely attributable to 
variability in uridine and monomeric nucleotide concentrations. 
The TPAN method was subsequently applied to the analysis of mature 
bovine, caprine, and ovine milk.  The contributions to TPAN from 
polymeric nucleotides, monomeric nucleotides, and nucleotide adducts 
were then calculated.  Ovine milk contained the highest concentration of 
TPAN (374.1 µmol dL-1), with lower concentrations in caprine milk 
(97.4 µmol dL-1) and bovine milk (7.9 µmol dL-1).  Ovine milk contained the 
highest concentrations of each of the different nucleoside and nucleotide 
forms, and bovine milk contained the lowest. 
A method for the simultaneous analysis of nucleosides and nucleotides in 
infant formula using reversed-phase liquid chromatography-tandem mass 
spectrometry was developed.  Following sample dissolution, protein was 
removed by centrifugal ultrafiltration.  Chromatographic analyses were 
performed using a C18 stationary phase and gradient elution, with mass 
spectrometric detection, and quantitation by stable isotope labelled 
internal standard technique.  A single laboratory validation study was 
performed with recoveries of 80.1–112.9% and repeatability relative 
standard deviations of 1.9–7.2%.  The method was validated for the 
analysis of bovine milk-based, soy-based, caprine milk-based and 
hydrolysate-based infant formula. 
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―The real voyage of discovery consists not in seeking new landscapes but 
in having new eyes.‖ — Marcel Proust, 1923 
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INTRODUCTION 1 
NUCLEOTIDE BIOCHEMISTRY 
1. INTRODUCTION 
In recent years, there has been considerable activity in the analysis of 
bovine milk for bioactive factors that may confer significant improvements 
to human health.  Found in a wide concentration range, from parts per 
billion to parts per million, these bioactive components influence the 
physiological development of the neonate. 
Nucleosides and nucleotides are a group of structurally related bioactive 
components present that exhibit a diverse range of nutritional benefits to 
infants.  The presence of nucleotides in human and bovine milk as DNA 
and RNA was established, with the concentration of RNA more than 20 
times higher than DNA (Sanguansermsri et al., 1974).  The nucleotide 
content in milk and the health benefits these impart have been fertile 
topics of research in recent years.  The focus of this study is restricted to 
ribonucleoside and ribonucleotides only, and excludes deoxyribose forms. 
Due to the role nucleotides play in metabolism, and in order to resemble 
more closely the nucleotide profile of human milk, infant formula (unless 
otherwise specified, infant formula refers to bovine milk-based or whey-
based formulas) has been routinely supplemented with nucleotides.  
However, nucleotide supplementation is still somewhat controversial, 
particularly when fortified to levels equivalent to the total potentially 
available nucleoside (TPAN) levels of human milk. 
When manufacturing products for infant consumption, analytical methods 
used to confirm product composition are held to a high standard.  The 
merit of an analytical method is demonstrated through a single laboratory 
validation (SLV) study whereby a method is shown to be accurate, precise, 
robust, and fit-for-purpose.  Coupled with the commercial requirements for 
rapid, high capacity sample throughput, there is a distinct need for an 
accurate and precise rapid, analytical method for the routine product 
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compliance analysis of nucleotides in a wide range of infant formula.  A 
robust method for the routine analysis of nucleotides was developed and 
validated as part of this study.  A description of this method and results 
obtained from this research were summarised and presented at the 123rd 
annual AOAC International conference in 2009 and subsequently 
published in the Journal of AOAC International (Gill et al., 2010) (see 
Appendix I, Appendix II). 
The development of an analytical method to measure TPAN has been an 
important contribution to further understanding the distribution of 
nucleosides and nucleotides, which has important implications for infant 
nutrition.  With the increasing trend towards nucleotide supplementation of 
infant formulas, it is surprising that an analysis of TPAN in bovine milk has 
not previously been reported.  Therefore, an analysis of TPAN in bovine 
colostrum and milk as well as mature bovine, caprine, and ovine milk 
forms a part of this study.  A description of this method and results 
obtained from this research were summarised and presented at the 124th 
annual AOAC International conference in 2010 and subsequently 
published in the International Dairy Journal (Gill et al., 2011; Gill et al., 
2012b) (see Appendix I, Appendix II). 
In recent years, a number of separation modes have been coupled, either 
online or off-line, to various mass spectrometric techniques in the analysis 
of nucleosides and nucleotides in biological tissues and fluids.  Currently, 
few of these techniques have been applied to the analysis of milk and 
infant formula.  A part of this study includes the development, optimisation, 
and validation of a liquid chromatography-mass spectrometry (LC-MS) 
method for the simultaneous quantitation of nucleosides and nucleotides. 
A description of this method and results obtained from this research were 
summarised and subsequently published in Analytical Bioanalytical 
Chemistry (Gill et al., 2013) (see Appendix I, Appendix II). 
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2. LITERATURE REVIEW 
2.1. Nucleotide Biochemistry 
Nucleotides are compounds of critical importance to cellular function.  
They operate as precursors to nucleic acids, as mediators of chemical 
energy transfer and cell signalling, and as integral components of 
coenzymes in the metabolism of carbohydrates, lipids, and protein (Carver 
and Walker, 1995; Cosgrove, 1998; Yu, 1998). 
2.1.1. STRUCTURE OF NUCLEOTIDES 
Nucleobases are low molecular weight heterocyclic aromatic compounds 
based on either a purine or pyrimidine structure; Figure 1a.  These include 
cytosine, thymine, uracil (pyrimidines) and adenine, guanine, 
hypoxanthine, xanthine (purines).  Nucleosides consist of a purine or 
pyrimidine base attached via an N-glycosidic linkage to -D-ribofuranose; 
Figure 1b.  Nucleotides are o-phosphoric acid esters of nucleosides 
containing one to three phosphate groups on the ribose 2–, 3– or most 
commonly 5–carbon.  Cyclic nucleotides contain a phosphate group that is 
bonded to two of the ribose hydroxyl groups forming a ring structure; 
Figure 2. 
 
Figure 1. Structure and numbering of purine, pyrimidine and ribose 
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The chemical behaviour of the polyvalent phosphate group, dominated by 
its negative charge at physiological pH (5–7) and its chemical stability, 
confers properties that make nucleotides suitable as building blocks within 
genetic material (Westheimer, 1987).  The presence of high-energy 
phosphate bonds in adenosine triphosphate (ATP) provides a mechanism 
whereby chemical energy can be stored and then liberated when needed 
(Gropper et al., 2009). 
2.1.2. PHYSICAL PROPERTIES OF NUCLEOTIDES 
The acid-base behaviour of a nucleobase is the critical factor that 
determines its charge, its tautomeric structure and the donation or 
acceptance of protons.  Cytosine and adenine are strongly basic and are 
protonated at moderately acidic conditions.  The dissociation constant for 
this process is defined as in Equation 1.  Uracil is weakly acidic and is 
deprotonated in weakly alkaline conditions.  The dissociation constant for 
this process is defined as in Equation 2.  Guanine and hypoxanthine are 
intermediate compounds, and are protonated in strongly acidic conditions, 
and are deprotonated in weakly alkaline conditions. 
pKa  =  -log Ka  =  -log 
[H+][B]
[HB+]
 (Equation 1) 
 
pKa  =  -log Ka  =  -log 
[H+][B-]
[HB]
 
 
(Equation 2) 
 
Those nucleobases with amine groups, adenine, guanine and cytosine, 
are protonated on the ring nitrogens rather than the free amine group.  
The positions of (de)protonation and pKa values of nucleobases are given 
in Figure 3.  All of the nucleobases are uncharged from pH = 5–7, that is, 
at physiological pH. 
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Nucleobases are capable of undergoing tautomeric isomerisation as either 
keto-enol or amine-imine equilibria.  Spectroscopic analysis has shown 
that the major nucleobases exist primarily (> 99.99%) in their keto or 
amine forms (Blackburn et al., 2006). 
The presence of the phosphate group in nucleotides has the effect of 
making the ring nitrogen atoms more basic as illustrated by a higher pKa 
value of the nucleotide compared to the corresponding nucleoside; 
Table 1.  The phosphate group of nucleotides possess two ionisable 
protons.  The pKa values of these are only slightly dependant on the 
 
Figure 3. Site and pKa values for (de)protonation of nucleotides (adapted 
from Bloomfield et al., 2000; Dawson et al., 1986) 
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nucleobases and position of the phosphate on the ribose sugar.  The pKa 
for the loss of the first and second proton from the phosphate group are ~1 
and ~6–7 respectively, and hence, the phosphate group carries a negative 
charge at physiological pH.  It is only at pH > 12 that a proton is removed 
from the 2′, 3′-diol of the ribose (Blackburn et al., 2006; Dawson et al., 
1986). 
Table 1. Nucleoside and nucleotide pKa values 
Base pKa 
[site of (de)protonation] Nucleoside Nucleotide 
adenine [N-1] 3.5 3.8 
cytosine [N-3] 4.2 4.4 
  guanine [N-1, N-7] 1.6, 9.2 2.4, 9.4 
uracil [N-3] 9.2 9.4 
hypoxanthine [N-1, N-7] 1.2, 8.9 1.5, 8.9 
2.1.3. NUCLEOTIDE METABOLISM 
In tissues such as the gut and in the immune system in which cells are 
rapidly turned over, there is a continuous requirement for production of 
nucleic acids and their constituent nucleotides.  To meet cellular demand, 
nucleotides are supplied via de novo synthesis, the salvage pathway, and 
dietary absorption (Boza and Martínez-Augustin, 2002). 
2.1.3.1 Dietary Nucleotides 
Nucleotides in the diet are ingested in the form of nucleoproteins, 
polymeric nucleotides (nucleic acids), nucleotide derivatives, and 
monomeric nucleotides.  These are digested in the gastrointestinal tract by 
proteases, nucleases, phosphatases and nucleotidases and are available 
for absorption predominantly as nucleosides; Figure 4 (Gil et al., 2007; 
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Quan et al., 1990; Sonoda and Tatibana, 1978; Thorell et al., 1996; Uauy 
et al., 1994).  
 
Only a small proportion of dietary nucleotides are incorporated directly into 
nucleotide tissue pools, with the rest converted to uric acid and other 
metabolites (Quan, 1992). 
2.1.3.2 Purine Nucleotide Biosynthesis 
The purine nucleotides are all derived from inosine 5′-monophosphate 
(IMP) (Blackburn et al., 2006; Garrett and Grisham, 1999; McMurry and 
Begley, 2005; NC-IUBMB, 2010).  The initial step in de novo IMP 
 
Figure 4. Enzymatic digestion of nucleotides to nucleosides in the gut 
(from Quan et al., 1990) 
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synthesis is the formation of 5-phosphoribosyl -diphosphate (PRPP) from 
-D-ribose 5-phosphate and ATP followed by multi-step formation of the 
purine base; Figure 5  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Biosynthesis of IMP from ribose 5′–phosphate (from McMurray 
and Begley, 2005; Garrett and Grisham, 1999) 
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The transfer of a diphosphate group from ATP to ribose-5-phosphate 
forms the -ribosyl pyrophosphate stereoisomer of PRPP.  Glutamine 
PRPP amidotransferase catalyses the subsequent transfer of an amine 
group via condensation of glutamine, followed by removal of glutamate 
from the product and involves an inversion of the configuration of the 
substituent on the C-1 of the sugar, thereby establishing the 
 configuration of the forthcoming nucleotide. 
Glycinamide ribonucleotide (GAR) is formed by the nucleophilic acyl 
substitution of glycine with phosphoribosylamine in a reaction catalysed by 
GAR synthetase.  Formylation of the amino group occurs via nucleophilic 
acyl substitution reaction catalysed by GAR transformylase whereby a 
formyl group is transferred from 10-formyltetrahydrofolate (10-formyl THF) 
to form formylglycinamide ribonucleotide (FGAR). 
The formation of the amidine formylglycinamidine ribonucleotide (FGAM) 
by reaction of FGAR with ATP and ammonia (from glutamine) is catalysed 
by FGAM synthetase.  The formation of the imidazole ring to form 
aminoimidazole ribonucleotide (AIR) is catalysed by AIR synthetase.  In 
vertebrates a single enzyme, AIR carboxylase, catalyses the addition of 
CO2 at the C-4 position of the imidazole ring giving 
carboxyaminoimidazole ribonucleotide (CAIR). 
The nucleophilic acyl substitution reaction of aspartate with CAIR to form 
N-succinylo-5-aminoimidazole-4-carboxamide ribonucleotide (SAICAR) is 
catalysed by SAICAR synthetase.  Adenylosuccinate lyase catalyses the 
elimination of fumarate from SAICAR to 5-aminoimidazole-4-carboxamide 
ribonucleotide (AICAR).  The AICAR transformylase catalysed addition of 
a formyl group from 10-formyl THF to AICAR produces 
N-formamidoimidazole-4-carboxamide ribonucleotide (FAICAR).   
The final step in the synthesis of IMP is the cyclisation of FAICAR 
catalysed by IMP cyclohydrolase.  The de novo synthesis of IMP from 
ribose 5-phosphate requires 7 moles of ATP equivalents, 2 moles of 
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glutamine, 2 moles of formate (from 10-formyl THF), and 1 mole each of 
glycine, aspartate, and CO2 (Blackburn et al., 2006; Garrett and Grisham, 
1999; McMurry and Begley, 2005; NC-IUBMB, 2010). 
From the synthesis of IMP, there is a divergence of pathways converting 
IMP to either adenosine 5′-monophosphate (AMP) or guanosine 
5′-monophosphate (GMP); Figure 6. 
 
 
 
 
 
 
 
Figure 6. Biosynthesis of GMP and AMP from IMP (from McMurray and 
Begley, 2005; Garrett and Grisham, 1999) 
 
The biosynthesis of GMP is a two-step process whereby C-2 of the inosine 
moiety is oxidised, followed by a glutamine dependent amidotransferase 
reaction replacing the oxygen with an amine group.  AMP is also derived 
from IMP in a two-step sequence whereby aspartate replaces the carbonyl 
group of inosine, followed by elimination of fumarate (Boza and Martínez-
Augustin, 2002; Garrett and Grisham, 1999; NC-IUBMB, 2010). 
Purine nucleoside di- and triphosphates are derived from corresponding 
nucleotide monophosphates via phosphate transfer from nucleotide 
triphosphates (frequently ATP) catalysed by nucleotide phosphate kinase 
and nucleoside diphosphate kinase (NC-IUBMB, 2010). 
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2.1.3.3 Regulation of Purine Nucleotide Synthesis 
The first committed step in the de novo purine biosynthetic pathway is the 
replacement of pyrophosphate at C-1 by an amine group from glutamine 
catalysed by PRPP aminotransferase; Figure 7.  
 
 
 
 
 
 
 
 
 
 
Figure 7. Feed back inhibition in purine synthesis (adapted from Garrett 
and Grisham, 1999) 
 
This step is regulated by allosteric control by feedback inhibition from 
adenosine and guanosine nucleotides.  Feedback inhibition occurs when 
an enzyme catalysing an early step in the metabolic pathway is inhibited 
by the end product of the pathway (Blackburn et al., 2006; Kornberg, 
1974). 
Biosynthesis of GMP and AMP is regulated to recognise which purine 
nucleotide is in excess and which is in short supply, whereby, the 
synthesis of AMP requires guanosine triphosphate (GTP) as a co-factor 
and conversely GMP synthesis requires ATP.  This regulation mechanism 
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ensures that AMP and GMP are in equivalent abundance (Garrett and 
Grisham, 1999; Kornberg, 1974). 
2.1.3.4 Pyrimidine Nucleotide Biosynthesis 
The pyrimidine nucleotides are all derived from uridine 5′-monophosphate 
(UMP).  The synthesis of pyrimidines differs significantly from that of 
purines in that the ring structure is assembled as a free base, not 
assembled stepwise from PRPP.  The biosynthetic pathway for 
pyrimidines is less complex than that of the purines and begins with the 
carbamoyl phosphate synthetase-II (CPS-II) catalysed formation of 
carbamoyl phosphate from bicarbonate, ATP and ammonia (from 
glutamine); Figure 8. 
The nucleophilic acyl substitution reaction of carbamoyl phosphate and 
aspartate, with phosphate as the leaving group forming carbamoyl 
aspartate, is catalysed by aspartate carbamoyltransferase.  Cyclisation 
catalysed by dihydroorotase then forms dihydroorotate; this is 
subsequently oxidised to orotate by dihydroorotate oxidase, a flavin-
dependent enzyme that uses coenzyme Q, as the ultimate electron 
acceptor.  The orotate phosphoribosyltransferase catalysed condensation 
of orotate and PRPP with elimination of inorganic pyrophosphate fixes the 
pyrimidine in the -configuration to form orotidine 5′-monophosphate 
(OMP).  The final step in UMP synthesis is the decarboxylation of OMP; 
catalysed by OMP decarboxylase.  Cytidine 5′-monophosphate (CMP) is 
not formed directly from UMP but in a series of reactions via uridine 
triphosphate (UTP) and cytidine triphosphate (CTP) (Boza and Martínez-
Augustin, 2002; Carver and Walker, 1995; Kornberg, 1974; McMurry and 
Begley, 2005). 
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Figure 8. Biosynthesis of UMP from glutamine and bicarbonate (from 
McMurray and Begley, 2005; Garrett and Grisham, 1999) 
 
UTP is derived from UMP via phosphate transfers from ATP catalysed by 
nucleoside monophosphate kinase to give uridine diphosphate (UDP), 
which in turn is phosphorylated to UTP by ATP in a reaction catalysed by 
nucleotide diphosphate kinase.  CTP is derived from amination of UTP 
catalysed by CTP synthetase (Garrett and Grisham, 1999; Kornberg, 
1974; McMurry and Begley, 2005). 
The de novo synthesis of UMP from bicarbonate and glutamine requires 2 
moles of ATP, and 1 mole each of aspartate and PRPP (Blackburn et al., 
2006; Garrett and Grisham, 1999; McMurry and Begley, 2005; NC-IUBMB, 
2010). 
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2.1.3.5 Regulation of Pyrimidine Nucleotide Synthesis 
Regulation of pyrimidine synthesis is controlled in animals at the first step 
through feedback inhibition of CPS-II by UDP and UTP.  ATP and PRPP 
are allosteric activators, whereby accumulation of these pyrimidine 
nucleotide precursors signals the need for more pyrimidine nucleotides; 
Figure 9 (Garrett and Grisham, 1999; Kornberg, 1974). 
 
 
 
 
 
 
 
 
 
Figure 9. Feed back inhibition in purine synthesis (adapted from Garrett 
and Grisham, 1999) 
2.1.3.6 The Salvage Pathway 
Biosynthesis of nucleotides de novo is expensive energetically requiring 
7 ATP equivalents per mole of IMP, and 4 ATP equivalents per mole of 
UMP.  Salvage and reuse of nucleotides is energetically more efficient 
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than de novo synthesis and requires only 1 mole ATP equivalent per mole 
UMP or IMP produced.  The salvage pathway utilises nucleobases and 
nucleosides scavenged from dietary sources or left over from cellular 
metabolism; Figures 10–11. 
 
 
 
 
 
 
 
 
Figure 10. Purine salvage pathways (adapted from la Marca et al. 2006) 
 
Salvage of nucleobases occurs via two mechanisms; one is the direct 
conversion of a nucleobase to the corresponding nucleotide catalysed by 
nucleotide pyrophosphorylase enzymes, and the other requires sequential 
conversion of the nucleobase to the nucleoside catalysed by nucleotide 
phosphorylase enzymes with subsequent phosphorylation of the 
nucleoside catalysed by a nucleoside kinase enzyme (Chu, 1991). 
Salvage of nucleotides occurs via the interconversion of nucleoside 
mono-, di-, and triphosphates in reactions catalysed by nucleoside 
monophosphate kinases and nucleoside diphosphate kinases.  In addition, 
base alteration via deamination of AMP→IMP, adenosine→inosine, and 
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inosine
RNA
GTP
GDP
GMP
guanosine
IMPXMP
xanthosine
xanthine
AMP
adenosine
ADP
ATP
cAMPcGMP
de novo synthesis
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
LITERATURE REVIEW 17 
NUCLEOTIDE BIOCHEMISTRY 
cytosine→uracil catalysed by specific enzymes readily occurs (Kornberg, 
1974). 
 
 
 
 
 
 
 
 
Figure 11. Pyrimidine salvage pathways (adapted from la Marca et al. 
2006) 
2.1.3.7 Purine Nucleotide Catabolism 
Guanosine catabolism begins with GMP conversion by 5′-nucleotidase into 
guanosine, which in turn is converted into guanine and ribose-1-phosphate 
by purine nucleoside phosphorylase, with guanine converted into xanthine 
by guanine deaminase.  Adenosine nucleotides are degraded to 
adenosine by 5′-nucleotidase.  In mammals, adenosine is not cleaved to 
its constituent base adenine, but is instead deaminated to inosine, with 
subsequent cleavage of the ribose by purine nucleoside phosphorylase to 
give hypoxanthine, which is oxidised to xanthine.  The final step of purine 
catabolism in primates is the oxidation of xanthine to uric acid, catalysed 
by xanthine oxidase.  In mammals other than primates, uric acid is 
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oxidised by urate oxidase to allantoin and excreted; Figure 12 (Garrett 
and Grisham, 1999; McMurry and Begley, 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Pathway of purine nucleotide catabolism to uric acid (from 
McMurray and Begley, 2005; Garrett and Grisham, 1999) 
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2.1.3.8 Pyrimidine Nucleotide Catabolism 
Cytidine catabolism begins with cytidine deaminase catalysed hydrolytic 
deamination to uridine.  Unlike the purine nucleosides, pyrimidine 
nucleosides undergo ring cleavage.  The catabolism of uridine starts with 
the cleavage of the ribose moiety yielding uracil, which after reduction by 
NADPH to dihydrouracil, is then hydrolysed to the open-chain 
-ureidopropionate, with further hydrolysis and decarboxylation yielding 
-alanine, ammonia and carbon dioxide; Figure 13 (Garrett and Grisham, 
1999; McMurry and Begley, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Pathway of pyrimidine nucleotide catabolism to -alanine (from 
McMurray and Begley, 2005; Garrett and Grisham, 1999) 
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2.2. Nucleosides and Nucleotides in Milk 
Non-protein nitrogen accounts for approximately 20% of the total nitrogen 
in human milk but only 2% in bovine milk (Atkinson et al., 1980; Donovan 
and Lönnerdal, 1989).  Nucleotides account for between 0.4% and 0.6% of 
non-protein nitrogen content and between 0.10% and 0.15% of the total 
nitrogen content of human milk.  From 2-12 weeks post-partum, it was 
found that as lactation advances, the contribution of nucleotide nitrogen to 
total nitrogen in milk increases (Janas and Picciano, 1982). 
The origin of nucleosides and nucleotides in milk; whether they diffuse 
from the blood into the milk via the blood-milk barrier, or are actively 
secreted from lactating cells or formed by post-secretory metabolic 
processes in milk, has not yet been established (Liao et al., 2011; 
Schlimme et al., 2000). 
The major nucleotide-related compound in bovine milk is orotic acid, a 
precursor in the synthesis of UMP, although it is not detected in human 
milk (Gil and Sánchez-Medina, 1982; Gill and Indyk, 2007b; Indyk and 
Woollard, 2004; Larson and Hegarty, 1979).  Bovine milk orotic acid levels 
increase as lactation progresses, beginning at very low levels in early 
colostrum to over 200 mol hg-1 in mid-season milk, before reducing in 
late-season milk (Gill and Indyk, 2007b).  This is in contrast to nucleoside 
and nucleotide levels, which decline rapidly with lactation.  High levels of 
dietary orotic acid leads to severely fatty livers in rats, which appear to be 
unique in this respect amongst a number of species studied.  None of the 
evidence suggests that orotic acid in milk poses a problem to human 
consumers (Durschlag and Robinson, 1980). 
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2.2.1. NUCLEOTIDES IN MILK 
Nucleotides were first isolated from human milk by Deutsch and Nilsson in 
1960, and since that time, at least 13 acid-soluble nucleotides have been 
identified (Böhles et al., 1998).  The expression of nucleotides is highest 
immediately after parturition with a general trend of decreasing amounts 
with advancing lactation and with levels stabilising by the third week of 
lactation in both human and bovine milks (Gil and Sánchez-Medina, 1981; 
Gill and Indyk, 2007b; Sugawara et al., 1995). 
This pattern of high concentration in early colostrum followed by a rapid 
decrease as lactation progresses is analogous to changes in 
concentration of other bioactive components, such as immunoglobulin.  
The presence of immunoglobulins in bovine colostrum provides passive 
immunity to the newborn calf, until maturation of its own immune system 
(Mehra et al., 2006).  Elevated levels of nucleotides present in colostrum 
may be due to their capacity to enhance immune response.  Recently, it 
was shown that dietary UMP affected the immune response of newborn 
calves and may stimulate humoral and mucosal immunity (Mashiko et al., 
2009). 
It has been generally reported that nucleotides are present in higher 
amounts in human milk compared to bovine milk (Gill and Indyk, 2007b; 
Oliveira et al., 1999; Sugawara et al., 1995).  Qualitatively, there is a clear 
difference in the nucleotide profile between mature human milk and 
mature bovine milk, the former containing measurable levels of GMP, IMP, 
UMP, CMP, and AMP, whereas the latter typically contains only CMP and 
AMP.  A survey of the free nucleotide levels that have been reported for 
milk of both species shows a wide range of results that depend, at least in 
part, on the various analytical methodologies utilised for quantitation; 
Tables 2–3.  
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
LITERATURE REVIEW 22 
NUCLEOSIDES AND NUCLEOTIDES IN MILK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
a
b
le
 2
. 
N
u
c
le
o
ti
d
e
s
 i
n
 m
a
tu
re
 b
o
v
in
e
 m
ilk
 (
a
d
a
p
te
d
 f
ro
m
 G
ill
 a
n
d
 I
n
d
y
k
 2
0
0
7
b
) 
 T
h
e
 
R
e
fe
re
n
c
e
 
K
o
b
a
ta
 e
t 
a
l.
, 
1
9
6
2
 
J
o
h
k
e
, 
1
9
6
3
 
G
il 
a
n
d
 S
á
n
c
h
e
z
-M
e
d
in
a
, 
1
9
8
1
c
 
G
il 
a
n
d
 S
á
n
c
h
e
z
-M
e
d
in
a
, 
1
9
8
1
d
 
T
ie
m
e
y
e
r 
e
t 
a
l.
, 
1
9
8
4
e
 
F
e
rr
e
ir
a
 e
t 
a
l.
, 
2
0
0
1
f  
S
u
g
a
w
a
ra
 e
t 
a
l.
, 
1
9
9
5
 
G
ill
 a
n
d
 I
n
d
y
k
, 
2
0
0
7
b
 
a
 
C
o
lla
te
d
 r
e
s
u
lt
s
 f
o
r 
m
ilk
s
 g
re
a
te
r 
th
a
n
 2
 w
e
e
k
s
 p
o
s
t 
p
a
rt
u
m
; 
a
ll 
re
s
u
lt
s
 r
o
u
n
d
e
d
 t
o
 1
 d
e
c
im
a
l 
p
la
c
e
 
b
 
A
M
P
 =
 a
d
e
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
C
M
P
 =
 c
y
ti
d
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
G
M
P
 =
 g
u
a
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
IM
P
 =
 i
n
o
s
in
e
 
 
5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
U
M
P
 =
 u
ri
d
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
c
 
Io
n
-e
x
c
h
a
n
g
e
 c
h
ro
m
a
to
g
ra
p
h
y
 
d
 
E
n
z
y
m
a
ti
c
 a
n
a
ly
s
is
 
e
 
A
d
a
p
te
d
 f
ro
m
 r
e
s
u
lt
s
 r
e
p
o
rt
e
d
 a
s
 
m
o
l 
L
-1
 
f  
A
d
a
p
te
d
 f
ro
m
 r
e
s
u
lt
s
 r
e
p
o
rt
e
d
 a
s
 m
g
 d
L
-1
 
n
d
 =
 n
o
t 
d
e
te
c
te
d
 
–
 =
 n
o
t 
m
e
a
s
u
re
d
 
 
A
n
a
ly
te
a
,b
 (
µ
m
o
l 
d
L
-1
) 
U
M
P
 
n
d
 
n
d
 
n
d
 
n
d
 
–
 
n
d
 
0
.1
 
n
d
 
IM
P
 
–
 
–
 
–
 
–
 
–
 
n
d
 
0
 
n
d
 
G
M
P
 
n
d
 
n
d
 
n
d
 
n
d
 
0
.2
 
n
d
 
n
d
 
n
d
 
C
M
P
 
0
.9
 
0
.9
–
2
.7
 
1
.2
–
4
.9
 
1
.9
–
3
.3
 
0
.3
 
3
.0
 
1
.0
 
0
.2
–
0
.3
 
A
M
P
 
n
d
 
n
d
–
0
.4
 
1
.8
–
2
.9
 
2
.0
–
2
.8
 
–
 
tr
a
c
e
 
0
.1
 
n
d
 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
LITERATURE REVIEW 23 
NUCLEOSIDES AND NUCLEOTIDES IN MILK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
a
b
le
 3
. 
N
u
c
le
o
ti
d
e
s
 i
n
 m
a
tu
re
 h
u
m
a
n
 m
ilk
 (
a
d
a
p
te
d
 f
ro
m
 G
ill
 a
n
d
 I
n
d
y
k
 2
0
0
7
b
) 
R
e
fe
re
n
c
e
 
K
o
b
a
ta
 e
t 
a
l.
, 
1
9
6
2
 
G
il 
a
n
d
 S
á
n
c
h
e
z
-M
e
d
in
a
, 
1
9
8
2
c
 
J
a
n
a
s
 a
n
d
 P
ic
c
ia
n
o
, 
1
9
8
2
d
 
S
u
g
a
w
a
ra
 e
t 
a
l.
, 
1
9
9
5
 
T
h
o
re
ll 
e
t 
a
l.
, 
1
9
9
6
e
 
G
ill
 a
n
d
 I
n
d
y
k
, 
2
0
0
7
b
 
L
ia
o
 e
t 
a
l.
, 
2
0
1
1
f  
a
 
C
o
lla
te
d
 r
e
s
u
lt
s
 f
o
r 
m
ilk
s
 g
re
a
te
r 
th
a
n
 2
 w
e
e
k
s
 p
o
s
t 
p
a
rt
u
m
; 
a
ll 
re
s
u
lt
s
 r
o
u
n
d
e
d
 t
o
 1
 d
e
c
im
a
l 
p
la
c
e
 
b
 
A
M
P
 =
 a
d
e
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
C
M
P
 =
 c
y
ti
d
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
G
M
P
 =
 g
u
a
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
IM
P
 =
 i
n
o
s
in
e
  
 
5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
U
M
P
 =
 u
ri
d
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
c
 
A
d
a
p
te
d
 f
ro
m
 r
e
s
u
lt
s
 a
t 
1
5
 d
a
y
s
, 
1
 m
o
n
th
, 
a
n
d
 3
 m
o
n
th
s
 p
o
s
t 
p
a
rt
u
m
 
d
 
A
d
a
p
te
d
 f
ro
m
 r
e
s
u
lt
s
 r
e
p
o
rt
e
d
 a
s
 m
g
 d
L
-1
 a
t 
4
, 
8
, 
a
n
d
 1
2
 w
e
e
k
s
 p
o
s
t 
p
a
rt
u
m
 
e
 
A
d
a
p
te
d
 f
ro
m
 r
a
n
g
e
 o
f 
re
s
u
lt
s
 r
e
p
o
rt
e
d
 a
s
 
m
o
l 
L
-1
 a
t 
3
–
2
4
 w
e
e
k
s
 p
o
s
t 
p
a
rt
u
m
 
f  
A
d
a
p
te
d
 f
ro
m
 r
a
n
g
e
 o
f 
re
s
u
lt
s
 r
e
p
o
rt
e
d
 a
s
 
m
o
l 
L
-1
 f
ro
m
 1
 w
e
e
k
 t
o
 9
 m
o
n
th
s
 p
o
s
t 
p
a
rt
u
m
 
n
d
 =
 n
o
t 
d
e
te
c
te
d
 
–
 =
 n
o
t 
m
e
a
s
u
re
d
 
   n
d
 =
 n
o
t 
d
e
te
c
te
d
 
–
 =
 n
o
t 
m
e
a
s
u
re
d
. 
 
A
n
a
ly
te
a
,b
 (
µ
m
o
l 
d
L
-1
) 
U
M
P
 
0
.4
 
0
.7
–
1
.3
 
1
.0
–
1
.7
 
n
d
–
0
.3
 
0
.5
–
2
.1
 
0
.2
–
0
.5
 
0
.1
–
2
.7
 
IM
P
 
–
 
–
 
0
.6
–
0
.8
 
n
d
–
0
.1
 
n
d
 
n
d
 
2
.2
–
5
.6
 
G
M
P
 
0
.2
 
n
d
–
0
.3
 
0
.3
–
0
.5
 
n
d
–
0
.1
 
0
–
0
.6
 
n
d
 
0
–
0
.3
4
 
C
M
P
 
3
.3
 
1
.8
–
2
.6
 
1
.0
–
1
.6
 
0
.3
–
4
.3
 
4
.1
–
1
0
.6
 
n
d
–
1
.9
 
0
.6
6
–
1
1
.4
 
A
M
P
 
0
.3
 
1
.5
–
2
.6
 
0
.4
–
0
.5
 
n
d
–
0
.4
 
0
.2
–
1
.9
 
n
d
 
0
.4
–
0
.8
2
 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
LITERATURE REVIEW 24 
NUCLEOSIDES AND NUCLEOTIDES IN MILK 
Nucleoside diphosphates and nucleotide sugars also contribute to the 
nucleotide pool in milks of both species (Gil and Sánchez-Medina, 1981, 
1982; Janas and Picciano, 1982; Johke, 1963; Sugawara et al., 1995).  
Significant levels of cytidine 5′-diphosphate (CDP), ranging from 6.95–
41.1 µmol dL-1 were found in a recent study of breast milk from Taiwanese 
women (Liao et al., 2011). 
Cyclic nucleotides are also present in human milk although results 
obtained show a wide range of concentrations from 0.1–0.7 nmol L-1 and 
0.01–0.15 nmol L-1 for adenosine 3′,5′-cyclic monophosphate (cAMP) and 
guanosine 3′,5′-cyclic monophosphate (cGMP), respectively.  Levels of 
cGMP were highest at the beginning of lactation and tended to decrease 
over the first fortnight, whereas levels of cAMP were relatively consistent 
throughout (Skala et al., 1981). 
The nucleotides levels in human milk are not consistent throughout each 
day but have been shown to vary in a diurnal rhythm.  This rhythmicity has 
been reported in AMP, UMP, GMP concentrations (Sánchez et al., 2009), 
and cGMP (Skala et al., 1981).  It is hypothesised that elevated nucleotide 
levels at night may induce sleep in infants (Sánchez et al., 2009). 
2.2.2. NUCLEOSIDES IN MILK 
Pyrimidine nucleosides are most abundant in mature bovine milk, whereas 
human milk has significant amounts of both purines and pyrimidine 
nucleosides; Tables 4–5.  In both human and bovine milk the nucleoside 
concentration decreases during the colostral phase and reaches a 
constant level approximately three weeks post-partum (Schlimme et al., 
2000). 
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In bovine milk, the levels of pyrimidine nucleosides are higher than purine 
nucleosides.  Uridine, while relatively high in early colostrum, decrease by 
approximately two orders of magnitude within hours post-partum, whereas 
cytidine reaches a maximum on the second day of lactation (Gill and 
Indyk, 2007b). 
Analysis of human and bovine milk by Schlimme et al. (1986a) found at 
least 10 nucleosides: uridine, cytidine, N-1-methyladenosine, inosine, N-3-
methyluridine, N-1-methylinosine, adenosine, N-2-methylguanosine, N-2-
dimethylguanosine, and N-6-carbamoyl-threonyladenosine. 
Cytidine, uridine, and adenosine are found at similar concentrations in 
most analyses of human milk, whereas guanosine is at lower 
concentrations and inosine was found only in one study (Liao et al., 2011).  
Dietary, geographical, and seasonal variations are all likely to have a 
significant influence upon nucleoside levels in the human milk (Liao et al., 
2011; Sugawara et al., 1995). 
2.2.3. TOTAL POTENTIALLY AVAILABLE NUCLEOSIDES 
IN MILK 
Leach et al. (1995) developed a method to quantify TPAN sources of 
human milk.  The TPAN method simulates enzymatic conversion of the 
various sources of nucleosides that occurs during digestion and 
absorption and hence, has the advantage of reporting a more 
representative result in terms of infant nutrition. 
The TPAN concentrations were determined in milks of both European and 
American women, with a mean concentration of 18.9 mol dL-1 and 
16.1 mol dL-1, respectively (Leach et al., 1995).  Similar results 
(20.3 mol dL-1) were obtained in a TPAN study of milk from Asian women 
(Tressler et al., 2003).  Little variation or trends in TPAN concentrations 
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were found over different stages of lactation in both studies (Leach et al., 
1995; Tressler et al., 2003).  The level of TPAN in human milk is more 
than twice the levels of nucleotides (Leach et al., 1995). 
2.3. Nutritional Effects of Nucleotides 
In times of rapid growth, the metabolic demand for nucleotides exceeds 
the capacity of de novo synthesis or the salvage pathway, and dietary 
sources of nucleotides may be essential for continued optimal metabolic 
function (Yu, 1998).  The role nucleotides play in infant nutrition has been 
reviewed comprehensively by Carver and Walker (1995) and more 
recently by Michaelidou and Steijns (2006), and by Schaller et al. (2007).  
The role nucleotides play in the immune and gastrointestinal systems was 
the focus of a recent review by Hess and Greenberg (2012). 
2.3.1. IMMUNE RESPONSE 
Nucleotide supplemented diets have been associated with enhanced 
humoral and cellular immune function, both in vitro and in vivo (Jyonouchi, 
1994).  The addition of nucleotides to infant formula provides immunologic 
benefits not available to unsupplemented infant formulas (Schaller et al., 
2007).  In particular, dietary nucleotide supplementation may be important 
for individuals at increased risk of acquiring infections such as infants, 
especially those born prematurely (Carver and Walker, 1995). 
Results reported from studies on the effect on serum immunoglobulin 
levels in infants receiving infant formula supplemented with nucleotides 
compared to those receiving unsupplemented formula are somewhat 
mixed.  Increased levels of serum immunoglobulin (Ig) A in healthy term 
infants fed nucleotide-supplemented formula (n = 166) were reported by 
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Yau et al. (2003).  Navarro et al. (1999) reported elevated levels of plasma 
IgA and IgM in a study of pre-term infants fed nucleotide-supplemented 
formula (n = 14).  In contrast to these results, no differences between 
infants fed nucleotide-supplemented or unsupplemented formula were 
found in serum levels of IgA and IgG (n = 101) (Pickering et al., 1998), IgM 
and IgE (n = 166) (Yau et al., 2003), and plasma levels of IgG (n = 14) 
(Navarro et al., 1999). 
The effect of dietary nucleotides has been shown to promote an increase 
in immune cell proliferation and may facilitate maturation in some 
lymphocyte populations similar to that of breast-fed infants (n = 138) (Buck 
et al., 2004).  A study by Carver et al. (1991) reported that at two months 
of age nucleotide-supplemented formula fed infants (n = 138) had 
significantly higher natural killer (NK) cell activity and interleukin-2 (IL2) 
levels than those receiving unsupplemented formula.  The difference 
between the two groups was only temporary however, as by four months 
of age no significant differences were found.  No effect of nucleotide 
supplementation on NK cell activity or IL2 levels was found in a similar 
study of 7-week-old infants (n = 98) by Hawkes et al. (2006).  A study of 
nucleotides supplemented to soy based infant formula (n = 94) resulted in 
no significant difference measured in NK cell levels in infants measured at 
6, 7 and 12 months of age (Cordle et al., 2002).  Unsupplemented 
soy-based formula contains high endogenous nucleotide levels rendering 
nucleotide supplementation unnecessary in contrast to bovine milk based 
formula.  The wide variation in individual results within these studies 
makes conclusions difficult with respect to any effect of nucleotide 
supplementation on NK and IL2 levels (Hawkes et al., 2006). 
Infant responses to immunisation have been used to assess development 
of the immune system.  Infants fed nucleotide-supplemented formula had 
increased Haemophilus influenzae type b (HiB) and diphtheria toxoid 
humoral antibody responses.  Antibody responses to tetanus and polio 
immunisation were not enhanced by nucleotide supplementation 
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(Pickering et al., 1998).  Yau et al. (2003) however, found no increase in 
the response to the HiB vaccine, but did measure an increased risk of 
upper respiratory tract infections in infants fed nucleotide-supplemented 
formula.  Schaller et al. (2004) found a significantly higher response to 
polio vaccine in nucleotide-supplemented formula fed infants (n = 138) 
compared to unsupplemented formula.   
Nucleotide-supplemented soy based infant formula (n = 94) showed no 
significant effect on childhood immunisation responses, as evidenced by 
normal IgA and IgG levels, and normal responses to vaccine antigens 
compared to breast-fed infants.  This may be attributable to the relatively 
high endogenous nucleotide levels in unsupplemented soy-based formula.  
However, human milk/formula-fed infants had higher poliovirus neutralising 
antibody at 12 months than soy-fed infants (Ostrom et al., 2002). 
A study of diarrhoeal disease in infants from a low socioeconomic group 
showed infants receiving nucleotide-supplemented formula (n = 141) 
experienced fewer episodes of diarrhoea, for a shorter duration, with fewer 
first episodes (Brunser et al., 1994).  Similar studies have also shown 
significant reduction in the incidences and severity of episodes of 
diarrhoea in infants fed nucleotide supplemented infant formula compared 
to the non-supplemented formula (Pickering et al., 1998; Yau et al., 2003).  
Not all studies have shown such effects, however.  Neri-Almeida et al. 
(2009) found that there was no therapeutic advantage during episodes of 
acute diarrhoea from consuming nucleotide-supplemented infant formula 
(n = 40) compared to unsupplemented formula. 
A meta-analysis of 15 randomised clinical trials studies comparing 
nucleotide-supplemented infant formula with non-supplemented formula or 
breast milk has been reported (Gutiérrez-Castrellon et al., 2007).  It was 
concluded that nucleotide-supplemented infant formula was associated 
with superior response to immunisation with the HiB vaccine, diphtheria 
toxoid and oral polio vaccine.  Additionally, episodes of diarrhoea were 
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fewer and there was no difference in risk of upper respiratory tract 
infections. 
2.3.2. INTESTINAL MICROFLORA 
In a comparison of faecal microflora of breast-fed infants and infants fed 
either nucleotide-supplemented formula (n = 11) or fed unsupplemented 
formula, breast-fed babies had significantly higher percentage of faecal 
bifidobacteria and lower percentages of lactobacilli and enterobacteria 
than either group of formula fed infants.  Infants fed nucleotide-
supplemented formula had intermediate values that were closer to breast-
fed infants (Gil et al., 1986a).  Conversely, a study by Balmer et al. (1994) 
did not confirm these observations, finding more Escherichia coli and less 
Bifidobacteria in nucleotide-supplemented infants (n = 32) than those fed 
standard infant formula.  In their review of prebiotics in human milk, Coppa 
et al. (2006) concluded that based upon available research, prebiotic 
effects of nucleotides are inconclusive. 
Results from a more recent study of infants in the United Kingdom showed 
an improved composition of gut microbiota in infants fed 
nucleotide-supplemented formula (n = 35), measured as the ratio of 
Bacteroides-Porphyromonas-Prevotella bacteria to Bifidobacteria, 
compared to the control formula, and similar to that of breast-fed infants 
(Singhal et al., 2008).  In contrast, a study on the effect of nucleotide 
supplementation in dairy calves, found that nucleotide-supplemented 
calves (n = 23) had the highest incidence of detrimental bacteria 
(Clostridium perfringens) and the lowest incidence of beneficial bacteria 
(bifidobacteria) of the calves in the study (Kehoe et al., 2008). 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
LITERATURE REVIEW 32 
NUTRITIONAL EFFECTS OF NUCLEOTIDES 
2.3.3. INTESTINAL GROWTH AND REPAIR 
Uauy et al. (1990) found increased mucosal protein, DNA, and villous 
height and disaccharidase activities in the intestine of weanling rats fed a 
diet over a 2-week period supplemented with 0.8% w/w dietary 
nucleosides (n = 10).  Moreover, López-Navarro et al. (1996) report a 
reduction in protein synthesis in the small intestine in rats fed nucleotide-
free diets (n = 10).  Following food deprivation dietary nucleotide intake 
may accelerate normal intestinal response.  Although the mechanism for 
this is not known, it is possible that increased nucleotide levels enhance 
DNA and RNA synthesis thereby enhancing cell growth and differentiation 
(Ortega et al., 1995). 
Dietary nucleotides may also be beneficial following intestinal injury with 
improved intestinal histology and ultra structure (Bueno et al., 1994), and 
increased DNA, lactase, maltase and sucrase activities (Nuñez et al., 
1990) in rats fed a nucleotide supplemented diet (n = 36) compared to rats 
fed an unsupplemented diet following diarrhoea.  Furthermore, healing of 
small bowel ulcers in rats was promoted by nucleotide supplementation 
(n = 6–18), which may be attributable to increase in cell proliferation 
(Sukumar et al., 1997). 
The intestinal epithelium has a high cell turnover rate and hence requires 
increased levels of nucleotides as precursors for nucleic acid synthesis 
(Carver, 1999; Yu, 2002).  Exogenous nucleotides may optimise tissue 
function as endogenous supplies may limit nucleic acid synthesis, 
particularly during periods of rapid growth, and during recovery from 
mucosal injury (Carver, 1999). 
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2.3.4. INFANT GROWTH 
Weight gain was observed in weanling rats receiving a low-protein diet 
supplemented with nucleotides compared to the control group, although 
this data was unpublished (György, 1971).  However, numerous clinical 
studies on healthy infants have not demonstrated any detectable effect of 
nucleotide supplementation on weight gain (Carver and Walker, 1995), 
suggesting that under normal conditions de novo nucleotide synthesis is 
sufficient to sustain normal growth (Cosgrove, 1998).  However, a study of 
term infants born severely small for gestational age (birth weight below the 
5th percentile), demonstrated enhanced growth in weight, length, and 
head circumference in the nucleotide supplemented formula group 
(n = 39).  The improved growth was attributed to tropic effects of 
nucleotides on the intestinal mucosa previously damaged by intrauterine 
malnutrition (Cosgrove et al., 1996). 
A study of severely malnourished infants showed that when fed infant 
formula with an appropriate calorie and protein content, the impact upon 
growth and other body composition indicators was favourable regardless 
of whether nucleotides were supplemented (n = 11) or not (Vásques-
Garibay et al., 2005). 
2.3.5. LIPID METABOLISM 
Supplementation of infant formula with nucleotides has been reported to 
influence plasma lipoprotein concentrations, particularly in pre-term infants 
(n = 10) (Sánchez-Pozo et al., 1994).  This differs from results obtained by 
Villarroel et al. (1987), who found no effect of nucleotide supplemented 
infant formula on serum lipoprotein levels in infants.  Siahanidou et al. 
(2004) showed pre-term infants fed nucleotide supplemented infant 
formula (n = 66) had significantly elevated high-density lipoprotein and 
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decreased low-density lipoprotein serum levels compared with infants fed 
unsupplemented formula. 
Nucleotide supplementation has also been associated with an increase in 
long-chain polyunsaturated fatty acids in plasma and erythrocytes in 
preterm and term infants (DeLucchi et al., 1987; Gil et al., 1986b; Pita 
et al., 1988) (n = 19, 35, 18, respectively).  However, other studies have 
shown no increase in long-chain polyunsaturated fatty acids production in 
erythrocytes in term and low birth-weight infants (Gibson et al., 2005; 
Woltil et al., 1995) (n = 98, 37, respectively). 
2.3.6. IRON ABSORPTION 
Inosine and its metabolites, hypoxanthine, xanthine and uric acid positively 
affect iron absorption in studies on rat intestine (n = 3–6) (Faelli and 
Esposito, 1970).  Iron is better absorbed from human milk than cow’s milk 
(McMillan et al., 1977), and it has been suggested that the relatively large 
component of nucleotides in human milk may have a biological effect on 
iron absorption (Cosgrove, 1998; Janas and Picciano, 1982).  However, 
the addition of nucleotides is reported to have no effect on the iron status 
of healthy-term infants fed low-iron formula (n = 10) (Hernell and 
Lönnerdal, 2002). 
2.4. Infant Formulas 
Human milk provides sufficient nourishment for growth as well as providing 
unique bio-immune factors for protecting infant health.  Human milk is 
therefore considered the ―gold standard‖ for infant nutrition with breast-
feeding regarded as one of the most important measures in improving 
child health (WHO, 1981).  However, in cases where breast-feeding is not 
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preferred, is not possible, or is insufficient, infant formulas are an 
appropriate substitute to breast-feeding infants during the first year of life.  
Infant formulas should be formulated to meet dietary needs and promote 
optimal growth, as well as to minimise stress upon the infants developing 
organ and enzymatic systems. 
Infant formulas fall into one of four broad categories; (1) milk-based, (2) 
whey-based, (3) milk-protein hydrolysates, and (4) soy-based.  The 
overwhelming majority of pediatric formulas are based on bovine milk or 
whey, with goat milk-based formula maintaining a niche position in the 
market.  For infants that experience intolerance of milk-based formulas, 
alternative products based on soy protein or milk-protein hydrolysates are 
available (Packard, 1982). 
2.4.1. NUCLEOTIDE SUPPLEMENTATION 
As understanding of the nucleotide composition of bovine and human milk 
has increased, manufacturers have endeavoured to modify the 
composition of infant formulas to resemble human milk more closely.  
Japan (1965) and Spain (1983) were the first countries to allow 
supplementation of nucleotides to infant formula, with the United States 
joining them in 1989 (Commission of the European Communities, 1991).  
Since the early 1990’s, nucleotides have been routinely added to infant 
formulas and to formulas manufactured specifically for pre-term infants 
since 2002 (Adamkin, 2007).  Due to the reported differences between 
bovine and human milk nucleotide levels, infant formulas are increasingly 
supplemented with nucleotides to levels equivalent to free nucleotide 
concentrations in human milk, to a maximum concentration of 
5 mg 100kcal-1 (Aggett et al., 2003).  While 12 nucleotides or more are 
present in human milk, supplementation is limited to only GMP, AMP, 
CMP, IMP and UMP in the form of the readily soluble sodium salts 
(Commission of the European Communities, 1991). 
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In recent years, numerous review articles have deliberated the evidence 
for the efficacy of nucleotide supplementation in infant formulas upon 
infant health (Adiv et al., 2004; Aggett et al., 2003; Agostini and Haschke, 
2003; Alles et al., 2004; Böhles et al., 1998; Carver, 2003; Hamosh, 1997; 
Klein, 2002; Motil, 2000; Riva et al., 2005; Schaller et al., 2007; Selimoğlu, 
2006; Yu, 2002).  Despite the purported benefits of nucleotides in infant 
nutrition, the supplementation of pediatric formulas with nucleotides is 
controversial (Adiv et al., 2004; Lerner and Shamir, 2000; Quan et al., 
1990; Yu, 2002), as unequivocal clinical evidence supporting 
supplementation is lacking (Hamosh, 1997; Lteif and Schwenk, 1998).  To 
date there have been no studies evaluating a dose-response relationship 
between nucleotide concentrations in infant formula and positive effects in 
infants (Niers et al., 2007) and more research is required into the 
appropriate levels of nucleotide supplementation and to assess the 
potential benefits (Yu, 2002).  However, infant formula products are 
currently considered safe when supplemented to levels equivalent to the 
free nucleotide levels of human milk (Gutiérrez-Castrellon et al., 2007; 
Riva et al., 2005). 
A study by Rueda et al. (2002) was undertaken to analyse extracts from 
an RNA-containing medium exposed to jejunal explants of weaning 
piglets.  Elevated levels of nucleosides found suggested that RNA present 
in human milk is hydrolysed in the intestinal tract of the breast-fed infant.  
This gives support to the argument that TPAN concentrations should be 
considered when formulating nucleotide-supplemented infant formula.  
The study by Leach et al. (1995) is cited as the rationale for advocating 
higher levels of nucleotide-supplementation in infant formulas, and in 
some respects has led to disagreement in determining the appropriate 
level of nucleotide supplementation to infant formulas.  Initially, infant 
formulas were supplemented to levels equivalent to free nucleotide 
concentrations in human milk, to a maximum concentration of 
5 mg 100kcal-1 (Aggett et al., 2003).  However, in recent years, fortification 
of infant formulas with nucleotides to the upper range of TPAN levels in 
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human milk (16 mg 100kcal-1) has been approved in more than 30 
countries (Aggett et al., 2003). 
In 2004, the Codex Committee on Nutrition and Foods for Special Delivery 
Uses asked the European Society for Pediatric Gastroenterology, 
Hepatology, and Nutrition to coordinate the formation of an international 
expert group (IEG) to find agreement on the optimum content of nutrients, 
including nucleotides, in infant formulas.  The IEG did not find sufficient 
data to support the optional addition of nucleotides to levels higher than 
5 mg 100kcal-1, and therefore recommended this as the maximum total 
content.  The recommended limits for individual nucleotides were 
2.5 mg 100kcal-1 for CMP, 1.75 mg 100kcal-1 for UMP, 1.5 mg 100kcal-1 
for AMP, 0.5 mg 100kcal-1 for GMP, and 1.0 mg 100kcal-1 IMP (Koletzko 
et al., 2005). 
Current regulations of nucleotide supplementation mandated by Codex 
have been left in the hands of individual nations (Codex Alimentarius 
Commission, 1981).  The maximum limits for nucleotides in infant formula 
defined by the IEG are recommended for use within European regulations 
(European Commission, 2003).  In Australasia, minimum limits have been 
set and maximum limits for each individual nucleotide are as those 
recommended above, curiously however, the limit for total nucleotides is 
set at proposed TPAN limits of 3.8 mg 100kJ (16 mg 100kcal-1, 
11.2 mg hg-1) (FSANZ, 2007).  Currently, nucleotides are not a regulated 
ingredient in infant formulas as specified in the US Code of Federal 
Regulations (FDA, 2012). 
In the future, it is possible that international agreement will lead to an 
update of Codex regulations that includes nucleotides.  However, 
coordinated international agreement on nucleotides has been hard to 
achieve particularly since two of the major parties, the European Union 
and the United States, have disparate views (Codex Alimentarius 
Commission, 2006; European Commission, 2003; LSRO, 1998). 
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2.4.2. ENZYMATIC DEGRADATION OF NUCLEOTIDES 
Over 70 endogenous enzymes have been identified in milk and their 
presence in milk arises from blood plasma through ―leaky junctions‖ 
between mammary cells, from secretory cell cytoplasm, from the milk fat 
globule membrane (MFGM), and from somatic cells (Fox and Kelly, 2006).  
Additionally, microbial contamination of milks introduces its own enzymes.  
These enzymes, either endogenous or microbially introduced, can 
influence the stability of nucleotide levels in dairy products.  During infant 
formula production there is a risk that exogenous nucleotides may be 
degraded by endogenous milk enzymes if the latter are not inactivated by 
heat prior to nucleotide introduction during manufacture; Figure 14. 
 
 
 
 
 
 
 
Figure 14. Time-temperature relationship of milk enzyme inactivation 
(adapted from Federal Dairy Research Centre, 1999; Richardson and 
Hyslop, 1985) 
 
Alkaline phosphatase [EC 3.1.3.1] is a phosphomonoester hydrolase with 
a wide range of substrate specificity, including nucleotides.  Since its heat 
stability profile is slightly higher than most pathogenic bacteria, residual 
bovine milk alkaline phosphatase activity is used as an indicator of the 
efficacy of pasteurisation.  Although alkaline phosphatase may be 
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inactivated initially, partial reactivation can occur after brief exposures to 
temperatures of 80–180 ºC followed by storage conditions of 4–40 ºC 
(Andrews, 1991; Shakeel-ur-Rehman et al., 2003).  Bacterial 
contamination of milk can result in the presence of microbial alkaline 
phosphatase, which is more heat resistant than bovine milk alkaline 
phosphatase (Karmas and Kleyn, 1990; Pratt-Lowe et al., 1987). 
Acid phosphatase [EC 3.1.3.2] is also a phosphomonoester hydrolase and 
although present in milk in significantly lower quantities, acid phosphatase 
is more resistant to heat treatment than alkaline phosphatase.  However, 
its substrate specificity is reportedly different from that of alkaline 
phosphatase and it does not appear to hydrolyse aliphatic 
phosphomonoesters such as adenosine 5′-monophosphate (Andrews, 
1991; Shakeel-ur-Rehman et al., 2003). 
Another phosphomonoester hydrolase for which nucleotides are 
substrates is 5′-nucleotidase [EC 3.1.3.5].  Both alkaline phosphatase and 
5′-nucleotidase are distributed in the MFGM (Andrews, 1991; Shakeel-ur-
Rehman et al., 2003).  Gill and Indyk (2007b) suggested that given that 
trace levels of intact, endogenous 5′-mononucleotides are found in raw 
milk, they might be segregated from phosphomonoester hydrolase 
enzymes in the MFGM, and hence protected as substrates from 
dephosphorylation 
In the analysis of nucleosides and nucleotides in human milk, Thorell et al. 
(1996) reported partial transformation of CMP and UMP to cytidine and 
uridine and of GMP and AMP to guanine and uric acid.  The presence of 
IMP reported in human milk by Janas and Picciano (1982) was postulated 
to be an artefact of enzymatic deamination of AMP after sample collection 
(Aggett et al., 2003; Gil and Rueda, 2000; Leach et al., 1995; Tressler 
et al., 2003). 
In a study of a retail sourced infant formula, the absence of supplemented 
nucleotides, coupled with an increase in nucleoside levels above those 
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normally expected in a bovine milk-based product, illustrated that 
dephosphorylation of nucleotides to nucleosides during manufacture had 
occurred (Gill and Indyk, 2007b).  While equivalent nutritionally, integrity of 
fortified nucleotides during manufacture is critical from a label claim and 
quality control perspective.  Further enzymatic degradation of nucleosides 
in infant formulas could lead to a complete loss of nutritional value, or even 
introduce potentially harmful compounds instead of nutritionally beneficial 
ones.  For example, dietary adenine has been shown to be nephrotoxic in 
animals when fed at high levels (Brule et al., 1988; Story et al., 1977) and 
hence the stability of supplemented AMP or adenosine should be 
documented throughout infant formula manufacture and storage (Quan 
et al., 1990). 
2.5. Analysis of Nucleosides and 
Nucleotides 
Chromatographic analysis of nucleosides and nucleotides has been the 
subject of review, the focus of which has been on analyses for clinical 
(Fallon et al., 1987; Perrett, 1986; Werner, 1993) and genomic studies 
(Brown et al., 2002).  Methods for analysis of nucleosides and nucleotides 
in milk have been reviewed by Gil and Uauy (1995) and more recently by 
Gill and Indyk (2007a). 
Due to the proliferation of nucleotide-supplemented infant formulas, 
methods incorporating minimal sample preparation and rapid 
chromatographic separations have been developed for routine product 
compliance analysis.  In general, the dominant strategy employed in 
analysis of nucleosides and nucleotides in milk and infant formulas has 
been protein removal by acid precipitation, with analysis of the crude 
extract by high performance liquid chromatography (HPLC) with ultraviolet 
(UV) detection. 
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2.5.1. SAMPLE EXTRACTION 
As milk is a highly complex biological fluid, some form of sample 
preparation is mandatory to simplify the matrix and facilitate unambiguous 
signal interpretation.  Further precautions may need to be taken before 
final analysis to ensure both signal fidelity and analyte integrity throughout 
the analytical process.  This is particularly critical in the analysis of raw 
milk, as nucleotides are susceptible to enzymatic conversions from a 
variety of endogenous enzymes (e.g., nucleotidases, nucleosidases, and 
phosphatases), which can rapidly degrade target analytes.  Therefore, it is 
important that following sampling, such potential post-secretory conversion 
of analytes be inhibited by inactivation of these enzymes immediately upon 
sample collection by such methods as acid-addition or flash freezing.  
Depending on the technique and the target analytes, prior separation of 
cellular and serum material may also be needed. 
2.5.1.1 Preparation of Crude Extracts 
Extraction of nucleosides and nucleotides from milk is usually achieved 
following initial protein precipitation with perchloric acid (PCA) or 
trichloroacetic acid (TCA).  Samples are then typically centrifuged and/or 
filtered, followed by neutralisation of the acid.  The use of PCA to obtain 
protein-free extracts has the advantage that PCA does not absorb UV 
light, although such extracts reportedly contain more residual 
UV-absorbing material than TCA extracts (Hernández and Sánchez-
Medina, 1981).  PCA offers the advantage of removal of poorly soluble salt 
KClO4 following neutralisation with KOH, however, occurrences of 
spurious chromatographic peaks from buffer salts, and loss of nucleotides, 
are risks following perchlorate precipitation (Werner, 1993). 
The extraction performed by Kobata et al. (1962) consisted of the addition 
of 2 M PCA.  After centrifugation, the precipitate was washed with 0.2 M 
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perchloric acid and the supernatants combined.  Gil and Sánchez-Medina 
(1981) utilised 1 M PCA and filtered the sample through glass wool after 
centrifugation.  Sow colostrum and milk were prepared for 
chromatographic analysis using 0.6 M PCA by Mateo et al. (2004), and 
this method was subsequently applied to canine milk and colostrum by 
Tonini et al. (2010).  The neutralisation of PCA was achieved with 
potassium hydroxide (Gil and Sánchez-Medina, 1981; Janas and Picciano, 
1982; Krpan et al., 2009; Mateo et al., 2004; Paubert-Braquet et al., 1992; 
Perrin et al., 2001) or potassium carbonate (Oliveira et al., 1999) with 
removal of precipitated potassium perchlorate.  Samples for end-point 
enzymatic analysis were adjusted to pH = 7.4–8.0 with a 0.2 M 
triethanolamine-0.16 M potassium carbonate solution (Gil and Sánchez-
Medina, 1981, 1982; Hernández and Sánchez-Medina, 1981).  Thorell 
et al. (1996) removed PCA by extraction with an equal volume of 0.5 M 
trioctylamine in 1,1,2-trichlorotrifluoroethane (Freon). 
Johke and Goto (1962) used a 10% TCA solution to remove proteins from 
cow milk and goat milk.  After centrifugation, the protein residue was 
homogenised, re-extracted, and the supernatants combined; the removal 
of excess TCA was accomplished by multiple extractions with diethyl 
ether.  A similar procedure was performed in the analysis of samples of 
human milk (Sugawara et al., 1995).  In the analysis of baby foods and 
infant formulas, a 3% TCA solution was used by Viñas et al. (2009).  A 10–
20% TCA solution employed in the analysis of cyclic nucleotides was 
neutralised with solid calcium carbonate (Skala et al., 1981). 
For the extraction of nucleotides from hypoallergenic formulas, an 
alternative protocol to the PCA extraction used for regular infant formulas 
was adopted by Perrin et al. (2001), whereby 1 M hydrochloric acid was 
added and the pH was adjusted to 7.0 with sodium hydroxide after 
centrifugation. 
Protein precipitation with acid, without neutralisation, offers the advantage 
of a rapid, simplified sample preparation.  However, there is potential for 
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losses of nucleotides with long-term storage of the nucleotides in acid 
(Perrett, 1986).  Gill and Indyk (2007b) prepared milk extracts with 3% 
acetic acid; the extracts were then centrifuged and filtered for immediate 
chromatographic analysis, with recoveries of 95–105% being reported.  
Boos et al. (1988) adjusted milk samples to pH = 4.0 with concentrated 
formic acid, stored the samples at -20 ºC for an unspecified time until 
analysis, and reported recoveries of 95–104%. 
In contrast to acid precipitation, alternative methods of deproteination have 
been described.  Tiemeyer et al. (1984) added sodium dodecyl sulfate to 
bovine milk to a final concentration of 1%; the milk was mixed with 
chloroform to eliminate proteins and lipids and centrifuged, and the upper 
layer was sampled for analysis.  Leach et al. (1995) added 1 M sodium 
hydroxide to pooled milk samples and neutralised to pH = 7.0–7.5 with 
hydrochloric acid.  Topp et al. (1993) extracted fat from samples with 
acetone:dichloromethane (9:1), discarded the supernatant, and extracted 
nucleosides from the sediment with 70% ethanol.  Proteins were then 
removed by addition of acetone and the supernatant was concentrated by 
rotary evaporator prior to analysis. 
Physical removal of proteinaceous material in infant formulas by use of 
centrifugal ultrafiltration (CUF) has been reported (Inoue et al., 2008; 
Inoue et al., 2010).  High molecular weight proteins and large peptides are 
retained by a semi-permeable membrane but low molecular weight solutes 
pass through the membrane.  This technique offers an advantage over the 
use of acid in that the risk of nucleotide loss in the protein removal step is 
reduced.  The disadvantages of this technique are that an evaluation of 
analyte recovery is required and that the tubes tend to be expensive and 
can significantly increase the cost of analysis per sample. 
The preferred sample extraction technique depends on the aim of the 
analysis.  In the first instance, it is necessary to eliminate endogenous 
enzyme activity, and second to simplify the sample matrix for further 
analysis.  For routine quantitation of nucleotides supplemented to infant 
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formula, the addition of acid followed by centrifugation of precipitated 
proteins is straightforward.  However, the stability of stored nucleotides at 
low pH is uncertain, therefore, acid neutralisation is advocated prior to 
extract storage. 
2.5.1.2 Extract Fractionation 
Further purification of protein-free extracts prior to analysis has often been 
recommended, and the early use of charcoal adsorption has been 
reported (Kobata et al., 1962; Rashid, 1973).  However, charcoal has 
variable adsorption characteristics and alternative methods of purifying 
extracts have been preferred in recent studies. 
Phenylboronate Affinity Chromatography 
The utilisation of a phenylboronate-modified affinity gel to improve the 
chromatographic selectivity of nucleosides in urine has been described 
(Davis et al., 1977; Uziel et al., 1976).  The affinity gel contains a 
phenylboronic acid bound to various solid supports via a meta-amino 
group.  The primary interaction of the phenylboronate functionality is the 
binding of 1,2 cis-diols, such as those found on the C-2 and C-3 of the 
ribose moiety of nucleosides.  This effectively separates ribose forms of 
nucleosides and nucleotides from similarly related molecules such as 
deoxyribose forms and cyclic nucleotides, which lack the required 1,2 
cis-diol moiety.  Under alkaline conditions, nucleosides are selectively 
retained as boronate complexes and released under acidic conditions; 
Figure 15 (Liu and Scouten, 2000). 
Secondary interactions such as hydrophobic effects, ionic interactions, 
hydrogen bonding, and charge transfer interactions may also play a role in 
promoting or retarding boronate cis-diol complex formation.  The purines 
tend to bind more strongly than pyrimidines, possibly due to hydrophobic 
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effects (Liu and Scouten, 2000).  Tuytten et al. (2007) illustrated that 
retention on the boronate gel is affected by mechanisms in addition to cis-
diol complexation.  The presence of an exocyclic amine group such as that 
present in adenosine and guanosine increased retention.  The lactam 
functionality found in uridine or xanthosine gives rise to reduced retention, 
postulated to be due the presence of an acidic proton, causing the 
nucleoside to be negatively charged at moderately alkaline pH, leading to 
electrostatic repulsion. 
 
 
 
 
 
 
 
 
Figure 15. Mechanism of cis-diol bonding to boronate affinity gel (adapted 
from Liu and Scouten, 2000) 
 
The presence of negatively charged phosphate groups adjacent to the 
ribose in nucleotides may reduce or prevent binding of the cis-diol 
functionality to the gel due to ionic repulsion with negatively charged 
tetrahedral boronate.  The addition of divalent ions, such as Mg2+, has 
been used to mask the negative charge from the nucleotide phosphate 
group and lessen this problem (Liu and Scouten, 2000). 
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Using a commercially available phenylboronate gel, this technique was 
applied to the analysis of human milk for the determination of nucleosides, 
with variable recoveries of 58–96% (Topp et al., 1993), and TPAN, with 
recoveries of 76–104% (Leach et al., 1995).  Perrin et al. (2001) found the 
phenylboronate gel to be unsuitable for use in the quantitative analysis of 
infant formulas, as only partial recovery of GMP, UMP, cytidine, 
guanosine, and uridine was achieved, from either infant formula or 
standard solutions. 
Reversed Phase Chromatography 
In the analysis of hypoallergenic infant formulas containing partially 
hydrolysed proteins, chromatographic analysis is more complicated due to 
the co-elution of peptides under conditions that are suitable for the 
separation of nucleotides.  A solid phase extraction (SPE) clean up 
procedure prior to chromatography was evaluated, and initial results 
obtained with a Chromabond-C18ec column showed only unspecified 
partial recovery of cytidine, guanosine, and adenosine, whereas uridine 
was not retained on the column (Perrin et al., 2001). 
Strata-X C18 SPE cartridges were used by Contreras-Sanz et al. (2012) to 
purify 12 nucleosides and nucleotides in urine and renal cells.  A 25 mM 
solution of ethanolamine was used to wash the cartridge and 30% 
methanol in 25 mM ethanolamine was used as elution solvent.  Recovery 
was evaluated at three different pH values of ethanolamine solution 
(pH = 5.0, 6.0, 7.0).  Optimal recovery was obtained at pH = 5.0 and this 
pH was chosen for use in the final method.  Excellent recovery was found 
values ranged from 98.8% to 104.4%, with the sole exception of uridine, 
which had recovery of 130.8%.  The high recovery was rationalised as 
being caused by a small peak eluting just prior to, but not resolved from, 
uridine. 
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Ion Exchange Chromatography 
Early strategies described protein-precipitated milk extracts adsorbed on 
to Dowex-1 (formate) columns, and elution with increasing concentrations 
of formic acid, ammonium formate, or sodium formate to determine 
acid-soluble nucleotides and nucleotide-sugars (Gil and Sánchez-Medina, 
1981; Johke and Goto, 1962; Kobata et al., 1962).  Subsequent removal of 
formate was achieved by freeze drying (Gil and Sánchez-Medina, 1982), 
by cation exchange (Johke and Goto, 1962), or by charcoal treatment 
(Kobata et al., 1962). 
More recently, a strong anion exchange (SAX) SPE column 
(Chromabond-SB) was evaluated with a nucleotide-spiked infant formula, 
with recoveries of individual nucleotides in the range of 92–99%, and the 
difference between duplicates of approximately 10% (Perrin et al., 2001).  
The use of two SPE columns in series reduced the differences between 
duplicates to approximately 1%, with an average recovery of 103%.  This 
study further evaluated SAX columns from different manufacturers, and 
established that two Bakerbond quaternary amine columns in series were 
optimal with repeatability of 0.8–2.7%, and recovery of individual 
nucleotides ranging from 93–113%. 
2.5.2. CHROMATOGRAPHIC ANALYSIS 
Milk of any mammalian species contains a complex mixture of nucleotides, 
nucleosides, nucleobases, and related molecular species.  Physico-
chemical analytical techniques rely on the unambiguous separation of 
these analytes following preliminary crude fractionation of the sample. 
Prior to the availability of HPLC systems, final analysis of nucleotides 
obtained from crude extracts was performed by paper chromatography 
(Hernández and Sánchez-Medina, 1981; Johke and Goto, 1962; Kobata 
et al., 1962), re-chromatography with a second low-pressure 
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chromatographic separation, and paper electrophoresis (Kobata et al., 
1962).  While gas chromatography (GC) and capillary electrophoresis (CE) 
have been employed for the analysis of nucleosides and nucleotides, in 
recent years, HPLC has become the dominant separation technique used. 
2.5.2.1 Gas Chromatography 
While chromatographic separation by GC is a rapid and sensitive 
technique, nucleotides and nucleosides need to be converted to volatile 
derivatives prior to analysis. 
The analysis of 14 nucleosides and modified nucleosides in the urine of 
cancer patients by gas chromatography-mass spectrometry (GC-MS) was 
reported by Langridge et al. (1993).  The nucleosides were isolated via a 
two-step SPE extraction procedure by means of both C18 and 
phenylboronate columns.  Trimethylsilyl (TMS) derivatives of the extracted 
nucleosides were prepared and analysed using a DB-5 capillary column 
(30 m x 0.25 mm, 0.25 m film thickness) with helium as carrier gas. 
2.5.2.2 Liquid Chromatography 
One of the great advantages of HPLC, particularly reversed-phase liquid 
chromatohraphy (RPLC) is the considerable number of parameters 
available to modify separation.  These parameters include altering the 
mobile phase pH, organic solvent content, temperature, and buffer 
concentration commensurate with the stability of the column.  The 
selection of buffer and its concentration are influenced by a number of 
factors; the pH desired, buffer solubility, and effects on detection. 
For UV, the buffer needs to be transparent at wavelengths suitable for 
detection of the analyte.  Where mass spectrometry (MS) detection is 
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used, compatible buffers are volatile to reduce maintenance and 
instrument downtime. 
Anion Exchange Chromatography 
Anion exchange liquid chromatography is a suitable technique for the 
separation of nucleotides through exploitation of the charged nature of the 
phosphate moieties over the operating range of silica (pH = 2–7).  The 
retention behaviour of nucleotides under ion-exchange chromatographic 
conditions tends to be predictable, as the prevailing mechanisms are 
largely electrostatic interactions between the negatively charged analyte 
and the positively charged stationary phase.  Thus, by varying pH, buffer 
ions, and ionic strength, retention can be manipulated (Brown et al., 2002). 
Separation of nucleotides (nucleoside mono-, di-, and triphosphates) of 
adenosine, guanosine, inosine, xanthosine, cytidine, uridine, and 
thymidine was achieved with an SAX column (Partisil 10-SAX) and an 
acidic phosphate buffer gradient (Hartwick and Brown, 1975).  This 
method was also applied in the analysis of nucleotides (nucleoside mono- 
and diphosphates) in human milk (Janas and Picciano, 1982).  Isocratic 
elution was used for the analysis of human milk by a similar approach, and 
good separation of nucleotide was achieved (Paubert-Braquet et al., 
1992).  Viñas et al. (2009), used a Tracer Extracil SAX and the mobile 
phase was a sodium phosphate buffer (10 mM, pH = 3.5) which provided 
high selectivity for four nucleotides, although the method was not applied 
to the analysis of samples that included supplemented IMP. 
Weak anion exchange chromatography was used for the analysis of a 
nucleoside analogue by LC-MS (Shi et al., 2002).  Satisfactory 
chromatographic separation was achieved for the mono-, di-, and 
triphosphorylated forms of β-D-2′,3′didehydro-2′,3′-dideoxy-5-
fluorocytosine.  Inoue et al. (2008) used a Capcellpak-NH2 column with a 
50 mM phosphate buffer optimised at pH = 4.0 for the analysis of the 
nucleotides in infant formula.  The column provides a mixed mode of 
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retention, which in addition to anion exchange properties, has significant 
reversed-phase characteristics. 
Reversed Phase Liquid Chromatography 
With the development of robust stationary phases based on porous silica 
and flexibility in mobile phase optimisation, RPLC, with or without the 
addition of ion-pair reagents, has become the method of choice for the 
analysis of nucleosides and nucleotides in milks. 
Buffer pH affects analyte retention due to dissociation properties of 
functional groups, and in its neutral form the analyte is better retained.  
When pH is near (usually ± 1.5 pH units) the functional group pKa, 
significant changes in retention are seen.  The capacity of a buffer (ability 
to resist changes in pH) is enhanced at higher concentrations leading to 
more reproducible separations of compounds.  Typically, buffer 
concentrations range from 10–50 mM.  Buffer solubility is important when 
considering gradient separations since the addition of organic solvent can 
lead to problems of buffer precipitation (Gloor and Johnson, 1977). 
The separation of nucleotides by RPLC is somewhat limited with 
conventional C18 columns due to inherently poor interaction of the polar 
analytes with the non-polar C18 phase resulting in poor retention and 
resolution.  However, by increasing the ionic strength and reducing the pH 
through the addition of acidic phosphate buffer, nucleotide 
monophosphates are adequately retained and resolved, with the order of 
elution typically correlated with hydrophobicity.  Organic solvents such as 
methanol or acetonitrile added to phosphate buffer can facilitate improved 
resolution (Fallon et al., 1987).  Additionally, recent advances in column 
technology, such as hybrid and polymer grafted columns and polar 
embedded C18 phases, offer advantages of suppressed silanol activity, 
phase stability under highly aqueous conditions, and unique selectivity 
compared with conventional C18 phases (Layne, 2002; Majors, 2004; 
Majors and Przybyciel, 2002).  In contrast, nucleosides lack the charged 
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phosphate groups present in nucleotides and are therefore relatively well 
retained on C18 phases. 
Hypoxanthine, xanthine, guanine, uridine, cytidine, pseudouridine, GMP, 
and CMP were determined in bovine milk using a -Bondapak C18 column 
with isocratic elution of a 0.01 M ammonium phosphate mobile phase 
adjusted to pH = 6.0 (Tiemeyer et al., 1984).  Human milk was analysed 
using a -Bondapak C18 column with a phosphate buffer:methanol:water 
linear gradient.  Detection of the nucleotides, nucleosides, and 
nucleobases was possible, although baseline resolution was not always 
achieved, and a second protocol was necessary to separate CMP from 
orotic acid (Thorell et al., 1996).  Quantitation of nucleosides and 
methylated nucleosides in human milk was achieved with ternary elution 
gradient of 10 mM ammonium phosphate buffer:methanol:acetonitrile 
(Topp et al., 1993). 
Derivatisation of nucleotides, nucleosides, and nucleobases has been 
reported to improve both reversed phase separation and MS responses.  
The analytes were derivatised by esterification of free hydroxyl groups 
using either propionyl or benzoyl acid anhydride.  The more hydrophobic 
derivatives exhibited enhanced retention under reversed phase conditions 
without the need for ion-pair reagents (Nordström et al., 2004).  
Elevated nucleoside and modified nucleoside levels are important 
biomarkers in cancer research, and hence the ability to accurately 
measure, low nucleoside levels is of critical importance.  Therefore, a 
number of authors have developed methods using LC-MS for the analysis 
of nucleosides and modified nucleosides in urine.  Dudley et al. (2004) and 
Bond et al. (2006) used a Spherisorb C18 column with 5 mM ammonium 
acetate and methanol gradient mobile phase system.  A similar analytical 
chromatographic system was used by Cho et al. (2006), who also 
incorporated a column switching technique in order to remove 
interferences prior to detection. 
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Nucleosides and nucleobases were analysed by LC-MS in Cordyceps 
sinensis by Fan et al. (2006) using a Zorbax Eclipse XDB-C18 column and 
an ammonium acetate buffer:methanol gradient mobile phase system, 
whereas, Guo et al. (2006) used a VP-ODS column with a higher (40 mM) 
ammonium acetate buffer content for a similar analysis. 
A reversed-phase gradient LC-MS method has been reported for the 
analysis of GMP, AMP and the corresponding cyclic nucleotides.  The 
chromatographic separation of nucleotides is poor however, and the 
selectivity of the MS detector was used to separately identify and quantify 
components (Lorenzetti et al., 2007). 
Gill and Indyk (2007b) developed a method for the simultaneous analysis 
of nucleotides and corresponding nucleosides in human and bovine milks, 
milk powders, and infant formulas using RPLC.  The separation of 
nucleotides was achieved predominantly based on increasing 
hydrophobicity.  The elution order for the corresponding nucleosides was 
the same with the exception that guanosine and inosine were reversed.  
This procedure used a polymer-grafted silica Gemini C18 column and 
gradient elution with a phosphate buffer:methanol mobile phase, 
facilitating the simultaneous analysis of nucleosides and nucleotides. 
An investigation of RPLC for the analysis of infant formulas and baby 
foods by Viñas et al. (2009) found that nucleotides were not retained on a 
Zorbax Eclipse XDB-C18 column.  This is hardly surprising however, since 
the mobile phases consisted of phosphate buffers with 30–100% 
acetonitrile. 
An LC-MS method for the analysis of supplemented nucleotides in a range 
of infant formulas was reported by Ren et al. (2011).  A reversed phase 
gradient from 100% mobile phase A (0.1% formic acid) to 100% mobile 
phase B (acetonitrile) was selected (mobile phase transition over 
7 minutes), with the best resolution achieved using a Symmetry C18 
column. 
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With the commercial availability of ultra high performance liquid 
chromatography (UHPLC), high-resolution separations with short run times 
and low solvent consumption are readily available.  This technique was 
applied to the simultaneous analysis of 14 nucleosides and nucleobases in 
fungi (Yang et al., 2007).  Ranogajec et al. (2010) assessed the retention 
of nucleosides and nucleotides on five different stationary phases.  A 
narrow-bore Synergy Hydro column was found to be the most efficacious 
to obtaining sufficient resolution and yet maintaining a relatively short run-
time.  This chromatographic method was then applied to the analysis of 
mushrooms. 
RPLC was applied to the analysis of nucleosides, nucleotides (nucleotide 
5′-monophosphates, 3′-monophosphates, and 2′-monophosphates), and 
nucleobases in animal feed supplements using an Atlantis T3 C18 column 
with a mobile phase gradient using 0.1% formic acid and 100% methanol.  
The resolution of analyte peaks was satisfactory, although significant peak 
tailing was observed (Neubauer et al., 2012). 
Ion-Pair Reversed Phase Liquid Chromatography 
Ion-pair reversed phase liquid chromatography (IPRPLC) has become the 
prevalent technique for the analysis of nucleotides in milk and pediatric 
products in recent years.  Retention of nucleotides at the appropriate pH is 
due to strong interactions between the anionic phosphate esters with 
cationic ion-pair reagents (Brown et al., 2002; Werner, 1993).  An 
alternative description of the separation mechanism is the adsorption of 
the positively charged ion-pair reagent onto the packing material, 
rendering it similar to an ion-exchange column (Fung et al., 2001).  At low 
pH, the charge increases with the number of phosphate residues and 
hence, in contrast to RPLC, nucleotide monophosphates elute first 
followed by di- and triphosphates. 
While IPRPLC offers significant advantages in chromatographic 
separation, however when coupled to LC-MS, sensitivity may be 
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compromised by ion suppression and source contamination.  Additionally, 
simultaneous detection of nucleosides and nucleotides using parallel 
positive and negative ionisation is not possible due to suppression and 
interference of added counter ions (Neubauer et al., 2012). 
A Spherisorb C18 column with tetrabutylammonium hydrogen sulfate 
(TBAHS) as ion-pair reagent and gradient elution was used for the 
analysis of nucleotides in dairy products (Ferreira et al., 2001; Oliveira 
et al., 1999).  Sugawara et al. (1995) used a Capcellpak C18 column with 
TBAHS for the analysis of nucleotides (nucleoside mono-, di-, and 
triphosphates) in breast milk from Japanese women.  A notable difference 
in elution under this protocol was the early elution of adenosine 
nucleotides, the late elution of which can, in other systems, be an 
impediment in developing assays with shorter run times.  A similar 
chromatographic system was used in the analysis of breast milk from 
Taiwanese women (Liao et al., 2011).  Contreras-Sanz et al. (2012) used 
TBAHS as ion-pair reagent with gradient elution of 12 nucleosides and 
nucleotides from urine and renal cells. 
Perrin et al. (2001) described a method based on isocratic elution with a 
mobile phase incorporating tetrabutylammonium dihydrogen phosphate as 
the ion-pair reagent, where two Nucleosil 120-C18 columns in series were 
required for adequate resolution.  A similar mobile phase was used by 
Krpan et al. (2009), although only a single C18 column (Supelcosil LC-18T) 
was sufficient to achieve the required separation. 
Alternative ion-pairing salts with more volatility have been employed 
successfully for MS detection.  Tetrabutylammonium bromide was applied 
in the analysis of cyclic nucleotides in rat brain (Witters et al., 1997).  In 
the analysis of nucleotide metabolites in bacteria, hexylamine was utilised 
as the ion-pair reagent (Coulier et al., 2006).  The LC-MS analysis of 11 
nucleotides in rat tissues was achieved using dibutylammonium formate 
(DBAA) as the ion-pair reagent (Klawitter et al., 2007).  Seifar et al. (2009) 
also used DBAA in the LC-MS analysis of nucleotides in cell cultures.  
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Pentafluorooctanoic acid was used as the ion-pair reagent in the analysis 
of Cordyceps militaris and C. sinensis by LC-MS (Yang et al., 2010). 
The ion-pair reagent most commonly used in studies of nucleotides and 
related compounds by LC-MS is N, N-dimethylhexylamine (DMHA) 
(Auriola et al., 1997; Cai, 2001; Cai et al., 2002; Cordell et al., 2008; Fung 
et al., 2001; Qian et al., 2004; Tuytten et al., 2002; Viñas et al., 2010).  
Auriola et al. (1997) reported that a higher concentration of DMHA was 
required to increase retention compared to typically used 
tetrabutylammonium salts and that 10 mM DMHA was required to obtain 
sufficient retention of nucleotides.  Similar concentrations of DMHA were 
found to be optimal by Qian et al. (2004) and Fung et al. (2001), 8 mM and 
20 mM respectively, to obtain good peak shapes and sufficient resolution.  
Reduced concentrations of DMHA were necessary when using capillary 
(0.5 mm) C18 columns (Cai et al., 2002).  Concentrations of DMHA in 
mobile phase below 0.5 mM have been shown to give poor retention of 
nucleotides.  Retention and peak shapes improved as DMHA 
concentration increased from 0.5–5 mM with only minor improvements in 
retention when the concentration was greater than 5 mM (Cordell et al., 
2008; Tuytten et al., 2002). 
The effects of DMHA containing mobile phase and pH on retention times 
and peak shapes on selected nucleotides were examined by Cordell et al. 
(2008).  Retention times generally decreased as pH decreased with peak 
shape degradation at lower mobile phase pH with nucleotides barely 
retained at pH = 3.  A mobile phase of pH = 7 was found to be optimal in 
terms of retention, resolution, and peak shape and it is this pH which is 
commonly used in chromatographic systems utilising DMHA as the ion-
pair reagent (Cai et al., 2002; Fung et al., 2001; Qian et al., 2004). 
Viñas et al. (2009) investigated the use of IPRPLC for the analysis of 
infant formulas and baby foods for nucleotides.  A Zorbax Eclipse XDB-C18 
with phosphate buffer (30 mM, pH = 4.3) containing 0.03% 
tetrabutylammonium hydroxide and different mixtures of acetonitrile (0–
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10%) was trialled.  While the best separation was achieved with 100% 
buffer, peaks were not completely resolved and peak tailing occurred.  
Variation of conditions such as mobile phase pH from 3.5–6.5; stationary 
phase, Zorbax Eclipse XDB-C8; flow rate of 0.25–1.0 mL min
-1 did not 
improve separation. 
Yamaoka et al. (2010) analysed nucleosides and nucleotides in dietary 
foods and beverages using LC-MS.  An Acquity UHPLC HSS T3 column 
was used with dimethylammonium acetate as ion-pair reagent in an 
ammonium formate buffer and acetonitrile gradient.  While good resolution 
was obtained for the nucleosides, the nucleotides tended to co-elute 
based on number of phosphate groups (i.e. the nucleotide 
monophosphates closely eluted with each other, as did the di- and 
triphosphate forms).  Before each injection, the column was pre-
conditioned using a solution containing 0.1% phosphoric acid and 100% 
acetonitrile mixed 1:1.  The pre-conditioning of the column is essential to 
obtain efficient separation and good resolution of nucleotides.  If this pre-
conditioning is not done, the peaks of nucleotides, especially triphosphate, 
will become low and broad (Kaneko, 2011).  Severe peak tailing of 
phosphorylated compounds was investigated by Wakamatsu et al. (2005) 
the cause postulated as the interaction of these compounds with stainless 
steel components of the analytical system. 
Hydrophilic Interaction Chromatography 
Hydrophilic interaction liquid chromatography (HILIC) is a separation mode 
where a polar stationary phase is enriched with a stationary water layer.  
The more polar a solute, the more it associates with the stationary phase 
and therefore the later it elutes.  That is, retention is analogous to normal 
phase chromatography and has been described as a ―reversed reversed 
phase‖ (Hemström and Irgum, 2006). 
The analysis of nucleosides and nucleotides using HILIC offers a number 
of advantages over RPLC and IPRPLC techniques, particularly when 
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applied to LC-MS analyses.  The high organic content of mobile phase 
enhances spraying and desolvation, thereby increasing signal intensity.  
The polar nucleotides are well retained without need for ion-pair reagents 
that can complicate spectra, and there is less need for gradient elution, 
thereby reducing the impact of variances of mobile phase on ion 
suppression. 
HILIC-MS has been applied to the analysis of nucleosides and 
nucleotides.  Numerous water-soluble cellular metabolites including 
nucleotides were analysed by HILIC-MS using an aminopropyl column 
with ammonium acetate (pH = 9.45) and acetonitrile gradient.  The polar 
analytes were effectively separated prior to detection (Bajad et al., 2006).  
The same column and mobile phase was used with a modified gradient by 
Pucci et al. (2009), in the determination of a modified nucleotide, 
2′-methylcytidine triphosphate, in rat liver. 
The retention of a number of nucleoside mono-, di-, triphosphates and 
nucleotide adducts was assessed using HILIC with a titania (TiO2) column.  
It was found that ligand-exchange and HILIC retention mechanisms were 
present and that HILIC was favoured at higher acetonitrile concentrations 
(Zhou and Lucy, 2008). 
Tuytten et al. (2008) describe an automated online SPE-LC-MS method 
designed for high throughput clinical laboratories to measure modified 
nucleosides biomarkers in urine.  This method comprised a boronate 
affinity clean up and HILIC separation followed by MS detection. 
The separation of cAMP and ATP was achieved using a zwitterionic HILIC 
column in an investigation of cAMP agonists (Goutier et al., 2010).  In 
method development, a column temperature of 20–50 ºC was found not to 
affect retention time of the analytes.  The ammonium bicarbonate buffer 
strengths were varied between 1–100 mM at a constant pH of 9.4, with 
10 mM selected for final analysis. 
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The separation of 12 nucleobases and nucleosides was investigated using 
HILIC by Marrubini et al. (2010).  Two columns were evaluated, a TSK-gel 
NH2-80 column and a ZIC-HILIC.  The retention of the analytes was 
studied by varying the ammonium formate concentration, the acetonitrile 
content, the pH, and column temperature.  The results obtained confirmed 
the elution order of nucleobases and nucleosides based on their 
hydrophobicity.  Retention and peak shape were influenced by the 
presence of ammonium formate at different concentrations with increasing 
retention with increasing salt concentration.  Variation in retention due to 
the mobile-phase pH (3–5) affected the TSK-gel NH2-80 column more than 
the ZIC-HILIC column.  Column temperature subtly affected retention with 
increasing temperature resulting in shorter retention times.  Gradient 
elution was necessary to achieve run times shorter than that possible with 
isocratic elution, with the ZIC-HILIC column providing full resolution of the 
12 analytes within a 60-minute run time. 
Inoue et al. (2010) describe the application of a HILIC-MS method for the 
analysis of nucleotides in infant formula.  A TSK-gel NH2-100 column was 
used with ammonium formate buffer and methanol gradient.  CMP was 
weakly retained under this system and GMP and IMP were not resolved. 
Phenylboronate Affinity Chromatography 
The development of an automated dual column system combining pre-
column affinity chromatography and RPLC for the analysis of nucleosides 
in biological fluids has been reported.  With the utilisation of an 
m-aminophenylboronic acid substituted gel and column switching, online 
dual column clean up and analysis of nucleosides in protein-free extracts 
was achieved (Schlimme et al., 1986b). 
Further development of this technique allowed for the analysis of 
proteinaceous material such as milk (Boos et al., 1988; Schlimme and 
Boos, 1990).  With a novel bonded-phase material prepared by 
immobilisation of phenylboronic acid to a size exclusion gel support, two 
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different modes of separation based on size exclusion and affinity were 
exploited and this technique was applied to the analysis of nucleosides in 
human and bovine milks (Schlimme et al., 1997; Schlimme et al., 1996).  
Martin and Schlimme (1997) reported the use of Ca2+ and Mg2+ ions 
(50 mM) to reduce the influence of the nucleotide phosphate group in the 
simultaneous analysis of nucleosides and nucleotides.  The recovery of 
AMP was highest (86–97%), but the recoveries of CMP, GMP, and UMP 
were much lower and further method optimisation is required.  Without the 
incorporation of these cations, nucleotides remained unbound to the 
column. 
Porous Graphite Chromatography 
The use of a porous graphite chromatography (PGC) coupled to MS was 
used in the analysis of > 40 nucleotide and nucleotide sugars in Chinese 
hamster ovary cells.  The use of PGC alleviated the need for ion-pair 
reagents, and satisfactory chromatographic performance was found by 
treatment of the column with reducing agent and HCl (Pabst et al., 2010). 
2.5.2.3 Capillary Electrophoresis 
Nucleotides are readily analysed by CE as they are negatively charged 
over a wide pH range.  CE methods are generally considered to be faster 
than comparable HPLC methods and use lower quantities of inexpensive 
buffer salts rather than comparatively large quantities of organic solvents.  
A review summarising CE analysis of nucleosides and nucleotides in food 
matrices has been recently published (Chen et al., 2010). 
The application of CE to analyse nucleotides has been primarily aimed at 
clinical assays (Grob et al., 2003; Qurishi et al., 2002).  The application of 
CE to the analysis of nucleotides in human breast milk was reported by 
Cubero et al. (2007). 
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CE-MS has been used for the analysis of a wide range of metabolites of 
Bacillus subtilis, including nucleosides and nucleotides (Soga et al., 2003).  
A pressure assisted capillary electrophoresis (PACE) method was 
developed and applied to the analysis of cellular cultures from Escherichia 
coli (Soga et al., 2007).  The PACE-MS technique used phosphate ions to 
precondition the capillary to mask silanol groups and prevent the 
adsorption of multi-phosphorylated analytes.  A CE-MS method was 
applied to the analysis of 12 nucleosides and nucleobases in Cordyceps 
sinensis by Yang et al. (2007). 
A CE-UV method was developed and applied to infant formula by Ding 
et al. (2011).  Excellent resolution of the five nucleotides was obtained with 
a run time of 48 min.  The accuracy of the method was evaluated by 
comparison with a published RPLC method (Gill and Indyk, 2007b) and by 
spiked recovery experiments.  The results obtained for five different infant 
formula samples obtained were similar for both methods (Table 6). 
Table 6. CE and HPLC method comparison (from Ding et al., 2011) 
Sample Methoda 
Measured results (mg hg-1) 
AMP CMP GMP IMP UMP Total 
1 
CE 2.0 10.4 1.4 –b 7.3 21.1 
HPLC 1.9 12.3 1.7 –b 8.4 24.3 
2 
CE 3.3 9.1 2.5 –b 5.0 19.9 
HPLC 3.3 10.8 2.8 –b 5.9 22.7 
3 
CE 6.3 16.3 10.3 –b 9.3 42.2 
HPLC 6.5 18.3 15.3 –b 10.0 50.1 
4 
CE 2.9 11.7 2.3 1.5 4.8 23.1 
HPLC 3.1 12.4 2.3 1.6 5.5 24.8 
5 
CE 2.4 4.1 –c 1.4 2.6 10.5 
HPLC 2.8 4.4 1.0 1.8 3.5 13.5 
a
 CE method of Ding et al., 2011 
 HPLC method of Gill and Indyk 2007b 
b
 Not detected 
c
 Detected but lower than LOQ 
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2.5.3. ULTRA-VIOLET DETECTION 
Pyrimidines and purines readily absorb light in the UV range with 
maximum absorbances typically between 240 and 270 nm (Cavalieri and 
Bendich, 1948).  However, since the chromatographic pattern of milk 
extracts is frequently complex, characterisation of putative peaks by 
retention time with detection at a single wavelength, is generally 
insufficient for unambiguous identification. 
The ratio of the absorbances at 254 and 280 nm, co-chromatography with 
authentic standards, and enzymatic conversion, were used for 
confirmation of peak identity of nucleic acid metabolites in bovine milk 
(Tiemeyer et al., 1984).  Characteristic peak shifting, or quenching, due to 
pre-chromatographic chemical or enzymatic treatments can assist in the 
identification of nucleosides and nucleotides.  After a tentative 
classification of a chromatographic peak, either a substrate-specific 
enzyme or a reagent known to modify the target analyte selectively is 
employed.  The effect is seen in the subsequent chromatogram whereby 
the putative peak disappears with the possible appearance of an 
additional peak elsewhere.  Pre-chromatographic modifications by 
enzymatic (e.g., adenosine deaminase, purine nucleoside phosphorylase) 
and chemical (e.g., periodate oxidation, Dimroth rearrangement, glyoxal 
modification, etheno-derivatisation) treatments have been utilised in the 
identification of nucleosides (Haink and Deussen, 2003; Schlimme et al., 
1997; Schlimme et al., 1996). 
In recent years, photodiode array (PDA) detectors have been increasingly 
employed for the detection and identification of nucleosides and 
nucleotides in milk (Ferreira et al., 2001; Gill and Indyk, 2007b; Oliveira 
et al., 1999; Perrin et al., 2001; Thorell et al., 1996).  The ability to 
discriminate different peaks over a range of wavelengths is particularly 
beneficial, by comparison of putative peak spectra with those of authentic 
compounds and in assessing the chromatographic peak spectral purity.  
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The use of PDA detectors also offers the advantage of optimal wavelength 
selection for multiple analytes, so that analyte absorption is maximised 
and chromatographic interferences may be minimised. 
2.5.4. MASS SPECTROMETRIC DETECTION 
MS is a powerful analytical technique that can provide both structural 
information of unknown compounds and can quantify known compounds.  
MS can be connected online to a variety of separation techniques such as 
GC, HPLC, and CE (El-Aneed et al., 2009). 
Ion sources are key components of the mass spectrometer that yield ions 
from neutral atoms or molecules.  Since different ion sources impart 
different amounts of energy to molecules during ionisation, the choice of 
ionisation mode is critical to the success of an experiment.  A number of 
ionisation techniques have been coupled to chromatographic techniques 
to analyse nucleosides and nucleotides and the applications of these in 
the early to mid 1990’s have been summarised by Esmans et al. (1998). 
In recent years, LC-MS has become widely used for both research and 
routine use in the pharmaceutical and related industries.  Due to the 
presence of one or more negatively charged phosphate groups, MS 
detection of nucleotides is frequently performed in the negative mode.  
However, detection in positive ion mode is used also, particularly for 
IPRPLC chromatographic methods where [nucleotide-adduct]+ ions are 
abundant. 
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2.5.4.1 Ionisation 
Electron Ionisation 
Electron ionisation (EI) is the oldest and one of the most commonly used 
ionisation techniques.  Molecules are ionised and fragmented by EI in a 
reproducible manner and large databases of spectra of known compounds 
are readily searchable.  However, EI is a harsh ionisation technique and is 
unsuitable for complex biomolecules since the analytes are destroyed.  
(El-Aneed et al., 2009). 
Characteristic fragment ions of TMS derivatives of nucleosides were 
obtained in the analysis of 14 nucleosides and modified nucleosides by 
GC-MS (Langridge et al., 1993).  Greater sensitivity and unambiguous 
identification through characteristic fragmentation of product ions make 
MS/MS preferable to flame ionisation detection for the analysis of 
nucleosides by GC (Schram, 1998). 
Electrospray Ionisation 
Electrospray ionisation (ESI) is an extremely effective technique for 
analysing polar compounds by MS.  Charged droplets are formed by the 
spraying of solution through an electrically charged needle, with 
evaporation and coulombic repulsion leading to release of free ions into 
the gas phase.  Since ions are generated directly from samples in solution, 
ESI is readily compatible with chromatographic separations such as CE 
and HPLC (El-Aneed et al., 2009; Niessen, 1999). 
Online chromatographic separation coupled to the sensitivity and 
selectivity of tandem mass spectrometry (MS/MS) techniques is effective 
when characterising complex mixtures that are difficult to analyse by 
standard HPLC-UV analysis.  The ―soft‖ ionisation afforded by ESI allows 
characterisation of non-volatile, thermally labile compounds with minimal 
fragmentation (Choi et al., 2001; Niessen, 1999). 
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In the LC-MS analysis of a nucleoside triphosphate analogue, ESI+ was 
used in order to overcome an interference found in ESI–, thereby 
sacrificing sensitivity for selectivity (Shi et al., 2002); however, this method 
suffers from compatibility problems between the LC and MS systems due 
to the high ionic strength of the mobiles phases. 
Ion suppression LC-MS for the analysis of cyclic nucleotides in rat tissue 
and plant leaves was found to be compatible with ESI (Witters et al., 
1996).  Quantitation of cyclic nucleotides in samples achieved a limit of 
detection (LOD) in the fmol range. 
Analysis of propionyl and benzoyl derivatives of nucleotides, nucleosides 
and nucleobases has shown that the derivatives possess better ionisation 
and ESI responses due to increased hydrophobicity and higher surface 
activity compared to the parent analyte.  A lower background noise tends 
to be found at higher molecular weights resulting in improved signal-to-
noise (S/N) (Nordström et al., 2004). 
DMHA as an ion-pair reagent was used in the development of an LC-MS 
method for the determination of 12 nucleotides, with ESI– detection 
(Tuytten et al., 2002).  It was reported that a decrease in signal intensity of 
the [M−H]− ion was seen as the concentration of DMHA was increased. 
ESI+ is more complex due to a high background from protonated DMHA 
and the presence of multiple adduct species (M+H+, M+Na+, M+K+, 
M+DMHA+H+), whereas this is not such a problem in ESI–.  While 
sensitivity is reduced, since total ion content of each compound is spread 
over a range of possible ions, the addition of the ion-pair reagent DMHA 
allows the possibility of enhancing the signal by detecting more easily 
ionised adduct ions that form between the ion-pairing agent and the 
nucleotides.  Cai et al. (2001) reported that the presence of DMHA ion-pair 
reagent enhanced protonation of nucleotides thereby enhancing ESI+ 
sensitivity.  This method was applied to the analysis of adenosine 
nucleotides in cultured cells (Qian et al., 2004). 
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The PACE-MS technique developed for the analysis of cellular cultures 
(Soga et al., 2007) used phosphate during a pre-conditioning phase with 
the nebuliser gas turned off to avoid contamination of the detector.  
Preconditioning of an UHPLC-MS system with phosphate was also used 
prior to the analysis of nucleosides and nucleotides (Yamaoka et al., 
2010). 
Nucleosides in pork were analysed by UHPLC-MS/MS by Clariana et al. 
(2010) with detection of adenosine in ESI+ mode, and detection of other 
nucleosides (guanosine, inosine, and uridine) in ESI– mode.  Quantitative 
product ions were detected from the loss of neutral ribosyl [M-132] group. 
Atmospheric Pressure Chemical Ionisation 
Atmospheric pressure chemical ionisation (APCI) combined with ESI was 
used to ionise analytes in a method to determine nucleotides in baby 
foods (Viñas et al., 2010).  While ESI is a gentler ionisation technique than 
APCI and suited to polar compounds, the coupling of ESI and APCI allows 
for a wider range of compounds to be ionised.  In positive ionisation 
modes, the spectra were more complex with high interference from the 
DMHA ion-pair reagent in the mobile phase.  Intensities of the molecular 
ions were much higher in negative mode with lower background. 
Inductively Coupled Plasma Ionisation 
Inductively coupled plasma-mass spectrometry (ICP-MS) is a technique 
for measuring elemental ions that are generated in hot plasma (6000–
8000 ºC).  A CE-ICP-MS method was developed for the analysis of 
nucleotides.  The coupling of CE with ICP-MS requires a special interface 
that introduces the sample to the plasma efficiently and does not degrade 
resolution achieved by the capillary.  Detection limits ranged from 0.036–
0.054 g mL-1 (phosphorus) and recovery ranged from 100–112% (Yeh 
and Jiang, 2002). 
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An LC-ICP-MS method was developed and applied to the analysis of 
nucleotides (nucleoside 5′-monophosphates, 3′-monophosphates, and 2′-
monophosphates) in animal feed supplements.  Phosphorus was 
measured as PO+ by use of a dynamic reaction cell.  Detection limits were 
significantly lower (>1 order of magnitude) using this technique compared 
to a complementary LC-MS/MS method (Neubauer et al., 2012). 
Matrix-Assisted Laser Desorption Ionisation 
Matrix-assisted laser desorption ionisation (MALDI) uses a pulsed laser to 
generate ions from analytes embedded in an appropriate solid matrix.  
MALDI is frequently coupled to a time-of-flight (TOF) detector and MALDI-
TOF-MS is popular for analysing both very large molecules as well as low 
molecular weight compounds.  Matrix interferences can be a problem in 
the analysis of low molecular weight compounds by the MALDI technique 
due to the similarity of molecular masses of the matrix compound and 
analyte ions (Hess et al., 1998). 
MALDI-TOF-MS has been applied to the analysis of nucleosides in urine.  
The nucleosides were extracted by affinity chromatography with 
phenylboronic acid gel, and then separated by either RPLC (Kammerer 
et al., 2005) or CE (Liebich et al., 2005).  The most suitable matrix with 
high sensitivity was found to be 2,5-dihydroxybenzoic acid (DHB).  For 
measurements with a high mass accuracy a thin layer of 
-cyano-4-hydroxycinnamic acid saturated in acetone:ethanol 50:50 v/v 
was used.  Using a DHB matrix 18 nucleosides were determined with the 
LOD from 0.1–10 pmol, with pyrimidines showing a higher LOD than 
purines (Kammerer et al., 2005). 
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2.5.4.2 Mass Analysers 
After ions have been formed by an ion source, mass analysers separate 
the ions by their mass-to charge ratio (m/z) and record relative 
abundances. 
In full-scan mode, a total ion current (TIC) plot records the total intensity 
summed across the entire range of masses being detected at every point 
in the analysis.  A TIC chromatogram often provides limited information as 
multiple analytes elute simultaneously, obscuring individual species. 
Selected ion monitoring (SIM) is used to record the abundances of specific 
ions instead of scanning the entire mass spectrum and is used in the 
quantitative analysis of known compounds to improve sensitivity.  Because 
a narrow mass range is used to collect data, SIM is more selective than 
full-scan TIC and since more time can be used to acquire a smaller mass 
range, S/N is improved. 
Quadrupole Mass Analyser 
Quadrupole instruments consist of four parallel rods, which are connected 
to direct current (DC) and radiofrequency (RF) generators.  By altering the 
DC and RF potentials, ions of certain m/z will be transmitted through the 
mass analyser to the detector, whereas ions with different m/z will possess 
a different trajectory and ultimately be eliminated prior to detection (El-
Aneed et al., 2009). 
A drawback to using a quadrupole mass analyser is that it is a scanning 
instrument; that is, it monitors a single m/z at any given time, which 
becomes an issue when scanning across a wide mass range.  Since 
quantitative analyses involve the measurement of known compounds, 
acquisition of a full mass spectrum is unnecessary, and increased signal 
can be obtained if specific ions are monitored in SIM mode (Choi et al., 
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2001).  Nucleotides and nucleotides in dietary food and beverages were 
analysed with a single quadrupole analyser by Yamaoka et al. (2010). 
A multiple reaction monitoring (MRM) experiment is accomplished by a 
tandem mass spectrometer.  In a triple quadrupole instrument, the first 
quadrupole selects a specific precursor ion, filtering out other ions with 
other m/z.  The selected ions are then collided with a neutral gas in the 
second quadrupole in a process called collision induced dissociation 
(CID).  Generated product ions are transferred into the third quadrupole 
where only a specific m/z is allowed to pass to the detector, with all other 
product ions filtered out.  Thus, MRM mode works like a double mass filter, 
and significantly increases S/N and selectivity.  MRM is a powerful tool for 
the identification of particular fragment ions in the determination of the 
molecular structure of an unknown analyte and also provides confirmation 
of identity of analyte parent ions of similar mass. 
Triple quadrupole instruments are popular instruments that use a number 
of different scanning modes, which can increase selectivity in studies of 
known analytes in complex matrices, and can achieve unambiguous 
identification of unknown analytes.  Triple quadrupole mass analysers are 
the most common detector type used in nucleoside and nucleotide 
analysis (Cai, 2001; Cohen et al., 2009; la Marca et al., 2006; Lorenzetti 
et al., 2007; Neubauer et al., 2012; Ren et al., 2011; Rodríguez-Gonzalo 
et al., 2011; Seifar et al., 2009; Shi et al., 2002; Soga et al., 2003; 
St Claire, 2000; Tuytten et al., 2002; Witters et al., 1997; Zhu et al., 2001). 
Quadrupole Ion Trap Mass Analyser 
Quadrupole ion trap mass analysers are highly sensitive instrument and 
can attain very low detection limits.  They consist of a circular ring 
electrode and two end caps.  Ions are trapped and accumulated within the 
ring and are sequentially ejected with each m/z measured.  Alternatively, a 
selected mass can be trapped and undergo CID from gas molecules within 
the trap producing fragment ions which may be then ejected, or undergo 
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further CID, producing further fragmentation.  Quadrupole ion trap 
instrumentation was used in the LC-MS/MS quantitation of nucleosides in 
human urine (Lee et al., 2004). 
Time of Flight Mass Analyser 
A TOF mass analyser accelerates ions through a potential, before they 
enter a free flight tube in which lighter ions travel faster than heavier ones 
allowing m/z ratios to be measured by arrival times at the detector.  In 
contrast to a quadrupole instrument, a TOF mass analyser is not a 
scanning instrument instead, the masses of all ions present are 
determined, and therefore sensitivity is not limited by the mass range 
making it suitable for qualitative applications (Choi et al., 2001). 
A TOF mass analyser has been used in the analysis of nucleosides in 
urine (Kammerer et al., 2005; Liebich et al., 2005), in the analysis of 
nucleotide and nucleotide sugars (Pabst et al., 2010), in the determination 
of 16 nucleosides and bases in marine organism extracts (Zhao et al., 
2011) and in the development of a method for analysis of nucleotides 
(Tuytten et al., 2004), as well as the application of a method for the 
analysis of nucleotides in baby foods (Viñas et al., 2010). 
Ion Mobility Spectrometry 
Ion mobility spectrometry separates ionised molecules by their arrival time 
at a detector.  The ions traverse a drift tube held filled with a gas at 
atmospheric pressure, rather than a vacuum.  Separation in ion mobility 
spectrometry occurs in response to ion size, ion shape, and ion charge. 
An ion-mobility spectrometer was constructed and coupled to an ESI 
source in the development of an ion mobility spectrometric method for the 
determination of 16 nucleotides and nucleosides.  Drift times and reduced 
mobility of nucleotides and nucleosides were determined and detection 
limits in the pmol range were reported (Kanu et al., 2010). 
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2.5.5. ENZYMATIC ANALYSIS 
An enzymatic assay for the determination of individual nucleotides and 
total nucleotides was developed by Hernández and Sánchez-Medina 
(1981) based on the method of Keppler (Keppler, 1974).  The method was 
applied to the analysis of cow, goat, sheep (Gil and Sánchez-Medina, 
1981), and human milks (Gil and Sánchez-Medina, 1982).  Nucleotides 
were released enzymatically from nucleotide pyrophosphates, nucleotide 
diphosphates, and nucleotide diphosphate sugars by snake venom 
phosphodiesterase and quantitatively reacted in a series of enzymatic 
reactions with measurement of the lactate-dehydrogenase catalysed 
stoichiometric decrease of NADH at 340 nm (AMP, CMP + UMP, GMP), 
with UMP determined by enzymatic conversion to UDP-glucose.  The 
recovery of AMP, CMP, GMP, and UMP was estimated at 96% with 
repeatability between determinations of less than 4%, comparing 
favourably to an ion-exchange technique (Hernández and Sánchez-
Medina, 1981). 
Determination of UDP-glucose in milk extracts was performed by a 
modification of the method of Keppler and Decker (1974), whereby an 
increase in absorption at 340 nm, due to the stoichiometric reduction of 
NAD+ to NADH catalysed by UDP-glucose dehydrogenase, was 
measured.  UDP-galactose was determined by conversion to UDP-glucose 
catalysed by UDP-glucose-hexose-1-phosphate uridylyltransferase in the 
presence of glucose-1-phosphate.  Free nucleotides were determined 
similarly, but without the phosphodiesterase hydrolysis step.  The recovery 
of UDP-glucose and UDP-galactose was estimated at 97% with a standard 
deviation between determinations of approximately 1 nmol mL-1 of milk 
(Hernández and Sánchez-Medina, 1981). 
While enzymatic techniques have been superseded by HPLC, enzyme-
based methods offer inherent advantages of analyte specificity, and aid in 
the identification of the multitude of nucleoside and nucleotide related 
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compounds.  In the TPAN analysis of human milks, a number of enzymes 
have been used to characterise the contributions of different molecular 
nucleoside sources to infant nutrition.  Polymeric nucleotides were 
hydrolyzed with nuclease, nucleotide adducts were hydrolyzed with 
pyrophosphatase, and nucleotides were dephosphorylated to nucleosides 
with phosphatase.  The enzymatic reactions employed in the TPAN 
analyses are illustrated in Figure 16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Enzymatic conversion of TPAN to free nucleosides 
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In this manner, contributions from polymeric nucleotides, monomeric 
nucleotides, nucleosides, and nucleotide adducts to TPAN were 
separately estimated (Gerichhausen et al., 2000; Leach et al., 1995).  The 
recovery of nucleosides ranged from 76% for guanosine to 104% for 
cytidine, with precision (as repeatability relative standard deviation) of 
2.0% for cytidine, guanosine, and adenosine, and 3.6% for uridine (Leach 
et al., 1995). 
Luciferase catalyses the oxidative decarboxylation of D-luciferin, and, 
when ATP is the limiting reagent, the photon count is proportional to the 
ATP present.  In bovine milk, ATP was measured enzymatically using the 
luciferase-ATP reaction, with light detection by scintillation counter 
(Richardson et al., 1980). 
2.5.6. RADIOIMMUNOASSAY 
The cyclic nucleotides cAMP and cGMP in milk were determined using a 
radioimmunoassay technique.  This assay is based upon competitive 
binding between the cyclic nucleotide and an isotopically labelled 
derivative for a specific cyclic nucleotide antibody (Skala et al., 1981; 
Steiner et al., 1972.). 
2.5.7. MICROBIOLOGICAL ASSAY 
Larson and Hegarty (1977) described a microbiological assay for the 
determination of orotic acid and pyrimidine nucleotides in ruminant milks.  
This method is of limited applicability since only pyrimidine nucleotides are 
measured and they were not individually differentiated. 
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2.6. Method Validation 
2.6.1. SYSTEM SUITABILITY 
The aim of a chromatographic analysis is an optimum separation of the 
analyte(s) from other components in the shortest time practicable.  It is 
essential that the chromatographic separation is functioning in a 
satisfactory manner for accurate and precise data to be obtained.  
Therefore, prior to validation experiments it should be established that the 
HPLC system is suitable for carrying out a particular analysis. 
A system suitability study defines a number of parameters used to assess 
chromatographic performance that may be then evaluated against set 
criteria.  These parameters include resolution, tailing, retention factor, 
theoretical plates count, and repeatability of peak response and retention 
time (Bruce et al., 1998; CDER, 1994; Shabir, 2003). 
2.6.1.1 Resolution 
Well-separated peaks with little or no overlap are crucial for dependable 
quantitative analysis.  Resolution (Rs) is a measure of the separation of 
two peaks and is therefore a critical parameter in assessing the suitability 
of a chromatographic analysis.  It is measured as a function of peak 
retention times and peak widths.  A resolution of 1.5 or greater is 
acceptable, and a resolution of less than 1.0 is deemed not useable 
(AOAC International, 2002). 
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2.6.1.2 Retention Factor 
The retention factor (k′), also called the capacity factor, is a measure of the 
retention of the peak of interest compared to a non-retained peak; that is 
the ratio of time spent for a compound in the mobile phase to the time 
spent in the stationary phase.  Modifying the retention factor is readily 
achieved by changing the mobile phase.  In RPLC, non-polar eluents have 
higher elution strength than polar eluents.  Increasing the non-polar nature 
of the mobile phase will elute peaks faster and decrease the retention 
factor.  Conversely, an increase in retention factor can be made by 
increasing the polarity of the mobile phase.  A peak should be resolved 
from interferences in the void volume and a generally accepted value is 
k′ > 2 (CDER, 1994). 
2.6.1.3 Theoretical Plate Number 
Band broadening is the extent to which molecules spread over time within 
the chromatographic system.  A more efficient chromatographic system is 
one that has less band broadening; this can be expressed numerically as 
theoretical plate number (N).  Larger values of N correspond to less band 
broadening and narrower peaks.  A generally accepted value for 
theoretical plate number is for N > 2000.  Since improvement in resolution 
is a function of the square root of N, a large change in plate number is 
required to make a small change in resolution.  Therefore, increasing the 
number of theoretical plates is often of less importance than increasing 
selectivity and retention factor (CDER, 1994). 
2.6.1.4 Tailing Factor 
Minor peak tailing is a consequence of band broadening, and hence, the 
trailing part of a peak tends to be wider than the front end.  However, 
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severely tailing peaks negatively affect the accuracy of quantitation due to 
difficulties in integration.  The determination of where a peak ends 
becomes much more subjective and hence introduces a source of error in 
peak area estimation.  The tailing factor (Tf) is a measurement of peak 
asymmetry and is calculated by comparing the relative distance of the 
leading and trailing halves of the peak. 
Significant peak tailing can be caused by number of reasons but is most 
commonly due to sample solvent strength being stronger than the mobile 
phase, silanol interaction with amines, adsorption of acidic compounds on 
silica, or void volumes in the column.  Once the cause of peak tailing is 
identified, steps can be taken to minimise it.  A recommended value for 
acceptable peak tailing is Tf  < 2 (CDER, 1994). 
2.6.1.5 Peak Retention Time/Area Repeatability 
Numerous factors can affect a chromatographic system; these include 
column temperature, mobile phase composition, injection volume, pump 
flow, detector drift, data sampling rates, and even variance in the way 
peaks are integrated.  An assessment of peak area stability is performed 
to determine whether the system is capable of reporting the same 
response for the same concentration of analyte.  Replicate injections of a 
standard are analysed to determine the repeatability of peak response 
(height or area) and retention time.  A repeatability of less than 1% is 
preferable (CDER, 1994). 
2.6.2. SINGLE LABORATORY VALIDATION 
Method validation is the process of proving that an analytical method is 
acceptable for its intended purpose (Green, 1996).  That is, an evaluation 
of the method’s reliability must be determined by a validation procedure.  
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Typically, SLV procedures usually involve linearity/range, precision, 
accuracy, limit of detection/quantitation, robustness/ruggedness, and 
specificity/selectivity studies (AOAC International, 2002; Bruce et al., 1998; 
CDER, 2001; Eurachem, 1998; Green, 1996; Thompson et al., 2002). 
2.6.2.1 Linearity 
Quantitation requires an understanding of how instrument response varies 
with concentration.  By either internal or external standard technique, a 
mathematical expression can be devised for calculating unknown analyte 
concentrations in samples.   
The correlation coefficient is widely used as an indication of a linear 
relationship between two measurements (Bruce et al., 1998; Green, 1996; 
ICH, 1996).  However, it can be misleading as a measure of linearity and 
hence, its use in not recommended and other tests for heteroscedacity are 
preferred (Analytical Methods Committee, 1988).  One of the simplest is a 
residuals plot where the differences of nominal measured values and that 
estimated by the calibration line are plotted as a function of concentration.  
If no structure is seen and random noise is small, then the calibration can 
be accepted (Bruce et al., 1998). 
2.6.2.2 Confirmation of Identity 
Matrix interferences are usually eliminated by sample extraction 
procedures.  However, residues from the sample matrix through sample 
preparation procedures may still contain compounds that interfere with the 
measurement.  Where applicable, confirmation of analyte identification can 
be achieved by comparison of the putative peak in the sample as 
compared to an authentic standard with respect to retention time (LC), 
spectral similarity and peak purity (PDA), detection of precursor 
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(molecular) ion (MS), and detection of characteristic fragment ions 
(MS/MS). 
2.6.2.3 Precision 
Repeatability is the smallest expected precision, whereby variability in 
results is estimated for a single analyst, over a short time frame.  
Intermediate precision is a useful measure of variability between analysts, 
over extended time-scale, in the same laboratory.  Reproducibility is the 
largest expected precision, whereby, variation in results is estimated for 
different analysts on different instruments, in different laboratories, on 
separate days (Eurachem, 1998).  Since reproducibility is measured over 
different laboratories, its determination requires a collaborative study. 
Several official guidelines give procedures for estimating precision (AOAC 
International, 2002, 2004; CDER, 2001; Eurachem, 1998).  The exact 
procedures for determining repeatability vary, but the principle is the same.  
A number of replicates are tested under repeatability conditions and is 
usually expressed as standard deviation (SD) or relative standard 
deviation (RSD). 
The Horwitz ratio (HorRat) has been implemented by a number of 
international technical and regulatory organisations to assess the 
acceptability of precision of a particular method.  The HorRat is a simple 
parameter that indicates the suitability of a method by comparing the 
reproducibility of the method to that of many other methods.  The HorRat 
may be applied to repeatability, although with less reliability.  Typically, the 
repeatability RSD is estimated as one-half to two thirds of reproducibility 
RSD (Horwitz and Albert, 2006), with limits of 0.3–1.3, although extreme 
values should be treated with caution (AOAC International, 2004). 
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2.6.2.4 Accuracy 
Accuracy of an analytical method is the closeness of agreement between 
the accepted true value and the measured value and can be assessed 
either as bias or recovery (Green, 1996; ICH, 1995; Snyder et al., 1997; 
Thompson et al., 2002). 
Method bias can be estimated by the analysis of a sample of known 
concentration, for example a Certified Reference Material (CRM), which 
can be obtained from standards organisations such as the National 
Institute of Standards and Technology (NIST).  Alternatively method bias 
can be determined as bias against a method known to be accurate.  This 
is particularly valuable when the method used for comparison is a 
reference method that has been assessed through a rigorous collaborative 
study, such as those reference methods published by AOAC International.  
The bias between methods is determined and a test for significance is 
performed with the null hypothesis, that there is no difference between 
methods, rejected if the p-value is less than 5%. 
In a recovery study, a sample of similar composition to a routine sample is 
analysed in its original state and after being spiked with a known amount 
of analyte.  An inherent problem with recovery studies as a measurement 
of accuracy is that the introduced analyte may not behave in the same 
manner through the analysis as analyte incorporated into the actual 
samples.  For this reason, good recovery may not necessarily be a 
guarantee of accuracy, but poor recovery is certainly a guarantee of lack 
of accuracy (Eurachem, 1998; Thompson et al., 2002).  The acceptable 
recovery range is dependent upon the sample concentration range and 
the purpose of the analysis.  As a guideline, acceptable limits have been 
proposed by AOAC International (2002).  In general, recoveries of less 
than 60–70% require further improvement, and recoveries greater than 
110% suggest a need for better separation. 
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2.6.2.5 Robustness 
A robustness trial is performed to assess the lack of influence of internal 
factors on the measured results.  The Youden ruggedness trial is an 
efficient experiment design, where seven factors can be evaluated with 
only eight analyses of one sample (AOAC International, 2002; Youden and 
Steiner, 1975).  The design is a two-level screening test in which the main 
effects of the factors are evaluated.  Higher order effects that are 
confounded with the main effects cannot be estimated separately in this 
design.  Typically, in a robustness trial, only the main effects are of 
concern and factor interactions can be considered negligible (Vander 
Heyden et al., 2001).  
The factors selected are those that are most likely to affect the analytical 
results.  They may not be limited to operational factors (explicit in the 
written procedure), but also include environmental factors (implicit in most 
procedures).  Generally, factors are studied at two extreme levels, with the 
interval between them equal to the likely variability that will occur during 
normal application of the method.  The choice of interval is a matter of 
experience; it should be noted however, that the broader the interval, the 
larger the probability that the factor will exhibit a significant effect.  
Conversely, the smaller the interval, the more likely the factor is deemed 
robust at that interval, but the more strictly it needs to be controlled during 
method use (Dejaegher and Vander Heyden, 2007). 
The results of a robustness trial can be interpreted both statistically and 
graphically.  Statistical analysis to identify critical effects consists of a 
t-test, whereby the calculated effect is compared to a critical value at a 
given level of statistical significance.  Graphical interpretation can be 
assessed by construction of a half-normal plot (measured effects vs. 
rankit), whereby non-significant effects tend to fall on a straight line 
through zero, while significant effects deviate from it (Vander Heyden 
et al., 2001).  
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2.6.2.6 Limits of Detection 
When measuring samples at low levels it is important to know the lowest 
concentration that can be detected by the method.  The instrument 
detection limit is based on visual evaluation of instrument output based on 
S/N (LOD = 3 x S/N; LOQ = 10 x S/N).  The method detection limit (MDL) 
is a value that defines how easily measurements of an analyte can be 
distinguished from background noise.  The MDL procedure sets the 
detection limit at the 99% confidence level, minimising false positive errors 
and is based upon the variability, or precision, between sample replicates 
run at identical concentrations (EPA, 1999; Su, 1998). 
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3. RESEARCH 
3.1. Nucleotide Analysis by LC-UV 
Despite the quantity of published methods, there has been no official 
internationally accepted reference method for the analysis of nucleotides 
in milk and infant formulas.  This situation has implications for international 
trade where disputes are possible. 
The aim of this study was to validate a simple, rapid, and robust method 
for routine compliance testing of nucleotide-supplemented infant formula.  
The method herein describes an SPE sample clean up that avoids the 
prior need to remove protein, coupled with a binary gradient RPLC system.  
Due to the multi-step nature of the analysis, the use of internal standard-
based quantitation provides additional confidence in analytical results.  
This technique has been applied to the analysis of bovine milk-based, 
caprine milk-based, soy-based, and hypoallergenic infant formula. 
A description of this method and the results obtained from this research 
were summarised and presented at the 123rd annual AOAC International 
conference in 2009 and subsequently published in the Journal of AOAC 
International (Gill et al., 2010) (see Appendix I, Appendix II). 
In September 2011, this method was reviewed by an expert review panel 
(ERP) convened by AOAC International.  Based on published SLV data as 
compared with the standard method performance requirements (SMPR) 
(Sullivan, 2012) established by the Stakeholder Panel on Infant Formula 
and Adult Nutritionals (SPIFAN), this method was determined to be 
acceptable and was approved for Official First Action status and identified 
as AOAC Official First Action Method 2011.20 (AOAC International, 
2012a; Gill et al., 2012a) (see Appendix II). 
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AOAC appointed the author as Study Director to evaluate the performance 
of the method in an SLV extension study against a set of infant formula 
and adult nutritional products (SPIFAN kit) that were designed to represent 
a wide range of different infant formula/adult nutritional products 
commercially available.  The SPIFAN kit covered intact protein and 
hydrolysate-based products, low and high fat products, soy protein-based, 
elemental products, used in adult nutritional (AN) and infant formulations, 
in ready-to-feed (RTF) and powder forms. 
In June 2012, an ERP evaluated the SLV extension data against the 
SMPR and in March 2013, the method was chosen ahead of another 
(AOAC International, 2012b; Inoue and Dowell, 2012) to continue to the 
next phase of validation.  This will require the determination of method 
reproducibility via a multi-laboratory collaborative study in order to become 
an AOAC Official Final Action Method. 
3.1.1. EXPERIMENTAL 
3.1.1.1 Apparatus 
HPLC separation was carried out with an LC-20AT pump, an SIL-20A 
sample injector unit equipped with a 50 L injection loop, a DGU-20A5 
degasser unit, a CTO-20AC column oven, and a SPD-M20A photodiode 
array detector.  LCSolutions software version 1.22 SP1 was used for 
instrument control and data processing (Shimadzu, Kyoto, Japan). 
Chromatographic separation was achieved with a Gemini C18, 5 m, 
4.6 mm x 250 mm column (Phenomenex, Torrance, CA).  UV absorbances 
for calibration standards were acquired with a model UV-1601 
spectrophotometer (Shimadzu) with digital readout to 4 decimal places.  A 
Meterlab PHM210 Standard pH Meter (Radiometer Analytical, Lyon, 
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France) was used for the determination of pH.  Polypropylene centrifuge 
tubes, 50 mL (Biolab, Auckland, New Zealand), 3 mL disposable syringes 
(Terumo, Laguna, Philippines), and Minisart 0.2 m syringe filters with 
cellulose acetate membranes (Sartorius, Göttingen, Germany) were used 
for sample preparation. 
SPE was performed on a Visiprep 12-port SPE vacuum manifold (Sigma-
Aldrich, St. Louis, MO) using Chromabond-SB polypropylene SAX SPE 
cartridges, 6 mL x 1000 mg (Macherey-Nagel, Düren, Germany). 
Prior to use, mobile phases were filtered and degassed using a filtration 
apparatus with 0.45 m nylon filter membranes (AllTech, Deerfield, IL). 
3.1.1.2 Reagents 
AMP (≥ 99%), CMP disodium salt (≥ 99%), GMP disodium salt hydrate 
(≥ 99%), IMP disodium salt (≥ 98%), and UMP (≥ 99%), thymidine 
5′-monophosphate (TMP) disodium salt hydrate (≥ 99%), and potassium 
bromide (≥ 99%), were purchased from Sigma-Aldrich.  Potassium 
dihydrogen phosphate, orthophosphoric acid, potassium hydroxide, 
ethylenediaminetetraacetic acid (EDTA), sodium chloride (GR ACS grade 
or equivalent), and methanol (HPLC grade) were supplied by Merck 
(Darmstadt, Germany).  Water was purified with resistivity ≥ 18 M using 
an E-pure water system (Barnstead, Dubuque, IA). 
A standardising buffer (KH2PO4, 0.25 M, pH = 3.5) was made by diluting 
34.02 g of KH2PO4 in 900 mL of water, adjusting the pH to 3.5 with 
orthophosphoric acid, and then making the solution to 1 L.  An extraction 
solution (NaCl,1 M: EDTA, 5 mM) was made by dissolving 58.5 g of NaCl 
and 1.9 g of EDTA in 1 L of water.  A wash solution (KBr, 0.3 M) was 
made by dissolving 3.57 g of KBr in 100 mL of water.  The SPE eluent 
(KH2PO4, 0.5 M, pH = 3.0) was made by dissolving 6.8 g of KH2PO4 in 
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90 mL of water, adjusting the pH = 3.0 with orthophosphoric acid, and then 
making the solution to 100 mL. 
Mobile phase A (KH2PO4, 0.1 M, pH = 5.6) was made by dissolving 13.6 g 
of KH2PO4 in 900 mL of water, adjusting the pH to 5.6 with KOH solution 
(25% w/v), and then making to 1 L with water.  Mobile phase B consisted 
of 100% methanol.  As microbial growth often occurs in phosphate buffers 
that contain little or no organic solvent at room temperature, the mobile 
phase was made fresh daily. 
3.1.1.3 Standard Solutions 
Nucleotide stock standards were prepared as described previously (Gill 
and Indykb, 2007), with concentrations measured using reported extinction 
coefficients; Table 7.  The extinction coefficient of TMP at the UV 
absorbance maximum (max) of 267 nm was determined experimentally as 
288.5 dL g-1 cm-1. 
 
Stock standards were prepared by accurately weighing approximately 
50 mg of each nucleotide into separate 50 mL volumetric flasks and 
making to volume with water.  The concentration of each nucleotide stock 
standard was determined by diluting 1.0 mL of stock standard to 50 mL 
Table 7. Nucleotide extinction coefficients 
Analyte max (nm) E
1%
1cm 
AMPa 257 430.4 
CMPa 280 398.0 
GMPa 254 393.3 
IMPa 249 357.3 
UMPa 262 313.5 
TMP 267 288.5 
a
 From Gill and Indyk, 2007b 
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with standardising buffer and measuring the absorbance at the appropriate 
max. 
An intermediate standard solution of TMP was made by diluting 4 mL of 
TMP stock standard into 50 mL of water.  A mixed intermediate standard 
solution of AMP, CMP, GMP, IMP, and UMP was made by diluting 2 mL of 
each stock standard in a single 50 mL volumetric flask and making to 
volume with water. 
Assay calibration standards were prepared by diluting the two intermediate 
standards with water to the required concentration.  The calibration 
standards contained a constant concentration of the internal standard 
TMP (~3 g mL-1) and variable concentrations (~0.5–7 g mL-1) of CMP, 
UMP, GMP, IMP, and AMP. 
3.1.1.4 Sample Preparation 
Approximately 1 g of infant formula powder was weighed accurately into a 
50 mL centrifuge tube and dissolved in 30 mL of extraction solution, 
1.0 mL of a TMP intermediate standard (~80 mg mL-1) was added, the 
tube was capped and vortex mixed.  The sample was allowed to stand for 
10 min to hydrate before dilution to a final volume of 50 mL with water. 
3.1.1.5 Solid Phase Extraction 
For each sample, a single SPE cartridge was placed on an SPE vacuum 
manifold.  The columns were conditioned by elution with 4 mL of methanol, 
followed by elution with 2 x 5 mL of water.  The cartridge was loaded with 
4 mL of sample solution at a flow rate of < 2 mL min-1.  The cartridge was 
washed (wash solution, 4 mL) to remove interferences.  The nucleotides 
were then eluted (eluent solution, 4 mL) into a test tube.  An aliquot of the 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 86 
NUCLEOTIDE ANALYSIS BY LC-UV 
eluent was filtered through a 0.2 m syringe filter into an autosampler vial 
ready for analysis. 
3.1.1.6 Chromatography 
Chromatographic separation was achieved using a modification of the 
procedure described previously (Gill and Indyk, 2007b).  Gradients were 
formed by low pressure mixing of two mobile phases, A and B, with 
separation of nucleotides achieved using the procedure shown in Table 8. 
Table 8. Gradient procedure for LC-UV method 
Time 
(min) 
Column 
temperature 
(°C) 
Flow rate 
(mL min-1) 
Phase compositiona 
%A %B 
0 20 0.5 100 0 
5 20 0.5 100 0 
14 20 0.5 90 10 
15 20 0.5 80 20 
35 20 0.5 80 20 
36 20 0.5 100 0 
50 20 0.5 100 0 
a
 Mobile phase A = KH2PO4, 0.1 M, pH = 5.6 
 Mobile phase B = 100% methanol 
3.1.1.7 Detection, Identification and Quantitation 
The photodiode array detector acquired spectral data between 210 and 
300 nm.  Integration of peak area was achieved at specific wavelengths: 
250 nm (IMP), 260 nm (AMP, GMP, and TMP), 270 nm (CMP and UMP).  
A linear regression plot of the ratios of peak area against concentration for 
each nucleotide relative to TMP was generated, and the nucleotide 
contents in unknown samples were interpolated from this calibration curve; 
Equation 3. 
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Nucleotide 
=  
1000
100
W
)V(C
L
1
A
A
S
ISIS
IS
NT 

  (Equation 3) 
(mg dL-1) 
where: ANT  =  analyte (nucleotide) peak area 
 AIS  =  internal standard (TMP) peak area 
 L  =  linear regression slope of calibration curve 
 CIS  =  concentration of internal standard in sample (µg mL
-1) 
 VIS  =  volume of internal standard in sample (µg mL
-1) 
 Ws  = weight of sample (g) 
 100  =  unit conversion (from g-1 to per hg-1) 
 1000  =  unit conversion (from g to mg) 
3.1.1.8 Modifications to Chromatography 
As part of the extended SLV evaluation of this method with the SPIFAN kit, 
minor modifications to the chromatographic procedure were made in the 
following manner. 
The potassium phosphate content in the mobile phase A was reduced, 
(KH2PO4, 10 mM, pH = 5.6), the column temperature and the flow rate 
were increased, and a more gradual gradient transition to mobile phase B 
was used; Table 9. 
Table 9. Modified gradient procedure for LC-UV method 
Time 
(min) 
Column 
temperature 
(°C) 
Flow rate 
(mL min-1) 
Phase compositiona 
%A %B 
0 40 0.6 100 0 
25 40 0.6 80 20 
26 40 0.6 100 0 
40 40 0.6 100 0 
a
 Mobile phase A = KH2PO4, 10 mM, pH = 5.6 
 Mobile phase B = 100% methanol 
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3.1.2. RESULTS AND DISCUSSION 
3.1.2.1 Method Optimisation 
Method optimisation consisted of adapting the sample preparation and 
chromatographic conditions reported previously (Gill and Indyk, 2007b) to 
accommodate a SPE step for the removal of non-nucleotide interferences, 
thereby simplifying the chromatographic separation. 
Both acid precipitation and CUF techniques to remove protein prior to SPE 
were initially evaluated.  Acid precipitation is a rapid and simple means of 
removing caseins; however, the low pH of the sample extract may 
negatively affect SPE retention unless the extract is first neutralised.  CUF 
removes all proteinaceous material above the molecular weight cut-off 
(MWCO), and the sample remains at physiological pH.  However, CUF 
was found to be an unsatisfactory means of protein removal as it proved to 
be time consuming, and it was difficult to obtain sufficient permeate for the 
subsequent SPE step. 
Based on these trials, the assumption that it was necessary to remove the 
protein prior to the SPE was re-considered.  The dissolution of a powder 
sample in the high salt solution was found to be efficacious in producing a 
uniform sample solution that, when applied directly to the SPE cartridge, 
did not compromise the recovery of nucleotides.  Residual milk protein 
content in the eluent post-SPE clean up was equivalent to that of an acid-
precipitated sample and it is probable that some caseins precipitate and 
are retained in the SPE cartridge upon addition of the low pH buffer. 
The SAX cartridges contain quaternary amine anion-exchange sites, which 
strongly attract the anionic phosphate moiety of nucleotides.  In order to 
remove the majority of interfering components in the sample, different 
aqueous wash solutions, containing a variety of anions at a number of 
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concentrations, were evaluated.  Bromide ions were found to be most 
effective in removing potentially interfering components, such as 
nucleosides, orotic acid, and uric acid, while retaining nucleotides on the 
cartridge. 
In order to elute the nucleotides from the SAX cartridge, two options were 
available.  One option was to add sufficient acid to lower the pH to the pKa 
of the nucleotide phosphate (~pH = 1), thereby neutralising the negative 
charge and eluting the nucleotides for collection.  However, in order to 
protect the analytical column, neutralisation of the extract would be 
required prior to HPLC analysis.  Alternatively, the addition of anions that 
have a high affinity for the quaternary amine and added at high ionic 
strength could be utilised to elute the nucleotides.  This was achieved by 
the addition of 0.5 M phosphate in the eluent, which readily displaces 
nucleotides bound on the SAX cartridge. 
In complex samples that require multiple clean-up steps, internal standard 
calibration is indispensable in compensating for variation of analyte 
recovery.  Internal standard calibration requires a known amount of the 
selected compound to be added to each sample, blank and standard.  
This is done to correct for potential variation of analyte recovery during 
sample preparation steps.  In the selection of an analogous compound 
suitable for use as internal standard, it is vital that it behaves in a similar 
manner as the analyte throughout all stages of the analysis.  A calibration 
curve is generated by plotting the ratio of the analyte response to the 
internal standard response as a function of the concentration of the 
standards. 
The selection of TMP as an internal standard was supported by a number 
of factors: structural similarity to analyte nucleotides, absence of 
detectable quantities in infant formulas, retention under desired 
chromatographic separation, and commercial availability. 
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3.1.2.2 Method Performance 
The use of phosphate as mobile phase buffer has been reported 
previously (Gill and Indyk, 2007b) and is commonly used in RPLC and 
IPRPLC methods (Krpan et al., 2009; Perrin et al., 2001; Viñas et al., 
2009).  The optimal pH for a given mobile phase buffer is at pH ± 1 unit of 
the pKa.  The mobile phase at pH = 5.6 is outside the optimal range 
(phosphate pKa2 = 7.21) for use as buffer.  However, the use of a number 
of other buffers such as acetate and citrate was found to give poor peak 
shape and poor repeatability of peak area and retention, a problem that 
may be attributable to the interaction of stainless steel in HPLC instrument 
with nucleotides (Tuytten et al., 2006; Wakamatsu et al., 2005).  No such 
problems were found when using phosphate as mobile phase and the 
stability of retention time illustrates its suitability for use as a mobile phase 
buffer. 
System Suitability 
Chromatographic performance was assessed by replicate analyses (n = 6) 
of a mixed nucleotide standard; Table 10.  An example of typical 
chromatography is given in Figures 17–18. 
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Performance within recommended guidelines was achieved, with the 
exception of the retention factors for CMP and UMP (guideline > 2.0); 
however, this was deemed acceptable because of uncompromised peak 
integrity of these two compounds in all samples analysed. 
Single Laboratory Validation 
A single laboratory validation study was performed on the method and 
results for linearity, precision, and detection limits are summarised in 
Table 11. 
Seven mixed standard nucleotide solutions covering the expected working 
range were analysed in duplicate.  Linearity of dose response was 
confirmed by least squares regression analysis, with acceptable values 
obtained for the correlation coefficient.  Plots of standard residuals showed 
no structure and only a small amount of random noise, further 
demonstrating linearity; Figures 19–30. 
Repeatability was determined by analysing duplicate pairs (n = 10) of 
nucleotide-supplemented bovine milk-based infant formula.  Intermediate 
precision was determined from replicate analyses (n = 20) of the same 
sample tested on five different days by two different analysts.  The 
precision was acceptable, as illustrated by repeatability HorRat of 0.2–0.6, 
and an intermediate precision RSD of 3.1–9.4%. 
The MDL was determined in accordance with EPA (1999) procedures.  
The concentrations used to generate the MDL (0.52–1.68 mg hg-1) were 
appropriate to estimate the MDL.  The MDL’s obtained are approximately 
an order of magnitude lower than the lowest levels measured in a 
nucleotide-supplemented infant formula (Gill and Indyk, 2007b). 
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Figure 19. LC-UV method: CMP linear regression plot 
 
 
 
Figure 20. LC-UV method: CMP residuals plot 
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Figure 21. LC-UV method: UMP linear regression plot 
 
 
 
Figure 22. LC-UV method: UMP residuals plot 
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Figure 23. LC-UV method: GMP linear regression plot 
 
 
 
Figure 24. LC-UV method: GMP residuals plot 
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Figure 25. LC-UV method: IMP linear regression plot 
 
 
 
Figure 26. LC-UV method: IMP residuals plot 
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Figure 27. LC-UV method: AMP linear regression plot 
 
 
 
Figure 28. LC-UV method: AMP residuals plot 
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Figure 29. LC-UV method: TMP linear regression plot 
 
 
 
Figure 30. LC-UV method: TMP residuals plot 
 
A robustness trial was performed using seven factors deemed to 
potentially affect the results and which were evaluated at levels likely to 
occur during normal use of the method.  These were concentration of salt 
in extraction solution (59 g L-1, 58 g L-1), sample wait time (12 min, 8 min), 
load volume (4.1 mL, 3.9 mL), wash solution (3.6 g dL-1, 3.5 g dL-1), wash 
y = 150494x - 455 
R² = 1.0000
0
800000
1600000
2400000
3200000
4000000
0 5 10 15 20 25
P
e
a
k
 A
re
a
Concentration (μg mL-1)
-10000
-5000
0
5000
10000
0 5 10 15 20 25
R
e
s
id
u
a
ls
Concentration (μg mL-1)
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 102 
NUCLEOTIDE ANALYSIS BY LC-UV 
volume (4.1 mL, 3.9 mL), eluent solution (pH = 3.1, pH = 2.9), and eluent 
volume (4.1 mL, 3.9 mL).  The two factor levels were symmetric around 
the nominal values from the described analytical procedure, with the 
interval representing probable experimental error.  The seven factors 
assessed were: initial sample water volume (27 mL, 23 mL); vortex time 
(40 s, 20 s); wait time (14 min, 6 min); centrifuge volume (4.2 mL, 3.8 mL); 
centrifuge speed (4000 x g, 3000 x g); centrifuge time (70 min, 50 min); 
and a dummy factor.  Statistical and graphical interpretation of the results 
shows that the method to be robust for these factors at the levels studied; 
Figures 31–35. 
 
Figure 31. LC-UV method: CMP half-normal plot 
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Figure 32. LC-UV method: UMP half-normal plot 
 
 
Figure 33. LC-UV method: GMP half-normal plot 
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Figure 34. LC-UV method: IMP half-normal plot 
 
 
Figure 35. LC-UV method: AMP half-normal plot 
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The recoveries measured were within the limits of 80–115% at the 
10 g g-1 level recommended by the AOAC (Horwitz, 2002).  Method bias 
was assessed by testing replicate samples (n = 12) of a nucleotide-
supplemented formula by the method described herein and by a method 
published previously (Gill and Indyk, 2007b).  No significant bias was 
found, with p-values (α = 0.05) calculated to be 0.079, 0.529, 0.676, 0.341, 
and 0.069 for AMP, CMP GMP, IMP, and UMP, respectively. 
3.1.2.3 Nucleotides in Infant Formulas 
The method was applied to a number of commercially available bovine 
milk-based, hydrolysed milk protein-based, caprine milk-based, and soy 
protein-based infant formulas; Table 13.  The recoveries determined 
against label claim were typically found to be > 100%, which is not 
unexpected due to the practice of overage of fortified ingredients during 
formulation and production.  In the analysis of caprine milk-based infant 
formula, the presence of significant levels of endogenous nucleotide 
diphosphates was observed. 
3.1.2.4 SLV Extension Study 
Modified Chromatography System Suitability 
Performance of the modified chromatographic system was assessed by 
replicate analyses (n = 14) of a mixed nucleotide standard; Table 14.  An 
example of typical chromatography is given in Figures 36–37.  
Performance within recommended guidelines was achieved, with the 
benefits of better resolution between critical pairs of peaks (GMP and IMP, 
TMP and AMP), an increase in retention of CMP, and an overall reduction 
in total run time with less interfering peaks near TMP and AMP retention 
times when compared with the original chromatographic procedure.  
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Single Laboratory Validation Extension 
Eight standards were prepared over the range specified in the Nucleotides 
SMPR (Sullivan, 2012).  Three replicate experiments were performed with 
standards analysed in random order.  The detector response was plotted 
against concentration and regression analysis performed; Figures 38–49.   
 
Figure 38. LC-UV method extension: CMP linear regression plot 
 
 
Figure 39. LC-UV method extension: CMP residuals plot 
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Figure 40. LC-UV method extension: UMP linear regression plot 
 
 
Figure 41. LC-UV method extension: UMP residuals plot 
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Figure 42. LC-UV method extension: GMP linear regression plot 
 
 
Figure 43. LC-UV method extension: GMP residuals plot 
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Figure 44. LC-UV method extension: IMP linear regression plot 
 
 
Figure 45. LC-UV method extension: IMP residuals plot 
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Figure 46. LC-UV method extension: AMP linear regression plot 
 
 
Figure 47. LC-UV method extension: AMP residuals plot 
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Figure 48. LC-UV method extension: TMP linear regression plot 
 
 
Figure 49. LC-UV method extension: TMP residuals plot 
 
Linearity of dose response was confirmed by least squares regression 
analysis, with correlation coefficients of >0.9995.  Plots of standard 
residuals showed no structure and only a small amount of random 
variability, also confirming linearity of the method. 
The instrument LOD and LOQ were determined and the standard 
concentrations were converted to sample concentrations on powder and 
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RTF liquid basis; Table 15.  The measured limit of quantitation of 
0.017 mg dL-1 is less than that specified in the SMPR of 0.02 mg dL-1, and 
correspond well with the MDLs reported previously (0.06–0.19 mg hg-1) 
(Gill et al., 2010). 
Table 15. LC-UV method extension: limit of detection and quantitation 
 
Analytea 
CMP UMP GMP IMP AMP 
LOD as dry weight (mg hg
-1
) 0.04 0.04 0.04 0.04 0.04 
LOQ as dry weight (mg hg
-1
) 0.13 0.14 0.13 0.13 0.13 
LOD as liquid (mg dL
-1
)b 0.005 0.005 0.005 0.005 0.005 
LOQ as liquid (mg dL
-1
)b 0.017 0.017 0.017 0.017 0.017 
a
 AMP = adenosine 5′-monophosphate 
 CMP = cytidine 5′-monophosphate 
 GMP = guanosine 5′-monophosphate 
 IMP = inosine 5′-monophosphate 
 UMP = uridine 5′-monophosphate 
b
 RTF calculated on 25g/200mL concentration basis as per SMPR 
LOD = limit of detection; LOQ = limit of quantitation 
 
Repeatability was evaluated in various infant formula products and 
assessed in a sample (low fat adult nutritional powder) spiked at the 
concentrations specified in the SMPR; Table 16. 
Repeatability for the method in typical samples ranges for 1.2–4.1% RSD 
with a HorRat of 0.4–0.9, within the expected range of 0.3–1.3.  
Repeatability was poorest in the milk-based infant formula RTF liquid, due 
to the low unfortified concentrations close to the MDL. 
For the adult nutritional sample spiked with nucleotides at higher 
concentrations (1 and 5 mg dL-1) repeatability ranged from 1.1–2.8%, well 
below the limit of 6% set in the SMPR.  The repeatability for the 
0.1 mg dL-1 concentration was 0.3–2.5% below the limit of 8% set in the 
SMPR.  The lowest concentration (0.02 mg dL-1) is near the limit of 
quantitation for this method and the poorer repeatability for GMP and AMP 
(13.1%) reflects this with values above the limit of 10% set in the SMPR. 
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Table 16. LC UV method extension: repeatability 
Sample 
Repeatabilitya,b 
CMP UMP GMP IMP AMP 
Milk-based IF powder 
1.2% 
(0.4) 
2.0% 
(0.6) 
1.8% 
(0.5) 
1.8% 
(0.5) 
1.8% 
(0.6) 
NIST1849a CRM 
2.1% 
(0.9) 
2.1% 
(0.8) 
2.0% 
(0.8) 
– 
1.8% 
(0.6) 
Milk-based IF powder 
1.2% 
(0.4) 
1.3% 
(0.4) 
2.0% 
(0.5) 
– 
1.7% 
(0.5) 
Milk-based IF RTF liquidc 
3.1% 
(0.8) 
2.6% 
(0.5) 
3.6% 
(0.7) 
– 
4.1% 
(0.9) 
AN powderd spiked to 
0.16 mg hg-1 
5.2% 
(0.7) 
3.2% 
(0.4) 
13.1% 
(1.8) 
5.9% 
(0.3) 
13.1% 
(1.8) 
AN powderd spiked to 
0.8 mg hg-1 
1.6% 
(0.3) 
2.5% 
(0.4) 
0.3% 
(0.1) 
1.7% 
(0.3) 
2.3% 
(0.4) 
AN powderd spiked to 
8 mg hg-1 
1.6% 
(0.4) 
1.3% 
(0.3) 
2.1% 
(0.5) 
1.5% 
(0.4) 
1.8% 
(0.4) 
AN powderd spiked to 
40 mg hg-1 
1.3% 
(0.4) 
2.8% 
(0.9) 
1.1% 
(0.4) 
1.6% 
(0.5) 
2.7% 
(0.9) 
a
 AMP = adenosine 5′-monophosphate; CMP = cytidine 5′-monophosphate; GMP = 
 guanosine 5′-monophosphate; IMP = inosine 5′-monophosphate; UMP = uridine 
 5′-monophosphate 
b Percent relative standard deviation (HorRat) 
c Endogenous levels near the limit of quantitation 
d
 Concentration spiked to a low fat adult nutritional powder 
IF = infant formula; CRM = certified reference material; RTF = ready-to-feed liquid;  
AN = adult nutritional 
– Not detected 
 
Intermediate precision for the method in nucleotide-supplemented samples 
was estimated between 3.0–5.7%; Table 17.  In a nucleotide-
unsupplemented infant formula RTF liquid sample, intermediate precision 
was poorest for UMP with 14.9% RSD, due to the low unfortified 
concentrations that were measured at or below the limit of quantitation. 
 
 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 119 
NUCLEOTIDE ANALYSIS BY LC-UV 
Table 17. LC-UV method extension: intermediate precision 
Sample 
Intermediate precisiona (RSD%) 
CMP UMP GMP IMP AMP 
Milk-based IF powder 4.3 5.7 3.8 3.0 4.1 
NIST1849a CRM 4.7 5.3 3.3 – 4.5 
Milk-based IF powder 4.1 5.1 4.6 – 4.9 
Milk-based IF RTF liquidb 5.5 14.9 5.3 – 5.8 
a
 AMP = adenosine 5′-monophosphate 
 CMP = cytidine 5′-monophosphate 
 GMP = guanosine 5′-monophosphate 
 IMP = inosine 5′-monophosphate 
 UMP = uridine 5′-monophosphate 
b 
Endogenous levels near the limit of quantitation 
– Not detected 
IF = infant formula 
CRM = certified reference material 
RTF = ready-to-feed liquid 
 
Recovery was evaluated in a range of different matrices from products in 
the SPIFAN kit.  Recovery was also evaluated in a single SPIFAN matrix 
(low fat adult nutritional powder) at each of the four concentrations levels 
as defined in the SMPR; Table 18. 
Recovery for samples spiked at 50% and 150% of typical concentrations 
were between 91.6–106.4%.  Recovery at three of the concentration levels 
defined in the SMPR (0.1, 1, 5 mg dL-1) were 92.5–103.4%.  The fourth 
and lowest concentration (0.02 mg dL-1) had recoveries of 91.3–124.7%, 
outside the 90–110% limit specified.  Since this concentration is near the 
limit of quantitation, higher uncertainty in results and a wider range of 
recoveries was observed. 
 
 
 
 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 120 
NUCLEOTIDE ANALYSIS BY LC-UV 
Table 18. LC-UV method extension: recovery 
Sample 
Recoverya,b (%) 
CMP UMP GMP IMP AMP 
Milk-based IF powderb 103 102 96.5 103 94.2 
AN milk protein-based powderb 98.3 92.8 104 99.3 97.7 
IF p/h milk-based powderb 101 94.1 106 96.5 106 
IF p/h soy-based powderb 99.3 103 96.7 95.7 97.0 
AN low fat powderb 103 98.0 102 102 95.3 
Child formula powderb 100 94.6 100 102 91.6 
Infant elemental powderb 97.8 100 104 97.9 98.0 
IF milk-based powderb 99.9 97.3 102 103 97.7 
IF milk-based RTF liquidb 101 96.9 102 101 101 
IF soy-based powderb 96.5 97.6 99.2 98.8 106 
AN high protein RTF liquidb 96.3 98.6 101 101 102 
AN high fat RTF liquidb 97.2 95.2 100 97.3 98.2 
AN powderc spiked to 
0.16 mg hg-1 
115 91.3 102 91.8 125 
AN powderc spiked to 
0.16 mg hg-1 c,d 
96.5 94.8 102 94.0 103 
AN powderc spiked to  
8 mg hg-1 
99.8 92.5 101 98.4 99.6 
AN powderc spiked to  
40 mg hg-1 
102 91.9 102 99.9 102 
a
 AMP = adenosine 5′-monophosphate; CMP = cytidine 5′-monophosphate; GMP = 
 guanosine 5′-monophosphate; IMP = inosine 5′-monophosphate; UMP = uridine 
 5′-monophosphate. 
b
 Mean of independent duplicate measurements for samples spiked at 50% and  150% 
 of typical concentration. 
c
 Mean recovery of independent triplicate measurements for spiked low fat adult 
 nutritional powder. 
IF = infant formula; AN = adult nutritional; RTF = ready-to-feed liquid; p/h = partially 
hydrolysed 
 
Bias was evaluated by replicate measurement of the NIST1849a CRM; 
Table 19.  Results vary somewhat from the tight limits expressed in the 
Certificate of Analysis.  At the 95% level of confidence, the reference 
values for UMP, GMP, and AMP are within the confidence interval of the 
measured data indicating no bias in the measured results, whereas CMP 
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is outside the confidence interval indicating the there is a bias between the 
reference value and the measured results. 
Table 19. LC-UV method extension: bias vs. CRM values 
Sample 
Resultsa (mg hg
-1
) 
CMP UMP GMP AMP 
Mean 28.0 12.5 14.9 10.8 
Standard deviation 1.3 0.6 0.5 0.5 
p–value (α=0.05, n=12, df=11) 0.01 0.07 0.06 0.11 
NIST1849a valueb 26.8 12.9 14.6 10.5 
CRM uncertainty 0.29 0.15 0.11 0.53 
Lower confidence limit 27.1 12.1 14.6 10.4 
Upper confidence limit 28.8 12.9 15.2 11.1 
a
 AMP = adenosine 5′-monophosphate; CMP = cytidine 5′-monophosphate; GMP = 
 guanosine 5′-monophosphate; IMP = inosine 5′-monophosphate; UMP = uridine 
 5′-monophosphate 
b
 nucleotide values for NIST1849a are reference values only and not certified 
α = level of significance, n = number of replicates, df = degrees of freedom 
 
Selectivity was assessed by determining chromatographic characteristics 
of retention time stability, peak asymmetry, capacity factor, resolution and 
peak purity for a nucleotide supplemented milk-based infant formula, and 
results are shown in Table 20. 
Table 20. LC-UV method extension: selectivity 
Nucleotide 
Retention 
Time (min) 
Asymmetry 
Capacity 
Factor 
Resolution 
3 point 
Peak 
Purity 
CMP 7.2 1.3 0.8 3.6 0.9995 
UMP 9.6 1.2 1.4 6.9 0.9997 
GMP 14.9 1.0 2.7 12.5 0.9997 
IMP 16.4 1.0 3.1 3.0 0.9996 
TMP 22.6 1.0 4.7 15.7 0.9998 
AMP 23.9 1.0 5.0 4.6 0.9999 
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3.2. Total Potentially Available Nucleosides 
in Milk 
The development of the TPAN method has been an important contribution 
to further understanding of the distribution of nucleosides and nucleotides 
in human milk.  However, the application of the TPAN methodology to the 
analysis of milk of species other than human has not been published 
previously.  The purpose of the first study was to analyse bovine milk to 
determine the relative contributions of nucleosides and different nucleotide 
forms to TPAN and determine how these varied over the first month of 
lactation.  A second study was then undertaken to assess the relative 
nucleoside and nucleotide contributions to TPAN in bovine, caprine, and 
ovine milk. 
A description of this method and results obtained from this research were 
summarised and presented at the 124th annual AOAC International 
conference in 2010 and subsequently published in the International Dairy 
Journal (Gill et al., 2011; Gill et al., 2012b) (see Appendix I, Appendix II). 
3.2.1. EXPERIMENTAL 
The enzymatic digestion and phenylboronate affinity sample clean-up 
steps of the TPAN analysis was performed in accordance with the method 
of Leach et al. (1995) as demonstrated by Molitor (2008). 
Oligonucleotides from RNA are released to nucleotide monophosphates 
by the phosphodiesterase, nuclease P1; nucleotides from adducts are 
converted by nucleotide pyrophosphatase; and nucleotides are 
dephosphorylated to nucleosides by alkaline phosphatase. 
Following enzymatic digestion, the free nucleosides are extracted from the 
reaction mixture using a boronate-derivatised gel and are separated 
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chromatographically by reversed-phase chromatography.  The TPAN 
value is obtained by summation of nucleosides measured through all 
enzyme treatments while speciation is determined from results obtained 
from individual enzyme treatments; Figure 50. 
3.2.1.1 Apparatus 
Milk samples were collected in disposable polypropylene containers 
(120 mL) and stored in disposable polypropylene centrifuge tubes (50 mL) 
supplied by Biolab.  Measurement of pH was achieved using a Meterlab 
PHM210 standard pH meter from Radiometer Analytical.  Samples were 
centrifuged using a Varifuge 3.0 centrifuge (Heraeus, Newport Pagnell, 
UK).  Syringe filtering of sample extracts was achieved using 3 mL 
disposable syringes (Terumo) and 0.22 m Millex MCE syringe filters 
(Millipore, Billerica, MA).  Sample treatment was performed in glass Kimax 
tubes (10 mL) with teflon-lined screw caps (Kimble-Chase, Vineland, NJ). 
The HPLC system used consisted of a SCL-10Avp system controller, 
LC-10ADvp pump, FCV-10ALvp low pressure gradient unit, SIL-10AF 
sample injector unit equipped with a 50 L injection loop, DGU-14A 
degasser unit, CTO-10ASvp column oven, and a SPD-M10Avp photodiode 
array detector (Shimadzu).  Class-vp software version 6.12 was used for 
instrument control and data processing.  The column used for HPLC 
analysis was a Prodigy C18 column, 5 m, 4.6 mm x 150 mm 
(Phenomenex). 
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3.2.1.2 Reagents 
Ado (≥ 99%), Cyd (≥ 99%), Guo (≥ 98%), Ino (≥ 99%), Urd (≥ 99%), 
5-methylcytidine  (5mCyd) (≥ 99%), 8-bromoguanosine (≥ 99%), uridine 
5′-diphosphoglucose (≥ 98%), RNA, cytidine 5′-diphosphocholine (≥ 99%), 
-nicotinamide adenine dinucleotide (≥ 99%), AMP (≥ 99%), CMP 
disodium salt (≥ 99%), GMP disodium salt hydrate (≥ 99%), UMP (≥ 99%); 
potassium acetate, zinc sulphate heptahydrate, and magnesium chloride 
hexahydrate (GR ACS grade or equivalent); pyrophosphatase, nuclease 
P1, and alkaline phosphatase, were purchased from Sigma-Aldrich.  The 
boronate affinity gel (Affi-gel 601) was purchased from Bio-Rad (Hercules, 
CA).  Glacial acetic acid, sodium hydroxide, dipotassium hydrogen 
phosphate, 85% phosphoric acid, 37% hydrochloric acid, potassium 
hydroxide, 30% ammonium hydroxide (GR ACS grade or equivalent), and 
methanol (HPLC grade) were supplied by Merck.  Water was purified to a 
resistivity ≥18 M using an E-pure water system (Barnstead).   
The alkaline phosphatase was tested for possible adenosine deaminase 
activity before use (Gehrke and Kuo, 1989; Molitor, 2008).  A 5 mg dL-1 
solution of adenosine was incubated with alkaline phosphatase under 
conditions described below (see 3.2.1.4 below) and no deamination of 
adenosine to inosine was found (recovery 94.8%). 
Solutions containing enzymes were prepared in the following manner:  
Nuclease P1 solution was made by adding sodium acetate (0.1 M, 
pH = 5.1, 4 mL) directly to the vial from the supplier containing ~1.2 mg of 
protein, followed by capping the vial and gently mixing.  Pyrophosphatase 
solution was made by adding ammonium acetate (0.5 M, pH = 8.5, 4 mL) 
directly to the vial from the supplier containing ~11 mg of protein, followed 
by capping the vial and gently mixing.  Alkaline phosphatase supplied as a 
suspension in 2.5 M (NH4)2SO4. 
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Stock nucleoside standard solutions (~1 mg mL-1) were prepared by 
adding ~50 mg of the nucleosides, uridine, cytidine, guanosine, inosine, 
adenosine, 5-methylcytidine, and 8-bromoguanosine to separate 50 mL 
volumetric flasks and making to volume with water.  A working internal 
standard solution (~100 µg mL-1) was made by pipetting 5 mL each of 
5-methylcytidine and 8-bromoguanosine stock internal standard solution 
into a 50 mL volumetric flask and making to volume with water. 
The boronate affinity gel was hydrated by adding the contents of a 5 g vial 
of Affi-gel 601 to a 100 mL beaker with a stir bar containing potassium 
phosphate (0.1 M, 50 mL) and left stirring for two hours.  After hydrating, 
350 L aliquots of slurry were transferred to 2 mL snap cap 
microcentrifuge tubes, which were then stored in the freezer at < -15 ºC for 
later use. 
Mobile phase A (NaCH3COO, 0.05 M, pH = 4.8) was made by dissolving 
4.10 g of NaCH3COO in 900 mL of water, adjusting the pH to 4.8 with 
acetic acid solution (25% w/v), and then making to 1 L with water.  Mobile 
phase B consisted of 100% methanol. 
3.2.1.3 Sample Collection and Storage 
Milk samples were collected from two herds of Jersey cows from two 
separate farms (9 km apart) in the eastern Waikato region of New Zealand 
(Figure 51).  From each herd, seven cows were selected to provide milk 
for analysis.  The first herd was a winter-milk herd with the first cow calving 
on the 24th March 2008 (early autumn) and the final one calving on the 
18th of April 2008.  The second herd was a summer-milk herd with the first 
one calving on the 1st August 2009 (late winter) and the final one calving 
on the 7th August 2009.  Cows selected for inclusion in this study were 
chosen because calving occurred between 6:00 and 10:00 am, provided 
they were healthy cows in their second or subsequent calving and had 
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normal calvings with no complications.  With the exception of the 6-hour 
sample, sample collection was performed in the morning between 6:00 
and 10:00 am, which coincided with regular milking times. 
 
Figure 51. Map of the Waikato region of New Zealand (source: Google 
Maps) 
 
From each cow, approximately 80 mL of milk/colostrum was collected in a 
120 mL disposable container by the farmer.  These were collected at 
various time intervals throughout the first month of lactation, more 
frequently in the beginning and less so as the month progressed.  The 
scheduled collection times were: 
 parturition + 0 hours 
 parturition + 6 hours 
 parturition + 24 hours 
 parturition + 2 days 
 parturition + 3 days 
 parturition + 5 days 
Hamilton
Morrinsville
Tauranga
Summer Milk Herd
Winter Milk Herd
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 parturition + 10 days 
 parturition + 20 days 
 parturition + 30 days 
 
Milk/colostrum samples were collected from the cows at the appropriate 
time and immediately refrigerated at 4 ºC.  The sample was then picked-
up from the farm as soon as practicable (within 6 hours), taken to the 
laboratory, and immediately prepared for storage.   
Upon return to the laboratory, each sample mixed by hand, and then 
divided into four separate 50 mL centrifuge tubes.  A 20 mL aliquot was 
taken for proximate testing, protein by Kjeldahl (IDF, 2001) and total solids 
by microwave gravimetric analysis (IDF, 1987).  A 10 mL aliquot was taken 
and prepared for storage for later TPAN analysis, with the remainder of 
milk sample frozen intact at -18 ºC. 
In May 2009, samples of bovine milk and caprine milk were collected 
directly from tanker silos prior to processing at two manufacturing sites in 
the Waikato region of New Zealand.  A mature ovine milk sample was 
supplied from a subset of a flock of sheep in a New Zealand research 
herd.  Upon collection, the samples were taken to the laboratory and 
immediately prepared for storage for later analysis. 
Samples were prepared for storage prior to TPAN analysis by pipetting a 
10 mL aliquot of sample, adding NaOH (1 M, 20 mL), vortex mixing, and 
standing for 30 min, before neutralising to pH = 7.35 ± 0.05 with HCl and 
making to 50 mL volume and freezing at < -15 ºC. 
3.2.1.4 Enzymatic Digestion 
Immediately prior to analysis, all milk samples were mixed by hand to 
ensure sample homogeneity. 
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Heat Deactivation of Enzymes 
Since milk contains a number of endogenous enzymes that can degrade 
polymeric and monomeric nucleotides, the sample was heated to denature 
the enzymes thereby eliminating any enzyme activity.  To 10 mL glass 
tubes, 5 mL of milk storage samples were added; the tubes were capped 
then immersed in a water bath (95 ºC) for 30 min with periodic mixing.  
The tubes were then removed from water bath and allowed to cool to room 
temperature for subsequent enzyme treatment.  Bovine milk samples from 
the seven cows in the lactation study were pooled for each post-partum 
time period prior to analysis. 
Determination of TPAN 
The sample preparation for the determination of TPAN, requires enzyme 
digestion with nuclease to release polymeric nucleotides, then enzyme 
digestion with pyrophosphatase to release nucleotide adducts, and 
alkaline phosphatase to convert nucleotides to nucleotides; Figure 50 
(enzyme treatment D). 
To a 10 mL glass tube from the enzyme deactivation treatment was 
added: sodium acetate (0.1 M, pH = 5.1, 2 mL), zinc sulphate (0.01 M, 
50 L), nuclease P1 solution (50 L), and working internal standard 
solution (100 L).  The tube was capped and incubated at 37 ± 1 ºC 
overnight for 18 ± 1 hour.  After initial incubation ammonium acetate 
(0.5 M, pH = 8.75, 1 mL), ammonium hydroxide (30%, 50 L), magnesium 
chloride (1 M, 50 L), alkaline phosphatase (50 µL, ~14 units), and 
pyrophosphatase (50 L) were added.  The tube was capped and 
incubated at 37 ± 1 ºC for 3 hours.  The contents of the tube were 
transferred to a 25 mL volumetric flask, which was made to volume with 
potassium phosphate (0.25 M, pH = 10.5).  The sample mixture was then 
cleaned-up on boronate affinity gel (see 3.2.1.5 below). 
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Determination of Polymeric RNA + Nucleotides + Nucleosides 
The sample preparation for the determination of free nucleosides, and 
nucleosides from RNA and nucleotides, requires enzyme digestion with 
nuclease to release polymeric nucleotides, then enzyme digestion with 
alkaline phosphatase to convert nucleotides to nucleosides; Figure 50 
(enzyme treatment C). 
To a 10 mL glass tube from enzyme deactivation treatment was added: 
sodium acetate (0.1 M, pH = 5.1, 2 mL), zinc sulphate (0.01 M, 50 L), 
nuclease P1 solution (50 L), and working internal standard solution 
(500 L).  The tube was capped and incubated at 37 ± 1 ºC overnight for 
18 ± 1 hour.  After initial incubation ammonium acetate (0.5 M, pH = 8.75, 
1 mL), ammonium hydroxide (30%, 50 L), magnesium chloride (1 M, 
50 L), and alkaline phosphatase (50 µL, ~14 units) were added.  The 
tube was capped and incubated at 37 ± 1 ºC for 3 hours.  The contents of 
the tube were transferred to a 25 mL volumetric flask, which was made to 
volume with potassium phosphate (0.25 M, pH = 10.5).  The sample 
mixture was then cleaned-up on boronate affinity gel (see 3.2.1.5 below). 
Determination of Nucleotides + Nucleosides 
The sample preparation for the determination of free nucleosides and 
nucleosides from nucleotides requires enzyme digestion with alkaline 
phosphatase to convert nucleotides to nucleotides; Figure 50 (enzyme 
treatment B). 
To a 10 mL glass tube from enzyme deactivation treatment ammonium 
acetate (0.5 M, pH = 8.75, 1 mL), ammonium hydroxide (30%, 50 L), 
magnesium chloride (1 M, 50 L), alkaline phosphatase (50 µL, ~14 units) 
and working internal standard solution (500 L) were added.  The tube 
was capped and incubated at 37 ± 1 ºC for 3 hours.  The contents of the 
tube were transferred to a 25 mL volumetric flask that was made to volume 
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with potassium phosphate (0.25 M, pH = 10.5).  The sample mixture was 
then cleaned-up on boronate affinity gel (see 3.2.1.5 below). 
Determination of Free Nucleosides  
The sample preparation for the determination of free nucleosides requires 
no enzyme digestion; Figure 50 (enzyme treatment A). 
To a 10 mL glass tube from enzyme deactivation treatment working 
internal standard solution (500 L) was added.  The contents of the tube 
were transferred to a 25 mL volumetric flask that was made to volume with 
potassium phosphate (0.25 M, pH = 10.5).  The sample mixture was then 
cleaned-up on boronate affinity gel (see 3.2.1.5 below). 
3.2.1.5 Boronate Affinity Clean-up 
For each sample, a 2 mL snap cap microcentrifuge tube containing the 
hydrated affinity gel was removed from the freezer and allowed to thaw to 
room temperature.  The microcentrifuge tube was centrifuged at 
10,000 x g for 2 min; the supernatant was aspirated to waste while 
avoiding significant gel loss.  Phosphoric acid (0.25 M, 1 mL) was added to 
the microcentrifuge tube to remove any interferences complexed to the 
boronate moiety.  The microcentrifuge tube was vortex mixed for 30 s to 
re-suspend the gel then centrifuged and the supernatant aspirated to 
waste.  Potassium phosphate (0.25 M, pH = 10.5, 1 mL) was added to the 
microcentrifuge tube to convert the affinity gel to its basic form.  The 
microcentrifuge tube was then vortex mixed for 30 s to re-suspend the gel 
then centrifuged and the supernatant aspirated to waste.  Potassium 
phosphate (0.25 M, pH = 10.5, 1 mL) was added once more to the 
microcentrifuge tube, which was then vortex mixed for 30 s to re-suspend 
the gel.  The microcentrifuge tube was allowed to stand for 15 min with 
vortex mixing for 30 s every 5 min to convert the gel to the basic form.  
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The tube was then centrifuged and the supernatant aspirated to waste.  
The sample extract (1.5 mL) from the enzyme digest was added to the 
microcentrifuge tube, which was allowed to stand for 15 min with vortex 
mixing for 30 s every 5 min during which formation of nucleoside-boronate 
complex occurs.  The tube was then centrifuged and the supernatant 
aspirated to waste.  The gel was washed twice by adding potassium 
phosphate (0.25 M, pH = 10.5, 1 mL), vortex mixing for 30 s, centrifuging, 
aspirating the supernatant to waste and repeating.  To release bound 
nucleosides phosphoric acid (0.25 M, 1 mL) was added to the tube, which 
was then vortex mixed for 30 s.  The entire contents of the tube were 
transferred to a syringe with a 0.22 m filter and filtered into an HPLC vial 
ready for chromatographic analysis. 
3.2.1.6 Chromatography 
The initial chromatographic protocol was a modification of a reversed-
phase system described by Gill and Indyk (2007b), using phosphate buffer 
and a methanol gradient.  As optimum separation of nucleosides was 
achieved at pH = 4.8, phosphate was replaced with acetate (pKa = 4.75), 
thereby offering greater buffer capacity at the desired pH. 
An organic solvent component is required in the mobile phase to facilitate 
the timely elution of nucleosides from the C18 column.  However, to obtain 
sufficient resolution between peaks, a gradient elution procedure would be 
necessary.  Gradients were formed by low pressure mixing of two mobile 
phases, A and B.  A number of gradient procedures were evaluated to 
determine an optimum protocol that would have a relatively short run-time 
coupled with sufficient resolution between peaks.  An optimum separation 
of nucleosides was achieved using the gradient procedure described in 
Table 21. 
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Table 21. TPAN method: chromatographic procedurea 
Time (min) 
Phase compositionb 
% A % B 
0 95 5 
3 95 5 
7 75 25 
22 75 25 
23 95 5 
30 95 5 
a
 Flow rate 0.7 mL min
-1
; column temperature 20 °C 
b
 Mobile phase A = 0.05 M NaCH3COO, pH = 4.8 
 Mobile phase B = 100% methanol 
3.2.1.7 Detection, Identification and Quantitation 
Spectral data were acquired by the PDA detector from 210–300 nm.  Peak 
identification was by retention time and similarity of chromatographic peak 
spectrum against standards (similarity index >0.99).  Chromatograms were 
integrated at a wavelength of 260 nm and results determined by internal 
standard technique using 5-methylcytidine; Equation 4. 
Internal standards were used to account for recovery losses through the 
enzymatic and phenylboronate affinity clean-up steps.  Leach et al. (1995) 
used 5-methylcytidine as internal standard to quantitate adenosine, 
cytidine, and uridine.  The use of 5-methylcytidine gave lower than 
expected recovery of guanosine; therefore, 1-methylguanosine was used 
to quantitate guanosine.  However, 1-methylguanosine was not 
commercially available and other modified guanosine alternatives were 
identified for this study.  Trials with 7-methylguanosine were not successful 
as standard concentrations were not stable and degraded rapidly with 
time.  This was attributed to the susceptibility of 7-methylguanosine to 
cleavage of the imidazole ring making it unsuitable as an internal standard 
(Barbarella et al., 1991).   
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Nucleoside 
=  
1000
100
V
V
V
)V(C
L
1
A
A
D
T
U
ISIS
IS
NT 

  (Equation 4) 
(mg dL-1) 
where: ANT  =  analyte (nucleoside) peak area 
 AIS  =  internal standard (5mCyd) peak area 
 L  =  linear regression slope of calibration curve 
 CIS  =  concentration of internal standard (µg mL
-1) 
 VIS  =  volume of internal standard (µg mL
-1) 
 VU  =  volume of aliquot of diluted sample analysed (mL) 
 VT  =  total volume of diluted sample (mL) 
 VD  =  volume of milk in diluted sample (mL) 
 100  =  unit conversion from mL-1 to dL-1 
 1000  =  convert mass result from g to mg 
 
8-bromoguanosine was selected as an internal standard candidate for 
guanosine.  However, the recoveries for this standard were no better than 
5-methylcytidine, therefore quantitation for all four nucleosides was 
measured against 5-methylcytidine, accepting that lower recoveries were 
possible for guanosine. 
3.2.1.8 Statistical Analysis 
Statistical analyses were performed using Minitab version 15.1 (State 
College, PA).  Data obtained in bovine colostrum and milk was analysed 
by one-way analysis of variance of the response of season (winter-milk, 
summer-milk) with covariate time (0, 0.25, 1, 2, 3, 5, 10, 20, 30 days post-
partum).  All results (X) were transformed log10(1 + X), so that the 
postulated model was an exponential decrease in levels with time, with the 
initial levels and the rates of decrease dependent upon season.  The 
―exponential decay‖ model was found to provide a better fit than a linear or 
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quadratic model in time.  For hypothesis testing, significance was 
evaluated at the  = 0.05 level.  Data obtained in mature bovine, caprine, 
and ovine milk were analysed by one-way analysis of variance of the 
response of each species (bovine, caprine, ovine) and Tukey’s multiple 
comparison test. 
3.2.2. RESULTS AND DISCUSSION 
3.2.2.1 Method Performance 
System Suitability 
Chromatographic performance was assessed by replicate analyses (n = 6) 
of a mixed nucleotide standard; Table 22, Figure 52.   
Performance within recommended guidelines was achieved, with the 
exception of the retention factors for cytidine, uridine, and 5-methylcytidine 
(guideline > 2.0).  The specific nature of the phenylboronate sample clean 
up provides analytical chromatography relatively free of interferences and 
therefore, early retention was deemed acceptable. 
Recovery 
A spiked recovery study was performed on free nucleosides and was 
assessed through the affinity gel clean up.  A stored pooled milk sample 
was spiked with a single mixed standard containing cytidine, guanosine, 
uridine, adenosine, and 5-methylcytidine (95.0–135.0 g mL−1).  Recovery 
was assessed by comparison of peak areas for the spiked and unspiked 
samples, relative to those of the mixed standard. 
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Recovery of nucleosides from the enzymatic digestion was estimated 
following the protocol described by Leach et al. (1995).  A solution (TPAN 
fortified) containing ribonucleosides, nucleotides, nucleotide adducts and 
RNA was prepared for a spiked recovery study.  A solution (TPAN digest) 
was made from an aliquot (5 mL) of the TPAN-fortified solution that was 
hydrolysed for 20 hours with KOH (0.2 mol L−1, 50 mL) in order to convert 
polymeric RNA to monomeric nucleotides.  The pH of the solution was 
adjusted to 9.0 with HCl and then incubated with alkaline phosphatase and 
nucleotide pyrophosphatase to convert adducts and monomeric 
nucleotides to nucleosides.  The concentration of nucleosides in the TPAN 
digest solution was determined by HPLC and was used to calculate the 
TPAN content in the TPAN-fortified solution. 
A stored pooled milk sample was then spiked (in triplicate) with an aliquot 
of the TPAN-fortified solution and, together with unspiked sample 
replicates, was analysed and TPAN concentrations determined.  Recovery 
was assessed by comparison of the difference in results for the spiked and 
unspiked samples, divided by the TPAN concentration of the TPAN-
fortified solution.  The recoveries of nucleosides through the affinity 
clean-up step, and both enzymatic digestion and affinity clean-up is given 
in Table 23.   
 
Table 23. Nucleoside recovery through TPAN sample preparation 
Sample Preparation Step 
Recovery% (SD) 
Cyda Urd Guo Ado 
Affi-gel clean-up 93.4 (1.1)b 92.3 (5.1) 88.3 (4.9) 95.2 (4.2) 
Enzymatic digestion and 
Affi-gel clean up 
95.5 (2.8) 101.7 (3.7) 89.2 (2.4) 94.7 (3.0) 
a
 Ado = adenosine; Cyd = cytidine; Guo = guanosine; Urd = uridine 
b
 Mean (standard deviation) of 3 replicates 
 
 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 139 
TOTAL POTENTIALLY AVAILABLE NUCLEOSIDES IN MILK 
The theoretical binding capacity of the Affi-gel is 0.033 milli-equivalents 
per tube.  This is over 40 times the concentration of the highest standard.  
However, in addition to nucleosides any other components containing a 
cis-diol functionality may also bind to the gel, reducing overall binding 
capacity available for nucleosides (Molitor, 2008).  
3.2.2.2 TPAN in Bovine Colostrum and Milk 
The levels and distribution of TPAN in mature bovine milk are important in 
the manufacture of infant formulas, particularly when formulating to TPAN 
regulatory limits.  If all endogenous forms of nucleosides and nucleotides 
that contribute to TPAN are not accounted for prior to nucleotide 
supplementation, possible over-fortification could occur during the 
manufacture of bovine milk-based infant formula. 
The contribution of each nucleobase and form obtained in this study of 
winter-milk and summer-milk lactation series are summarised in 
Tables 24–25.  For each parameter (each base within each form), 
comparisons of the initial levels and rates of decrease were made between 
seasons and whether each seasonal slope differed from zero; Tables 26.  
The trend of nucleobase and form over lactation for each season is 
illustrated graphically in Figures 53–54.   
 
Table 24. Total potentially available nucleosides in winter herd milk 
Daya Form 
Resultsb,c (mol dL-1) 
Cyd Urd Guo Ado Total 
0 
Nucleoside 
5.4 
(0.1) 
57.9 
(1.6) 
0.3 
(0.0) 
– 63.6 
(1.5) 
Monomeric 
NT 
6.1 
(0.3) 
143.7 
(8.5) 
2.8 
(0.0) 
2.9 
(0.2) 
156   
(8.7) 
NT Adduct 
0.9 
(0.2) 
23.7 
(9.0) 
3.9 
(0.8) 
2.4 
(0.0) 
30.9 
(9.6) 
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Polymeric 
NT 
0.6 
(0.0) 
5.4 
(7.2) 
1.4 
(0.2) 
1.4 
(0.1) 
8.7 
(7.4) 
TPAN 
13.0 
(0.5) 
230.7 
(6.1) 
8.5 
(0.9) 
6.6 
(0.2) 
258.7 
(6.8) 
0.25 
Nucleoside 
4.0 
(0.2) 
39.8 
(0.2) 
0.2 
(0.0) 
– 44.0 
(0.4) 
Monomeric 
NT 
1.3 
(0.4) 
26.9 
(4.7) 
1.0 
(0.0) 
1.4 
(0.0) 
30.6 
(5.0) 
NT Adduct 
0.9 
(0.2) 
3.2 
(0.9) 
1.1 
(0.2) 
0.5 
(0.1) 
5.8 
(0.6) 
Polymeric 
NT 
0.1 
(0.0) 
3.9 
(1.1) 
1.1 
(0.1) 
0.9 
(0.0) 
6.0 
(0.9) 
TPAN 
6.3 
(0.0) 
73.8 
(4.3) 
3.5 
(0.1) 
2.8 
(0.1) 
86.4 
(4.3) 
1 
Nucleoside 
3.5 
(0.1) 
49.8 
(0.8) 
0.5 
(0.0) 
– 53.9 
(0.7) 
Monomeric 
NT 
13.1 
(0.3) 
77.5 
(2.8) 
4.0 
(0.2) 
3.0 
(0.2) 
97.5 
(3.2) 
NT Adduct 
0.4 
(0.2) 
11.9 
(6.8) 
2.4 
(0.2) 
2.0 
(0.6) 
16.5 
(7.6) 
Polymeric 
NT 
0.5 
(0.5) 
3.0 
(3.8) 
1.3 
(0.2) 
1.5 
(0.5) 
6.4 
(3.6) 
TPAN 
17.5 
(0.9) 
142.2 
(6.6) 
8.1 
(0.0) 
6.5 
(0.3) 
174   
(7.9) 
2 
Nucleoside 
2.5 
(0.3) 
60.4 
(0.4) 
0.8 
(0.0) 
0.6 
(0.1) 
64.2 
(0.8) 
Monomeric 
NT 
16.9 
(0.6) 
30.4 
(3.4) 
2.0 
(0.1) 
2.6 
(0.0) 
51.6 
(4.2) 
NT Adduct 
0.3 
(0.2) 
6.7 
(1.4) 
2.4 
(0.2) 
2.6 
(0.3) 
12.0 
(1.3) 
Polymeric 
NT 
1.0 
(0.1) 
2.7 
(1.3) 
1.0 
(0.1) 
1.2 
(0.1) 
6.0 
(1.3) 
TPAN 
  20.7 
(0.0) 
99.8 
(3.2) 
6.2 
(0.1) 
7.1 
(0.3) 
134   
(3.4) 
3 
Nucleoside 
2.0 
(0.2) 
42.7 
(2.0) 
0.5 
(0.1) 
0.6 
(0.1) 
45.9 
(2.4) 
Monomeric 
NT 
16.2 
(0.4) 
22.2 
(3.4) 
1.5 
(0.2) 
3.6 
(0.9) 
43.5 
(4.9) 
NT Adduct 
0.4 
(0.5) 
5.9 
(0.3) 
2.2 
(0.2) 
2.3 
(0.1) 
10.7 
(0.9) 
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Polymeric 
NT 
0.3 
(0.1) 
1.0 
(0.3) 
0.6 
(0.1) 
0.5 
(0.6) 
2.5 
(0.4) 
TPAN 
19.0 
(0.2) 
71.8 
(1.5) 
4.8 
(0.2) 
7.0 
(0.2) 
103   
(1.2) 
5 
Nucleoside 
1.5 
(0.3) 
21.5 
(0.8) 
– 0.2 
(0.0) 
23.3 
(0.5) 
Monomeric 
NT 
12.1 
(0.3) 
1.4 
(0.1) 
0.6 
(0.0) 
3.3 
(0.1) 
17.4 
(0.3) 
NT Adduct 
0.1 
(0.0) 
0.8 
(0.0) 
0.6 
(0.2) 
0.6 
(0.2) 
2.2 
(0.4) 
Polymeric 
NT 
0.5 
(0.1) 
0.4 
(0.4) 
0.8 
(0.1) 
0.7 
(0.1) 
2.4 
(0.5) 
TPAN 
14.1 
(0.3) 
24.2 
(1.0) 
2.1 
(0.1) 
4.8 
(0.3) 
45.2 
(1.7) 
10 
Nucleoside 
0.8 
(0.2) 
3.2 
(0.2) 
– 0.1 
(0.0) 
4.1 
(0.0) 
Monomeric 
NT 
6.9 
(0.3) 
0.4 
(0.0) 
0.2 
(0.0) 
2.4 
(0.1) 
9.9 
(0.4) 
NT Adduct 
0.1 
(0.1) 
0.2 
(0.2) 
0.1 
(0.0) 
0.2 
(0.1) 
0.6 
(0.4) 
Polymeric 
NT 
0.3 
(0.4) 
0.1 
(0.1) 
0.4 
(0.1) 
0.2 
(0.0) 
1.0 
(0.6) 
TPAN 
8.0 
(0.1) 
3.9 
(0.2) 
0.7 
(0.1) 
3.0 
(0.2) 
15.6 
(0.2) 
20 
Nucleoside 
0.7 
(0.2) 
1.3 
(0.1) 
– 0.1 
(0.0) 
2.1 
(0.3) 
Monomeric 
NT 
3.9 
(0.0) 
0.1 
(0.1) 
– 0.8 
(0.1) 
4.8 
(0.2) 
NT Adduct 
0.1 
(0.0) 
0.2 
(0.1) 
0.1 
(0.1) 
0.1 
(0.0) 
0.4 
(0.2) 
Polymeric 
NT 
0.2 
(0.1) 
0.1 
(0.0) 
0.3 
(0.0) 
0.2 
(0.1) 
0.7 
(0.2) 
TPAN 
4.8 
(0.2) 
1.6 
(0.1) 
0.4 
(0.0) 
1.3 
(0.2) 
8.0 
(0.1) 
30 
Nucleoside 
0.6 
(0.1) 
0.8 
(0.1) 
– 0.1 
(0.0) 
1.5 
(0.0) 
Monomeric 
NT 
2.5 
(0.0) 
0.1 
(0.0) 
– 0.3 
(0.1) 
3.0 
(0.1) 
NT Adduct 
– – – 0.1 
(0.0) 
0.2 
(0.1) 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 142 
TOTAL POTENTIALLY AVAILABLE NUCLEOSIDES IN MILK 
Polymeric 
NT 
0.2 
(0.0) 
0.1 
(0.0) 
0.2 
(0.0) 
0.1 
(0.0) 
0.7 
(0.1) 
TPAN 
3.4 
(0.0) 
1.1 
(0.0) 
0.3 
(0.0) 
0.6 
(0.1) 
5.3 
(0.1) 
a
 Day post-partum ± 2 h 
b
 Mean (standard deviation) of duplicate analyses 
c
 Cyd = cytidine, Urd = uridine, Guo = guanosine, Ado = adenosine 
– = not detected 
 
Table 25. Total potentially available nucleosides in summer herd milk 
Daya Form 
Resultsb,c (mol dL-1) 
Cyd Urd Guo Ado Total 
0 
Nucleoside 
2.6 
(0.2) 
50.6 
(5.8) 
2.2 
(0.3) 
– 55.4 
(5.8) 
Monomeric 
NT 
1.5 
(0.1) 
1.2 
(0.0) 
0.2 
(0.0) 
– 2.8 
(0.2) 
NT Adduct 
0.1 
(0.1) 
0.5 
(0.1) 
0.3 
(0.0) 
0.2 
(0.0) 
1.1 
(0.2) 
Polymeric 
NT 
0.4 
(0.0) 
0.3 
(0.3) 
1.1 
(0.0) 
0.9 
(0.0) 
2.7 
(0.3) 
TPAN 
4.7 
(0.2) 
52.5 
(6.1) 
3.7 
(0.3) 
1.2 
(0.0) 
62.1 
(6.2) 
0.25 
Nucleoside 
3.6 
(0.1) 
28.0 
(0.4) 
1.8 
(0.0) 
– 33.4 
(0.5) 
Monomeric 
NT 
0.5 
(0.3) 
0.4 
(0.1) 
0.1 
(0.0) 
– 1.0 
(0.5) 
NT Adduct 
0.2 
(0.0) 
0.9 
(0.2) 
0.1 
(0.0) 
0.1 
(0.0) 
1.4 
(0.1) 
Polymeric 
NT 
0.3 
(0.0) 
1.7 
(0.3) 
0.8 
(0.1) 
0.8 
(0.0) 
3.6 
(0.2) 
TPAN 
4.7 
(0.2) 
31.0 
(0.8) 
2.9 
(0.2) 
0.9 
(0.1) 
39.4 
(0.3) 
1 
Nucleoside 
5.4 
(0.4) 
40.9 
(1.2) 
2.1 
(0.2) 
– 48.5 
(1.0) 
Monomeric 
NT 
7.3 
(0.1) 
4.3 
(0.3) 
0.3 
(0.0) 
– 11.9 
(0.2) 
NT Adduct 
1.6 
(0.3) 
6.8 
(0.9) 
1.2 
(0.1) 
0.3 
(0.1) 
10.0 
(1.2) 
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Polymeric 
NT 
0.6 
(0.1) 
1.1 
(0.4) 
1.0 
(0.1) 
0.7 
(0.3) 
3.4 
(0.0) 
TPAN 
15.0 
(0.4) 
53.1 
(0.4) 
4.7 
(0.1) 
1.0 
(0.3) 
73.8 
(0.4) 
2 
Nucleoside 
3.7 
(0.4) 
39.2 
(0.1) 
2.7 
(0.4) 
– 45.6 
(0.9) 
Monomeric 
NT 
10.4 
(0.8) 
0.4 
(0.1) 
0.2 
(0.0) 
0.9 
(0.1) 
11.8 
(1.0) 
NT Adduct 
– 1.7 
(0.4) 
0.9 
(0.0) 
0.4 
(0.0) 
2.9 
(0.4) 
Polymeric 
NT 
0.5 
(0.0) 
1.0 
(0.0) 
0.4 
(0.1) 
0.3 
(0.0) 
2.3 
(0.0) 
TPAN 
14.5 
(0.4) 
42.3 
(0.4) 
4.2 
(0.4) 
1.5 
(0.2) 
62.6 
(0.2) 
3 
Nucleoside 
6.7 
(0.2) 
21.5 
(1.6) 
1.2 
(0.1) 
– 29.4 
(1.3) 
Monomeric 
NT 
5.8 
(0.8) 
3.6 
(0.8) 
0.3 
(0.0) 
2.1 
(0.4) 
11.9 
(1.2) 
NT Adduct 
0.1 
(0.0) 
0.5 
(0.0) 
0.4 
(0.1) 
0.4 
(0.0) 
1.5 
(0.1) 
Polymeric 
NT 
0.5 
(0.1) 
1.4 
(0.5) 
0.4 
(0.0) 
0.3 
(0.0) 
2.7 
(0.6) 
TPAN 
13.2 
(0.7) 
27.0 
(3.0) 
2.3 
(0.1) 
2.9 
(0.4) 
45.3 
(3.4) 
5 
Nucleoside 
1.0 
(0.1) 
9.2 
(0.1) 
0.2 
(0.3) 
– 10.4 
(0.3) 
Monomeric 
NT 
8.0 
(0.2) 
0.4 
(0.0) 
0.2 
(0.0) 
2.0 
(0.1) 
10.7 
(0.1) 
NT Adduct 
0.3 
(0.2) 
0.4 
(0.0) 
0.1 
(0.0) 
0.3 
(0.0) 
1.0 
(0.3) 
Polymeric 
NT 
0.8 
(0.2) 
0.5 
(0.1) 
0.3 
(0.0) 
0.2 
(0.1) 
1.9 
(0.2) 
TPAN 
10.2 
(0.1) 
10.5 
(0.3) 
0.8 
(0.3) 
2.4 
(0.0) 
24.0 
(0.1) 
10 
Nucleoside 
0.6 
(0.1) 
3.0 
(0.0) 
– – 3.6 
(0.0) 
Monomeric 
NT 
4.1 
(0.2) 
0.1 
(0.0) 
– 1.2 
(0.1) 
5.3 
(0.0) 
NT Adduct 
0.2 
(0.1) 
– 0.1 
(0.0) 
0.2 
(0.1) 
0.5 
(0.2) 
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Polymeric 
NT 
0.2 
(0.1) 
0.2 
(0.0) 
0.4 
(0.0) 
0.1 
(0.0) 
0.9 
(0.1) 
TPAN 
5.0 
(0.4) 
3.4 
(0.0) 
0.4 
(0.0) 
1.5 
(0.1) 
10.3 
(0.4) 
20 
Nucleoside 
0.7 
(0.0) 
1.5 
(0.5) 
– – 2.1 
(0.5) 
Monomeric 
NT 
3.0 
(0.2) 
0.1 
(0.0) 
– 0.4 
(0.0) 
3.4 
(0.1) 
NT Adduct 
0.1 
(0.0) 
0.1 
(0.0) 
– 0.1 
(0.0) 
0.2 
(0.0) 
Polymeric 
NT 
– 0.1 
(0.0) 
– 0.1 
(0.0) 
0.1 
(0.0) 
TPAN 
3.8 
(0.2) 
1.6 
(0.5) 
– 0.5 
(0.1) 
5.9 
(0.4) 
30 
Nucleoside 
0.6 
(0.0) 
1.3 
(0.0) 
– – 1.9 
(0.0) 
Monomeric 
NT 
1.6 
(0.2) 
– – – 1.6 
(0.2) 
NT Adduct 
0.1 
(0.0) 
0.1 
(0.0) 
– 0.3 
(0.0) 
0.5 
(0.0) 
Polymeric 
NT 
– – – – 0.1 
(0.0) 
TPAN 
2.3 
(0.2) 
1.4 
(0.0) 
– 0.3 
(0.0) 
4.0 
(0.2) 
a
 Day post-partum ± 2 h 
b
 Mean (standard deviation) of duplicate analyses 
c
 Cyd = cytidine, Urd = uridine, Guo = guanosine, Ado = adenosine 
– = not detected 
 
Nucleoside Contribution to TPAN 
Uridine was the most prevalent nucleoside in both winter and summer 
milk, with levels of ~50 mol dL−1 in colostrum, but these levels were not 
sustained beyond the third day post-partum and rapidly decreased to 
levels similar to those of cytidine and guanosine at 1–3 mol dL−1.  
Adenosine was present at much lower levels but these low levels were 
maintained throughout the lactation period for both seasons’ milk.  The 
nucleoside levels measured in this study were consistent with those 
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reported previously (Gill and Indyk, 2007b).  Although nucleosides were 
present at higher concentrations in bovine colostrum than in mature bovine 
milk, they rapidly decreased to levels similar to that in mature human milk, 
as reported by Leach et al. (1995). 
 
Table 26. Significance of rates of decrease through lactationa 
Form 
Resultsa,b 
Cydb Urd Guo Ado Total 
Seasonal differences (winter vs. summer) between slopes: p-valuesc 
Nucleoside < 0.001 < 0.001 < 0.001    0.600 < 0.001 
Monomeric NT    0.310 < 0.001 < 0.001    0.007 < 0.001 
NT Adduct    0.048 < 0.001 < 0.001    0.002 < 0.001 
Polymeric NT    0.303    0.002 < 0.001 < 0.001 < 0.001 
Total Base    0.676 < 0.001 < 0.001    0.107 < 0.001 
Non-zero slope (summer): p-valuesd 
Nucleoside < 0.001 < 0.001 < 0.001    1.000 < 0.001 
Monomeric NT    0.168    0.182    0.384    0.002    0.207 
NT Adduct    0.437    0.051    0.097   0.552    0.030 
Polymeric NT    0.196    0.233 < 0.001    0.001 < 0.001 
Total Base    0.769 < 0.001 < 0.001    0.386 < 0.001 
Non-zero slope (winter): p-valuesd 
Nucleoside < 0.001 < 0.001    0.048    0.316 < 0.001 
Monomeric NT    0.511 < 0.001 < 0.001    0.905 < 0.001 
NT Adduct    0.019 < 0.001 < 0.001    0.001 < 0.001 
Polymeric NT    0.399    0.001 < 0.001 < 0.001 < 0.001 
Total Base    0.408 < 0.001 < 0.001    0.053 < 0.001 
a
 p-value, level of significance = 0.05 
b
 Cyd = cytidine, Urd = uridine, Guo = guanosine, Ado = adenosine 
c
 Statistical significance means there is evidence of a real difference between 
 seasons 
d
 Statistical significance means there is evidence that the levels are actually 
 decreasing 
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Figure 53. Nucleotides and nucleosides in winter herd milk 
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Figure 54. Nucleotides and nucleosides in summer herd milk 
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Monomeric Nucleotide Contribution to TPAN 
Levels of nucleotides measured in this study were generally higher than 
those reported previously (Gill and Indyk, 2007b); however, there was 
likely to have been a contribution from multiple phosphorylated forms, 
which the TPAN analytical method aggregates as a single value.  
Differences in colostral monomeric nucleotide levels between the two 
herds were evident, with the winter-milk herd initially containing 5–10 times 
the levels of the summer-milk herd.  However, by the fifth day, nucleotide 
levels decreased to approximately 10 mol dL−1 in both herds, somewhat 
lower than those reported in human milk (Leach et al., 1995).  The high 
initial uridine nucleotides levels and subsequent rapid decrease in 
concentration seen in winter-milk was absent in summer-milk which 
maintained constant levels throughout lactation.  Cytidine and adenosine 
nucleotides are stable throughout lactation for both seasons.  The most 
abundant nucleotides in bovine colostrum were based on uridine; 
however, as colostrum transitioned into mature milk, cytidine nucleotides 
became the dominant form. 
Uridine nucleotides are critical components in the biosynthesis of lactose.  
As lactose is a major osmotic component of milk, there is a correlation 
between the amount of lactose and the volume of milk produced (Arthur 
et al., 1991; Linzell and Peaker, 1971).  It has been suggested that high 
levels of uridine and UMP are present in milk, as breakdown products of 
UDP and UTP, due to their function in the synthesis of lactose (Mateo 
et al., 2004; Schlimme et al., 2000).  It was proposed that support for this 
hypothesis is seen by the correlation of decreasing total milk solids and 
UMP concentrations in sow’s milk as lactation progresses (Mateo et al., 
2004).  However, as colostrum contains higher total milk solids and lower 
lactose levels (on a dry weight basis) than mature milk (Heng, 1999), a 
reduced proportion of uridine nucleotides compared to mature milk might 
be expected based on this proposal.  Alternative reasons must therefore 
be sought to account for the higher relative proportions of uridine 
nucleotides in colostrum.  It has also been suggested that uridine accounts 
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for many of the immunological properties of nucleotides in colostrum 
(Kulkarni et al., 1986; Leach et al., 1995; Van Buren et al., 1985) and 
recently, Mashiko et al. (2009) demonstrated that dietary UMP affected the 
immune response of newborn calves. 
Nucleotide Adduct Contribution to TPAN 
The results for uridine adducts in the present study ranged from not 
detected to 23.7 mol dL−1 in the winter-milk herd and from not detected to 
6.8 mol dL−1 in the summer-milk herd, with a rapid reduction in 
concentration after the third day post-partum.  Guanosine adducts 
measured ranged from not detected to 3.9 mol dL−1 in the winter milk 
herd and from not detected to 1.2 mol dL−1 in the summer-milk herd.  
Similar levels of adenosine adducts were found, presumably derived from 
flavin adenine dinucleotide (FAD) and nicotinamide adenine dinucleotide 
(Fox and McSweeney, 1998; Kanno et al., 1991).  Utilising enzymatic 
techniques, UDP hexosamine, UDP hexose and UDP galactose 
concentrations were measured in bovine colostrum and milk, and ranged 
from not detected to ~104 mol dL−1.  Levels were highest at 27 and 78 h 
and much lower or absent in subsequent stages of lactation.  Guanosine 
diphosphate fucose was also reported at 27 and 78 h, at levels of 6.7 and 
4.1 mol dL−1 respectively (Gil and Sánchez-Medina, 1981). 
Polymeric Nucleotide Contribution to TPAN 
The concentration of polymeric nucleotides in bovine colostrum was 
similar to that in human colostrum and milk (Leach et al., 1995), however, 
with advancing lactation, the levels in bovine milk decreased below those 
in human milk.  Both cytidine and uridine contributions to polymeric 
nucleotides are steady throughout lactation for summer-milk, whereas the 
higher initial levels of polymeric uridine shows distinct decrease in 
concentration as lactation progresses in winter-milk. 
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Nucleobase Contribution to TPAN 
Differences in the contributions of each nucleobase from the various 
nucleoside and nucleotide forms were found.  The pyrimidines differed 
markedly from each other through lactation.  Whereas the quantities of 
cytidine and cytidine nucleotides were relatively constant throughout, 
uridine and uridine nucleotides levels varied considerably.  Cytidine 
concentrations were similar to those in human milk, whereas uridine was 
present at considerably higher levels in bovine colostrum and in lower 
amounts in mature bovine milk compared to results in human milk reported 
by Leach et al. (1995). 
The concentrations of the purines also differed, with adenosine levels 
constant throughout the first month of lactation for both herd milks, 
whereas guanosine showed a significant decrease in levels for both herds.  
The quantities of both guanosine and adenosine, and their respective 
nucleotides were slightly higher in bovine colostrum than in human 
colostrum and milk, but concentrations were lower as colostrum 
transitioned to mature milk.  In bovine milk, purine nucleosides and 
nucleotides made a relatively small contribution to TPAN (6–20%), 
whereas human milk purine nucleosides and nucleotides consistently 
represent a greater proportion of TPAN (> 30%)  (Leach et al., 1995). 
Total Potentially Available Nucleosides 
In general, the absolute concentrations indicated a distinct difference 
between the two herds, although the general trends were the same; 
Figures 55–56.  Winter had higher initial levels of TPAN but the rate of 
decrease was greater, such that the seasonal differences in TPAN 
concentration found in colostrum were largely absent in mature milk. 
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TPAN levels in winter-milk colostrum were attributable largely to 
significantly higher amounts of uridine nucleotides compared with summer-
milk colostrum; however, by the tenth day, both herd milks showed similar 
TPAN levels.  The TPAN levels in bovine colostrum were higher than 
those in both human colostrum and milk; however, after transition to 
mature milk, the TPAN levels were lower than those reported in human 
milk (Leach et al., 1995).  
It has been reported that nucleotides in human milk exhibit a circadian 
rhythmicity (Sánchez et al., 2009).  Anomalous results for uridine and 
uridine nucleotides were found in bovine colostrum samples collected from 
both herds at 6 hours post-partum, and such diurnal variation may suggest 
a plausible rationale given that this sample was uniquely collected in the 
afternoon. 
Herd Conditions 
Although the feeding practices were similar on both farms, it is possible 
that seasonal or pasture differences could have had a significant effect on 
the nucleoside precursors expressed in the milk of each herd.  Prior to 
calving, the cows’ diet was extensive grass grazing supplemented with 
maize silage and palm kernel, and after calving, intake of grass and palm 
kernel increased with inclusion of whey permeate.  One uncontrolled 
variable that may have had a significant influence is the climate.  Calving 
for the winter milk herd began in the early autumn of 2008, which followed 
a summer characterised by a La Niña weather pattern that contributed to 
record high temperatures (20.3 °C mean air temperature) and a drought 
with severe soil moisture deficits (>130 mm) in the Waikato.  The summer 
milk herd began calving in late winter 2009, which had the warmest August 
on record nationally, with above average rainfall in the Waikato (NIWA, 
2010).  In addition to obvious climatic factors, other factors could have 
affected TPAN levels in both herds, such as the conditions under which 
the cows were raised and fed, tolerance to stress, sunlight exposure and 
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other environmental factors.  Further study controlling each of these 
factors would be required to identify those factors that influence 
nucleoside and nucleotide expression in milk.  Limitations of the current 
study could be expanded upon in future experiments that consider the 
effects of breed, location, and diet on TPAN expression in milk. 
3.2.2.3 TPAN in Bovine, Caprine, and Ovine milk 
With the increasing awareness of the nutritional benefit of nucleotides in 
infant nutrition, and the proliferation of milk of various species being used 
as replacements for breast milk, the data on endogenous TPAN in milk in 
this study are timely. 
The TPAN concentrations obtained in this study of bovine, caprine and 
ovine milk are summarised in Table 27, and illustrated in Figure 57. 
Nucleoside Contribution to TPAN 
The cytidine concentrations ranged from 0.9–2.3 µmol dL−1 and were 
comparable among the milk of the three species, as were the relatively low 
concentrations of both adenosine and guanosine.  In contrast, uridine was 
present in higher concentrations in both caprine milk (11.3 µmol dL−1) and 
ovine milk (14.8 µmol dL−1), differentiating these milks from bovine milk 
(1.9 µmol dL−1).  This dominance of uridine in ovine milk and caprine milk 
has been reported previously (Martin et al., 2005; Plakantara et al., 2010). 
The higher nucleoside concentrations in caprine and ovine milk 
represented only minor contributions to TPAN, whereas the contribution of 
nucleosides to the TPAN of bovine milk was > 30%.  Ruminant milk 
contains higher concentrations of total nucleosides than those reported in 
human milk (Leach et al., 1995). 
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Table 27. TPAN in bovine, caprine, and ovine milk 
Species Form 
Resultsa (mol dL-1) 
Cydb Urd Guo Ado Total 
Bovine 
Nucleoside 
0.9 
(0.1)a 
1.9 
(0.1) 
– – 2.8  
(0.3) 
Monomeric NT 
3.3 
(0.1) 
0.5 
(0.2) 
– – 3.8 
(0.3) 
NT Adduct 
0.1 
(0.0) 
0.1 
(0.0) 
0.4 
(0.1) 
0.1 
(0.0) 
0.6 
(0.0) 
Polymeric NT 
0.1 
(0.1) 
0.1 
(0.1) 
– 0.5 
(0.0) 
0.7 
(0.3) 
TPAN 
4.4 
(0.2) 
2.6 
(0.2) 
0.4 
(0.1) 
0.5 
(0.0) 
7.9 
(0.5) 
Caprine 
Nucleoside 
1.6 
(0.1) 
11.3 
(0.4) 
– – 12.9 
(0.3) 
Monomeric NT 
3.6 
(0.2) 
37.2 
(0.8) 
9.4 
(0.5) 
2.4 
(0.2) 
52.7 
(1.7) 
NT Adduct 
0.7 
(0.0) 
10.1 
(1.2) 
14.5 
(0.1) 
3.4 
(0.1) 
28.7 
(1.2) 
Polymeric NT 
0.6 
(0.2) 
1.0 
(0.9) 
1.1 
(0.5) 
0.5 
(0.2) 
3.2 
(1.9) 
TPAN 
6.5 
(0.3) 
59.5 
(1.8) 
25.0 
(0.7) 
6.3 
(0.3) 
97.4 
(2.8) 
Ovine 
Nucleoside 
2.3 
(0.1) 
14.8 
(1.1) 
0.6 
(0.0) 
– 17.6 
(1.2) 
Monomeric NT 
5.7 
(0.3) 
187.4 
(4.4) 
6.3 
(0.0) 
12.1 
(0.0) 
211.4 
(4.0) 
NT Adduct 
0.9 
(0.1) 
100.4 
(7.8) 
22.1 
(0.2) 
14.4 
(0.6) 
137.8 
(8.7) 
Polymeric NT 
0.5 
(0.3) 
4.3 
(0.1) 
1.2 
(0.3) 
1.3 
(0.6) 
7.3 
(1.2) 
TPAN 
9.4 
(0.4) 
306.8 
(9.0) 
30.2 
(0.3) 
27.8 
(0.9) 
374.1 
(9.8) 
a 
Mean (standard deviation) of duplicate analyses 
b
 Cyd = cytidine, Urd = uridine, Guo = guanosine, Ado = adenosine 
– = not detected 
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Figure 57. TPAN in bovine, caprine, and ovine milk 
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Monomeric Nucleotide Contribution to TPAN 
The trends in nucleotide concentrations measured in this study were 
similar to those reported previously in bovine, caprine, and ovine milk 
(Ferreira et al., 2001; Gil and Sánchez-Medina, 1981; Gill and Indyk, 
2007b; Martin et al., 2005; Plakantara et al., 2010).  The cytidine 
nucleotide concentration ranges were comparable among the three 
species, as were the nucleotide concentration ranges for both adenosine 
and guanosine, which were at similarly low concentrations.  The 
concentrations of uridine nucleotides varied greatly among the milk of the 
three species, with the range spanning 0.5–187 µmol dL−1, with the lowest 
concentration in bovine milk and the highest concentration in ovine milk.  
Bovine milk contained significantly lower concentrations of monomeric 
nucleotides than caprine and ovine milk. 
Nucleotide Adduct Contribution to TPAN 
The uridine adducts measured in ovine milk were an order of magnitude 
higher than those in caprine milk and were three orders of magnitude 
higher than those in bovine milk.  Similar results were obtained in mature 
milk by Gil and Sánchez-Medina (1981) in their determination of UDP 
hexosamine, UDP hexose, and UDP galactose in the milk of the three 
species.  The concentrations of guanosine adducts measured were 0.4, 
14.5, and 22.1 µmol dL−1 in bovine, caprine, and ovine milk, respectively.  
Nucleotide adducts contributed significantly (> 30%) to TPAN in caprine 
and ovine milks, whereas their contribution to TPAN in bovine milk was 
~10%. 
The result for guanosine adducts compared well with the aggregate of 
guanosine−sugar adduct concentrations previously reported at 1 month 
(Martin et al., 2005).  Similar concentrations of adenosine adducts were 
found, presumably derived from FAD and NADH (Fox and McSweeney, 
1998; Kanno et al., 1991).  The adenosine concentrations in bovine milk 
were much lower than those in caprine milk and ovine milk. 
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Polymeric Nucleotide Contribution to TPAN 
Polymeric nucleotides showed the least difference among the milk of the 
three species and, as with the other nucleoside forms, polymeric uridine 
from ovine milk was most abundant and was comparable to the 
concentration in human milk (Leach et al., 1995).  Given the overwhelming 
concentration of uridine in ovine milk from monomeric nucleotides, it is 
possible that polymeric uridine concentrations were elevated as a 
consequence of calculation by difference. 
Nucleobase Contribution to TPAN 
The pyrimidines, cytidine and uridine, were present primarily as 
monomeric nucleotides in the milk of the three species.  This was in 
contrast to the purines, guanosine and adenosine, which were 
predominantly present as adducts in the milk of each of these species.  
Cytidine and cytidine nucleotides were the most prevalent forms in bovine 
milk; similar results were obtained in the TPAN analysis of human milk 
(Leach et al., 1995).  In contrast, uridine was the dominant nucleobase in 
caprine and ovine milk.  The total cytidine concentration was lowest in 
bovine milk, whereas caprine and ovine milk contained similar amounts.  
The concentrations of total uridine, guanosine, and adenosine were lowest 
in bovine milk and highest in ovine milk.  The concentrations of total 
uridine, guanosine, and adenosine reported in human milk (Leach et al., 
1995) were higher than those measured in bovine milk but much lower 
than those of caprine milk and ovine milk. 
Total Potentially Available Nucleosides 
The TPAN concentrations in the milk of the three species varied markedly, 
with ovine milk having the highest concentrations and bovine milk having 
the lowest concentrations; Figures 58–59.   
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Figure 58. TPAN concentration in bovine, caprine, and ovine milk 
 
 
 
 
 
 
 
 
 
 
Figure 59. Relative TPAN levels in bovine, caprine, and ovine milk 
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Ovine milk contained the highest concentrations of nucleosides, free 
nucleotides, nucleotide adducts, and polymeric nucleotides, as well as the 
highest contribution from each nucleobase.  Similarly, bovine milk 
contained the lowest concentrations of all forms of nucleosides and 
nucleotides, with caprine milk being intermediate.  The TPAN 
concentration reported in human milk (Leach et al., 1995) is higher than 
that measured in bovine milk but much lower than those of caprine milk 
and ovine milk. 
Previous studies on nucleotides in both bovine and caprine milk have 
shown higher concentrations of free nucleotides and related compounds in 
the latter (Gil and Sánchez-Medina, 1981; Johke and Goto, 1962), while 
the nucleotide concentrations in caprine milk have been favourably 
compared with those in human milk (Prosser et al., 2008).  Because of 
this, supplementation of caprine milk-based infant formulas with 
nucleotides is not necessary, as such products provide similar quantities of 
free nucleotides to those in nucleotide supplemented bovine milk-based 
infant formulas.  However, this present study showed that, when TPAN 
concentrations were calculated, caprine milk contained 97.4 µmol dL−1, 
i.e., more than four times greater than the highest TPAN concentration 
reported in human milk (Leach et al., 1995). 
The contribution of various forms to TPAN in bovine milk in this study, 
correspond well to the results for mature milk (days 10, 20, 30) for both 
winter and summer milk in the preceding study.  This is expected since 
bovine milk collected from a pooled in factory silo will be sourced from 
cows producing mature milk. 
The TPAN concentration in bovine milk measured in the present study was 
most comparable with the concentration in human milk, as reported by 
Leach et al. (1995).  Bovine milk contained cytidine and uridine 
nucleosides and nucleotides in approximately equal molar proportions, 
whereas ovine and caprine milk were dominated by uridine and uridine 
nucleotides. 
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3.3. Nucleoside and Nucleotide Analysis by 
LC-MS 
The analysis of nucleosides as well as nucleotides was identified by the 
Nucleotides Working Group within SPIFAN as a key tool for compliance 
testing of nucleotides in infant formulas (Sullivan, 2012).  The aim of this 
study is to develop and validate an accurate and robust method for the 
simultaneous analysis of nucleosides and nucleotides in fortified infant 
formulas.   
For many compounds, LC-MS is a more sensitive and specific technique 
than LC-UV.  It can analyse compounds that lack a suitable chromophore 
as well as identifying components in unresolved chromatographic peaks, 
thereby reducing the need for perfect chromatography.  Security of 
accurate analytical results is enhanced by the use of isotopically labelled 
internal standards.  The method herein describes a simple centrifugal 
ultrafiltration clean up followed by LC-MS/MS analysis.  This method has 
been validated for the analysis of bovine milk-based, caprine milk-based, 
soy-based, elemental, and hypoallergenic infant formula. 
A description of this method and results obtained from this research were 
summarised and have been submitted for publication. 
3.3.1. EXPERIMENTAL 
3.3.1.1 Apparatus 
The HPLC system used consisted of a CBM20A system controller, two 
LC20ADXR pumps for a high-pressure gradient, a CTO20AC column 
oven, and a SIL20ACXR autosampler equipped with a 50 L injection 
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loop, (Shimadzu).  The MS/MS system consisted of a 3200 QTRAP 
quadrupole mass spectrometer with a Turbo V ion source equipped with 
an ESI probe; Analyst 1.5.1 software was used for instrument control and 
data processing (ABSciex, Foster City, CA).   
UV absorbances for calibration standards were acquired with a model 
UV-1601 spectrophotometer (Shimadzu) with digital readout to 4 decimal 
places.  An Orion SA520 pH meter (Thermo Scientific, Waltham, MA) was 
used for the determination of pH. 
Chromatographic separation was achieved using a Gemini column, 5 m, 
4.6 mm x 250 mm (Phenomenex).  Polypropylene centrifuge tubes were 
sourced from Biolab and Amicon Ultra-4 3 kDa MWCO centrifugal filter 
units from Millipore. 
3.3.1.2 Reagents 
Ammonium acetate (≥ 98%), ammonium bicarbonate (≥ 99.5%), Ado 
(≥ 99%), Cyd (≥ 99%), Guo (≥ 98%), Ino (≥ 99%), Urd (≥ 99%), AMP 
(≥ 99%), CMP disodium salt (≥ 99%), GMP disodium salt hydrate (≥ 99%), 
IMP disodium salt (≥ 98%), and UMP (≥ 99%) were obtained from Sigma-
Aldrich.  SIL nucleoside standards (chemical purity), 13C5 Ado (≥ 97%), 
13C9
15N3 Cyd (≥ 98%), 
15N5 Guo (≥ 98%), 
15N4 Ino (≥ 98%), and 
13C9
15N2 
Urd (≥ 98%), were purchased from Cambridge Isotope Laboratories 
(Andover, MA, USA).  SIL nucleotide standards (chemical purity), 
13C10
15N5 AMP (≥ 90%), 
13C9
15N3 CMP (≥ 90%), 
13C10
15N5 GMP (≥ 90%),  
and 13C9
15N2 UMP (≥ 90%), were purchased from Sigma-Aldrich; 
13C10
15N4 
IMP (≥ 90%), was purchased from Medical Isotopes (Pelham, NH, USA).  
Potassium dihydrogen phosphate, orthophosphoric acid, potassium 
hydroxide (GR ACS grade or equivalent), and methanol (LC-MS grade) 
were supplied by Merck.  Water was purified with resistivity ≥ 18 M using 
an E-pure water system (Barnstead). 
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A standardising buffer (KH2PO4, 0.25 M, pH = 3.5) was made as described 
previously (see 3.1.1.2).  Mobile phase A (NH4CH3COO, 10 mM; 
NH4HCO3, 5 mM, pH = 5.6) was made daily by dissolving 0.771 g 
NH4CH3COO and 0.395 g NH4HCO3 in 950 mL of water, adjusting the pH 
to 5.6 with acetic acid solution (10% w/v), then making to 1 L with water.  
Mobile phase B consisted of 100% methanol. 
3.3.1.3 Standard Solutions 
SIL nucleoside and nucleotide stock standards were prepared by 
accurately weighing 50 mg each of 13C5 adenosine (
13C isotope label, 
subscript number of atoms labelled), 13C9
15N3 cytidine, 
15N5 guanosine, 
15N4 inosine, 
13C9
15N2 uridine, 
13C10
15N5 AMP, 
13C9
15N3 CMP, 
13C10
15N5 
GMP, 13C10
15N4 IMP, and 
13C9
15N2 UMP into separate 50 mL volumetric 
flasks.  To each flask 40 mL of water was added, and then shaken (with 
gentle warming if necessary) until the standard was completely dissolved, 
before water was added to volume.  Aliquots (~1.5 mL) of SIL stock 
standards were immediately dispensed into individual cryogenic vials and 
frozen at -15°C for later use.  Prior to analysis cryogenic vials containing 
each SIL nucleoside and nucleotide stock standard were allowed to thaw 
to room temperature. 
Non-isotopically labelled (NIL) nucleoside and nucleotide stock standards 
were prepared in the similar manner as described previously (Gill and 
Indyk, 2007b; see 3.1.1.3) by accurately weighing approximately 50 mg of 
each nucleotide into separate 50 mL volumetric flasks and making to 
volume with water.  These were refrigerated at 4 °C for up to 1 month. 
Estimation of moisture content in nucleosides was performed by the oven 
moisture method (102 °C) and the concentration was calculated on a dry 
weight basis.  Extinction coefficients at UV absorbance maxima were then 
determined for each nucleoside.  These were compared with the values 
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previously determined in nucleotides (Gill and Indyk, 2007b), with 
correction for molecular weights.  The values obtained for each nucleoside 
were in close agreement with those for the corresponding nucleotide.  
Mean extinction coefficient values (nucleoside and corresponding 
nucleotide) were calculated and are reported in Table 28. 
The concentration of each NIL nucleoside and nucleotide stock standard 
was determined by adding 500 µL of each stock standard into separate 
25 mL volumetric flasks, diluting with standardising buffer, and measuring 
the absorbance at the appropriate max. 
 
A mixed SIL intermediate standard was prepared by diluting 2.0 mL of 
each SIL stock standard into a 25 mL volumetric flask and making to 
volume with water.  A mixed NIL intermediate standard was made by 
Table 28. Nucleoside and nucleotide extinction coefficients 
Analytea E 1%1cm max (nm) 
AMP 428.6 
257 
Ado 557.0 
CMP 390.9 
280 
Cyd 519.5 
GMP 392.0 
254 
Guo 502.8 
IMP 356.5 
249 
Ino 462.7 
UMP 312.7 
262 
Urd 415.1 
a 
AMP = adenosine 5′-monophosphate 
 CMP = cytidine 5′-monophosphate 
 GMP = guanosine 5′-monophosphate 
 IMP = inosine 5′-monophosphate 
 UMP = uridine 5′-monophosphate 
 Ado = adenosine 
 Cyd = cytidine 
 Guo = guanosine 
 Ino = inosine 
 Urd = uridine 
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adding 1.0 mL of each NIL stock standard into a 25 mL volumetric flask 
and making to volume with water. 
Four calibration standards were prepared by pipetting 1.0, 1.0, 0.5, and 
0.2 mL of SIL intermediate standard and 2.0, 4.0, 5.0, and 8.0 mL of NIL 
intermediate standard into 50, 50, 25, and 10 mL volumetric flasks 
respectively.  The calibration standards were then made to volume with 
water and mixed thoroughly. 
3.3.1.4 Sample Preparation 
Approximately 5.0 g of infant formula powder was weighed accurately into 
a 50 mL polypropylene centrifuge tube (Biolab, Auckland, New Zealand) 
and dissolved in 25 mL of water.  To this was added 1.0 mL of SIL 
intermediate standard and the tube was capped and vortex mixed, 
followed by 10 min standing to allow sample to hydrate, before dilution to a 
final volume of 50 mL with water. 
A 4.0 mL aliquot of sample solution was added to an Amicon Ultra-4 3 kDa 
MWCO centrifugal ultrafiltration unit (Millipore, Billerica, MA, USA) and 
centrifuged at 3500 x g for 60 min.  The filter was then removed and 
discarded and a 1 mL aliquot of filtrate was transferred to an HPLC vial 
ready for analysis. 
3.3.1.5 Chromatography 
High-pressure gradients were formed by mixing two mobile phases, 
A and B, at a constant flow rate of 0.75 mL min-1, Table 29. 
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Table 29. Gradient procedure for RPLC-MS method 
Time 
(min) 
Temperature 
(°C) 
Flow rate 
(mL min-1) 
Mobile phase compositiona 
%A %B 
  0.0 40 0.75 100   0 
  3.5 40 0.75 100   0 
10.0 40 0.75   80 20 
20.0 40 0.75   80 20 
21.0 40 0.75 100   0 
35.0 40 0.75 100   0 
a Mobile phase A = NH4CH3COO, 10 mM; NH4HCO3, 5 mM, pH = 5.6 
 Mobile phase B = 100% methanol 
3.3.1.6 Mass Spectrometry 
The mass spectrometer was operated using an ESI source in positive 
mode with nitrogen utilised as drying and collision gas.  The instrumental 
parameters were set as follows: curtain gas at 30 psi, nebuliser gas GS1 
and GS2 at 50 and 70 psi respectively, desolvation temperature at 700 °C, 
CID gas at medium, and ion spray voltage at 5500 V.  MRM transitions 
and instrument settings for generation of product ions for nucleosides and 
nucleotides is given in Table 30–31. 
.  
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3.3.2. RESULTS AND DISCUSSION 
3.3.2.1 Method Development 
Sample Preparation 
The aim of the sample preparation procedure was to remove co-eluting 
matrix components without reducing overall recoveries of analytes.  Any 
risk of reduced recovery though sample preparation is mitigated in an 
LC-MS assay by the use of an SIL standard, therefore, provided sufficient 
analyte is recovered to ensure than ample signal is obtained, quantitative 
recovery through sample preparation step is not essential for accurate 
results. 
Initial sample preparation was developed with the intention of using HILIC 
for quantitative analysis.  The pH of the sample was lowered with acetic 
acid, followed by centrifugation and separating off the supernatant, which 
was adjusted to pH 6.5 with ammonium hydroxide.  An aliquot was added 
to an HPLC vial with sufficient acetonitrile added to reduce aqueous 
content to < 30%, thereby facilitating optimal chromatographic separation 
and eliminate peak splitting.  However, it was observed that phase 
separation was occurring within the HPLC vial.  Normally water and 
acetonitrile are miscible, but phase separation was attributed to the high 
salt content of the sample extract.  This is the principle involved in the 
QuEChERS (quick, easy, cheap, effective, rugged and safe) technique, 
typically applied to the analysis of pesticide residues (Anastassiades et al., 
2003).   
The QuEChERS technique was investigated and is based on acetonitrile 
partitioning whereby water and proteins are removed from the sample by 
salting out with magnesium sulphate and sodium chloride.  This is then 
followed up with dispersive SPE to remove potential interferences.  The 
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method was developed for the analysis of pesticides in low-fat commodity 
products, although more recently it has been adapted to intermediate and 
high-fat products (Lehotay et al., 2005).  The QuEChERS method covers a 
wide range of analytes including polar pesticides (Payá et al., 2007).  The 
extraction of nucleosides and nucleotides into an acetonitrile/water phase 
in the sample preparation is potentially attractive, as this can be readily 
coupled to a HILIC system, which offers a number of advantages over 
RPLC in the LC-MS analysis of polar compounds.  Although the initial use 
of QuEChERS in this study gave quantitative recovery of nucleosides, the 
recovery of nucleotides was negligible, as they remained in the aqueous 
phase and did not partition into the organic phase.  The ionic nature of 
nucleotides therefore makes them unsuitable as candidates for use with 
the QuEChERS extraction procedure. 
The use of CUF for protein removal from infant formula in the analysis of 
nucleotides was previously described by Inoue et al. (2008) and was 
evaluated in the development of the LC-UV method described previously 
(see 3.1.2.1).  Two brands of CUF tubes were assessed, Vivaspin (GE 
Healthcare, Little Chelfont, UK) and Amicon, in 4 and 15 or 20 mL sizes 
and at 3 and 10 kDa.  Powder samples were reconstituted at 10 % and 
25 % w/v and it was found that at either concentration, high centrifuge 
speeds were required to obtain sufficient filtrate (~1 mL), which 
necessitated the use of the smaller 4 mL CUF tubes.  A higher 
concentration of powder was considered ideal in order to increase signal in 
subsequent LC-MS analysis.  Because only a small volume of extract was 
required for LC-MS analysis, the higher concentration sample and lower 
MWCO tubes were chosen for use as part of the method.  For cost 
reasons, the Amicon Ultra-4, 3 kDa MWCO CUF tubes were selected for 
continued use in method development and evaluation. 
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Chromatography 
HILIC has been used previously in the analysis of nucleosides and 
nucleotides, and the use of this technique was evaluated.  However, 
problems associated with nucleotide peak shape and retention were 
found.  An additional concern was the solubility of nucleotides at high 
organic solvent conditions (> 90%).  PGC was also assessed, but similar 
problems with nucleotide peak shape and retention were found. 
The simultaneous chromatographic analysis of both nucleosides and 
nucleotides in infant formulas has previously been described using LC-UV 
(Gill and Indyk, 2007b).  However, the mobile phase contained a 0.1 M 
phosphate buffer, which is generally regarded as unsuitable for use in 
LC-MS.  Ammonium acetate (10 mM, pH = 5.6) was chosen to buffer the 
mobile phase due to its compatibility with LC-MS and its pH buffering 
range of ~3.8–5.8 which is appropriate given the pKa of various 
nucleosides and nucleotides.  However, significant peak tailing was 
observed for nucleotide peaks when this buffer was used. 
The interaction of phosphorylated compounds with metal surfaces in liquid 
chromatographic applications has been reported previously (Asakawa 
et al., 2008; De Vijlder et al., 2011; Kim et al., 2004; Liu et al., 2005; 
Wakamatsu et al., 2005).  Peak tailing of phosphorylated compounds has 
been observed in a wide range of liquid chromatographic techniques such 
that acquiring symmetrical peaks can be extremely difficult (Asakawa 
et al., 2008).  Conventional LC-UV nucleotide analyses typically contain 
phosphate in the mobile phase and no significant peak tailing is observed 
(Gill and Indyk, 2007b; Perrin et al., 2001).  It was postulated that the 
interaction between phosphate compounds and stainless steel may be 
suppressed by a passive film formed on the stainless steel surface at 
relatively low phosphate concentrations, thereby obtaining good peak 
shapes (Wakamatsu et al., 2005).  Unfortunately, the use of non-volatile 
buffers such as phosphate in LC-MS is generally not recommended due to 
a decrease in sensitivity, and contamination of the ion source. 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 172 
NUCLEOSIDE AND NUCLEOTIDE ANALYSIS BY LC-MS 
A number of approaches have been employed in order to overcome this 
problem.  Wakamatsu et al. (2005) evaluated a pre-treatment phase for 
the chromatographic system using phosphoric acid prior to switching to a 
non-phosphate eluent during analysis.  This approach was applied to the 
analysis of nucleosides and nucleotides in dietary foods using 1% 
phosphoric acid in 50% acetonitrile (0.3 mL min-1, 60 min) to pre-condition 
the UHPLC system without introduction to the mass spectrometer prior to 
each measurement Yamaoka et al. (2010).  While successful in reducing 
peak tailing, pre-treatment of the chromatographic system came at the 
cost of a substantial increase in analysis time.  The substitution of 
polyether ether ketone (PEEK) tubing for stainless steel can reduce peak 
tailing (Wakamatsu et al., 2005), however, the removal of all stainless 
steel is problematic, and PEEK has limited tolerance to back pressure.  A 
highly basic mobile phase (25-50% ammonium hydroxide, pH ≈ 12) was 
used by Tuytten et al. (2006); however, these conditions would be 
detrimental to silica-based HPLC columns.  The addition of EDTA to either 
sample or the mobile phase was also found to be beneficial in reducing 
phosphorylated compounds metal interactions (Liu et al., 2005); however, 
as EDTA is not volatile, its use in LC-MS is not ideal.   
Several mass spectrometer manufacturers have evaluated the use of 
phosphate buffers for use with their instruments and shown that modern 
source designs can handle non-volatile buffers better than older designs 
(Agilent Technologies, 1998; Applied Biosystems, 2006; Dionex 
Corporation, 2001; Waters Corporation, 1998).  A phosphate-based 
IPRPLC−MS method was successfully applied to the quantitative analysis 
of intracellular nucleotides utilising a microbore column to reduce the 
amount of phosphate introduced to the ion source (St. Claire, 2000). 
In the present study, a low phosphate buffer (NH4H2PO4 0.08 mM, 
pH = 5.6) was evaluated for use with the mass spectrometer.  
Chromatographic parameters of resolution, retention factor, peak area 
repeatability, retention time repeatability, plate number, and asymmetry 
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were evaluated, and with acceptable results obtained; Table 32.  There 
was some loss of sensitivity as the analytical run progressed, and a small 
build-up of buffer on the cone was observed, but did not block the orifice.  
The method was applied to the analysis of nucleotides in infant formula 
samples in a validation study; Table 33.   
Linear response was demonstrated for the ratio of NL/SIL peak areas vs. 
the ratio of NL/SIL analyte concentration (r2 = 0.997–0.999).  Accuracy 
and precision were evaluated with both spike recovery (84.2–107.1%) and 
repeatability (1.5–3.1% RSD) deemed acceptable.  A limitation with this 
approach was that the number of samples within each analytical run was 
limited due to build-up of phosphate in the ion source, which required 
regular cleaning.  
Asakawa et al. (2008) investigated the effect of a number of mobile phase 
additives on peak tailing and found some that showed positive effects 
similar to that found with phosphate and EDTA.  Of those evaluated, only 
ammonium bicarbonate is volatile and deemed suitable for use in LC-MS.   
Under acidic conditions, only a small fraction of the dissolved CO2 is 
present as H2CO3.  The dissolved CO2 concentration in water is in 
equilibrium with the partial pressure of CO2 in the atmosphere.  Acid/base 
equilibria for ammonium bicarbonate are illustrated in Figure 60.  This 
complicates the use of bicarbonate as a buffering agent, therefore 
bicarbonate was used as an additive to acetate buffered mobile phase.   
 
 
 
 
Figure 60. Ammonium bicarbonate equilibria  
pKa = 6.3
H2CO3 HCO3
– + H+
pKa = 9.2
NH4
+ NH3+ H
+
pKa = 10.3
HCO3
– CO3
2– + H+
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 174 
NUCLEOSIDE AND NUCLEOTIDE ANALYSIS BY LC-MS 
 
 
 
  
T
a
b
le
 3
2
. 
S
y
s
te
m
 s
u
it
a
b
ili
ty
 o
f 
p
h
o
s
p
h
a
te
 b
u
ff
e
r 
L
C
-M
S
 m
e
th
o
d
 
A
n
a
ly
te
a
 
A
M
P
 
(8
.0
%
) 
(9
.1
%
) 
(2
3
.5
%
) 
(3
.4
%
) 
(1
6
.9
%
) 
(0
.8
%
) 
a
 
A
M
P
 =
 a
d
e
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
; 
 
 
C
M
P
 =
 c
y
ti
d
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
 
G
M
P
 =
 g
u
a
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
 
IM
P
 =
 i
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
 
U
M
P
 =
 u
ri
d
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
b
 
M
e
a
n
 (
p
e
rc
e
n
t 
re
la
ti
v
e
 s
ta
n
d
a
rd
 d
e
v
ia
ti
o
n
) 
o
f 
7
 r
e
p
lic
a
te
s
 o
f 
a
 m
ix
e
d
 n
u
c
le
o
ti
d
e
 s
ta
n
d
a
rd
 
c
 
R
e
te
n
ti
o
n
 t
im
e
 (
m
in
) 
1
7
.8
 
6
.1
 
1
0
2
5
4
2
 
1
.1
 
1
3
.3
 
5
1
2
4
0
9
 
IM
P
 
(1
.1
%
) 
(2
.2
%
) 
(2
7
.6
%
) 
(1
5
2
%
) 
(4
.7
%
) 
(1
.1
%
) 
1
4
.8
 
4
.9
 
9
1
3
5
2
 
1
.3
 
1
.1
 
2
2
5
5
1
9
 
G
M
P
 
(0
.9
%
) 
(1
.0
%
) 
(2
7
.1
%
) 
(0
.0
%
) 
(1
6
.3
%
) 
(1
.9
%
) 
1
4
.5
 
4
.8
 
9
5
6
4
1
 
0
.0
 
1
6
.3
 
3
5
9
4
7
9
 
U
M
P
 
(3
.9
%
) 
(5
.3
%
) 
(2
.1
%
) 
(5
.1
%
) 
(2
.2
%
) 
(1
.2
%
) 
1
0
.3
 
3
.1
 
1
4
9
2
0
 
1
.0
 
6
.9
 
2
4
7
6
5
5
 
C
M
P
b
 
(3
.8
%
)b
 
(4
.2
%
) 
(2
.9
%
) 
(5
.0
%
) 
(–
) 
(0
.9
%
) 
8
.2
 
2
.3
 
1
4
6
3
7
 
1
.0
 
–
 
2
0
6
1
8
4
 
P
a
ra
m
e
te
r 
R
e
te
n
ti
o
n
 t
im
e
c
 
R
e
te
n
ti
o
n
 f
a
c
to
r,
 k
′ 
T
h
e
o
re
ti
c
a
l 
P
la
te
s
, 
N
 
T
a
ili
n
g
, 
T
f 
R
e
s
o
lu
ti
o
n
, 
R
s
 
P
e
a
k
 a
re
a
 r
e
p
e
a
ta
b
ili
ty
 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 175 
NUCLEOSIDE AND NUCLEOTIDE ANALYSIS BY LC-MS 
 
 
  
T
a
b
le
 3
3
. 
V
a
lid
a
ti
o
n
 o
f 
p
h
o
s
p
h
a
te
 b
u
ff
e
r 
L
C
-M
S
 m
e
th
o
d
 
H
o
rR
a
td
 
0
.8
 
0
.7
 
0
.6
 
0
.9
 
0
.5
 
 
a
 
A
M
P
 =
 a
d
e
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
 
C
M
P
 =
 c
y
ti
d
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
 
G
M
P
 =
 g
u
a
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
 
iM
P
 =
 i
n
o
s
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
 
U
M
P
 =
 u
ri
d
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
 
 
T
M
P
 =
 t
h
y
m
id
in
e
 5
′-
m
o
n
o
p
h
o
s
p
h
a
te
. 
b
 
9
5
%
 c
o
n
fi
d
e
n
c
e
 i
n
te
rv
a
l 
fo
r 
re
p
e
a
ta
b
ili
ty
 s
ta
n
d
a
rd
 d
e
v
ia
ti
o
n
. 
c
 
R
e
p
e
a
ta
b
ili
ty
 r
e
la
ti
v
e
 s
ta
n
d
a
rd
 d
e
v
ia
ti
o
n
 (
R
S
D
r)
 =
 s
d
/m
e
a
n
 x
 1
0
0
 (
n
 =
 6
) 
d
 
H
o
rR
a
t 
=
 R
S
D
r/
p
R
S
D
, 
w
h
e
re
 p
R
S
D
 =
 C

0
.1
5
0
5
 a
t 
1
0
 
g
 g
-1
 c
o
n
c
e
n
tr
a
ti
o
n
 l
e
v
e
l 
R
S
D
rc
 
(%
) 
2
.6
 
2
.0
 
2
.4
 
3
.1
 
1
.5
 
 
S
D
rb
 
(m
g
 h
g
–
1
) 
0
.0
7
–
0
.1
7
 
0
.1
3
–
0
.3
3
 
0
.0
2
–
0
.0
6
 
0
.0
3
–
0
.0
9
 
0
.0
3
–
0
.0
9
 
 
R
e
c
o
v
e
ry
 
(%
) 
1
0
7
 
1
0
0
 
 9
6
 
 9
8
 
1
0
5
 
 
r2
 
0
.9
9
9
3
 
0
.9
9
7
7
 
0
.9
9
7
2
 
0
.9
9
8
6
 
0
.9
9
6
9
 
0
.9
9
8
4
 
0
.9
9
8
3
 
0
.9
9
3
6
 
0
.9
8
9
2
 
0
.9
9
5
1
 
L
in
e
a
r 
re
g
re
s
s
io
n
 
y
 =
 6
9
0
6
4
1
x
 +
 2
3
0
6
3
6
 
y
 =
 3
4
5
4
1
1
 x
 +
 1
4
1
8
2
0
 
y
 =
 3
1
4
8
6
2
x
 +
 1
6
4
7
6
5
 
y
 =
 4
2
0
4
4
2
x
 +
 1
2
8
9
2
4
 
y
 =
 8
2
7
7
3
3
x
 +
 2
9
4
4
0
2
 
y
 =
 5
9
6
4
5
2
x
 +
 1
9
7
0
7
7
 
y
 =
 3
5
2
8
3
7
x
 +
 1
2
6
4
2
5
 
y
 =
 3
4
0
2
6
3
x
 +
 1
4
4
8
9
7
 
y
 =
 3
1
8
7
5
3
x
 +
 2
1
9
8
6
9
 
y
 =
 7
7
1
0
5
7
x
 +
 3
6
2
9
4
0
 
R
a
n
g
e
 
(
g
 m
L
–
1
) 
0
.1
9

1
9
.4
0
 
0
.1
5

1
5
.1
8
 
0
.1
7

1
7
.2
4
 
0
.1
3

1
2
.7
9
 
0
.1
1

1
1
.0
6
 
0
.1
8

1
8
.4
9
 
0
.1
4

1
3
.7
7
 
0
.1
5

1
4
.6
2
 
0
.1
3

1
3
.2
4
 
0
.1
3

1
2
.5
1
 
A
n
a
ly
te
a
 
A
M
P
 
C
M
P
 
G
M
P
 
IM
P
 
U
M
P
 
1
3
C
1
0
,1
5
N
5
 A
M
P
 
1
3
C
9
,1
5
N
3
 C
M
P
 
1
3
C
1
0
,1
5
N
5
 G
M
P
 
1
3
C
1
0
,1
5
N
4
 I
M
P
 
1
3
C
9
,1
5
N
2
 U
M
P
 
ANALYSIS OF NUCLEOSIDES AND NUCLEOTIDES IN MILK AND INFANT FORMULA 
RESEARCH 176 
NUCLEOSIDE AND NUCLEOTIDE ANALYSIS BY LC-MS 
The mechanism of how bicarbonate reduces peak tailing was not 
explained by Asakawa et al., however, it is likely that it acts in the same 
manner to phosphate, which has been postulated to act as a layer on the 
stainless steel reducing interactions with nucleotides (Wakamatsu et al., 
2005). 
Mass Spectrometry 
The optimisation of the MS conditions was performed by infusion of a 
standard of each nucleoside or nucleotide (~10 µg mL−1) diluted in a 
mixture of mobile phases A and B (90:10).  Initial development focused on 
ESI+ for nucleosides and ESI– for nucleotides, it was found that ESI+ gave 
superior response for both analytes, with the [M+H]+ ion most abundant 
with low levels of potassium adducts.  This simplified the analysis given 
that polarity switching would not be necessary.  Conditions for MRM were 
optimised by selecting individual fragments and adjusting collision 
energies in order to maximise product ion signal. 
Quantitative product ions for nucleosides were obtained from parent ions 
by loss of neutral ribosyl group (m/z = 132).  This fragmentation is typical, 
since a relatively small amount of energy is required to break one 
(glycosidic) bond, and has been seen in numerous studies (Clariana et al., 
2010; Kammerer et al., 2005; la Marca et al., 2006; Lee et al., 2004; 
Tuytten et al., 2008).  While fragmentation of CMP, GMP, IMP, and AMP 
resulted in the loss of the ribosyl-phosphate group (212 Da) with detection 
of the positively charged base, UMP underwent a more complicated 
fragmentation to obtain a predominant product ion of m/z = 97.  This 
product ion for UMP was also reported by Inoue et al. (2010).  A possible 
pathway to generate this product ion is given in Figure 61.   
A similar fragmentation scheme was described by Curtis et al. (2010), for 
the generation of a product ion with m/z = 81.0 from the fragmentation of 
deoxycytidine 5′-monophosphate. 
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This fragment satisfies a number of conditions:  
1) for non-labelled UMP the product ion, m/z = 97 is seen, whereas for 
SIL UMP the corresponding product ion m/z = 102; therefore of the 
11 isotope labels in parent isotopically labelled UMP, 5 must appear 
in product ion. 
2) the nitrogen rule indicates that the product ion must have either 
both of the nitrogen’s from the precursor ion, or neither of them 
(Yadav, 2005). 
3) since a similar product is not found with uridine, it is probable that 
the phosphate group is critical to the formation of the product ion. 
 
 
Figure 61. Possible fragmentation of UMP 
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Using the developed LC-MS/MS method, the simultaneous detection of 
nucleosides and nucleotides in a standard solution was achieved; 
Figures 62–63. 
 
 
Figure 62. NIL nucleoside and nucleotide MRM chromatograms 
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Quantitation 
When a compound is introduced into the ion source not all of the 
molecules are ionised.  The ionisation efficiency is the fraction of 
introduced compound that becomes ionised, and this differs depending 
upon the chemical structure of the compound, but also due to various 
source parameters, such as temperature and pressure, within the source 
that can vary during day-to-day operation, and are impossible to control 
precisely (Stokvis et al., 2005).  LC-MS is different from other modes of 
detection, such as UV and fluorescence, in that co-eluting compounds that 
are not detected can enhance or suppress the analyte response.  
Additionally, even similar samples may have different combinations and 
concentrations of endogenous compounds that yield different ionisation 
responses of the analyte (Hewavitharana, 2011).  A number of strategies 
can be employed in order to reduce or eliminate matrix effects upon MS 
signal.  However, with complex matrices such as milk products, there is a 
limit to the effectiveness of sample clean-up strategies. 
Matrix matched calibration curves are a common way to compensate for 
signal suppression or enhancement.  However, when a blank matrix is not 
readily available, this approach becomes less feasible (Lehotay et al., 
2010). 
An internal standard calibration technique is appropriate, since it does not 
depend upon the absolute response of the analyte, as long as the 
changes in sensitivity are consistent for the analyte and internal standard.  
If the analyte and internal standard co-elute, changes in sensitivity of the 
analyte due to matrix effects are compensated for.  However, if the analyte 
and internal standard have different retention times they can experience 
different ionisation environments, yielding inaccurate results. 
SIL internal standards are forms of the analyte in which several atoms are 
replaced by isotopes such as 13C, 2H, 18O, or 15N.  It is generally accepted 
that SIL internal standards are chemically and physically identical to the 
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analyte and therefore they have the same retention time, and since their 
atomic mass differs by a few Daltons, they are distinguishable from one 
another by MS making them ideal candidates as internal standards.  It 
should be noted that deuterated internal standards can have stronger 
bonding to carbon atoms, thereby subtly affecting their physicochemical 
properties such that they may exhibit different retention times or recoveries 
(Stokvis et al., 2005; Wang et al., 2007).  For this reason, 13C and 15N 
labelled nucleosides and nucleotides were selected as internal standards 
in the development of this method.  
3.3.2.2 Method Performance 
System Suitability 
A high degree of selectivity is afforded by an MRM experiment; however, 
chromatographic separation is required for critical peaks with similar MRM 
transitions if accurate quantitation is to be achieved.  Chromatographic 
performance was assessed by replicate analyses (n = 6) of a mixed 
nucleoside and nucleotide standard with satisfactory resolution being 
obtained between IMP/AMP (6.7), Ino/Ado (6.8), and Cyd/Urd (4.3) critical 
pairs which differ in mass by < 2 D.  While some peak tailing of 
nucleotides was seen when comparing them with corresponding 
nucleosides, peak tailing was acceptable and would not impede accurate 
estimation of peak area for quantitative purposes; Table 34. 
Single Laboratory Validation 
Method validation experiments to determine linearity, detection limits, and 
precision are summarised in Table 35.  Linearity was evaluated by least-
squares regression analysis, with acceptable values being obtained for the 
correlation coefficient and with standard residuals plots showing no pattern 
and only a small amount of random variation; Figures 64–83.    
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Figure 64. LC-MS method: Cyd linear regression plot 
 
 
Figure 65. LC-MS method: Cyd residuals plot 
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Figure 66. LC-MS method: Urd linear regression plot 
 
 
 
Figure 67. LC-MS method: Urd residuals plot 
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Figure 68. LC-MS method: Guo linear regression plot 
 
 
 
Figure 69. LC-MS method: Guo residuals plot 
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Figure 70. LC-MS method: Ino linear regression plot 
 
 
 
Figure 71. LC-MS method: Ino residuals plot 
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Figure 72. LC-MS method: Ado linear regression plot 
 
 
 
Figure 73. LC-MS method: Ado residuals plot 
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Figure 74. LC-MS method: CMP linear regression plot 
 
 
 
Figure 75. LC-MS method: CMP residuals plot 
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Figure 76. LC-MS method: UMP linear regression plot 
 
 
Figure 77. LC-MS method: UMP residuals plot 
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Figure 78. LC-MS method: GMP linear regression plot 
 
 
 
Figure 79. LC-MS method: GMP residuals plot 
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Figure 80. LC-MS method: IMP linear regression plot 
 
 
 
Figure 81. LC-MS method: IMP residuals plot 
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Figure 82. LC-MS method: AMP linear regression plot 
 
 
 
Figure 83. LC-MS method: AMP residuals plot 
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Indyk, 2007b).  Precision was evaluated as repeatability from 1.9–14.5% 
(HorRat = 0.2–0.8) and intermediate precision from 2.9–14.4%. 
Accuracy determined as spiked recovery results measured in the six 
different product types were within the acceptable limits of 80–115% at the 
10 µg g-1 level as suggested by the AOAC (Horwitz, 2002); Table 36.  
Accuracy estimated as bias was evaluated against reference values for 
NIST 1849a CRM and against AOAC Method 2011.20; Tables 37–38.  
Although there were statistically significant differences for some of the 
results, the differences were small enough (0–13%) that they are unlikely 
to be of practical significance for compliance and labelling requirements. 
A robustness trial was performed evaluating seven factors at levels likely 
to occur during normal use of the method.  The seven factors assessed 
were: initial sample water volume (27 mL, 23 mL); vortex time (40 s, 20 s); 
wait time (14 min, 6 min); centrifuge volume (4.2 mL, 3.8 mL); centrifuge 
speed (4000 x g, 3000 x g); centrifuge time (70 min, 50 min); and a 
dummy factor.  The two factor levels were symmetric around the nominal 
values from the described analytical procedure, with the interval 
representing probable experimental error.  The method was found to be 
robust for the seven parameters studied with variances in the results 
obtained not being significantly different from those expected by chance; 
Figures 84–93.  Given the method’s simplicity, two critical steps are 
required to ensure the accuracy of the results obtained: accurate 
measurement of the amount of sample weighed, and accurate addition of 
the internal standard. 
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Table 38. LC-MS method: bias vs. AOAC Official Method 2011.20 
 
Biasa 
CMP UMP GMP IMP AMP 
Measured resultsb 
12.9 
(0.39) 
4.1 
(0.14) 
1.6 
(0.04) 
0 
(0) 
3.6 
(0.11) 
AOAC 2011.20 
results
b
 
12.3 
(0.5) 
4.0 
(0.21) 
1.6 
(0.07) 
0 
(0) 
3.2 
(0.16) 
Bias (p-value) <0.001 0.24 0.44 0 <0.001 
a
 AMP = adenosine 5′-monophosphate 
 CMP = cytidine 5′-monophosphate 
 GMP = guanosine 5′-monophosphate 
 IMP = inosine 5′-monophosphate 
 UMP = uridine 5′-monophosphate
 
b
 Mean (standard deviation) of analytical results for bovine milk-based infant formula in 
 mg hg
-1
 (n = 12 replicates) 
 
 
 
Figure 84. LC-MS method: Cyd half-normal plot 
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Figure 85. LC-MS method: Urd half-normal plot 
 
 
 
Figure 86. LC-MS method: Guo half-normal plot 
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Figure 87. LC-MS method: Ino half-normal plot 
 
 
 
Figure 88. LC-MS method: Ado half-normal plot 
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Figure 89. LC-MS method: CMP half-normal plot 
 
 
 
Figure 90. LC-MS method: UMP half-normal plot 
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Figure 91. LC-MS method: GMP half-normal plot 
 
 
 
Figure 92. LC-MS method: IMP half-normal plot 
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Figure 93. LC-MS method: AMP half-normal plot 
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4. CONCLUSIONS 
LC-UV Method 
The optimisation and validation of a simple and rapid method for the 
routine analysis of nucleotides in infant formulas has been described.  The 
simplicity of analysis is facilitated by the use of SPE without the need for 
prior protein removal.  The use of an internal standard gives additional 
confidence in the accuracy of the results obtained.  The method has been 
demonstrated to be applicable to the analysis of bovine milk-based, 
caprine milk-based, soy-based, and hydrolysed milk protein-based infant 
formulas.  An extension study demonstrated the expansion in scope to a 
wider range of different infant formula products.  This method was 
approved for Official First Action status by by AOAC International and 
approved for further evaluation of reproducibility via a collaborative study, 
which will be undertaken in the near future. 
TPAN Analysis of Milk 
The increasing trend towards nucleotide supplementation of bovine milk-
based infant formulas, and the need for compliance with TPAN regulatory 
limits, the data presented in this study provide a greater understanding of 
the contributions of endogenous nucleosides and nucleotides in bovine 
milk.  The TPAN concentrations in bovine milk and colostrum were 
studied, with differences in TPAN concentrations between summer-milk 
and winter-milk herds attributed particularly to variability in uridine and 
nucleotide concentrations.  As lactation progressed, TPAN concentration 
decreased, as did each of the contributing forms.  In a study of mature 
bovine, caprine, and ovine milk, significant differences among the milk of 
each species were found.  Data obtained for samples collected during the 
afternoon may be evidence of diurnal rhythmicity of nucleoside and 
nucleotide production in milk.  Further study would be useful in 
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establishing the extent and possible causes for the diurnal pattern of 
nucleoside and nucleotide expression in milk. 
Numerous climatic and dietary factors could affect TPAN levels in milk.  
Further study controlling each of these factors would be required to identify 
those factors that influence nucleoside and nucleotide expression in milk.  
An expansion of the current study could be undertaken to consider the 
effects of breed, location, and diet on TPAN expression in milk. 
LC-MS/MS Method 
It has been identified that a key industry need was an accurate, precise, 
and robust method for the simultaneous analysis of both nucleotides and 
nucleosides to ensure food safety to the infant consumer and to provide a 
reference method for dispute resolution across trade borders.  The 
optimisation and validation of an LC-MS/MS method for the analysis of 
nucleosides and nucleotides in infant formulas has been described. 
The use of SIL internal standards provides confidence in the accuracy of 
the results obtained.  Despite the attributes of tandem MS in facilitating a 
potentially unequivocal analysis, the technique is challenging with respect 
to mobile phase conditions and the need for stable isotope labelled 
standards.  The method was demonstrated to be precise and accurate, 
and has been validated for the analysis of nucleotides and nucleosides in 
bovine milk-based, soy-based, caprine milk-based and hydrolysed milk 
protein-based infant formulas. 
The infant formula industry is currently evaluating methods to be used as 
standards for analysing various nutrients, and this method makes a novel 
and significant addition to those currently under consideration. 
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THE ANALYSIS OF 5’-MONONUCLEOTIDES 
IN PEDIATRIC FORMULAS BY HPLC
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Nucleotides are compounds of critical importance to cellular function. They operate as precursors to nucleic acids, as mediators of 
chemical energy transfer and cell signalling, and as integral components of coenzymes in the metabolism of carbohydrates, lipids
and protein.
Fm[d]gla\]kmhhd]e]fl]\af^Yfl^gjemdYk`Yn]Z]]fj]hgjl]\lg]f`Yf[]aeemf]j]khgfk]$afÅm]f[]e]lYZgdakeg^^YllqY[a\k
and improve gastrointestinal tract repair after damage. With the proliferation of nucleotide-supplemented pediatric formulas, 
robust methods that incorporate minimal sample preparation and rapid chromatographic separations are required for routine 
product compliance analysis.
This method below describes a simple SPE sample clean-up that avoids the prior need to remove protein, coupled with a binary 
gradient reversed-phase liquid chromatographic system for the purpose of routine analysis of nucleotide supplemented infant 
formula. Analytical security is enhanced with an internal standard based quantitation.
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Parametersa CMPb UMP GMP IMP TMP AMP
J]l]flagflae] 0&0 (&**!c ))&0 (&)/! )1&0 (&)-! *(&. (&)(! *-&( (&(,! *-&0 (&(,!
Capacity factor (&. (! )&* (&0+! *&/ (! *&0 (! +&. (! +&0 (!
J]kgdmlagf – .&+ (&(/! ).&1 )&))! *&* (&,-! )-&. (&)1! +&- (&-/!
Tailing )&+ +&0,! )&* +&++! )&( (! )&( -&((! )&) (! )&) +&.!
Theoretical Plates .0)( (&0/! 0-*/ -&-)! ++.1* +&*0! .(,,0 )&**! )1,+.+ (&0)! *,)/,1 (&**!
Peak Area ),**-- (&-)! *((,00 )&+1! **-*,* (&*+! )**-+. (&/-!o ,00-0- (&))! +(0/-, (&(-!
a;Yd[mdYlagfkYk\]Äf]\ZqMKH`YjeY[gh]aY
b AMP = adenosine 5’-monophosphate, CMP = cytidine 5’-monophosphate, GMP = guanosine 5’-monophosphate, IMP = inosine 5’-monophosphate, UMP = uridine 5’-monophosphate, TMP = 
thymidine 5’-monophosphate” 
cE]Yf h]j[]flj]dYlan]klYf\Yj\\]naYlagf!g^kapj]hda[Yl]kg^Yeap]\fm[d]gla\]klYf\Yj\&
E=L@G<H=J>GJE9F;=
Analytea
Range
(mg mL–1)
Linear regression r2
MDL
(mg 100 g–1)b
RSDr
(%)c
HorRat
r
d
RSD
iR
(%)e
Recovery
(%)f
AMP 1.25 - 17.49 y = 255805x + 11862 1.0000 0.19 2.0 0.4 4.5 11&. *&,!
CMP 0.61 - 8.55 y = 287762x - 2493 0.9999 0.08 1.0 0.3 6.0 11&/ )&1!
GMP 1.11 - 15.55 y = 200342x - 1807 1.0000 0.06 2.1 0.4 5.2 )((&- )&/!
IMP 1.09 - 15.27 y = 198519x + 3879 1.0000 0.10 1.4 0.3 3.8 1/&0 *&,!
UMP 1.12 - 15.68 y = 146931x - 1839 0.9999 0.08 2.3 0.5 8.6 1.&- +&.!
TMP 1.61 - 22.54 y = 150494x - 455 1.0000 – – – – )((&) +&)!
a AMP = adenosine 5’-monophosphate, CMP = cytidine 5’-monophosphate, GMP = guanosine 5’-monophosphate, IMP = inosine 5’-monophos phate, UMP = uridine 5’-monophosphate, TMP = 
thymidine 5’-monophosphate
b Determined from nj]hda[Yl]kYlgjf]Yjl`]]ph][l]\\]l][lagfdaeal$E<D5t f¹)$)¹_! x sd, where n = 10 and _ = 0.01. 
cJK<j]h]YlYZadalq5k\'e]Yfp)(( f5.!»
d@gjoalrjYlag5JK<
r
'hJK<J$o`]j]hJK<r = C-0.15 at 10 ppm concentration level 
eJK<afl]je]\aYl]j]hjg\m[aZadalq5k\'e]Yfp)(( f5*,!
fE]Yfj][gn]jq h]j[]flj]dYlan]klYf\Yj\\]naYlagf!Yll`j]]d]n]dk]Y[`^gjZgnaf]eadc%ZYk]\$kgq%ZYk]\$Yf\`qhgYdd]j_]fa[af^Yfl^gjemdYk¼
J=KMDLKG:L9AF=<>JGE;GEE=J;A9DDQ9N9AD9:D=EADCHJG<M;
Sample Typea
Nucleotide
Supplemented
Results (mg/100g-1)
CMPb UMP GMP IMP AMP
Bovine milk-based IF Q]k ))&. )).!c +&/ 1-! )&/ )(.! *&( )*-! ,&- ),-!
Bovine milk-based FO Q]k .&( )(/! *&, 0/! (&1 01! )&( 1)! *&) )(+!
Bovine milk-based FO No 1.0 0 0 0.1 0
Bovine milk-based FO Q]k 0&- )/*! *&, 01! )&( )((! )&( 1*! *&+ ))-!
Bovine milk-based AN Q]k )/&, )*(! ,&/ /-! 0&( )(/! 0    – /&* )+(!
Soy-based IF No 0.1 0.3 0.3 0 0.5
Caprine milk-based IF No 4.0 8.2 6.4 0.3 2.3
Bovine milk-based WMP No 4.0 0 0 0 0
Hypoallergenic IF Nod *&. )()! *&. 1*! *&/ 0-! *&. 1.! +&) )((!
Hypoallergenic IF No 0.0 0 0 0 0
a  IF = infant formula, FO = follow-on formula, AN = adult nutritional product, WMP = whole milk powder.
b  AMP = adenosine 5’-monophosphate, CMP = cytidine 5’-monophosphate, GMP = guanosine 5’-monophosphate, IMP = inosine 5’ monophosphate, UMP = uridine 5’-monophosphate.
c J][gn]jqYkh]j[]flY_]g^dYZ]d[dYae&
d  Hypoallergenic sample spiked with nucleotide mixed standard prior to analysis.
–  IMP not added
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pediatric formulas and milk products is described. Following sample dissolution, potential interferences were removed by strong
anion-exchange solid-phase extraction. Chromatographic analyses were performed using a C18 stationary phase with gradient 
]dmlagf$MN\]l][lagfYf\oal`imYflalYlagfY[`a]n]\ZqYfafl]jfYdklYf\Yj\l][`faim]&9kaf_d]dYZgjYlgjqnYda\YlagfoYk
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analysis of nucleotide-supplemented bovine milk-based infant and follow-on formulas.
Paper submitted to Journal of AOAC International, 2009.
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SOLID PHASE EXTRACTION
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, pH 3.0 into a 
test tube. 
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HPLC ANALYSIS
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Detection: Photo-diode array, quantify at 250nm 
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small amount of random noise further demonstrating linearity. Method detection limits determined are well below levels typically supplemented to pediatric formulas. A Plackett-Burman robustness 
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The method was applied to a number of commercially available pediatric and nutritional powders. Products included for testing were infant formulas, follow-on formulas and an adult nutritional 
product. These products included a range of different sources; bovine milk, hydrolysed milk protein, caprine milk, and soy protein.
A rapid robust analytical method for the analysis of 5’-mononucleotides 
supplemented to pediatric formulas is described
}
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Sample Collection
Samples from a winter-milk herd were collected over a 1 month period in late March 2008 
and samples from a summer-milk herd were collected over a 1 month period in early August 
2009. Collected samples were initially refrigerated at 4 ºC, then taken to the laboratory where 
endogenous enzymes were chemically inactivated prior to storage at < -15 ºC.
Sample Preparation
Each sample was pooled, then split into four 5 mL sub-samples, to each of which internal 
standard (10 μg, 5-methylcytidine) was added, and then each sub-sample was subjected to a 
different enzymatic treatment.
Figure 1: Schematic of TPAN experiments
Solid Phase Extraction
Clean-up of enzymatic extracts was achieved by solid phase extraction using a phenylboronate 
affinity gel (Bio-Rad), whereby nucleosides are covalently bonded to the gel at high pH, and 
interferences were then removed with two washings in high pH buffer. The nucleosides were 
then eluted from the affinity gel at low pH with the addition of phosphoric acid, and filtered 
ready for analysis.
Chromatographic Analysis
Column: Prodigy C18 5 μm, 4.6 x 150 mm (Phenomenex)
Mobile Phase: (A) NaCH3COO (0.05 M), pH = 5.6, (B) MeOH (100%)
Flowrate: 0.7 mL/min with low-pressure gradient mixing (A) & (B)
Detection: Photo-diode array 210–300 nm, quantitation at 260 nm
Quantitation: Internal standard technique (5-methylcytidine)
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AnAlytiCAl tECHniQuE
introDuCtion
Nucleosides and nucleotides are compounds of critical importance to cellular function.  Dietary 
sources of nucleotides are considered conditionally essential for continued optimal metabolic 
function.  Dietary nucleotides are ingested in the form of nucleoproteins, polymeric nucleotides 
(nucleic acids) and nucleotide adducts as well as free nucleotides.
In order to determine the total potentially available nucleosides (TPAN), an analytical protocol 
to characterise the contributions of different molecular nucleoside sources to infant nutrition 
was developed (Leach et al. Am. J. Clin. Nutr. 1995, 61, 1224–1230). The analytical method uses a 
number of enzymatic treatments and incorporates combinations of nuclease, pyrophosphatase 
and phosphatase enzymes into the sample preparation. The development of this protocol has 
been an important contribution to further understanding the distribution of nucleosides and 
nucleotides and their implications for infant nutrition.
Bovine milk is almost exclusively used in the manufacture of infant formula intended to 
substitute for human breast milk, and since the levels of TPAN in bovine milk have not been 
previously reported, the purpose of the current study was to evaluate bovine milk TPAN levels 
and variation over the first month of lactation.
Bovine milk samples from two herds were studied over the course of the first month of lactation, 
and total potentially available nucleosides were determined. 
• Uridine and uridine nucleotides were the major contributor to TPAN in early colostrum 
• Differences in TPAN concentrations between summer milk and winter-milk herds were largely  
 attributable to variability in uridine and nucleotide concentrations.
• TPAN concentration decreased as lactation progressed, as did each of the contributing forms.
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The absolute concentrations indicated a distinct difference between the two herds, although the 
general trends were the same.  High levels of TPAN were found in colostrum, with a decrease in 
their concentrations as lactation progressed.  
Figure 3: TPAN in bovine milk over the first month of lactation
A comparison of the two herds showed little difference in total free nucleoside content as 
lactation progressed. Differences in colostral monomeric nucleotide levels between the herds
were seen, with the winter-milk herd containing 5–10 times the levels of the summer-milk 
herd although by the fifth day, nucleotide levels decreased to similar levels between the two 
herds. The levels of monomeric nucleotides measured in this study were generally higher than 
those reported previously (Gill and Indyk, Int. Dairy J. 2007, 17, 596–605), most likely due to a 
significant contribution from multiple phosphorylated forms, which the TPAN analytical method 
aggregates as a single value.
The pyrimidines (cytidine and uridine) differed markedly from each other through lactation.  
Whereas the quantities of cytidine and cytidine nucleotides were relatively constant throughout, 
uridine and uridine nucleotides levels varied considerably.  In contrast, concentrations of the 
purines (guanosine and adenosine) in bovine milk were more consistent through lactation.  
Purine nucleosides and nucleotides made a relatively small contribution to TPAN (6–20%).
The nucleoside results for each of the four sub-samples allowed the contributions of the 
different forms (nucleosides, nucleotide adducts, monomeric and polymeric nucleotides) to TPAN 
to be calculated.
Figure 2: Chromatograms of a mixed standard and colostrum sample
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An RP-HPLC method for the routine determination
of supplemented 5′-mononucleotides (uridine
5′-monophosphate, inosine 5′-monophosphate,
adenosine 5′-monophosphate, guanosine
5′-monophosphate, and cytidine
5′-monophosphate) in pediatric formulas and milk
products is described. Following sample
dissolution, potential interferences were removed
by anion-exchange SPE. Chromatographic
analyses were performed using a C18 stationary
phase with gradient elution, UV detection, and
quantitation by an internal standard technique. A
single-laboratory validation was performed, with
recoveries of 92–101% and repeatability RSDs of
1.0–2.3%. The method was optimized for the rapid,
routine analysis of nucleotide-supplemented
bovine milk-based infant and follow-on formulas.
Nucleotides are compounds of critical importance tocellular function. They operate as precursors tonucleic acids, as mediators of chemical energy
transfer and cell signaling, and as integral components of
coenzymes in the metabolism of carbohydrates, lipids, and
proteins (1–3). Nucleotides are not essential dietary nutrients
as they can be synthesized de novo or recovered via salvage
pathways. However, in times when the endogenous supply is
inadequate, such as during periods of rapid growth or after
injury, they may become conditionally essential (1).
Nucleotide-supplemented infant formulas have been
reported to enhance immune response (4–6), influence
metabolism of fatty acids, and improve gastrointestinal tract
repair after damage (1, 7). Infants fed formula supplemented
with nucleotides are reportedly less likely to experience
diarrhea and have elevated serum immunoglobulin A
concentrations (8). Nucleotide-supplemented infant formula
has been shown to positively modify the composition of the
intestinal microflora, compared with unsupplemented
formula (1, 9).
As understanding of the nucleotide composition of bovine
milk and human milk has increased, manufacturers have
endeavored to modify the composition of infant formulas to
resemble that of human milk more closely. Nucleotides have,
therefore, been added routinely to infant formulas since the
1980s, and added to formulas manufactured specifically for
pre-term infants since 2002 (10). Although more than 12
nucleotides are present in human milk, supplementation is
limited to adenosine 5′-monophosphate (AMP), cytidine
5′-monophosphate (CMP), guanosine 5′-monophosphate
(GMP), inosine 5′-monophosphate (IMP), and uridine
5′-monophosphate (UMP) in the form of the readily soluble
sodium salts (11).
With the proliferation of nucleotide-supplemented
pediatric formulas, robust methods that incorporate minimal
sample preparation and rapid chromatographic separations
have been developed for routine product compliance analysis. 
Analytical methods for nucleos(t)ides in milk have been
reviewed previously by Gil and Uauy (12), and more recently
by Gill and Indyk (13). Initial preparation of infant formulas
for analysis is usually achieved by acid precipitation of casein
proteins from the reconstituted sample (14, 15), although
ultrafiltration has also been reported (16). Additional cleanup
of sample extracts using ion-exchange SPE has been
reported (14).
Over the last decade, LC with UV detection has become the
dominant technique for the final determination of nucleotides in 
milk products following sample preparation. Ion-pair
reversed-phase liquid chromatography (IP-RPLC) is frequently 
used to separate nucleotides and can offer advantages in
selectivity and efficiency over RPLC for the separation of
charged analytes (14, 17, 18). However, IP-RPLC can require
long equilibration times, and ion-pair reagents tend to be
corrosive, thereby reducing column life (19). Unmodified
reversed-phase chromatography offers the advantage of a
simplified mobile phase system and is preferable if acceptable
retention and resolution are achieved. Therefore, at an
appropriate mobile phase pH, mononucleotides are readily
966 GILL ET AL.: JOURNAL OF AOAC INTERNATIONAL VOL. 93, NO. 3, 2010
Received August 16, 2009. Accepted by SG October 2, 2009.
Corresponding author’s e-mail: brendon.gill@fonterra.com
retained on a C18 column and a methanol gradient is sufficient
to remove late-eluting nucleotides (15).
However, despite the quantity of published methods, there
is currently no official internationally accepted reference
method for the analysis of nucleotides in milk and pediatric
formulas, a situation that renders international trade and infant 
nutrition difficult to standardize.
The aim of this study is to validate a simple, rapid and
robust method for routine compliance testing of
nucleotide-supplemented pediatric formulas. The method
herein describes an SPE sample cleanup that avoids the prior
need to remove protein, coupled with a binary gradient
RP-HPLC system. Analytical security is enhanced with an
internal standard-based quantitation. This technique has been
applied to the analysis of bovine milk-based, caprine
milk-based, soy-based, and hypoallergenic pediatric
formulas.
Experimental
Apparatus
HPLC was carried out with an LC-20AT pump, an
SIL-20A sample injector unit equipped with a 50 µL injection
loop, a DGU-20A5 degasser unit, a CTO-20AC column oven, 
and an SPD-M20A photodiode array detector (Shimadzu,
Kyoto, Japan). Shimadzu LC solutions software Version 1.22
SP1 was used for instrument control and data processing.
Separation was achieved with a Gemini C18 column, 5 µm,
4.6 × 250 mm (Phenomenex, Torrance, CA). UV absorbances 
for calibration standards were acquired with a model
UV-1601 spectrophotometer (Shimadzu) with digital readout
to four decimal places. A Meterlab PHM210 standard pH
meter (Radiometer Analytical, Lyon, France) was used for the 
determination of pH. Polypropylene centrifuge tubes, 50 mL
(Biolab, Auckland, New Zealand), Terumo 3 mL disposable
syringes (Terumo Corp., Laguna, Philippines), and Minisart
0.2 µm syringe filters with cellulose acetate membranes
(Sartorius, Göttingen, Germany) were used for sample
preparation.
SPE was performed on a Visiprep 12 port SPE vacuum
manifold (Sigma Chemical Co., St. Louis, MO) using
Chromabond SB polypropylene strong-anion exchange
(SAX) SPE cartridges, 6 mL × 1000 mg (Macherey-Nagel,
Düren, Germany).
Before use, mobile phases were filtered and degassed
using a filtration apparatus with 0.45 µm nylon filter
membranes (Alltech, Deerfield, IL).
Reagents
Thymidine 5′-monophosphate (TMP), AMP sodium salt,
CMP disodium salt, GMP disodium salt, IMP disodium salt,
UMP disodium salt, and potassium bromide were
purchased from Sigma Chemical Co. Potassium dihydrogen
phosphate, orthophosphoric acid, potassium hydroxide,
ethylenediaminetetraacetic acid (EDTA), sodium chloride,
and methanol were supplied by Merck (Darmstadt, Germany). 
Water was purified with resistivity ≥18 MΩ using an E-pure
water system (Barnstead, Dubuque, IA).
A standardizing buffer (KH2PO4, 0.25 M, pH = 3.5) was
made by diluting 34.02 g KH2PO4 in 900 mL water, adjusting
the pH to 3.0 with orthophosphoric acid, and then making the
solution to 1 L. An extraction solution (NaCl, 1 M: EDTA
5 mM) was made by dissolving 58.5 g NaCl and 1.9 g EDTA
in 1 L water. A wash solution (KBr, 0.3 M) was made by
dissolving 3.57 g KBr in 100 mL water. The SPE eluent
(KH2PO4, 0.5 M, pH = 3.0) was made by dissolving 6.805 g
of KH2PO4 in 90 mL water, adjusting the pH to 3.0 with
orthophosphoric acid, and then making the solution to
100 mL.
Mobile phase A (KH2PO4, 0.1 M, pH = 5.6) was made by
dissolving 13.6 g KH2PO4 in 900 mL of water, adjusting the
pH to 5.6 with KOH solution (25% w/v), and then making to
1 L with water. Mobile phase B consisted of 100% methanol.
As microbial growth often occurs in phosphate buffers that
contain little or no organic solvent at room temperature, the
mobile phase was made fresh daily.
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Table 1. UV absorbance maxima and extinction
coefficients for 5′-mononucleotides
Nucleotidea λmax, nm E cm1
1%
AMPb 257 430.4
CMPb 280 398.0
GMPb 254 393.3
IMPb 249 357.3
UMPb 262 313.5
TMP 267 288.5
a AMP = adenosine 5′-monophosphate; CMP = cytidine
5′-monophosphate; GMP = guanosine 5′-monophosphate; 
IMP = inosine 5′-monophosphate; UMP = uridine
5′-monophosphate; TMP = thymidine 5′-monophosphate.
b From reference (15).
Table 2. Gradient procedure for chromatographic
separation
Phase composition
Time, min
Flow rate,
mL/min % A % B
  0 0.5 100 0
  5 0.5 100 0
14 0.5  90 10 
15 0.5  80 20 
35 0.5  80 20 
36 0.5 100 0
50 0.5 100 0
Standard Solutions
The extinction coefficient of internal standard TMP at the
UV absorbance maximum (λmax) of 267 nm was determined
experimentally. The concentrations of analyte nucleotide
stock standards were measured using previously reported
extinction coefficients (Table 1; 15).
Stock standards were prepared by accurately weighing
approximately 50 mg of each nucleotide into separate 50 mL
volumetric flasks and filling to volume with water. The
concentration of each nucleotide stock standard was
determined by diluting 1.0 mL of stock standard to 50 mL
with standardizing buffer (KH2PO4, 0.25 M, pH = 3.5) and
measuring the absorbance at the appropriate λmax.
An intermediate standard solution of TMP was made by
diluting 4 mL TMP stock standard into 50 mL water. A mixed
intermediate standard solution of AMP, CMP, GMP, IMP,
and UMP was made by diluting 2 mL of each stock standard in 
a single 50 mL volumetric flask and filling to volume with
water.
Assay calibration standards were prepared by diluting the
two intermediate standards with water to the required
concentration. The calibration standards contained a constant
concentration of the internal standard TMP (about 3 µg/mL)
and variable concentrations (about 0.5–7 µg/mL) of CMP,
UMP, GMP, IMP, and AMP.
Sample Preparation
Approximately 1 g of infant formula powder was weighed
accurately into a 50 mL centrifuge tube and dissolved in
30 mL of extraction solution (NaCl,1 M: EDTA 5 mM);
1.0 mL of a TMP intermediate standard (about 80 µg/mL) was 
added, and the tube was capped and vortex mixed. The sample 
was allowed to stand for 10 min to ensure complete hydration
before dilution to a final volume of 50 mL with water.
SPE
For each sample, a single SPE cartridge was placed on an
SPE vacuum manifold. The columns were conditioned by
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Table 3. Chromatographic performance
Parametersa CMPb UMPb GMPb IMPb TMPb AMPb
Retention time, min       8.8 (0.22%)c       11.8 (0.17%)     19.8 (0.15%)      20.6 (0.10%)       25.0 (0.04%)      25.8 (0.04%)
Capacity factor    0.6 (0%)        1.2 (0.83%)    2.7 (0%)     2.8 (0%)     3.6 (0%)     3.8 (0%)
Resolution —       6.3 (0.07)     16.9 (1.11%)      2.2 (0.45%)      15.6 (0.19%)       3.5 (0.57%)
Tailing       1.3 (3.84%)        1.2 (3.33%)    1.0 (0%)      1.0 (5.00%)     1.1 (0%)      1.1 (3.6%)
Theoretical plates   6810 (0.87%)   8527 (5.51%) 33692 (3.28%) 60448 (1.22%) 194363 (0.81%) 241749 (0.22%)
Peak area 142255 (0.51%) 200488 (1.39%) 225242 (0.23%) 122536 (0.75%) 488585 (0.11%) 308754 (0.05%)
a Calculations as defined by U.S. Pharmacopeia.
b AMP = Adenosine 5′-monophosphate; CMP = cytidine 5′-monophosphate; GMP = guanosine 5′-monophosphate; IMP = inosine
5′-monophosphate; UMP = uridine 5′-monophosphate; TMP = thymidine 5′-monophosphate.
c Mean (percent RSD) of six replicates of a mixed nucleotide standard.
Table 4. Method performance as linearity, detection limit, and precision
Analytea
Range, 
µg/mL Linear regression r2
MDL, 
mg/100 gb RSDr, %c HorRatrd RSDiR, %e
AMP 1.25–17.49 y = 255805x + 11862 1.0000 0.19 2.0 0.4 4.5
CMP 0.61–8.55  y = 287762x – 2493 0.9999 0.08 1.0 0.3 6.0
GMP 1.11–15.55 y = 200342x – 1807 1.0000 0.06 2.1 0.4 5.2
IMP 1.09–15.27 y = 198519x + 3879 1.0000 0.10 1.4 0.3 3.8
UMP 1.12–15.68 y = 146931x – 1839 0.9999 0.08 2.3 0.5 8.6
TMP 1.61–22.54 y = 150494x – 455 1.0000 — — — —
a AMP = Adenosine 5′-monophosphate; CMP = cytidine 5′-monophosphate; GMP = guanosine 5′-monophosphate; IMP = inosine
5′-monophosphate; UMP = uridine 5′-monophosphate; TMP = thymidine 5′-monophosphate.
b Determined from n replicates at or near the expected detection limit, MDL = t(n – 1, 1 – α) × SD, where n = 10 and α = 0.01.
c Relative standard deviation repeatability(RSDr) = SD/mean × 100 (n = 6).
d Horwitz ratio = RSDr/pRSDr, where pRSDr = C–0.15 at 10 ppm concentration level.
e RSD intermediate reproducibility = SD/mean × 100 (n = 24).
elution with 4 mL methanol, followed by elution with
2 × 5 mL water. The cartridge was loaded with 4 mL sample
solution at a flow rate of <2 mL/min. The cartridge was
washed (KBr, 0.3 M, 4 mL) to remove interferences. The
nucleotides were then eluted with SPE eluent solution
(KH2PO4, 0.5 M, pH 3.0, 4 mL) into a test tube. An aliquot of
the eluent was filtered through a 0.2 µm syringe filter into an
autosampler vial.
Chromatography
Chromatographic separation was achieved using a
modification of the procedure described previously (15).
Gradients were formed by low pressure mixing of two mobile
phases, A and B, with separation of nucleotides achieved
using the procedure shown in Table 2.
The photodiode array detector acquired spectral data
between 210 and 300 nm. Integration of peak area was
achieved at specific wavelengths: 250 nm for IMP; 260 nm for 
AMP, GMP, and TMP; and 270 nm for CMP and UMP. A
linear regression plot of the ratios of peak area against
concentration for each nucleotide relative to TMP was
generated, and the nucleotide contents in unknown samples
were interpolated from this calibration curve.
( )Nucleotide mg g A
A L
C
W
NT
IS
IS/ 100 1 100= × × ×
where ANT = nucleotide peak area in sample; AIS = TMP peak 
area in sample; L = linear regression slope of calibration
curve; CIS = amount in milligrams of internal standard added;
W = weight of sample in grams; and 100 = mass conversion
of result to per 100 g.
Method Validation
Seven mixed standard nucleotide solutions covering the
expected working range were analyzed in duplicate, and
linearity of dose response was evaluated by least-squares
regression analysis. A value of 0.997 for the correlation
coefficient (r2) was deemed to be the minimum suitable for
acceptable analysis. Plots of standard residuals were assessed
as a further test for linearity.
Repeatability was determined by analyzing replicates
(n = 6) of a nucleotide-supplemented bovine milk-based
infant formula. Intermediate precision was determined from
replicate analyses (n = 6) of the same sample tested on
4 different days by two different analysts.
Method detection limits (MDLs) were determined in
accordance with U.S. Environmental Protection Agency
procedures (20). The MDL procedure sets the detection limit
at the 99% confidence level, minimizing false positive errors.
The robustness of the method was assessed by conducting
a Plackett-Burman trial (21), with evaluation of seven factors
deemed to potentially affect the final results, at levels likely to
occur during normal use of the method. Statistical analysis to
identify critical effects consisted of a t-test, whereby a
calculated t-value based on the effect, EX, and an estimation of 
the standard error, (SE)E, were compared with a critical value
(significance level α = 0.05). Graphical interpretation was
assessed by construction of a half-normal plot, whereby
nonsignificant effects tended to fall on a straight line through
zero, whereas significant effects deviated from the straight
line. The standard error estimate was used to calculate the
margin of error (ME), which was plotted on the half-normal
plot to identify the limit above which effects were deemed to
be significant (22, 23).
In the absence of a currently available infant formula
standard reference material (SRM) with certified levels of
nucleotides, method accuracy was determined based on
recovery and bias. Recovery was evaluated at three
concentration levels for three different sample matrixes:
bovine milk-based infant formula; soy-based infant formula;
and a hypoallergenic infant formula containing hydrolyzed
milk protein. Method bias was assessed by testing replicate
samples (n = 12) of a nucleotide-supplemented formula by the 
method described herein and a method published
previously (15).
Results and Discussion
Method Optimization
Method optimization consisted of adapting the sample
preparation and chromatographic conditions reported
previously (15) to accommodate direct SPE for the removal of 
non-nucleotide interferences, thereby simplifying both the
overall analytical scheme and the chromatographic
separation.
Both acid precipitation and ultrafiltration techniques to
remove protein prior to SPE were initially evaluated. Acid
precipitation is a rapid and simple means of removing caseins; 
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Table 5. Recovery (%) of nucleotides in spiked samplesa
AMP CMP GMP IMP UMP TMP
Bovine milk-based infant formula 100 (2.10%)b 99 (1.82%) 98 (2.14%) 98 (1.63%) 94 (3.30%) 97 (1.34%)
Soy-based infant formula 98 (3.57%) 98 (3.57%) 99 (2.42%) 97 (4.74%) 97 (5.88%) 101 (5.94%)
Hypoallergenic infant formula 100 (3.70%) 99 (1.92%) 101 (1.29%) 98 (3.78%) 92 (5.00%) 100 (3.70%)
a AMP = adenosine 5′-monophosphate; CMP = cytidine 5′-monophosphate; GMP = guanosine 5′-monophosphate; IMP = inosine
5′-monophosphate; UMP = uridine 5′-monophosphate; TMP = thymidine 5′-monophosphate.
b Mean recovery (percent RSD) of six replicates over three concentration levels.
however, the low pH of the sample extract may negatively
impact SPE retention unless the extract is first neutralized.
Ultrafiltration removes all proteinaceous material above the
molecular weight cut-off, and the sample remains at
physiological pH, thereby removing a potential neutralization
step prior to SPE. However, ultrafiltration was found to be an
unsatisfactory means of protein removal as it proved to be
time-consuming, difficult to obtain sufficient permeate, and
variable in the recovery of individual nucleotides.
Based on these trials, the assumption that it was necessary to
remove protein prior to SPE was considered. The dissolution of 
a powder sample in the high salt solution was found to be
efficacious in producing a uniform sample solution that, when
applied directly to the SPE cartridge, did not compromise the
recovery of nucleotides. Residual milk protein content in the
eluent was equivalent to that of an acid-precipitated sample
and it is probable that some caseins precipitate in the SPE
cartridge with the addition of the low pH buffer.
The SAX cartridges contain quaternary amine
anion-exchange sites, which strongly attract the anionic
phosphate moiety of nucleotides. In order to remove the
majority of interfering components in the sample, different
aqueous wash solutions, containing a variety of anions at a
number of concentrations, were evaluated. Bromide ions were 
found to be most effective in removing potentially interfering
components, such as nucleosides, orotic acid, and uric acid,
while still retaining nucleotides on the cartridge.
In order to elute the nucleotides from the SAX cartridge,
two options were available. One option was to add sufficient
acid to lower the pH to the pKa of the nucleotide phosphate
(approximate pH = 1), thereby neutralizing the negative
charge and eluting the nucleotides for collection. However, in
order to protect the analytical column, neutralization of the
extract would be required prior to HPLC analysis.
Alternatively, the addition of anions that have a high affinity
for the quaternary amine and added at high ionic strength,
could be utilized to elute the nucleotides. This was achieved
by the addition of 0.5 M phosphate in the eluent, which
readily displaces nucleotides bound on the SAX cartridge.
In multi-step analytical procedures, such as those
involving SPE cleanup, there is potential for analyte loss and,
hence, the use of an internal standard is considered to be
mandatory to obtain consistently accurate and precise results.
With an internal standard, it is possible to correct for losses
associated with SPE cleanup, either by analyte breakthrough
or by incomplete desorption. The selection of TMP as an
internal standard was supported by a number of factors:
structural similarity to analyte nucleotides; absence of
detectable quantities in infant formulas; retention under
desired chromatographic separation; and commercial
availability.
Method Performance
Chromatographic performance was assessed by replicate
analyses (n = 6) of a mixed nucleotide standard (Table 3).
Performance within recommended guidelines was achieved,
with the exception of the capacity factors for CMP and UMP
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Figure 1. Half-normal plot of results for robustness
trial (a) inosine 5′-monophosphate, (b) adenosine
5′-monophosphate, (c) cytidine 5′-monophosphate, 
(d) uridine 5′-monophosphate, and (e) guanosine
5′-monophosphate. ME = margin of error.
(guideline >2.0); however, this was deemed to be acceptable
because of uncompromised peak integrity of these two
compounds in all samples analyzed.
The results from validation studies are summarized in
Tables 4 and 5. Linearity of dose response was confirmed by
least-squares regression analysis, with acceptable values
obtained for the correlation coefficient. Plots of standard
residuals showed no structure and only a small amount of
random noise, further demonstrating linearity.
The precision was acceptable and similar to what could be
expected, as illustrated by a repeatability Horwitz ratio
between 0.3 and 0.5, slightly better than the acceptable range
of 0.5–2.0, and an intermediate precision of 3.8–8.6% (24).
As the calculated MDL is dependent on the concentration
of the replicate samples, the level of analyte in the sample
should not exceed 10 times the calculated MDL; nor should it
be less than the MDL. The concentrations used to generate the
MDL (0.52–1.68 mg/100 g) were appropriate to correctly
establish the MDL.
The seven factors assessed in the robustness trial were:
concentration of salt solution, sample wait time, load volume,
wash solution, wash volume, eluent solution, and eluent
volume. The two factor levels were symmetric around the
nominal values from the described analytical procedure, with
the interval representing experimental error of the equipment
used (pipets, volumetric flasks, balances) and an estimated
error on the part of the analyst. The method was found to be
robust for these factors at the levels studied (Figure 1).
Acceptable recovery is a function of the concentration and
the purpose of the analysis. The recoveries measured were
well within the limits of 80–115% at the 10 µg/g level
suggested by AOAC (24).
An estimation of bias between the method described herein 
and a method published previously (15) showed no bias, with
P values (95%) calculated to be 0.079, 0.529, 0.676, 0.341,
and 0.069 for AMP, CMP GMP, IMP, and UMP,
respectively.
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Figure 2. Chromatography of (a) standard mixture of nucleotides, (b) bovine milk-based infant formula,
(c) soy-based infant formula, (d) hydrolyzed milk protein-based infant formula, and (e) caprine milk-based infant
formula. AMP = Adenosine 5′-monophosphate; CMP = cytidine 5′-monophosphate; GMP = guanosine
5′-monophosphate; IMP = inosine 5′-monophosphate; UMP = uridine 5′-monophosphate; TMP = thymidine
5′-monophosphate. HPLC conditions: column, Gemini C18, 5 µm, 4.6 × 250 mm (Phenomenex); mobile phase A,
KH2PO4 (0.1 M, pH = 5.6); mobile phase B, methanol (100%); gradient elution, flow rate 0.5 mL/min, 0–5 min (100% A,
0% B), 14 min (90% A, 10% B), 15–35 min (80% A, 20% B), 36–50 min (100% A, 0% B). UV detection: 260 nm.
Method Application
The method was applied to a number of commercially
available pediatric and nutritional powders. Products included 
for testing were infant formulas, follow-on formulas, and an
adult nutritional product. These products included a range of
different sources: bovine milk, hydrolyzed milk protein,
caprine milk, and soy protein (Figure 2). The concentrations
of 5′-mononucleotides are given in Table 6. The recoveries
determined against label claim, where available, further
indicate the reliability of the method. In the analysis of caprine 
milk-based infant formula, the presence of significant levels
of endogenous nucleotide diphosphates was confirmed.
Conclusions
The optimization and validation of a simple, rapid
method for the routine analysis of nucleotides in
nucleotide-supplemented infant formulas has been described.
The simplicity of analysis is facilitated by the use of SPE
without the need for prior protein removal. The use of an
internal standard gives additional confidence in the accuracy
of the result obtained. The applicability of the method has
been demonstrated for the analysis of bovine milk-based,
caprine milk-based, soy-based, and hydrolyzed milk
protein-based infant formulas
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a b s t r a c t
Bovine colostrum and milk samples were collected from two herds over the course of the first month
post-partum, pooled for each herd by stage of lactation and total potentially available nucleosides were
determined. Sample analysis consisted of parallel enzymatic treatments, phenylboronate clean-up, and
liquid chromatography to quantify contributions of nucleosides, monomeric nucleotides, nucleotide
adducts, and polymeric nucleotides to the available nucleosides pool. Bovine colostrum contained high
levels of nucleosides and monomeric nucleotides, which rapidly decreased as lactation progressed into
transitional milk. Mature milk was relatively consistent in nucleoside and monomeric nucleotide
concentrations from approximately the tenth day post-partum. Differences in concentrations between
summer-milk and winter-milk herds were largely attributable to variability in uridine and monomeric
nucleotide concentrations.
 2010 Elsevier Ltd. All rights reserved.
1. Introduction
Nucleosides are low molecular weight compounds consisting of
a purine or pyrimidine base (e.g., adenine, cytosine, guanine and
uridine) attached via a b-glycosidic linkage to a ribose sugar
(ribonucleosides). Nucleotides are o-phosphoric acid esters of
nucleosides containing one to three phosphate groups on C-2, C-3
or most commonly C-5 of the ribose (ribonucleotides).
Nucleotides are compounds of critical importance to cellular
function. They operate as precursors to nucleic acids, as mediators
of chemical energy transfer and cell signalling, and as integral
components of coenzymes in the metabolism of carbohydrates,
lipids and proteins (Carver & Walker, 1995; Cosgrove, 1998).
Nucleotides can be synthesised de novo or recovered via salvage
pathways and thus are not essential dietary nutrients. However,
during periods of rapid growth or after injury, when the metabolic
demand for nucleotides exceeds the combined capacity of de novo
synthesis and the salvage pathway, dietary sources of nucleotides
are considered to be conditionally essential for continued optimal
metabolic function (Carver & Walker, 1995; Yu, 1998). Dietary
nucleotides are ingested in the form of nucleoproteins, polymeric
nucleotides (nucleic acids) and nucleotide adducts as well as free
nucleotides. These are digested in the gastrointestinal tract by
proteases, nucleases, phosphatases and nucleotidases, and are
available for absorption predominantly as nucleosides (Quan,
Barness, & Uauy, 1990; Uauy, Quan, & Gil, 1994).
Dietary nucleotides have been shown to increase immune
response in infants (Carver, Pimentel, Cox, & Barness, 1991;
Pickering et al., 1998), to influence metabolism of long chain fatty
acids and to enhance gastrointestinal tract repair after damage,
when compared with nucleotide-unsupplemented diets (Carver &
Walker, 1995; Gil, Corral, Martínez, & Molina, 1986). Dietary
supplementation of infant formula with nucleotides has also been
reported to beneficially modify the composition of intestinal
microflora (Uauy et al., 1994), to elevate serum immunoglobulin
concentrations and to reduce incidences of diarrhoea (Yau et al.,
2003).
The expression of nucleosides and nucleotides in bovine milk is
highest immediately after parturition with a general decreasing
trend in concentration with advancing lactation, with levels sta-
bilising by the third week of lactation (Gill & Indyk, 2007b; Gil &
Sánchez-Medina, 1981; Schlimme, Martin, & Meisel, 2000;
Sugawara, Sato, Nakano, Idota, & Nakajima, 1995). This pattern of
high concentration in early colostrum followed by a rapid reduction
as lactation progresses is analogous to changes of other bioactive
components, such as immunoglobulins.
In general, the dominant strategy employed in analysis of free
nucleosides and nucleotides in colostrum and milk has been
protein removal by acid precipitation, followed by HPLCeUV
analysis of the crude or fractionated extract (Ferreira, Mendes,
Gomes, Faria, & Ferreira, 2001; Gill & Indyk, 2007a, 2007b;
Sugawara et al., 1995).
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Early clinical studies employed infant formulas containing
nucleotides supplemented to levels based on estimates of the free
nucleotide content of human milk (Aggett, Leach, Rueda, &
MacLean, 2003). However, the measurement of free nucleotide
levels does not account for nucleosides, polymeric nucleotides or
nucleotide adducts that are also nutritionally available to the infant.
In order to determine the total potentially available nucleosides
(TPAN), an analytical protocol to characterise the contributions of
different molecular nucleoside sources to infant nutrition was
developed (Leach, Baxter, Molitor, Ramstack, & Masor, 1995). The
development of this protocol has been an important contribution to
further understanding the distribution of nucleosides and nucleo-
tides and their implications for infant nutrition. The analytical
method uses a number of enzymatic treatments incorporating
combinations of nuclease, pyrophosphatase and phosphatase
enzymes into the sample preparation. In this manner, contributions
from nucleoside precursors to TPAN in human milk have been
estimated, and it was reported that the nutritionally relevant
concentrations of nucleosides and nucleotides in human milk had
been underestimated by approximately 50% when compared with
free nucleotide concentrations only (Gerichhausen, Aeschlimann,
Baumann, Inäbnit, & Infanger, 2000; Leach et al., 1995; Tressler
et al., 2003).
Bovine milk is almost exclusively used in the manufacture of
infant formula intended to substitute for human breast milk, and
since the levels of TPAN in bovine milk have not been previously
reported, the purpose of the current study was to evaluate bovine
milk TPAN levels and variation over the first month of lactation.
2. Materials and methods
2.1. Apparatus
The high performance liquid chromatography (HPLC) system
consistedof anSCL-10Avpsystemcontroller, LC-10ADvppump, FCV-
10ALvp low pressure gradient unit, SIL-10AF sample injector unit
equipped with a 50 mL injection loop, DGU-14A degasser unit, CTO-
10ASvp column oven and SPD-M10Avp photodiode array detector
(Shimadzu, Kyoto, Japan). Instrument control and data processing
were implemented using Shimadzu Class-VP version 6.12.
The column selected was a Prodigy C18 column, 5 mm,
4.6150 mm (Phenomenex, Torrance, CA, USA). Prior to use,
mobile phases were filtered and degassed using a filtration appa-
ratus with 0.45 mm nylon filter membranes (AllTech, Deerfield, IL,
USA). Solid phase extraction of nucleosides was performed using
Affi-gel 601 (Bio-Rad, Hercules, CA, USA).
2.2. Reagents
Adenosine, cytidine, guanosine, uridine, 5-methylcytidine,
uridine 50-diphosphoglucose, RNA, cytidine 50-diphosphocholine,
b-nicotinamide adenine dinucleotide, adenosine 50-mono-
phosphate (AMP), cytidine 50-monophosphate (CMP), guanosine
50-monophosphate (GMP), uridine 50-monophosphate (UMP)
nuclease P1, pyrophosphatase, and alkaline phosphatase were
purchased from Sigma Chemical Co. (St. Louis, MO, USA). Potassium
dihydrogen phosphate, orthophosphoric acid, hydrochloric acid,
sodium hydroxide and potassium hydroxide were supplied by
Merck (Darmstadt, Germany). Water was purified with resistivi-
ty 18 MU using an E-pure water system (Barnstead, IA, USA).
2.3. Sample collection
Milk and colostrum samples were collected from seven cows
from each of two Jersey herds from two separate farms in the
eastern Waikato region of New Zealand. Samples from a winter-
milk herd were collected over a 1 month period in late March 2008
and samples from a summer-milk herd were collected over a 1
month period in early August 2009. Cows selected for inclusion in
this study were in general good health, in their second or subse-
quent calving and had experienced normal calvings without
complications. With the exception of the 6 h sample, sample
collection was performed between 6:00 and 10:00 am, which
coincided with regular morning milking times.
From each cow, approximately 80 mL of sample was collected in
a 120 mL disposable container. These samples were collected at
various time intervals throughout the first month of lactation, with
a frequency that reduced as the month progressed.
Collected samples were refrigerated at 4 C, picked up from the
farm as soon as practicable (within 6 h), taken to the laboratory and
immediately prepared for storage. NaOH (1 M, 20 mL) was added to
a 10 mL sample aliquot and mixed, and the sample was then left to
stand for 30 min, neutralised to pH¼ 7.35 0.05 with HCl and
made to 50 mL volume before freezing at <15 C.
2.4. Sample analysis
Samples from the seven cows at each time period post-partum
were pooled for analysis, and enzymatic hydrolysis and boronate
affinity extraction were performed as described by Leach et al.
(1995). Each pooled sample was tested in duplicate with the
mean and standard deviation calculated.
Samples were enzymatically hydrolysed using nucleotide
pyrophosphatase, nuclease P1 and bacterial alkaline phosphatase
(Sigma Chemical Co., St. Louis, MO, USA). Each pooled sample was
split into four 5 mL sub-samples, to each of which internal standard
(10 mg, 5-methylcytidine) was added, and each sub-sample was
subjected to a different enzymatic treatment. The first treatment
had no added enzymes and innate nucleosides only were therefore
measured. The second treatment involved phosphatase (pH¼ 8.5,
3 h), which dephosphorylated monomeric nucleotides to nucleo-
sides. The third treatment incorporated nuclease (pH¼ 5.1, 16 h)
and phosphatase (pH¼ 8.5, 3 h), which hydrolysed polymeric
nucleotides to monomeric nucleotides, which were subsequently
dephosphorylated to nucleosides. The fourth treatment consisted
of nuclease (pH¼ 5.1, 16 h), pyrophosphatase and phosphatase
(pH¼ 8.5, 3 h), which converted all nucleoside precursors (poly-
meric and monomeric nucleotides, and nucleotide adducts) to free
nucleosides.
Clean-up of enzymatic extracts was achieved by solid phase
extraction using a phenylboronate affinity gel as described by Leach
et al. (1995), whereby nucleosides were covalently bonded to the
gel at high pH, and interferences removed with two washings of
high pH buffer. The nucleosides were eluted from the affinity gel at
low pH by the addition of phosphoric acid (0.25 M), and filtered
ready for analysis (Liu & Scouten, 2000).
2.5. Chromatographic analysis
The initial chromatographic protocol was a modification of
a reversed-phase system described by Gill and Indyk (2007b), using
phosphate buffer and a methanol gradient. As optimum separation
of nucleosides was achieved at pH¼ 4.8, phosphate was replaced
with acetate (pKa¼ 4.75), thereby offering greater buffer capacity
at the desired pH.
An organic solvent component is required in themobile phase to
facilitate elution of nucleosides from the C18 column. However, to
obtain sufficient resolution between peaks, a gradient elution
procedure was necessary. A number of gradient procedures were
evaluated to determine an optimum protocol that had a relatively
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short run-time coupled with sufficient resolution between peaks.
An optimum separation of nucleosides was achieved at a flow rate
of 0.7 mLmin1 with gradients formed by low pressure mixing of
twomobile phases, A (0.05 M sodium acetate, pH¼ 4.8) and B (100%
methanol) (0e3 min, 95:5, v/v, A:B; 7e22 min 75:25, v/v, A:B;
23e30 min 95:5, v/v, A:B).
The photodiode array detector acquired spectral data between
210 and 300 nm. Peak identification was by co-chromatography
and similarity of the chromatographic peak spectrum to authentic
standards, as estimated by a similarity index of >0.99. Chromato-
grams were integrated at a wavelength of 260 nm and results
were determined by an internal standard technique using 5-
methylcytidine.
The contributions of the different forms (nucleosides, nucleo-
tide adducts, monomeric and polymeric nucleotides) to TPAN were
calculated in the manner described by Leach et al. (1995) using
Excel spreadsheet software (Microsoft, Redmond, WA, USA).
2.6. Recovery
A spiked recovery study was performed on free nucleosides and
was assessed through the affinity gel sample clean-up. A stored
pooled milk sample was spiked with a single mixed standard
containing cytidine, guanosine, uridine, adenosine and 5-methyl-
cytidine (95.0e135.0 mgmL1). Recovery was assessed by compar-
ison of peak areas for the spiked and unspiked samples, relative to
those of the mixed standard.
Recovery of nucleosides from the enzymatic digestion was
estimated following the protocol described by Leach et al. (1995). A
solution (TPAN-fortified) containing ribonucleosides, 50-mono-
nucleotides, nucleotide adducts and RNAwas prepared for a spiked
recovery study. A solution (TPAN-digest) was made from an aliquot
(5 mL) of the TPAN-fortified solution that was hydrolysed for 20 h
with KOH (0.2 mol L1, 50 mL) to convert polymeric RNA to
monomeric nucleotides. The pH of the solution was adjusted to 9.0
with HCl and then incubated with alkaline phosphatase and
nucleotide pyrophosphatase to convert adducts and monomeric
nucleotides to nucleosides. The concentration of nucleosides in the
TPAN-digest solution was determined by HPLC and was used to
calculate the TPAN content in the TPAN-fortified solution.
A stored pooled milk sample was then spiked (in triplicate) with
an aliquot of the TPAN-fortified solution and, along with unspiked
sample replicates, was analysed and TPAN concentrations deter-
mined. Recovery was assessed by comparison of the difference in
results for the spiked and unspiked samples, divided by the TPAN
concentration of the TPAN-fortified solution.
2.7. Statistical analysis
The experimental data were analysed by one-way analysis of
variance (ANOVA) of the response of season (winter-milk, summer-
milk) with covariate time (0, 0.25, 1, 2, 3, 5, 10, 20, 30 days post-
partum). All results (X) were transformed log10(1þ X), so that the
postulated model was an exponential decrease in levels with time,
with the initial levels and the rates of decrease dependent upon
season. The “exponential decay”modelwas found toprovideabetter
fit than a linear or quadratic model in time. For hypothesis testing,
significance was evaluated at the p< 0.05 level. Statistical analyses
were performed using Minitab version 15.1 (State College, PA, USA).
3. Results and discussion
3.1. Recovery
The recoveries of nucleosides (recovery standard deviation)
through the affinity gel clean-up were as follows: cytidine
(93.41.1%), uridine (92.3 5.1%), guanosine (88.3 4.9%), aden-
osine (95.2 4.2%), and 5-methylcytidine (92.6 2.3%). Recoveries
measured through the enzymatic digestion and subsequent affinity
gel clean-up were: cytidine (95.5 2.8%), uridine (101.7 3.7%),
guanosine (89.2 2.4%) and adenosine (94.73.0%). These
recovery values were acceptable for the quantitative analysis of
nucleosides at concentrations typical of bovine milk samples
(AOAC, 2002).
3.2. Chromatography
Chromatographic performance evaluated as resolution, peak
tailing, retention factor, and peak area repeatability, was deemed
acceptable by replicate analyses (n¼ 6) of a mixed nucleotide
standard (Fig. 1A). The specificity of the phenylboronate sample
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clean-up provides analytical chromatography relatively free of
interferences (Fig. 1B).
3.3. Total potentially available nucleosides in bovine milk
The TPAN concentrations and contribution of each nucleobase
and form obtained in this study of winter-milk and summer-milk
lactation series are summarised in Tables 1 and 2 and illustrated
graphically in Figs. 2 and 3. For each parameter (each base within
each form), comparisons of the initial levels and rates of decrease
were made between seasons and whether each seasonal slope
differed from zero (Table 3).
3.3.1. Nucleoside contribution to total potentially available
nucleosides
Uridine was the most prevalent nucleoside, at levels of
w50 mmol dL1 in colostrum, but these levels were not sustained
beyond the third day post-partum and rapidly decreased to levels
similar to those of cytidine and guanosine, at 1e3 mmol dL1.
Adenosine was present at much lower levels but these low levels
were maintained throughout the lactation period for both seasons
milk. The nucleoside levels measured in this study were consistent
with those reported previously (Gill & Indyk, 2007b). Although
nucleosides were present at higher concentrations in bovine
colostrum than in mature bovine milk, they rapidly decreased to
levels similar to that in mature human milk, as reported by Leach
et al. (1995).
3.3.2. Monomeric nucleotide contribution to TPAN
Levels of nucleotides measured in this study were generally
higher than those reported previously (Gill & Indyk, 2007b);
however, there was likely to have been a significant contribution
from multiple phosphorylated forms (cyclic-, mono-, di- and tri-
phosphorylated nucleotides), which the TPAN analytical method
Table 1
Nucleosides and nucleotides in bovine milk from a winter-milk herd (mmol dL1).a
Dayb Formc Cytidine Uridine Guanosine Adenosine Total
0 Nucleoside 5.4 0.1 57.9 1.6 0.3 0.0 nd 63.6 1.5
Monomeric NT 6.1 0.3 143.7 8.5 2.8 0.0 2.9 0.2 155.5 8.7
NT adduct 0.9 0.2 23.7 9.0 3.9 0.8 2.4 0.0 30.9 9.6
Polymeric NT 0.6 0.0 5.4 7.2 1.4 0.2 1.4 0.1 8.7 7.4
Total base 13.0 0.5 230.7 6.1 8.5 0.9 6.6 0.2 258.7 6.8
þ0.25 Nucleoside 4.0 0.2 39.8 0.2 0.2 0.0 nd 44.0 0.4
Monomeric NT 1.3 0.4 26.9 4.7 1.0 0.0 1.4 0.0 30.6 5.0
NT adduct 0.9 0.2 3.2 0.9 1.1 0.2 0.5 0.1 5.8 0.6
Polymeric NT 0.1 0.0 3.9 1.1 1.1 0.1 0.9 0.0 6.0 0.9
Total base 6.3 0.0 73.8 4.3 3.5 0.1 2.8 0.1 86.4 4.3
þ1 Nucleoside 3.5 0.1 49.8 0.8 0.5 0.0 nd 53.9 0.7
Monomeric NT 13.1 0.3 77.5 2.8 4.0 0.2 3.0 0.2 97.5 3.2
NT adduct 0.4 0.2 11.9 6.8 2.4 0.2 2.0 0.6 16.5 7.6
Polymeric NT 0.5 0.5 3.0 3.8 1.3 0.2 1.5 0.5 6.4 3.6
Total base 17.5 0.9 142.2 6.6 8.1 0.0 6.5 0.3 174.4 7.9
þ2 Nucleoside 2.5 0.3 60.4 0.4 0.8 0.0 0.6 0.1 64.2 0.8
Monomeric NT 16.9 0.6 30.4 3.4 2.0 0.1 2.6 0.0 51.6 4.2
NT adduct 0.3 0.2 6.7 1.4 2.4 0.2 2.6 0.3 12.0 1.3
Polymeric NT 1.0 0.1 2.7 1.3 1.0 0.1 1.2 0.1 6.0 1.3
Total base 20.7 0.0 99.8 3.2 6.2 0.1 7.1 0.3 133.8 3.4
þ3 Nucleoside 2.0 0.2 42.7 2.0 0.5 0.1 0.6 0.1 45.9 2.4
Monomeric NT 16.2 0.4 22.2 3.4 1.5 0.2 3.6 0.9 43.5 4.9
NT adduct 0.4 0.5 5.9 0.3 2.2 0.2 2.3 0.1 10.7 0.9
Polymeric NT 0.3 0.1 1.0 0.3 0.6 0.1 0.5 0.6 2.5 0.4
TPAN 19.0 0.2 71.8 1.5 4.8 0.2 7.0 0.2 102.6 1.2
þ5 Nucleoside 1.5 0.3 21.5 0.8 nd 0.2 0.0 23.3 0.5
Monomeric NT 12.1 0.3 1.4 0.1 0.6 0.0 3.3 0.1 17.4 0.3
NT adduct 0.1 0.0 0.8 0.0 0.6 0.2 0.6 0.2 2.2 0.4
Polymeric NT 0.5 0.1 0.4 0.4 0.8 0.1 0.7 0.1 2.4 0.5
Total base 14.1 0.3 24.2 1.0 2.1 0.1 4.8 0.3 45.2 1.7
þ10 Nucleoside 0.8 0.2 3.2 0.2 nd 0.1 0.0 4.1 0.0
Monomeric NT 6.9 0.3 0.4 0.0 0.2 0.0 2.4 0.1 9.9 0.4
NT adduct 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.6 0.4
Polymeric NT 0.3 0.4 0.1 0.1 0.4 0.1 0.2 0.0 1.0 0.6
Total base 8.0 0.1 3.9 0.2 0.7 0.1 3.0 0.2 15.6 0.2
þ20 Nucleoside 0.7 0.2 1.3 0.1 nd 0.1 0.0 2.1 0.3
Monomeric NT 3.9 0.0 0.1 0.1 nd 0.8 0.1 4.8 0.2
NT adduct 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.4 0.2
Polymeric NT 0.2 0.1 0.1 0.0 0.3 0.0 0.2 0.1 0.7 0.2
Total base 4.8 0.2 1.6 0.1 0.4 0.0 1.3 0.2 8.0 0.1
þ30 Nucleoside 0.6 0.1 0.8 0.1 nd 0.1 0.0 1.5 0.0
Monomeric NT 2.5 0.0 0.1 0.0 nd 0.3 0.1 3.0 0.1
NT adduct nd nd nd 0.1 0.0 0.2 0.1
Polymeric NT 0.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.7 0.1
Total base 3.4 0.0 1.1 0.0 0.3 0.0 0.6 0.1 5.3 0.1
a Values are given as the mean standard deviation of duplicate analyses; nd, not detected.
b Day post-partum 2 h.
c NT, nucleotide.
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aggregates as a single value. Differences in colostral monomeric
nucleotide levels between the herds were evident, with the winter-
milk herd initially containing 5e10 times the levels of the summer-
milk herd. However, by the fifth day, nucleotide levels decreased to
approximately 15 mmol dL1 in both herds, somewhat lower than
those reported in human milk (Leach et al., 1995). The high initial
uridine nucleotides levels and subsequent rapid decrease in
concentration seen in winter-milk was absent in summer-milk
which maintained constant levels throughout lactation. Cytidine
and adenosine nucleotides are stable throughout lactation for both
seasons. The most abundant nucleotides in bovine colostrum were
based on uridine; however, as colostrum transitioned into mature
milk, cytidine nucleotides became the dominant form.
Uridine nucleotides are critical components in the biosynthesis
of lactose. As lactose is a major osmotic component of milk, there is
a correlation between the amount of lactose and the volume ofmilk
produced (Arthur, Kent, & Hartmann, 1991; Linzell & Peaker, 1971).
It has been suggested that high levels of uridine and UMP are
present in milk, as breakdown products of uridine diphosphate
(UDP) and uridine triphosphate (UTP), due to their function in the
synthesis of lactose (Mateo, Peters, & Stein, 2004; Schlimme et al.,
2000). It has been proposed that support for this hypothesis is
seen by the correlation of decreasing total milk solids and 50-UMP
concentrations in sow’s milk as lactation progresses (Mateo et al.,
2004). However, as colostrum contains higher total milk solids
and lower lactose levels (on a dry weight basis) than mature milk
(Heng, 1999), a reduced proportion of uridine nucleotides than in
mature milk might be expected based on this proposal. Alternative
reasons must therefore be sought to account for the higher relative
proportions of uridine nucleotides in colostrum. It has also been
suggested that uridine accounts for many of the immunological
properties of nucleotides in colostrum (Kulkarni, Fanslow, Rudolph,
& Van Buren, 1986; Leach et al., 1995; Van Buren, Kulkarni, Fanslow,
& Rudolph, 1985) and, more recently, Mashiko et al. (2009)
demonstrated that dietary UMP affected the immune response of
newborn calves.
3.3.3. Nucleotide adduct contribution to TPAN
The results for uridine adducts in the present study ranged from
not detected to 23.7 mmol dL1 in the winter-milk herd and from
not detected to 6.8 mmol dL1 in the summer-milk herd, with
a rapid reduction in concentration after the third day post-partum.
Guanosine adducts measured ranged from not detected to
3.9 mmol dL1 in the winter-milk herd and from not detected to
1.2 mmol dL1 in the summer-milk herd. Similar levels of adenosine
adducts were found, presumably derived from flavin adenine
dinucleotide and nicotinamide adenine dinucleotide (Fox &
McSweeney, 1998; Kanno, Shirahuji, & Hoshi, 1991). Utilising
enzymatic techniques, Gil and Sánchez-Medina (1981) measured
UDP hexosamine, UDP hexose and UDP galactose concentrations in
bovine colostrum and milk, which ranged from not detected to
w104 mmol dL1. Levels were highest at 27 and 78 h and much
lower or absent in subsequent stages of lactation. Guanosine
diphosphate fucosewas also reported at 27 and 78 h, at levels of 6.7
and 4.1 mmol dL1, respectively.
3.3.4. Polymeric nucleotide contribution to TPAN
The concentration of polymeric nucleotides in bovine colostrum
was similar to that in human colostrum and milk, however, with
advancing lactation, the levels in bovine milk decreased below
those in human milk. Both cytidine and uridine contributions to
polymeric nucleotides are steady throughout lactation for summer-
milk, whereas the higher initial levels of polymeric uridine shows
distinct decrease in concentration as lactation progresses inwinter-
milk.
3.3.5. Nucleobase contribution to TPAN
Differences in the contributions of each nucleobase from the
various nucleoside and nucleotide forms were found. The pyrimi-
dines differed markedly from each other through lactation.
Whereas the quantities of cytidine and cytidine nucleotides were
relatively constant throughout, uridine and uridine nucleotides
levels varied considerably. Cytidine concentrations were similar to
those in human milk reported by Leach et al. (1995), whereas
uridine was present at considerably higher levels in bovine colos-
trum and in lower amounts in mature bovine milk.
The concentrations of the purines also differed with adenosine
levels throughout the first month of lactation for milk from both
herds, whereas guanosine showed a significant decrease in levels
for both herds. The quantities of both guanosine and adenosine, and
Table 2
Nucleosides and nucleotides in bovine milk from a summer-milk herd (mmol dL1).a
Dayb Formc Cytidine Uridine Guanosine Adenosine Total
0 Nucleoside 2.6 0.2 50.6 5.8 2.2 0.3 nd 55.4 5.8
Monomeric NT 1.5 0.1 1.2 0.0 0.2 0.0 nd 2.8 0.2
NT adduct 0.1 0.1 0.5 0.1 0.3 0.0 0.2 0.0 1.1 0.2
Polymeric NT 0.4 0.0 0.3 0.3 1.1 0.0 0.9 0.0 2.7 0.3
Total base 4.7 0.2 52.5 6.1 3.7 0.3 1.2 0.0 62.1 6.2
þ0.25 Nucleoside 3.6 0.1 28.0 0.4 1.8 0.0 nd 33.4 0.5
Monomeric NT 0.5 0.3 0.4 0.1 0.1 0.0 nd 1.0 0.5
NT adduct 0.2 0.0 0.9 0.2 0.1 0.0 0.1 0.0 1.4 0.1
Polymeric NT 0.3 0.0 1.7 0.3 0.8 0.1 0.8 0.0 3.6 0.2
Total base 4.7 0.2 31.0 0.8 2.9 0.2 0.9 0.1 39.4 0.3
þ1 Nucleoside 5.4 0.4 40.9 1.2 2.1 0.2 nd 48.5 1.0
Monomeric NT 7.3 0.1 4.3 0.3 0.3 0.0 nd 11.9 0.2
NT adduct 1.6 0.3 6.8 0.9 1.2 0.1 0.3 0.1 10.0 1.2
Polymeric NT 0.6 0.1 1.1 0.4 1.0 0.1 0.7 0.3 3.4 0.0
Total base 15.0 0.4 53.1 0.4 4.7 0.1 1.0 0.3 73.8 0.4
þ2 Nucleoside 3.7 0.4 39.2 0.1 2.7 0.4 nd 45.6 0.9
Monomeric NT 10.4 0.8 0.4 0.1 0.2 0.0 0.9 0.1 11.8 1.0
NT adduct nd 1.7 0.4 0.9 0.0 0.4 0.0 2.9 0.4
Polymeric NT 0.5 0.0 1.0 0.0 0.4 0.1 0.3 0.0 2.3 0.0
Total base 14.5 0.4 42.3 0.4 4.2 0.4 1.5 0.2 62.6 0.2
þ3 Nucleoside 6.7 0.2 21.5 1.6 1.2 0.1 nd 29.4 1.3
Monomeric NT 5.8 0.8 3.6 0.8 0.3 0.0 2.1 0.4 11.9 1.2
NT adduct 0.1 0.0 0.5 0.0 0.4 0.1 0.4 0.0 1.5 0.1
Polymeric NT 0.5 0.1 1.4 0.5 0.4 0.0 0.3 0.0 2.7 0.6
Total base 13.2 0.7 27.0 3.0 2.3 0.1 2.9 0.4 45.3 3.4
þ5 Nucleoside 1.0 0.1 9.2 0.1 0.2 0.3 nd 10.4 0.3
Monomeric NT 8.0 0.2 0.4 0.0 0.2 0.0 2.0 0.1 10.7 0.1
NT adduct 0.3 0.2 0.4 0.0 0.1 0.0 0.3 0.0 1.0 0.3
Polymeric NT 0.8 0.2 0.5 0.1 0.3 0.0 0.2 0.1 1.9 0.2
Total base 10.2 0.1 10.5 0.3 0.8 0.3 2.4 0.0 24.0 0.1
þ10 Nucleoside 0.6 0.1 3.0 0.0 nd nd 3.6 0.0
Monomeric NT 4.1 0.2 0.1 0.0 nd 1.2 0.1 5.3 0.0
NT adduct 0.2 0.1 nd 0.1 0.0 0.2 0.1 0.5 0.2
Polymeric NT 0.2 0.1 0.2 0.0 0.4 0.0 0.1 0.0 0.9 0.1
Total base 5.0 0.4 3.4 0.0 0.4 0.0 1.5 0.1 10.3 0.4
þ20 Nucleoside 0.7 0.0 1.5 0.5 nd nd 2.1 0.5
Monomeric NT 3.0 0.2 0.1 0.0 nd 0.4 0.0 3.4 0.1
NT adduct 0.1 0.0 0.1 0.0 nd 0.1 0.0 0.2 0.0
Polymeric NT nd 0.1 0.0 nd 0.1 0.0 0.1 0.0
Total base 3.8 0.2 1.6 0.5 nd 0.5 0.1 5.9 0.4
þ30 Nucleoside 0.6 0.0 1.3 0.0 nd nd 1.9 0.0
Monomeric NT 1.6 0.2 nd nd nd 1.6 0.2
NT adduct 0.1 0.0 0.1 0.0 nd 0.3 0.0 0.5 0.0
Polymeric NT nd nd nd nd 0.1 0.0
Total base 2.3 0.2 1.4 0.0 nd 0.3 0.0 4.0 0.2
a Values are given as the mean standard deviation of duplicate analyses; nd, not
detected.
b Day post-partum 2 h.
c NT, nucleotide.
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their respective nucleotides were slightly higher in bovine colos-
trum than in human colostrum and milk, but concentrations were
lower as colostrum transitioned to mature milk. In bovine milk,
purine nucleosides and nucleotides made a relatively small
contribution to TPAN (6e20%), whereas human milk purine
nucleosides and nucleotides consistently represent a greater
proportion of TPAN (>30%).
3.3.6. Total potentially available nucleosides
In general, the absolute concentrations indicated a distinct
difference between the two herds, although the general trends
were the same. Winter had higher initial levels of TPAN but the
rate of decrease was greater, such that the seasonal differences in
TPAN concentration found in colostrum were largely absent in
mature milk.
TPAN levels in winter-milk colostrum were attributable largely
to significantly higher amounts of uridine nucleotides compared
with summer-milk colostrum; however, by the tenth day, milk
from both herds showed similar TPAN levels. The TPAN levels in
bovine colostrumwere higher than those in both human colostrum
and milk, however, after transition to mature milk, the TPAN levels
were lower than those reported in human milk (Leach et al., 1995).
It has been reported that nucleotides in human milk exhibit
a circadian rhythmicity (Sánchez et al., 2009). Anomalous results
for uridine and uridine nucleotides were found in bovine colostrum
samples collected from both herds at 6 h post-partum, and such
Winter-Milk
0
50
100
150
200
250
300
0 0.25 1 2 3 5 10 20 30
C
o
n
c
e
n
t
r
a
t
io
n
 (
µm
o
l 
d
L
-
1
)
0
50
100
150
200
250
300
0 0.25 1 2 3 5 10 20 30
Days post-partum
Summer-Milk
0
50
100
150
200
250
300
0 0.25 1 2 3 5 10 20 30
C
o
n
c
e
n
t
r
a
t
io
n
 (
µm
o
l 
d
L
-
1
)
0
50
100
150
200
250
300
0 0.25 1 2 3 5 10 20 30
Days post-partum
A C
DB
Fig. 2. Total potentially available nucleosides in pooled bovine milk samples from winter-milk (A, B) and summer-milk (C, D) herds over the first month of lactation. A, C: ,
cytidine; , uridine; , guanosine; , adenosine. B, D: , polymeric nucleotides; , nucleotide adducts; , monomeric nucleotides; , nucleosides.
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diurnal variation may suggest a plausible rationale given that this
sample was uniquely collected in the afternoon.
The levels and distribution of TPAN in mature bovine milk are
important in the manufacture of infant formulas, particularly when
formulating to TPAN regulatory limits. If all endogenous forms of
nucleosides and nucleotides that contribute to TPAN are not
accounted for prior to nucleotide supplementation, possible over-
fortification could occur during the manufacture of bovine milk-
based infant formula.
3.4. Herd conditions
Although the feeding practices were similar on both farms, it
is possible that seasonal or pasture differences could have had
a significant effect on the nucleoside precursors expressed in
the milk of each herd. Prior to calving, the cows’ diet was
extensive grass grazing supplemented with maize silage and
palm kernel, and after calving, intake of grass and palm kernel
increased with inclusion of whey permeate. One uncontrolled
variable that may have had a profound influence is the climate.
Calving for the winter-milk herd began in the early autumn of
2008, which followed a summer characterised by a La Niña
weather pattern that contributed to record high temperatures
and a drought with severe soil moisture deficits in the Waikato
region of New Zealand. The summer-milk herd began calving in
late winter 2009, which had the warmest August on record,
although rainfall was normal (National Institute of Water and
Atmospheric Research [NIWA], 2010). In addition to obvious
climatic factors, other factors could have affected TPAN levels in
both herds, such as the conditions under which the cows were
raised and fed, tolerance to stress, sunlight exposure and other
environmental factors. Further study controlling each of these
factors would be required to identify those factors that influ-
ence nucleoside and nucleotide expression in milk. Limitations
of the current study could be expanded upon in future experi-
ments that consider the effects of breed, location and diet on
TPAN expression in milk.
4. Conclusions
Nucleosides and monomeric nucleotides were the dominant
forms of TPAN in bovine milk and colostrum, whereas nucleotide
adducts and polymeric nucleotides contributed relatively little.
Uridine and uridine nucleotides were the major contributor to
TPAN in early colostrum, and cytidine and cytidine nucleotides
dominated later in lactation. Differences in TPAN concentrations
between summer-milk and winter-milk herds were largely attrib-
utable to variability in uridine and nucleotide concentrations. As
lactation progressed, TPAN concentration decreased, as did each of
the contributing forms.
With the increasing trend towards nucleotide supplementation
of bovine milk-based infant formulas, and the need for compliance
with TPAN regulatory limits, the data presented in this study
provide a greater understanding of the contributions of endoge-
nous nucleosides and nucleotides in bovine milk. In addition,
colostrum is increasingly being used as a dietary supplement and
the high level of TPAN present may be nutritionally significant.
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The total potentially available nucleosides (TPAN) in bovine, caprine, and ovine milk were analyzed
through the sequential application of phosphatase, pyrophosphatase, and nuclease enzyme treatments
prior to high performance liquid chromatographic analysis of released nucleosides. The contributions to
TPAN from polymeric nucleotides, monomeric nucleotides, and nucleotide adducts were then calculated.
Ovine milk contained the highest concentration of TPAN, i.e., 374.1 mmol dL1, with lower concentrations
in caprine milk (97.4 mmol dL1) and bovine milk (7.9 mmol dL1). Ovine milk contained the highest
concentrations of each of the different nucleoside and nucleotide forms, and bovine milk contained the
lowest.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
The dietary significance of nucleosides and nucleotides, the
forms in which they can exist in milk, their role as semi-essential
nutrients in the human diet and their analytical determination in
bovine milk have been described in a recent study that formed the
basis for the developments currently presented (Gill, Indyk, &
Manley-Harris, 2011).
Dietary nucleotides have been shown to beneficially affect
intestinal growth, gut microflora, and liver growth and repair, and
clinical studies have shown that infant formula supplementation
with nucleotides provides a benefit to neonatal immune function
when compared with unsupplemented formulae (Boza &Martínez-
Augustin, 2002; Schaller, Buck, & Rueda, 2007; Yu, 2002). Nucleo-
tides have been routinely supplemented in bovine milk-based
infant formulae since the 1980s in recognition of the purported
health benefits of nucleotide supplementation and the lower
concentrations of free nucleotides in bovine milk compared with
human milk (Adamkin, 2007). In recent years, nucleotide supple-
mentation of infant formulae to TPAN concentrations (72 mg L1)
has been approved inmore than 30 countries (Aggett, Leach, Rueda,
& MacLean, 2003).
Enzymatic methods were used by Gil and Sánchez-Medina
(1981) to measure nucleotides in bovine, ovine, and caprine milk.
Nucleoside 50-monophosphates were released enzymatically from
nucleoside precursors using snake venom phosphodiesterase and
were quantitatively reacted in a series of enzymatic reactions with
an NADH end-point at 340 nm. In recent years, nucleosides and
nucleotides have most commonly been analyzed by protein
removal using acid precipitation, followed by high performance
liquid chromatographyultraviolet (HPLCUV) analysis of the
crude or fractionated extract (Ferreira, Mendes, Gomes, Faria, &
Ferreira, 2001; Gill & Indyk, 2007a, b).
The content of free nucleosides and nucleotides have been
studied in milk of a number of mammalian species, including
human, bovine, caprine, and ovine, and the concentration and
relative proportions of their free forms in the milk of different
species has been reported to vary (Gil & Sánchez-Medina, 1981; Gill
& Indyk, 2007a; Johke & Goto, 1962; Martin, Clawin-Rädecker,
Lorenzen, Ziebart, & Barth, 2005; Schlimme et al., 1997).
However, measurement of the concentrations of free nucleosides
and monomeric nucleotides does not account for the significant
nucleotide adducts or polymeric nucleotides that are also nutri-
tionally available to the neonate of mammalian species.
To determine the total potentially available nucleosides (TPAN)
in human milk and to characterize the contributions of different
molecular TPAN sources to infant nutrition, a combined multi-
enzyme method incorporating a boronate extract clean-up fol-
lowed by HPLCeUV analysis was developed (Leach, Baxter, Molitor,
Ramstack, & Masor, 1995; Liu & Scouten, 2000). This analytical
strategy allows specific contributions to the TPAN pool from poly-
meric nucleotides, monomeric nucleotides, nucleosides, and
nucleotide adducts to be estimated. Recently, this technique was
applied to a lactational study of bovine colostrum and milk given
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the importance of this component in infant formula production
(Gill et al., 2011).
Given the global importance of large domesticated ruminants to
human nutrition, the purpose of the current study was to provide
a comparative assessment of the TPAN contents of mature bovine,
caprine, and ovine milk and to differentiate the contributing
nucleoside and nucleotide forms for each species.
2. Materials and methods
Materials, instrumentation and methods were as described in
Gill et al. (2011). Sample collection and statistical analysis in the
present study are detailed below.
2.1. Sample collection
In May 2009, samples of bovine milk (mixed Holstein-Friesian
and Jersey) and caprine milk (Saanen) were collected directly from
tanker silos prior to processing at two manufacturing sites in the
Waikato region of New Zealand. A mature ovine milk sample (East
Friesian) was supplied from a flock of sheep from the Southland
region of New Zealand. Upon collection, the samples were taken to
the laboratory and immediately prepared for storage in the same
manner as previously described (Gill et al., 2011).
2.2. Statistical analysis
The experimental data were statistically analyzed by one-way
analysis of variance (ANOVA) of the response of each species
(bovine, caprine, ovine) and Tukey’s multiple comparison test
(Minitab v.15, State College, PA).
3. Results and discussion
3.1. Chromatographic analysis of sample extracts
Chromatographic performance was evaluated on the basis of
retention factor, peak symmetry, peak resolution, and area
repeatability, and was deemed to be acceptable from replicate
analyses (n ¼ 6) of a mixed nucleoside standard (Fig. 1).
3.2. TPAN in bovine, caprine, and ovine milk
The results of the TPAN analysis of the milks of the three species
are given in Table 1. A comparison of the concentration and the
relative contribution of each nucleoside source is illustrated in
Fig. 2. A comparison of the concentration and the relative contri-
bution of each nucleoside, categorised by nucleobase, is shown in
Fig. 3.
3.2.1. Nucleoside contribution to TPAN
The cytidine concentrations ranged from 0.9 to 2.3 mmol dL1
and were comparable among the milk of the three species, as were
the relatively low concentrations of both adenosine and guanosine.
In contrast, uridine was present in higher concentrations in both
caprine milk (11.3 mmol dL1) and ovine milk (14.8 mmol dL1),
differentiating these milks from bovine milk (1.9 mmol dL1). This
dominance of uridine in ovine milk and caprine milk has been re-
ported previously (Martin et al., 2005; Plakantara, Michaelidou,
Polychroniadou, Menexes, & Alichanidis, 2010).
Nevertheless, the higher nucleoside concentrations in caprine
and ovine milk represented only minor contributions to TPAN,
whereas the contribution of nucleosides to the TPAN of bovine milk
was >30%. It is noteworthy that ruminant milk contains higher
concentrations of total nucleosides than those reported in human
milk (Leach et al., 1995).
Fig. 1. Chromatogramsof amixednucleoside standard, and of bovine, caprine, and ovine
milk. Conditions: mobile phase A: 0.05 M sodium acetate, pH 4.8; mobile phase B: 100%
methanol; gradient elution: flow rate 0.7mLmin1 throughout, 0e3min (95% A, 5% B, v/
v), 7e22 min (75% A, 25% B, v/v), 23e30 min (95% A, 5% B, v/v). UV detection 260 nm.
Table 1
Total potentially available nucleosides in bovine, caprine, and ovine milk.a
Milk Form Cytidine Uridine Guanosine Adenosine Total
Bovine Nucleoside 0.9  0.1 1.9  0.1 nd nd 2.8  0.3
Monomeric NT 3.3  0.1 0.5  0.2 nd nd 3.8  0.3
NT adduct 0.1  0.0 0.1  0.0 0.4  0.1 0.1  0.0 0.6  0.0
Polymeric NT 0.1  0.1 0.1  0.1 nd 0.5  0.0 0.7  0.3
Total base 4.4  0.2 2.6  0.2 0.4  0.1 0.5  0.0 7.9  0.5
Caprine Nucleoside 1.6  0.1 11.3  0.4 nd nd 12.9  0.3
Monomeric NT 3.6  0.2 37.2  0.8 9.4  0.5 2.4  0.2 52.7  1.7
NT adduct 0.7  0.0 10.1  1.2 14.5  0.1 3.4  0.1 28.7  1.2
Polymeric NT 0.6  0.2 1.0  0.9 1.1  0.5 0.5  0.2 3.2  1.9
Total base 6.5  0.3 59.5  1.8 25.0  0.7 6.3  0.3 97.4  2.8
Ovine Nucleoside 2.3  0.1 14.8  1.1 0.6  0.0 nd 17.6  1.2
Monomeric NT 5.7  0.3 187.4  4.4 6.3  0.0 12.1  0.0 211.4  4.0
NT adduct 0.9  0.1 100.4  7.8 22.1  0.2 14.4  0.6 137.8  8.7
Polymeric NT 0.5  0.3 4.3  0.1 1.2  0.3 1.3  0.6 7.3  1.2
Total base 9.4  0.4 306.8  9.0 30.2  0.3 27.8  0.9 374.1  9.8
a Values (mmol dL1) are means  standard deviation of duplicate analyses: NT, nucleotide; nd, not detected.
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3.2.2. Monomeric nucleotide contribution to TPAN
The trends in nucleotide concentrations measured this study
were similar to those reported previously in bovine, caprine, and
ovinemilk (Gil & Sánchez-Medina,1981; Gill & Indyk, 2007a;Martin
et al., 2005; Plakantara et al., 2010). Bovine milk contained signifi-
cantly lower concentrations ofmonomeric nucleotides than caprine
and ovine milk. The cytidine nucleotide concentration ranges were
comparable among the three species, as were the nucleotide
concentration ranges for both adenosine and guanosine, which
were at similarly low concentrations. The concentrations of uridine
nucleotides varied greatly among themilk of the three species, with
the range spanning 0.5e187 mmol dL1, with the lowest concen-
tration in bovine milk and the highest concentration in ovine milk.
The uridine nucleotide concentration of 37.2 mmol dL1 in caprine
milk is similar to those reported previously (Ferreira et al., 2001;
Plakantara et al., 2010), and although these studies did not report
substantially higher levels of uridine nucleotides in ovine milk, the
value of 187.4 mmol dL1 in the present study is similar to the levels
reported in early lactation ovine milk reported by Gil and Sánchez-
Medina (1981). Elevated uridine nucleotide levels may, in part, be
rationalised on the basis of their role in lactose biosynthesis (Arthur,
Kent, & Hartmann, 1991; Linzell & Peaker, 1971) and their potential
immunological properties (Kulkarni, Fanslow, Rudolph, & Van
Buren, 1986; Van Buren, Kulkarni, Fanslow, & Rudolph, 1985) as
has been noted previously (Gill et al., 2011).
3.2.3. Nucleotide adduct contribution to TPAN
The range of concentrations of nucleotide adducts in the milk
of the three species was similar to that of nucleotides, with the
lowest concentration in bovine milk and the highest concentration
in ovine milk. The uridine adducts measured in ovine milk were
an order of magnitude higher than those in caprine milk and three
orders of magnitude higher than those in bovine milk. Similar
results were obtained in mature milk by Gil and Sánchez-Medina
(1981) in their determination of UDP hexose, UDP hexosamine,
and UDP galactose in the milk of the three species. The concen-
trations of guanosine adducts measured were 0.4, 14.5, and
22.1 mmol dL1 in bovine, caprine, and ovine milk, respectively.
Nucleotide adducts contributed significantly (>30%) to TPAN in
caprine and ovine milks, whereas their contribution to TPAN in
bovine milk was w10%.
The result for guanosine adducts compared well with the
aggregate of guanosinesugar adduct concentrations previously
reported at 1 month (Martin et al., 2005). Similar concentrations
of adenosine adducts were found, presumably derived from
flavin adenine dinucleotide and NADH (Fox & McSweeney, 1998;
Kanno, Shirahuji, & Hoshi, 1991). The adenosine concentrations in
bovine milk were much lower than those in caprine milk and
ovine milk.
3.2.4. Polymeric nucleotide contribution to TPAN
Polymeric nucleotides showed the least difference among themilk
of the three species and, aswith theothernucleoside forms, polymeric
uridine from ovine milk was most abundant and was comparable to
the concentration in human milk (Leach et al., 1995). Given the over-
whelming concentration of uridine in ovine milk from monomeric
nucleotides, it is possible that polymeric uridine concentrations were
elevated as a consequence of calculation by difference.
Fig. 3. A comparison of the concentration and the relative contribution of each
nucleoside (by nucleobase) in bovine, caprine, and ovine milk samples (mean of
duplicate analyses): , uridine; , guanosine; , adenosine; , cytidine.
Fig. 2. A comparison of the concentration and the relative contribution of each
nucleoside (by phosphorylated form) in bovine, caprine, and ovine milk samples
(mean of duplicate analyses): , nucleosides; , nucleotide adducts; , monomeric
nucleotides; , polymeric nucleotides.
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3.2.5. Nucleobase contribution to TPAN
The pyrimidines, cytidine and uridine, were present primarily as
monomeric nucleotides in the milk of the three species. This was in
contrast to the purines, guanosine and adenosine, which were
predominantly present as adducts in the milk of each of these
species (Table 1). Cytidine and cytidine nucleotides were the most
prevalent forms in bovinemilk; similar results were obtained in the
TPAN analysis of human milk (Leach et al., 1995). In contrast,
uridine was the dominant nucleobase in caprine and ovine milk.
The total cytidine concentration was lowest in bovine milk and
highest in ovine milk. The concentrations of total uridine, guano-
sine, and adenosine were lowest in bovine milk and highest in
ovine milk. The concentrations of total uridine, guanosine, and
adenosine of human milk (Leach et al., 1995) were higher than
those measured in bovine milk but much lower than those of
caprine milk and ovine milk.
3.2.6. Total potentially available nucleosides
The TPAN concentrations in the milk of the three species varied
markedly, with ovine milk having the highest concentrations and
bovine milk having the lowest concentrations. Ovine milk contained
the highest concentrations of nucleosides, nucleotide adducts, free
nucleotides, and polymeric nucleotides, as well as the highest
contribution from each nucleobase. Similarly, bovine milk contained
the lowest concentrations of all forms of nucleosides andnucleotides,
with caprine milk being intermediate. The TPAN concentration of
humanmilk (Leachetal.,1995) ishigher than thatmeasured inbovine
milk but much lower than those of caprine milk and ovine milk.
Previous studies on nucleotides in both bovine and caprine milk
have shown higher concentrations of free nucleotides and related
compounds in the latter (Gil & Sánchez-Medina, 1981; Johke &
Goto, 1962), while the nucleotide concentrations in caprine milk
have been favourably compared with those in humanmilk (Prosser,
McLaren, Frost, Agnew, & Lowry, 2008). Because of this, supple-
mentation of caprine milk-based infant formulae with nucleotides
is not necessary as such products provide similar quantities of free
nucleotides to those in nucleotide-supplemented bovine milk-
based infant formulae. However, this present study showed that,
when TPAN concentrations were calculated, caprinemilk contained
97.4 mmol dL1, i.e., more than four times greater than the highest
TPAN concentration reported in human milk (Leach et al., 1995).
The TPAN concentration in bovine milk measured in the present
study was most comparable with the concentration in humanmilk,
as reported by Leach et al. (1995). Bovine milk contained cytidine
and uridine nucleosides and nucleotides in approximately equal
molar proportions, whereas ovine and caprine milk were domi-
nated by uridine and uridine nucleotides.
4. Conclusions
Despite the increasing awareness of the nutritional benefit of
nucleotides in infant nutrition, and the proliferation of milk of
various species being used as replacements for breast milk,
a comparative study of TPAN across three ruminant species has not
been previously reported.
The TPAN concentrations in bovine, caprine, and ovine milk
were studied and significant differences among the milk of each
species were found. The highest concentration of TPAN was found
in ovine milk, with significantly lower concentrations in caprine
milk and bovine milk. Ovine milk contained the highest concen-
trations of each of the individual nucleoside and nucleotide forms,
whereas bovine milk contained the lowest. Bovine milk contained
cytidine and uridine nucleosides and nucleotides in approximately
equal molar proportions, whereas ovine milk and caprine milk
were dominated by uridine and uridine nucleotides.
Acknowledgements
The authors thank Colin Prosser (Dairy Goat Co-operative, New
Zealand) and Derek Knighton (AgResearch, New Zealand) for the
supply of samples of caprine and ovinemilks.We alsowish to thank
Roger Kissling (Fonterra, Co-operative Group, New Zealand) for his
statistical analysis of the results. Advice on the application of the
analytical protocol given by Bruce Molitor (Abbott Laboratories,
USA) is greatly appreciated.
The financial assistance of Fonterra Co-operative Group and of
the New Zealand Tertiary Education Commission in providing an
Enterprise Scholarship is gratefully acknowledged.
References
Adamkin, D. H. (2007). Controversies in neonatal nutrition: docosahexanoic acid
(DHA) and nucleotides. Journal of Perinatology, 27, S79eS82.
Aggett, P., Leach, J. L., Rueda, R., & MacLean, W. C., Jr. (2003). Innovation in infant
formula development: a reassessment of ribonucleotides in 2002. Nutrition, 19,
375e384.
Arthur, P. G., Kent, J. C., & Hartmann, P. E. (1991). Metabolites of lactose synthesis in
milk from women during established lactation. Journal of Pediatric Gastroen-
terology and Nutrition, 13, 260e266.
Boza, J. J., & Martínez-Augustin, O. (2002). Role and function of nucleotides in infant
nutrition. Nestle Nutrition Workshop Series, 47(Suppl.), 165e184.
Ferreira, I. M. P. L. V. O., Mendes, E., Gomes, A. M. P., Faria, M. A., & Ferreira, M. A.
(2001). The determination and distribution of nucleotides in dairy products
using HPLC and diode array detection. Food Chemistry, 74, 239e244.
Fox, P. F., & McSweeney, P. L. H. (1998). Dairy chemistry and biochemistry. New York,
NY, USA: Kluwer Academic/Plenum Publishers.
Gil, A., & Sánchez-Medina, F. (1981). Acid-soluble nucleotides of cow’s, goat’s and
sheep’s milks, at different stages of lactation. Journal of Dairy Research, 48, 35e44.
Gill, B. D., & Indyk, H. E. (2007a). Development and application of a liquid chro-
matographic method for analysis of nucleotides and nucleosides in milk and
infant formulas. International Dairy Journal, 17, 596e605.
Gill, B. D., & Indyk, H. E. (2007b). Determination of nucleotides, nucleosides and
nucleobases in milks and pediatric formulas: a review. Journal of AOAC Inter-
national, 90, 1354e1364.
Gill, B. D., Indyk, H. E., & Manley-Harris, M. (2011). Determination of total poten-
tially available nucleosides in bovine milk. International Dairy Journal, 21, 34e41.
Johke, T., & Goto, T. (1962). Acid-soluble nucleotides in cow’s and goat’s milk.
Journal of Dairy Science, 45, 735e741.
Kanno, C., Shirahuji, K., & Hoshi, T. (1991). Simple method for separate determi-
nation of three flavins in bovine milk by high performance liquid chromatog-
raphy. Journal of Food Science, 56, 678e681.
Kulkarni, A. D., Fanslow, W. C., Rudolph, F. B., & Van Buren, C. T. (1986). Effect of
dietary nucleotides on response to bacterial infections. Journal of Parenteral and
Enteral Nutrition, 10, 169e171.
Leach, J. L., Baxter, J. H., Molitor, B. E., Ramstack, M. B., & Masor, M. L. (1995). Total
potentially available nucleosides of human milk by stage of lactation. American
Journal of Clinical Nutrition, 61, 1224e1230.
Linzell, J. L., & Peaker, M. (1971). Mechanism of milk secretion. Physiological Reviews,
51, 564e597.
Liu, X.-C., & Scouten, W. H. (2000). Boronate affinity chromatography. In P. Bailon,
G. K. Ehrlich, W.-J. Fung, & W. Berthold (Eds.), Affinity chromatography: Methods
and protocols (pp. 119e128). Totowa, NJ, USA: Humana Press.
Martin, D., Clawin-Rädecker, I., Lorenzen, P. C., Ziebart, M., & Barth, K. (2005).
Ribonucleoside contents in sheep and goat milk. Kieler Milchwirtschaftliche
Forschungsberichte, 57, 21e32.
Plakantara, S., Michaelidou, A. M., Polychroniadou, A., Menexes, G., & Alichanidis, E.
(2010). Nucleotides and nucleosides in ovine and caprine milk during lactation.
Journal of Dairy Science, 93, 2330e2337.
Prosser, C. G., McLaren, R. D., Frost, D., Agnew, M., & Lowry, D. J. (2008). Composition
of the non-protein nitrogen fraction of goat whole milk powder and goat milk-
based infant and follow-on formulae. International Journal of Food Sciences and
Nutrition, 59, 123e133.
Schaller, J. P., Buck, R. H., & Rueda, R. (2007). Ribonucleotides: conditionally
essential nutrients shown to enhance immune function and reduce diarrheal
disease in infants. Seminars in Fetal and Neonatal Medicine, 12, 35e44.
Schlimme, E., Martin, D., Meisel, H., Schneehagen, K., Hoffmann, S., Sievers, E., et al.
(1997). Species-specific composition pattern of milk ribonucleosides and
-nucleotides: chemical and physiological aspects. Kieler Milchwirtschaftliche
Forschungsberichte, 49, 305e326.
Van Buren, C. T., Kulkarni, A. D., Fanslow, W. C., & Rudolph, F. B. (1985). Dietary
nucleotides, a requirement for helper/inducer T lymphocytes. Transplantation,
40, 694e697.
Yu, V. Y. H. (2002). Scientific rationale and benefits of nucleotide supplementation
of infant formula. Journal of Paediatrics and Child Health, 38, 543e549.
B.D. Gill et al. / International Dairy Journal 24 (2012) 40e43 43
Gill et al.: Journal of aoaC international Vol. 95, no. 3, 2012 599
Analysis of 5′-Mononucleotides in Infant Formula and 
Adult/Pediatric Nutritional Formula by Liquid 
Chromatography: First Action 2011.20
Brendon d. Gill
Fonterra Co-operative Group Ltd, PO Box 7, Waitoa 3380, New Zealand 
University of Waikato, Private Bag 3105, Hamilton 3240, New Zealand
Harvey e. indyk, Maureen C. kuMar, and natHan k. SievwriGHt
Fonterra Co-operative Group Ltd, PO Box 7, Waitoa 3380, New Zealand
Merilyn Manley-HarriS
University of Waikato, Private Bag 3105, Hamilton 3240, New Zealand
dawn dowell
AOAC INTERNATIONAL, 481 N. Frederick Ave, Suite 500, Gaithersburg, MD 20877-2417
Submitted for publication February 8, 2012.
The method was approved by the Expert Review Panel on Infant 
Formula and Adult Nutritionals as First Action. See “Standards News,” 
(2011) Inside Laboratory Management, September/October issue.
The AOAC Stakeholder Panel on Infant Formula and Adult 
Nutritionals (SPIFAN) invites method users to provide feedback 
on the First Action methods. Feedback from method users will 
help verify that the methods are fit for purpose and are critical 
to gaining global recognition and acceptance of the methods. 
Comments can be sent directly to the corresponding author.
Corresponding author’s e-mail: Brendon.Gill@fonterra.com
DOI: 10.5740/jaoacint.CS2011_20
INFANT FORMULA AND ADULT NUTRITIONALS
A method for the routine determination of 
5′-mononucleotides (uridine 5′-monophosphate, 
inosine 5′-monophosphate, adenosine 
5′-monophosphate, guanosine 5′-monophosphate, 
and cytidine 5′-monophosphate) in infant formula 
and adult nutritionals is described. After sample 
dissolution and addition of internal standard, potential 
interferences were removed by anion-exchange SPE 
followed by HPLC-UV analysis. Single-laboratory 
validation performance parameters include recovery 
(92–101%) and repeatability (1.0–2.3% RSD). The 
method was approved for Official First Action status 
by an AOAC expert review panel.
Nucleotides are compounds of critical importance to cellular function, and although not essential dietary nutrients, it has been demonstrated that supplementation 
of pediatric formulas with nucleotides is of benefit in neonatal 
nutrition. The described method was developed to provide 
an accurate, rapid, and robust technique for the routine 
compliance testing of uridine 5′-monophosphate (UMP), 
inosine 5′-monophosphate (IMP), adenosine 5′-monophosphate 
(AMP), guanosine 5′-monophosphate (GMP), and cytidine 
5′-monophosphate (CMP) in infant formula and adult/pediatric 
nutritional formula, and was recently reported (1).
In September 2011, the method was reviewed by an AOAC 
expert review panel and, based on the published single-
laboratory validation (SLV) data as compared with the standard 
method performance requirements (AOAC SMPR 2011.008; 
2) set by the Stakeholder Panel on Infant Formula and Adult 
Nutritionals (SPIFAN), it was approved for Official First Action 
status as AOAC Official MethodSM 2011.20.
AOAC Official Method 2011.20 
5′-Mononucleotides in Infant Formula
and Adult/Pediatric Nutritional Formula
Liquid Chromatography 
First Action 2011
(Applicable to the determination of 5′-mononucleotides in 
infant formula and adult/pediatric nutritional formula.)
Caution: Refer to the material safety data sheets for all 
chemicals prior to use. Use all appropriate personal 
protective equipment, and follow good laboratory 
practices.
A.  Principle
Sample is dissolved in high-salt solution to inhibit protein 
and fat interactions. The 5′-mononucleotides—uridine 
5′-monophosphate (UMP), inosine 5′-monophosphate 
(IMP), adenosine 5′-monophosphate (AMP), guanosine 
5′-monophosphate (GMP), and cytidine 5′-phosphate (CMP)—
are separated from the sample matrix by strong-anion exchange 
solid-phase extraction (SPE), followed by chromatographic 
analysis using a C18 stationary phase with gradient elution, UV 
detection, and quantitation by an internal standard technique 
using thymidine 5′-monophosphate (TMP).
B.  Apparatus
(a) HPLC system.—Equipped with pump, sample injector 
unit with a 50 μL injection loop, degasser unit, column oven, 
and photodiode array detector.
(b) C18 column.—Gemini C18, 5 μm, 4.6 × 250 mm 
(Phenomenex, Torrance, CA).
(c) Spectrophotometer.—Capable of digital readout to 
3 decimal places.
(d) pH meter.
(e) Polypropylene centrifuge tubes.—50 mL.
(f) Disposable syringes.—3 mL.
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(g) Syringe filters.—0.2 μm with cellulose acetate 
membranes.
(h) SPE vacuum manifold.
(i) Chromabond SB polypropylene strong-anion exchange 
SPE cartridges.—6 mL × 1000 mg (Macherey-Nagel, Düren, 
Germany).
(j) Filter membranes.—0.45 µm nylon.
C.  Reagents
(a) Standards.—Should be ≥99% pure (Sigma or equivalent). 
Nucleotide sodium salts or sodium salt hydrates may be 
substituted if free acid forms are not readily available.
(1) TMP.—CAS No. 365-07-1.
(2) AMP.—CAS No. 61-19-8.
(3) CMP.—CAS No. 63-37-6.
(4) GMP.—CAS No. 85-32-5.
(5) IMP.—CAS No. 131-99-7.
(6) UMP.—CAS No. 58-97-9.
(b) Potassium bromide.
(c) Potassium dihydrogen phosphate.
(d) Orthophosphoric acid.
(e) Potassium hydroxide.
(f) Ethylenediaminetetraacetic acid.
(g) Sodium chloride.
(h) Methanol.
(i) Water.—Purified with resistivity ≥18 MΩ. 
D.  Reagent Preparation
(a) Standardizing buffer (KH2PO4, 0.25 M, pH 3.5).—
Dissolve 34.02 g KH2PO4 in 900 mL water and adjust pH to 3.5 
with orthophosphoric acid. Dilute to 1 L.
(b) Extraction solution (NaCl, 1 M:EDTA, 5 mM).—
Dissolve 58.5 g NaCl and 1.46 g EDTA. Dilute in 1 L water.
(c) Wash solution (KBr, 0.3 M).—Dissolve 3.57 g KBr in 
100 mL water.
(d) Eluent (KH2PO4, 0.5 M, pH 3.0).—Dissolve 
6.805 g KH2PO4 in 90 mL water and adjust pH to 3.0 with 
orthophosphoric acid. Dilute to 100 mL.
(e) Mobile phase A (KH2PO4, 10 mM, pH 5.6).—Dissolve 
1.36 g KH2PO4 in 900 mL water and adjust pH to 5.6 with KOH 
solution (10%, w/v). Dilute to 1 L with water. Make daily as 
microbial growth often occurs at room temperature in phosphate 
buffers that contain little or no organic solvent.
(f) Mobile phase B (100% methanol).
E.  Standard Preparation
See Table 2011.20A for the UV absorbance maxima and 
extinction coefficients for 5′-mononucleotides.
(a) Stock standards (~1 mg/mL).—(1) Accurately weigh 
approximately 50 mg each nucleotide into separate 50 mL 
volumetric flasks. (2) Add 40 mL water, mix until dissolved, 
and fill to volume with water.
(b) Purity standards.—Pipet 1.0 mL each stock standard 
into separate 50 mL volumetric flasks, make to volume with 
standardizing buffer (KH2PO4, 0.25 M, pH 3.5), and measure 
absorbance at the appropriate λmax to determine the concentration 
of each nucleotide stock standard.
(c) Internal standard solution (~80 µg/mL).—Dilute 4 mL 
TMP stock standard into 50 mL water.
(d) Working standard solution (~40 µg/mL).—Pipet 2 mL 
each stock standard (AMP, CMP, GMP, IMP, and UMP) into a 
single 50 mL volumetric flask and make to volume with water.
(e) Calibration standard solutions.—See Table 2011.20B for 
nucleotide concentrations of the calibration standard solutions.
(1) Calibration solution 1.—Pipet 0.25 mL working standard 
solution and 1 mL internal standard solution into a 25 mL 
volumetric flask and make to volume with water.
(2) Calibration solution 2.—Pipet 0.5 mL working standard 
solution and 1 mL internal standard solution into a 25 mL 
volumetric flask and make to volume with water.
(3) Calibration solution 3.—Pipet 2 mL working standard 
solution and 1 mL internal standard solution into a 25 mL 
volumetric flask and make to volume with water.
(4) Calibration solution 4.—Pipet 5 mL working standard 
solution and 1 mL internal standard solution into a 25 mL 
volumetric flask and make to volume with water.
F.  Sample Preparation
(a) Accurately weigh approximately 1 g powder, or 10 mL 
liquid milk or ready-to-feed infant/nutritional formula, into a 
50 mL centrifuge tube.
(b) Dissolve in 30 mL extraction solution (NaCl, 1 M:EDTA 
5 mM).
(c) Add 1.0 mL TMP intermediate standard (~80 µg/mL).
(d) Cap the tube and vortex mix.
(e) Allow sample to stand for 10 min to ensure complete 
hydration.
(f) Dilute to a final volume of 50 mL with water.
(g) Cap the tube and vortex mix.
G.  Extraction
Throughout the extraction procedure, do not let the cartridge 
run dry but drain to the top of the cartridge bed only. When 
draining the cartridge the flow rate should be <2 mL/min.
Table 2011.20A. UV absorbance maxima and 
extinction coefficients for 5′-mononucleotides
Nucleotide λmax, nm
1%
1cmE
 
Adenosine 5′-monophosphate 257 430.4
Cytidine 5′-monophosphate 280 398.0
Guanosine 5′-monophosphate 254 393.3
Inosine 5′-monophosphate 249 357.3
Uridine 5′-monophosphate 262 313.5
Thymidine 5′-monophosphate 267 288.5
Table 2011.20B. Nominal concentration of 
calibration solutions
Calibration solution
AMP, CMP, GMP,  
IMP, UMP, µg/mL TMP, µg/mL
1 0.4 3.2
2 0.8 3.2
3 3.2 3.2
4 8 3.2
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(a) For each sample, place a single SPE cartridge on a 
vacuum manifold.
(b) Condition the columns by elution with 4 mL methanol 
followed by elution with 2 × 5 mL water. 
(c) Load the cartridge with 4 mL sample solution.
(d) Wash the cartridge with KBr (0.3 M, 4 mL) to remove 
interferences.
(e) Elute the nucleotides with SPE eluent solution (KH2PO4, 
0.5 M, pH 3.0, 4 mL) into a test tube.
(f) Filter an aliquot (~2 mL) of the eluent through a 0.2 µm 
syringe filter into an autosampler vial.
H.  Chromatography
(a) Form gradients by low pressure mixing of the two mobile 
phases, A and B, with separation of nucleotides achieved using 
the procedure shown in Table 2011.20C.
(b) Acquire spectral data between 210 and 300 nm by the 
photodiode array detector with chromatograms monitored at the 
specified wavelengths below for quantitation.
(1) IMP wavelength at 250 nm.
(2) AMP, GMP, and TMP wavelengths at 260 nm.
(3) CMP and UMP wavelengths at 270 nm.
(c) Set column oven to 40°C.
I.  Calculations
(a) Percentage purity of each nucleotide (as free acid) in 
purity standard:
Purity, % = 
1
5050
××
wtSSE
Abs
1%
1cm
λmax
 
where Absλmax = UV absorbance at maximum wavelength; 
1%
1cmE
 
 = extinction coefficient for nucleotide; wtSS = weight 
of nucleotide in stock standard (g); 50 = total volume of stock 
standard (mL); 50 = total volume of purity standard (mL); 1 = 
volume of stock standard added to purity standard (mL).
(b) Concentration of nucleotide in stock standards:
Stock standard, µg/mL = 610
100
%
50
××
PwtSS
 
where wtSS = weight of nucleotide in stock standard (g); 50 
= total volume of stock standard (mL); 106 = concentration 
conversion (g/mL to µg/mL); P% = purity (%); 100 = mass 
conversion from % to decimal.
(c) Concentration of TMP in internal standard:
Internal standard, µg/mL = 
50
4
×SS
 
where SS = concentration of nucleotide in stock standard 
(µg/mL); 4 = volume of stock standard in internal standard 
(mL); 50 = total volume of internal standard (mL).
(d) Concentration of nucleotide in calibration standards:
Calibration standard, µg/mL = 
2550
2 VS
SS ××
 
where SS = concentration of nucleotide in stock standard 
(µg/mL); 2 = volume of stock standard in working standard 
(mL); 50 = total volume of working standard (mL); VS = 
volume of working standard in calibration standard (mL); 25 = 
total volume of calibration standard (mL).
(e) Concentration of TMP in calibration standards:
Calibration standard, µg/mL = 
25
1
×IS
 
where IS = concentration of TMP in internal standard (µg/mL); 
1 = volume of working standard in calibration standard (mL); 
25 = total volume of calibration standard (mL).
(f) Determine the linear regression curve for the ratio of peaks 
areas (nucleotide/TMP; y-axis) vs the ratio of concentrations 
(nucleotide/TMP; x-axis) for calibration standards and calculate 
the slope with the y-intercept forced through 0.
(g) Interpolate the nucleotide contents in unknown samples 
from this calibration curve.
For powders:
Nucleotide, mg/hg = 
1000
100)(1
×
×
××
S
SISI
SI
TN
W
VC
LA
A
For ready-to feed liquids:
Nucleotide, mg/dL = 
1000
100)(1
×
×
××
S
SISI
SI
TN
V
VC
LA
A
where ANT = nucleotide peak area in sample; AIS = TMP peak 
area in sample; L = linear regression slope of calibration curve; 
CIS = concentration of internal standard added to sample 
(µg/mL); VIS = volume of internal standard added to sample 
(mL); WS = weight of sample (g); 100 = mass conversion of 
result (g to hg); 1000 = mass conversion of result (µg to mg); VS 
= volume of sample (mL); 100 = volume conversion of result 
(mL to dL).
J.  Data Handling
Report results in mg/hg to 1 decimal place.
Reference: J. AOAC Int. 95, 599(2012)
Results and Discussion
An SLV of the method previously published (1) indicated 
that this method is suitable for the routine determination of the 
5′-mononucleotide content in milk and milk-based pediatric and 
adult nutritional products. The validation parameters investigated 
included linearity and working range, method detection limit, 
accuracy as recovery and bias, precision as repeatability 
and intermediate precision, and robustness. Linearity was 
demonstrated for all five nucleotides with correlation coefficients 
of >0.9999, and a visual inspection of residual plots. The method 
detection limits for individual nucleotides ranged from 0.06 
to 0.19 mg/kg. The working range for individual nucleotides 
evaluated was from 0.06 to 17.4 mg/kg. Accuracy was determined 
as recovery, with values measured from 92 to 101%, within the 
suggested AOAC limits of 80−115% at the 10 ppm level (3), and 
no bias was found (P values all >0.05) when compared with a 
Table 2011.20C. Gradient procedure for 
chromatographic separation
Time, min Flow rate, mL/min Phase A, % Phase B, %
0 0.6 100 0
25 0.6 80 20
26 0.6 100 0
40 0.6 100 0
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previously published method (4). Precision as repeatability was 
estimated as 1.0–2.3 %RSD with a range for HorRat of 0.3–0.5 
and for intermediate precision of 3.8–8.6 RSD%. A Plackett−
Burman robustness study (5) was performed and the seven factors 
evaluated were shown not to affect the final results within typical 
experimental variations.
The method was applied to the analysis of a number of 
commercially available pediatric and nutritional powders. The 
products used for sampling included infant formula, follow-on 
formulas, and an adult nutritional product. The range of sources 
for these products included bovine milk, hydrolyzed milk 
protein, caprine milk, and soy protein. The method was found 
to be suitable for use with these various product matrixes.
It is recommended that this method be further examined 
against a set of infant formula and adult nutritional matrixes 
developed for this purpose by the SPIFAN community, and 
its performance evaluated against the SMPRs established by 
SPIFAN.
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Abstract A method for the simultaneous analysis of nucle-
osides and nucleotides in infant formula using reversed-
phase liquid chromatography–tandem mass spectrometry is
described. This approach is advantageous for compliance
testing of infant formula over other LC-MS methods in
which only nucleotides or nucleosides are measured. Fol-
lowing sample dissolution, protein was removed by centrif-
ugal ultrafiltration. Chromatographic analyses were
performed using a C18 stationary phase and gradient elution
of an ammonium acetate/bicarbonate buffer, mass spectro-
metric detection and quantitation by a stable isotope-
labelled internal standard technique. A single laboratory
validation was performed, with spike recoveries of 80.1–
112.9 % and repeatability relative standard deviations of
1.9–7.2 %. Accuracy as bias was demonstrated against
reference values for NIST1849a certified reference material.
The method has been validated for the analysis of bovine
milk-based, soy-based, caprine milk-based and hydrolysed
milk protein-based infant formulae.
Keywords Nucleotides . Nucleosides . Infant formula .
LC-MS
Introduction
The structure of nucleosides and nucleotides and their im-
portance to infant nutrition have been described previously
[1–3]. In view of their physiological benefits, nucleotides
are routinely supplemented into infant formulae as sodium
salts of adenosine 5′-monophosphate (AMP), cytidine 5′-
monophosphate (CMP), guanosine 5′-monophosphate
(GMP), inosine 5′-monophosphate (IMP) and uridine 5′-
monophosphate (UMP) [4]. Although nucleosides are not
supplemented into infant formulae, dephosphorylation of
nucleotides to the corresponding nucleosides—adenosine
(Ado), cytidine (Cyd), guanosine (Guo), inosine (Ino)
and uridine (Urd)—can occur under certain processing
conditions [5].
Analytical methods for nucleosides and nucleotides in in-
fant formulae and milk have previously been reviewed [6].
Sample preparation of infant formulae is frequently achieved
by acidic precipitation of casein proteins from the reconstituted
sample [5, 7]. Alternatively, centrifugal ultrafiltration has also
been reported [8] and offers a simple mechanism to remove
high-molecular-weight material. Further cleanup of sample
extracts using ion exchange solid phase extraction and a
phenylboronate affinity gel has been reported [9–11].
Liquid chromatography, i.e. reversed-phase liquid chro-
matography (RPLC), ion pair RPLC, ion exchange liquid
chromatography and hydrophilic interaction liquid chroma-
tography, with UV detection is commonly used for the
quantitation of nucleotides in milk products [5, 7, 8,
12–15]. RPLC is easily adapted for the analysis of nucleo-
sides, although the retention of nucleotides is more chal-
lenging. However, at the appropriate mobile phase pH, polar
nucleotides are retained on a C18 column and an organic
solvent gradient is able to remove late-eluting nucleosides.
The use of mass spectrometry (MS) offers potential
advantages with respect to accuracy and simplicity by
incorporating the addition of stable isotope-labelled (SIL)
internal standards, whilst the selectivity of tandem MS
reduces the need to remove other components that often
compromise UV analyses [16–18]. The aim of this study
was, therefore, to develop an LC-MS/MS method for the
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simultaneous analysis of nucleosides and nucleotides in
infant formulae. The method described involves a simple
centrifugal ultrafiltration procedure followed by high-
performance liquid chromatography (HPLC) with detec-
tion and quantitation by tandem MS. Confidence in an-
alytical accuracy is assured through the use of a SIL
standard for each analyte. This technique has been vali-
dated for a range of bovine milk-based, caprine milk-
based, soy-based and hypoallergenic infant formulae.
Experimental
Reagents
Ammonium acetate (NH4CH3COO), ammonium bicarbonate
(NH4HCO3), AMP sodium salt, CMP disodium salt, GMP
disodium salt, IMP disodium salt, UMP disodium salt, and
corresponding nucleosides were obtained from Sigma-Aldrich
(St. Louis, MO, USA). SIL nucleoside standards—13C5 Ado,
13C9
15N3 Cyd,
15N5 Guo,
15N4 Ino and
13C9
15N2 Urd—were
purchased from Cambridge Isotope Laboratories (Andover,
MA, USA). SIL nucleotide standards—13C10
15N5 AMP,
13C9
15N3 CMP,
13C10
15N5 GMP and
13C9
15N2 UMP—were
purchased from Sigma-Aldrich. 13C10
15N4 IMP was purchased
from Medical Isotopes (Pelham, NH, USA).
Potassium dihydrogen phosphate (KH2PO4), acetic acid,
orthophosphoric acid, potassium hydroxide and methanol
were supplied by Merck. Water was purified with resistivity
≥18 M Ω using an E-pure water system (Barnstead, Du-
buque, IA, USA).
A standardising buffer (KH2PO4, 0.25 M, pH 3.5) was
made by dissolving 34.02 g of KH2PO4 in 900 mL of water,
adjusting the pH to 3.5 with orthophosphoric acid and then
making the solution to 1 L. Mobile phase A (NH4CH3COO,
10 mM; NH4HCO3, 5 mM, pH 5.6) was made daily by
dissolving 0.771 g of NH4CH3COO and 0.395 g of
NH4HCO3 in 950 mL of water, adjusting the pH to 5.6 with
acetic acid solution (10 %, w/v) and then making to 1 L with
water. Mobile phase B consisted of 100 % methanol.
Standard solutions
SIL nucleoside and nucleotide stock standards were pre-
pared by accurately weighing 50 mg each of 13C5 Ado,
13C9
15N3 Cyd,
15N5 Guo,
15N4 Ino,
13C9
15N2 Urd,
13C10
15N5 AMP,
13C9
15N3 CMP,
13C10
15N5 GMP,
13C10
15N4 IMP and
13C9
15N2 UMP into separate 50-mL
volumetric flasks. To each flask, 40 mL of water was added
and then shaken (with gentle warming if necessary) until the
standard was completely dissolved before water was added
to volume. Aliquots (∼1.5 mL) of SIL stock standards were
immediately dispensed into individual cryogenic vials and
frozen at −15 °C for later use. Prior to analysis, cryogenic
vials containing each SIL nucleoside and nucleotide stock
standard were allowed to thaw to room temperature.
Non-isotopically labelled (NL) nucleoside and nucleotide
stock standards were prepared in a similar manner by accu-
rately weighing approximately 50 mg of each into separate
50-mL volumetric flasks and making to volume with water.
These were refrigerated at 4 °C for up to 1 month.
Estimation of the moisture content of nucleosides was
performed using the oven moisture method (102±2 °C,
4 h) and the concentration was calculated on a dry
weight basis. Extinction coefficients at UV absorbance
maxima were then determined for each nucleoside. These
were compared with the values previously determined for
nucleotides [5], with correction for molecular weight.
The values obtained for each nucleoside were in close
agreement with those for the corresponding nucleotide.
Mean extinction coefficient values (nucleoside and cor-
responding nucleotide) were calculated by adjusting for
molecular weight and are reported in Table 1. The con-
centration of each nucleoside and nucleotide stock stan-
dard was determined by adding 500 μL of each stock
standard into separate 25-mL volumetric flasks, diluting
with standardising buffer and measuring the absorbance
at the appropriate lmax.
A mixed SIL intermediate standard was prepared by
diluting 2.0 mL of each SIL stock standard into a 25-mL
volumetric flask and making to volume with water. A mixed
NL intermediate standard was made by adding 1.0 mL of
each NL stock standard into a 25-mL volumetric flask and
making to volume with water.
Four calibration standards were prepared by pipetting
1.0, 1.0, 0.5 and 0.2 mL of SIL intermediate standard and
2.0, 4.0, 5.0 and 8.0 mL of NL intermediate standard into
Table 1 Mean extinction coefficients at UV absorbance maxima of
nucleosides and corresponding nucleotides
Nucleoside/nucleotide Extinction
coefficient (E1 %)
lmax
(nm)
AMP 428.6 257
Ado 557.0
CMP 390.9 280
Cyd 519.5
GMP 392.0 254
Guo 502.8
IMP 356.5 249
Ino 462.7
UMP 312.7 262
Urd 415.1
Ado adenosine, Cyd cytidine, Guo guanosine, Ino inosine, Urd uridine,
AMP adenosine 5′-monophosphate, CMP cytidine 5′-monophosphate,
GMP guanosine 5′-monophosphate, IMP inosine 5′-monophosphate,
UMP uridine 5′-monophosphate
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50-, 50-, 25- and 10-mL volumetric flasks, respectively. The
calibration standards were then made to volume with water
and mixed thoroughly.
Samples
A range of different infant formula samples were evaluated
during the validation of the method. These included a par-
tially hydrolysed bovine milk-based powder, a partially
hydrolysed soy-based powder, an infant elemental powder,
a bovine milk-based powder, a soy-based powder and a
caprine milk-based powder.
Sample preparation
Approximately 5.0 g of infant formula powder was weighed
accurately into a 50-mL polypropylene centrifuge tube
(Biolab, Auckland, New Zealand) and dissolved in 25 mL
of water. To this was added 1.0 mL of the SIL intermediate
standard and the tube was capped and vortex-mixed. The
sample was allowed to stand for 10 min to ensure complete
hydration before dilution to a final volume of 50 mL with
water.
A 4.0-mL aliquot of sample solution was added to an
Amicon Ultra-4 3000 MWCO centrifugal ultrafiltration unit
(Millipore, Billerica, MA, USA) and centrifuged at 3,500×g
for 60 min. The filter was then removed and discarded and a
1-mL aliquot of filtrate was transferred to an HPLC vial
ready for analysis.
Instrumentation
The HPLC system used consisted of a CBM20A system
controller, two LC20ADXR pumps for high-pressure gradi-
ents, a CTO20AC column oven and a SIL20ACXR
autosampler equipped with a 50-μL injection loop
(Shimadzu, Kyoto, Japan). Chromatographic separation
was achieved using a Gemini column, 5 μm, 4.6×250 mm
(Phenomenex, Torrance, CA, USA), with a high-pressure
gradient elution programme as described in Table 2.
The MS/MS system consisted of a 3200 QTRAP quadru-
pole mass spectrometer with a Turbo V ion source equipped
with an electrospray ionisation (ESI) probe. Analyst 1.5.1
software was used for instrument control and data processing
(ABSciex, Foster City, CA, USA). The mass spectrometer
was operated in ESI+ modewith nitrogen utilised as the drying
and collision gas. The instrumental parameters were set as
follows: curtain gas at 30 psi, nebuliser gases GS1 and GS2 at
50 and 70 psi, respectively, desolvation temperature at 700 °C,
collision-induced dissociation gas at medium and ion spray
voltage at 5,500 V. Instrument settings and multiple reaction
monitoring (MRM) transitions for the generation of product
ions for nucleosides and nucleotides are given in Table 3.
Method validation
Six mixed nucleoside and nucleotide solutions covering the
expected working range were prepared and linearity was
evaluated by least-squares regression analysis of the SIL-
corrected response (ratio of NL/SIL analyte peak area versus
ratio of NL/SIL analyte concentration). A minimum value of
Table 2 Gradient procedure for chromatographic separation
Time (min) Flow rate
(mL min−1)
Phase
composition
%Aa %Bb
0.0 0.75 100 0
3.5 0.75 100 0
10.0 0.75 80 20
20.0 0.75 80 20
21.0 0.75 100 0
35.0 0.75 100 0
aMobile phase A: NH4CH3COO, 10 mM; NH4HCO3, 5 mM, pH 5.6
bMobile phase B: 100 % methanol
Table 3 MS/MS parameters
Analyte Precursor ion
[M-H]+ (m/z)
Product
ions (m/z)
DP
(V)
EP
(V)
CEP
(V)
CE
(V)
CXP
(V)
CMP 324.1 112.0 26 3.5 32 27 4
SIL CMP 336.1 119.0
UMP 325.0 97.0 21 9.5 18 23 4
SIL UMP 336.1 102.1
GMP 364.1 152.0 36 4.5 22 23 4
SIL GMP 379.1 160.0
IMP 349.1 137.0 31 6.0 28 23 4
SIL IMP 362.1 145.0
Cyd 244.1 112.0 11 6.5 22 19 4
SIL Cyd 256.1 119.0
Urd 245.1 113.0 16 5.0 16 19 4
SIL Urd 256.1 119.0
AMP 348.1 136.0 36 1.0 24 25 4
SIL AMP 363.1 146.0
Ino 269.1 137.0 16 4.5 18 23 4
SIL Ino 273.1 141.0
Guo 284.1 152.0 11 4.0 24 23 4
SIL Guo 289.1 157.0
Ado 268.1 136.0 21 8.5 16 39 4
SIL Ado 273.1 136.0
SIL stable isotope-labelled, Ado adenosine, Cyd cytidine, Guo guano-
sine, Ino inosine, Urd uridine, AMP adenosine 5′-monophosphate,
CMP cytidine 5′-monophosphate, GMP guanosine 5′-monophosphate,
IMP inosine 5′-monophosphate, UMP uridine 5′-monophosphate, DP
declustering potential, EP entrance potential, CEP collision cell en-
trance potential, CE collision energy, CXP collision cell exit potential
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0.997 for the correlation coefficient (r2) was deemed to be
suitable. Plots of standard residuals were visually assessed
as a further test of linearity.
Repeatability was estimated by analysing replicate pairs
(n=9 pairs) of a bovine milk-based infant formula and NIST
1849a. Intermediate precision was determined from replicate
analyses (n=6) of a bovine milk-based infant formula and
NIST 1849a tested on three different days. Method detection
limits (MDLs) were estimated in accordance with US Envi-
ronmental Protection Agency procedures [19].
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Fig. 1 LC-MS/MS MRM chromatograms of a mixed nucleotide and nucleotide standard solution (∼7 μg mL−1)
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The robustness of the method was assessed by conducting
a Plackett–Burman trial [20], as described previously [15].
The seven factors assessed were: initial sample water volume
(27 and 23 mL), vortex time (40 and 20 s), wait time (14 and
6 min), centrifuge volume (4.2 and 3.8 mL), centrifuge speed
(4,000 and 3,000×g), centrifuge time (70 and 50 min) and a
dummy factor.
Method accuracy was determined as both recovery
and bias. Recovery of both nucleosides and nucleotides
was evaluated by spiking a range of sample matrices at
50 and 150 % of the concentration levels typically
found in infant formulae. Bias was evaluated by
performing a paired t test for nucleotides both against
reference values of a NIST 1849a powder and against
values for a bovine milk-based infant formula tested
using AOAC Official Method 2011.20 [21].
Results and discussion
Method optimisation
The simultaneous chromatographic analysis of both nucleo-
sides and nucleotides in infant formulae using LC-UV has
previously been described [5]. However, the mobile phase
contained a 0.1 M phosphate buffer, which is unsuitable for
use in LC-MS. In this study, ammonium acetate (10 mM,
pH 5.6) was initially chosen to buffer the mobile phase because
of its compatibility with electrospray mass spectrometric detec-
tion and a pH buffering range (∼3.8–5.8) consistent with nu-
cleoside and nucleotide pKa values. However, significant peak
tailing for nucleotides was observed when this buffer was used.
Conventional LC-UV nucleotide analyses typically
contain phosphate in the mobile phase and no signifi-
cant peak tailing is observed [5, 7]. Unfortunately, the
use of non-volatile buffers such as phosphate in LC-MS
is generally not recommended because of contamination
of the ion source leading to a decrease in sensitivity.
Furthermore, the interaction of phosphorylated com-
pounds with metal surfaces in liquid chromatographic
applications resulting in peak tailing has been reported
[22–26]. Pretreatment of the chromatographic system
using phosphoric acid prior to switching to a non-
phosphate eluent during analysis [26, 27], the substitu-
tion of polyether ether ketone tubing for stainless steel,
the use of a high pH mobile phase [28] and the addition
of EDTA to the mobile phase [25] have all been
employed to overcome this problem.
A number of mass spectrometer manufacturers have
evaluated phosphate buffers for use with their instru-
ments and have demonstrated that modern source de-
signs can tolerate the use of non-volatile buffers
[29–32]. A phosphate-based ion pair RPLC-MS method
was successfully applied to the quantitative analysis of
intracellular nucleotides utilising a microbore column to
reduce the amount of phosphate introduced to the ion
source [33].
In the present study, a low ionic strength phosphate
buffer (NH4H2PO4 0.08 mM, pH 5.6) was initially evaluat-
ed for compatibility with the mass spectrometer. The chro-
matographic parameter resolution, retention factor, peak
area repeatability, retention time repeatability, plate number
and asymmetry were evaluated, with acceptable results be-
ing obtained (data not shown). There was some loss of
sensitivity as replicate analyses progressed, consistent with
a small accumulation of phosphate on the cone. The method
was applied to the analysis of nucleotides in infant formula
samples in a validation study. Linear response was demon-
strated for NL/SIL peak area versus NL/SIL analyte con-
centration (r2=0.997–0.999). Accuracy and precision were
Table 4 Chromatographic performance
Parameter Analyte
Cyd Urd Guo Ino Ado CMP UMP GMP IMP AMP
Retention time
(min)
9.6 (0.0)c 10.8 (0.0) 12.6 (0.0) 12.3 (0.0) 15.3 (0.0) 5 (0.0) 6.1 (0.0) 8.5 (0.0) 9.0 (0.0) 11.6 (0.0)
Capacity factora 2.0 (0.0) 2.4 (0.0) 2.9 (0.0) 2.8 (0.0) 3.8 (0.0) 0.6 (0.0) 0.9 (0.0) 1.6 (0.0) 1.8 (0.0) 2.6 (0.0)
Resolutiona 1.3 (0.2) 3.5 (0.9) 0.8 (0.2) 2.2 (0.4) 4.6 (0.8) − 2.8 (0.4) 4.3 (0.6) 0.9 (0.1) 2.8 (0.4)
Tailing factora 1.8 (1.0) 1.2 (0.3) 1.7 (0.5) 1.4 (0.6) 1.8 (0.7) 1.6 (0.3) 1.7 (0.4) 1.6 (0.3) 1.5 (0.3) 1.7 (0.3)
Peak area ratio
repeatabilityb
0.42 (0.01) 0.46 (0.02) 0.51 (0.02) 0.55 (0.02) 0.50 (0.01) 0.49 (0.03) 0.36 (0.01) 0.46 (0.01) 5.34 (0.13) 0.51 (0.03)
Ado adenosine, Cyd cytidine, Guo guanosine, Ino inosine, Urd uridine, AMP adenosine 5′-monophosphate, CMP cytidine 5′-monophosphate, GMP
guanosine 5′-monophosphate, IMP inosine 5′-monophosphate, UMP uridine 5′-monophosphate
a Calculations as defined by US Pharmacopeia
b Peak area ratio measured as non-labelled nucleoside or nucleotide/stable isotope-labelled nucleoside or nucleotide
c Analysis of six replicates of a mixed nucleoside and nucleotide standard reported as the mean (standard deviation)
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evaluated, with both spike recovery (84.2–107.1 %) and
repeatability relative standard deviation (1.5–3.1 %) deemed
to be acceptable. Despite this performance, a limitation with
this phosphate-based approach was that the number of sam-
ples within each analytical run was limited due to the
requirement for regular maintenance of the source.
An alternative chromatographic system was evaluated
based on the observations of Asakawa et al. [22], who found
a beneficial chromatographic effect with a number of mobile
phase additives. Of those evaluated, only ammonium bicar-
bonate is volatile and considered suitable for use in LC-MS
and was therefore incorporated as an additive in the ammo-
nium acetate eluent.
The optimisation of the MS conditions was performed by
infusion of a standard of each nucleoside or nucleotide
(∼10 μg mL−1) diluted in a mixture of mobile phases A
and B (90:10). Initial development focused on ESI+ for
nucleosides and ESI− for nucleotides. However, it was
found that ESI+ gave superior response for both analytes,
with the [M+H]+ ion most abundant and low levels of
potassium adduct, thereby simplifying the analysis with
the detection of all analytes in positive mode.
The conditions for MRM were optimised by selecting
individual fragments and adjusting collision energies to
maximise the product ion signal. The most abundant frag-
ment ion observed for nucleosides and nucleotides was
Table 6 Mean recovery of nucleosides and nucleotides in spiked samples at 50 and 150 % of typical concentrations
Sample Recovery
(%)
Cyd Urd Guo Ino Ado CMP UMP GMP IMP AMP
IF powder p/h bovine milk-based 95.4 84.9 104.4 94.1 99.3 101.3 81.8 104.8 112.9 95.1
IF powder p/h soy-based 101.1 98.9 107.2 96.8 100.1 101.8 88.8 101.6 98.4 101.7
Infant elemental powder 98.7 97.2 104.1 98.2 99.0 103.8 91.0 104.8 109.0 98.6
IF powder bovine milk-based 93.4 86.6 102.6 100.1 97.9 95.7 90.7 102.0 101.3 101.8
IF powder soy-based 101.7 80.1 107.9 103.0 95.3 101.8 90.3 103.5 94.8 98.7
IF powder caprine milk-based 96.4 109.1 112.0 100.1 100.5 103.0 97.5 100.9 98.9 110.1
AMP adenosine 5′-monophosphate, CMP cytidine 5′-monophosphate, GMP guanosine 5′-monophosphate, IMP inosine 5′-monophosphate, UMP
uridine 5′-monophosphate, Ado adenosine, Cyd cytidine, Guo guanosine, Ino inosine, Urd uridine, IF infant formula, p/h partially hydrolysed
Table 5 Method performance as linearity, detection limit and precision
Analyte Range
(μg mL−1)
Linear regressiona r2 MDLb
(mg hg−1)
RSDr
c (%) HorRatr
d RSDiR
e (%)
Cyd 0.7–58.6 y=0.737x+0.1053 0.9996 0.03 4.8 0.4 14.4
Urd 0.8–60.9 y=0.957x−0.3441 0.9987 0.12 4.1 0.4 14.1
Guo 0.7–54.9 y=0.837x+0.2553 0.9996 0.01 6.2 0.4 7.9
Ino 0.8–62.1 y=1.059x−0.0417 0.9982 0.01 7.2 0.4 11.2
Ado 0.7–59.2 y=0.778x+0.1853 0.9997 0.01 –f – –
CMP 0.6–45.3 y=0.94x+0.0113 0.9998 0.13 4.0 0.6 4.6
UMP 0.5–42.6 y=0.872x−0.1152 0.9997 0.01 5.0 0.6 6.2
GMP 0.6–45.7 y=0.928x+0.1423 0.9993 0.01 1.9 0.2 2.9
IMP 0.6–46.8 y=1.069x+0.5071 0.9999 0.03 – – –
AMP 0.8–60.6 y=0.787x+0.35 0.9986 0.01 2.8 0.4 7.8
AMP adenosine 5′-monophosphate, CMP cytidine 5′-monophosphate, GMP guanosine 5′-monophosphate, IMP inosine 5′-monophosphate, UMP
uridine 5′-monophosphate, Ado adenosine, Cyd cytidine, Guo guanosine, Ino inosine, Urd uridine
a Linear regression plotted as the ratio of peak area of unlabelled analyte to stable isotope-labelled standard versus the ratio of the concentration of
unlabelled analyte to stable isotope-labelled standard
b Determined from n replicates at or near the expected detection limit: MDL=t(n−1, 1−α)×SD, where n=7 and α=0.01
c Relative standard deviation repeatability (RSDr)=SD of n duplicate pairs/mean×100 (n=9)
d Horwitz ratio=RSDr/pRSDR, where pRSDR=2C
−0.1505 at the 10-ppm concentration level (typical range, 0.3–1.3)
e Intermediate reproducibility of six replicates measured on three different days (n=18). RSD%=SD/mean×100
f Concentration at or below the detection limit
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formed by cleaving of the glycosidic bond, resulting in
the loss of ribose or ribose + phosphate group and the
detection of the positively charged nucleobase. The ex-
ception to this was UMP, which underwent fragmentation
and rearrangement to generate the m/z 97.0 ion. A similar
fragmentation scheme has been reported for the generation of
a product ion with m/z 81.0 from the fragmentation of
deoxycytidine 5′-monophosphate [34].
Using the LC-MS/MS method developed, the simulta-
neous detection of nucleosides and nucleotides in a standard
solution was achieved (Fig. 1).
Method performance
A high degree of selectivity is afforded by an MRM exper-
iment; however, chromatographic separation is required for
critical peaks with similar MRM transitions if accurate
quantitation is to be achieved. Chromatographic perfor-
mance was assessed by replicate analyses (n=6) of a mixed
nucleoside and nucleotide standard, with satisfactory reso-
lution being obtained between IMP/AMP (6.7), Ino/Ado
(6.8) and Cyd/Urd (4.3) critical pairs, compounds which
differ in mass by <2 Da (Table 4).
Method validation experiments to determine linearity,
detection limits and precision are summarised in Table 5.
Linearity was evaluated by least-squares regression analy-
sis, with acceptable values being obtained for the correlation
coefficient and with standard residual plots showing no
pattern and only a small amount of random variation. The
detection limits were appropriate, as defined by the infant
formula industry, with the exception of those for CMP and
Urd [35]. Although the detection limits of CMP and Urd
were higher than those specified, the MDL was two orders
of magnitude lower than that found in unfortified milk
powder [5]. Precision was evaluated as repeatability (1.9–
7.2 %) and intermediate precision (2.9–14.4 %). The suit-
ability of these results was demonstrated by a Horwitz
(repeatability) ratio of 0.2–0.6 [36].
The method was found to be robust for the seven method
performance parameters studied, with variances in the
results obtained not being significantly different from those
expected by chance. Given the method’s simplicity, two
critical steps are required to ensure the accuracy of the
results obtained: accurate measurement of the amount of
sample weighed and accurate addition of the internal
standard.
Accuracy determined as spiked recovery results measured in
the six different product types were within the acceptable limits
of 80–115% at the 10-μg g−1 level, as suggested by the AOAC
[36] (Table 6). Accuracy estimated as bias was evaluated
against reference values for NIST 1849a CRM (Table 7) and
against an LC-UVmethod for determining nucleotides in infant
formula (AOAC method 2011.20; Table 8). Although there
were statistically significant differences for some of the results,
the differences were small enough (0–13 %) that they are
unlikely to be of practical significance for compliance and
labelling requirements.
Conclusions
The optimisation and validation of an LC-MS/MS method
for the analysis of nucleosides and nucleotides in infant
formulae has been described. The use of SIL internal
Table 8 Method bias against AOAC Official Method 2011.20
Analyte
CMP UMP GMP IMP AMP
Measured
resultsa
12.9 (0.39) 4.1 (0.14) 1.6 (0.04) 0 (0) 3.6 (0.11)
AOAC
2011.20
resultsa
12.3 (0.50) 4.0 (0.21) 1.6 (0.07) 0 (0) 3.2 (0.16)
Bias (p value) <0.001 0.24 0.44 0 <0.001
AMP adenosine 5′-monophosphate, CMP cytidine 5′-monophosphate,
GMP guanosine 5′-monophosphate, UMP uridine 5′-monophosphate,
IMP inosine 5′-monophosphate
aMean (standard deviation) of analytical results for bovine milk-based
infant formula in milligrams per hectogram (n=12 replicates)
Table 7 Method bias against NIST 1849a reference values
Analyte
CMP UMP GMP AMP CMP+Cyd UMP+Urd GMP+Guo AMP+Ado
Measureda results 27.0 (0.99) 12.0 (0.66) 14.8 (0.45) 10.3 (0.29) 28.1 (1.00) 14.4 (0.68) 15.0 (0.45) 10.3 (0.29)
Reference values 26.8±2.9 12.9±1.5 14.6±1.1 10.51±0.5 31.7 15.5 14.6 10.8
Bias (p value) 0.44 <0.001 0.16 0.03 <0.001 <0.001 0.01 0.05
AMP adenosine 5′-monophosphate, CMP cytidine 5′-monophosphate, GMP guanosine 5′-monophosphate, UMP uridine 5′-monophosphate, Ado
adenosine, Cyd cytidine, Guo guanosine, Urd uridine
aMean (standard deviation) of analytical results of NIST 1849a CRM in milligrams per hectogram (n=12 replicates)
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standards provides confidence in the accuracy of the results
obtained. The method has been demonstrated to be precise
and accurate and has been validated for the analysis of
bovine milk-based, soy-based, caprine milk-based and
hydrolysed milk protein-based infant formulae.
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Table 39. LC-UV method: resolution 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 2.2 17.2 3.5 0.0 6.5 15.6 
Rep-2 2.2 16.7 3.5 0.0 6.3 15.6 
Rep-3 2.2 16.9 3.5 0.0 6.3 15.7 
Rep-4 2.2 16.8 3.5 0.0 6.3 15.6 
Rep-5 2.2 16.9 3.5 0.0 6.3 15.6 
Rep-6 2.2 16.8 3.6 0.0 6.3 15.6 
 
Table 40. LC-UV method: retention factor 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1–6 2.8 2.7 3.8 0.6 1.2 3.6 
 
Table 41. LC-UV method: theoretical plate number 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 58936 31344 242105 6728 9549 193432 
Rep-2 60714 33807 242122 6759 8144 196772 
Rep-3 60658 34690 240791 6895 8319 195607 
Rep-4 61290 34469 241952 6872 8249 195092 
Rep-5 60300 34120 241297 6822 8470 192936 
Rep-6 60792 33724 242225 6785 8431 192337 
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Table 42. LC-UV method: tailing factor 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 1.0 1.0 1.2 1.3 1.2 1.1 
Rep-2–3 1.1 1.0 1.1 1.3 1.2 1.1 
Rep-4 1.0 1.0 1.1 1.4 1.2 1.1 
Rep-5 1.0 1.0 1.1 1.4 1.1 1.1 
Rep-6 1.0 1.0 1.1 1.3 1.2 1.1 
 
Table 43. LC-UV method: retention time 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 20.6a 19.7 25.8 8.8 11.8 25.0 
Rep-2–6 20.6 19.8 25.8 8.8 11.8 25.0 
a
 time (min) 
 
Table 44. LC-UV method: peak area 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 123748 225546 309034 141090 201075 489133 
Rep-2 121833 225604 308867 142148 200878 488891 
Rep-3 121746 225576 308684 141865 199218 489026 
Rep-4 121446 225612 308522 143459 203759 488691 
Rep-5 122807 224207 308783 142219 199183 488058 
Rep-6 123633 224907 308633 142749 202813 487711 
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Table 45. LC-UV method: CMP linearity 
Standard Concentration Peak Area 
Number (μg mL-1) Expt-1 Expt-2 Mean 
1 0.61 176776 174227 175502 
2 1.22 347187 349061 348124 
3 2.44 708336 707102 707719 
4 3.67 1048784 1052265 1050525 
5 4.89 1385545 1395938 1390742 
6 6.11 1753167 1758614 1755891 
7 8.55 2461364 2467887 2464626 
 
Table 46. LC-UV method: UMP linearity 
Standard Concentration Peak Area 
Number (μg mL-1) Expt-1 Expt-2 Mean 
1 1.12 164979 163776 164378 
2 2.24 324607 326570 325589 
3 4.48 663277 661509 662393 
4 6.72 983556 988010 985783 
5 8.96 1298586 1307318 1302952 
6 11.20 1641850 1649499 1645675 
7 15.68 2301120 2310325 2305723 
 
Table 47. LC-UV method: GMP linearity 
Standard Concentration Peak Area 
Number (μg mL-1) Expt-1 Expt-2 Mean 
1 1.11 221513 221836 221675 
2 2.22 439150 439407 439279 
3 4.44 893367 889918 891643 
4 6.66 1339470 1340023 1339747 
5 8.88 1778542 1749201 1763872 
6 11.11 2225169 2229101 2227135 
7 15.55 3126921 3103321 3115121 
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Table 48. LC-UV method: IMP linearity 
Standard Concentration Peak Area 
Number (μg mL-1) Expt-1 Expt-2 Mean 
1 1.09 217540 217228 217384 
2 2.18 430114 439407 434761 
3 4.36 876836 875499 876168 
4 6.54 1302257 1304263 1303260 
5 8.72 1725020 1733135 1729078 
6 10.90 2169873 2175433 2172653 
7 15.27 3028787 3037687 3033237 
 
Table 49. LC-UV method: AMP linearity 
Standard Concentration Peak Area 
Number (μg mL-1) Expt-1 Expt-2 Mean 
1 1.25 328042 326090 327066 
2 2.50 643253 642699 642976 
3 5.00 1299637 1305955 1302796 
4 7.49 1940122 1929875 1934999 
5 9.99 2558580 2565982 2562281 
6 12.49 3202858 3217996 3210427 
7 1.25 328042 326090 327066 
 
Table 50. LC-UV method: TMP linearity 
Standard Concentration Peak Area 
Number (μg mL-1) Expt-1 Expt-2 Mean 
1 1.61 237138 240469 238804 
2 3.22 479645 481904 480775 
3 6.44 977263 978047 977655 
4 9.66 1458787 1452497 1455642 
5 12.88 1931108 1933364 1932236 
6 16.10 2418014 2430058 2424036 
7 22.54 3389353 3392650 3391002 
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Table 51. LC-UV method: precision 
Sample 
Day 
Tested 
Result (mg hg-1) 
CMP UMP GMP IMP AMP 
Milk-based IF dup-1 1 12.6 4.0 1.9 2.0 4.7 
Milk-based IF dup-2 1 12.3 4.0 1.8 2.0 4.5 
Milk-based IF dup-1 1 12.4 4.1 1.8 2.0 4.6 
Milk-based IF dup-2 1 12.4 4.1 1.8 2.0 4.5 
Milk-based IF dup-1 2 12.8 4.1 1.8 2.0 4.4 
Milk-based IF dup-2 2 12.7 4.2 1.8 2.1 4.3 
Milk-based IF dup-1 2 13.1 4.2 1.9 2.1 4.8 
Milk-based IF dup-2 2 12.9 4.4 1.8 2.1 4.7 
Milk-based IF dup-1 3 11.1 3.4 1.7 1.9 4.2 
Milk-based IF dup-2 3 11.0 3.4 1.7 1.9 4.2 
Milk-based IF dup-1 3 11.0 3.5 1.7 1.9 4.1 
Milk-based IF dup-2 3 10.9 3.5 1.7 1.9 4.1 
Milk-based IF dup-1 4 12.1 3.6 1.7 2.0 4.3 
Milk-based IF dup-2 4 12.2 3.8 1.7 2.1 4.3 
Milk-based IF dup-1 4 12.2 3.8 1.7 2.1 4.3 
Milk-based IF dup-2 4 12.3 3.9 1.8 2.1 4.4 
Milk-based IF dup-1 5 11.3 4.6 1.7 2.0 4.2 
Milk-based IF dup-2 5 11.7 4.2 1.8 2.0 4.6 
Milk-based IF dup-1 5 11.4 4.5 1.5 2.0 4.3 
Milk-based IF dup-2 5 11.4 4.5 1.5 2.0 4.3 
 
Table 52. LC-UV method: robustness 
Experiment 
Results (mg hg-1) 
IMP GMP AMP CMP UMP 
1 1.95 1.66 4.26 11.19 3.65 
2 1.99 1.70 4.32 11.38 3.68 
3 1.99 1.70 4.34 11.41 3.79 
4 2.00 1.75 4.40 11.46 3.70 
5 2.01 1.75 4.43 11.53 3.67 
6 2.01 1.74 4.43 11.54 3.74 
7 2.01 1.78 4.50 11.72 3.69 
8 1.99 1.70 4.32 11.38 3.78 
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Table 53. LC-UV method: method detection limit 
Replicatea 
Results (mg hg-1) 
CMP UMP GMP IMP AMP 
1 1.74 0.56 0.53 0.50 0.72 
2 1.75 0.57 0.54 0.53 0.72 
3 1.74 0.56 0.53 0.52 0.70 
4 1.70 0.56 0.53 0.50 0.69 
5 1.65 0.55 0.50 0.49 0.72 
6 1.75 0.53 0.53 0.52 0.68 
7 1.64 0.57 0.48 0.49 0.64 
8 1.56 0.57 0.52 0.54 0.70 
9 1.63 0.52 0.54 0.56 0.71 
10 1.62 0.49 0.49 0.59 0.73 
a
 Milk-based infant formula not fortified with nucleotides 
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Table 56. LC-UV method: CMP bias 
Replicate 
Numbera 
Day Tested 
CMP Paired Results (mg hg-1) 
Candidate Method Reference Methodb 
1  1 12.8 12.8 
2  1 12.7 12.4 
3  1 13.1 13.0 
4  1 12.9 12.7 
5  1 12.6 13.1 
6  1 13.1 12.8 
7  2 11.3 11.7 
8  2 11.7 11.6 
9  2 11.3 11.6 
10  2 11.4 11.5 
11  2 11.5 11.6 
12  2 11.4 11.6 
a
 Milk-based infant formula 
b 
Gill and Indyk, 2007 
 
Table 57. LC-UV method: UMP bias 
Replicate 
Numbera 
Day Tested 
UMP Paired Results (mg hg-1) 
Candidate Method Reference Methodb 
1  1 4.1 4.3 
2  1 4.2 4.2 
3  1 4.2 4.4 
4  1 4.4 4.1 
5  1 4.4 4.4 
6  1 4.1 4.4 
7  2 4.6 4.0 
8  2 4.2 4.0 
9  2 4.2 3.6 
10  2 4.5 4.0 
11  2 4.2 3.7 
12  2 4.0 3.7 
a
 Milk-based infant formula 
b 
Gill and Indyk, 2007 
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Table 58. LC-UV method: GMP bias 
Replicate 
Numbera 
Day Tested 
GMP Paired Results (mg hg-1) 
Candidate Method Reference Methodb 
1  1 1.8 1.7 
2  1 1.8 1.7 
3  1 1.9 1.8 
4  1 1.8 1.7 
5  1 1.7 1.6 
6  1 1.8 1.7 
7  2 1.7 1.6 
8  2 1.8 1.6 
9  2 1.5 1.9 
10  2 1.5 1.9 
11  2 1.7 1.6 
1  1 1.8 1.7 
a
 Milk-based infant formula 
b 
Gill and Indyk, 2007 
 
 
Table 59. LC-UV method: IMP bias 
Replicate 
Numbera 
Day Tested 
IMP Paired Results (mg hg-1) 
Candidate Method Reference Methodb 
1  1 2.0 2.0 
2  1 2.1 2.1 
3  1 2.1 2.0 
4  1 2.1 1.8 
5  1 2.0 1.9 
6  1 2.1 2.0 
7  2 2.0 2.0 
8  2 2.0 2.0 
9  2 2.0 2.0 
10  2 2.0 2.0 
11  2 2.0 2.0 
12  2 1.8 2.0 
a
 Milk-based infant formula 
b 
Gill and Indyk, 2007 
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Table 60. LC-UV method: AMP bias 
Replicate 
Numbera 
Day Tested 
AMP Paired Results (mg hg-1) 
Candidate Method Reference Methodb 
1  1 4.4 4.2 
2  1 4.3 4.2 
3  1 4.8 4.4 
4  1 4.7 4.2 
5  1 4.4 4.2 
6  1 4.4 4.2 
7  2 4.2 4.3 
8  2 4.6 4.4 
9  2 4.1 4.3 
10  2 4.3 4.3 
11  2 4.4 4.2 
12  2 4.3 4.2 
a
 Milk-based infant formula 
b 
Gill and Indyk, 2007 
 
 
Table 61. LC-UV method extension: resolution 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 0.0 7.2 12.4 2.7 15.7 4.4 
Rep-2 0.0 7.3 12.4 2.7 15.5 4.4 
Rep-3 0.0 7.3 12.4 2.7 15.3 4.4 
Rep-4 0.0 7.5 12.6 2.7 15.0 4.3 
Rep-5 0.0 7.5 12.6 2.7 14.8 4.4 
Rep-6 0.0 7.5 12.7 2.7 14.5 4.4 
Rep-7 0.0 7.6 12.7 2.8 14.1 4.4 
Rep-8 0.0 7.6 12.8 2.8 14.0 4.4 
Rep-9 0.0 7.6 12.9 2.8 14.2 4.5 
Rep-10 0.0 7.7 13.0 2.8 14.5 4.6 
Rep-11 0.0 7.7 13.1 2.8 14.8 4.5 
Rep-12 0.0 7.7 13.2 2.8 15.1 4.6 
Rep-13 0.0 7.7 13.4 2.7 15.5 4.6 
Rep-14 0.0 7.8 13.6 2.7 15.6 4.6 
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Table 62. LC-UV method extension: retention factor 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 1.9 2.8 4.8 5.4 8.0 8.5 
Rep-2 1.9 2.8 4.9 5.4 8.0 8.5 
Rep-3 1.9 2.8 4.9 5.5 8.0 8.5 
Rep-4 2.0 2.9 5.0 5.5 8.0 8.5 
Rep-5 2.0 2.9 5.0 5.6 8.0 8.6 
Rep-6 2.0 2.9 5.1 5.7 8.1 8.6 
Rep-7 2.0 3.0 5.1 5.7 8.1 8.6 
Rep-8 2.0 3.0 5.2 5.8 8.1 8.6 
Rep-9 2.0 3.0 5.3 5.8 8.1 8.7 
Rep-10 2.0 3.0 5.3 5.9 8.1 8.7 
Rep-11 2.0 3.0 5.4 5.9 8.1 8.7 
Rep-12 2.1 3.1 5.4 5.9 8.1 8.7 
Rep-13–14 2.1 3.1 5.5 6.0 8.1 8.7 
 
 
Table 63. LC-UV method extension: theoretical plates 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 10192 12996 14017 13867 95549 99638 
Rep-2 10602 12859 14300 14343 96916 101672 
Rep-3 10664 12897 14281 14326 99592 99300 
Rep-4 11237 13186 14415 14738 96668 99121 
Rep-5 10875 12992 14645 14826 98134 97892 
Rep-6 10877 12896 14472 15032 97540 97943 
Rep-7 11006 12978 14271 15783 94302 95966 
Rep-8 11106 12857 14268 16709 91588 93421 
Rep-9 10789 12806 14332 18375 91755 93547 
Rep-10 10918 12901 14524 21504 91098 92581 
Rep-11 10731 12615 14624 23934 88864 90545 
Rep-12 10795 12487 14878 27248 87701 90249 
Rep-13 10728 12386 15711 30341 87727 90184 
Rep-14 10737 12441 16317 32304 86550 88390 
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Table 64. LC-UV method extension: tailing factor 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 1.2 1.2 1.1 1.1 1.1 1.1 
Rep-2 1.3 1.2 1.1 1.1 1.1 1.1 
Rep-3–5 1.2 1.2 1.1 1.1 1.1 1.1 
Rep-6 1.3 1.2 1.1 1.1 1.1 1.1 
Rep-7–8 1.2 1.2 1.1 1.1 1.0 1.1 
Rep-9–12 1.2 1.2 1.1 1.0 1.1 1.1 
Rep-13 1.2 1.2 1.0 1.0 1.0 1.1 
Rep-14 1.3 1.2 1.1 1.0 1.1 1.1 
 
 
Table 65. LC-UV method extension: retention time 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 7.2 9.4 14.5 15.9 22.4 23.7 
Rep-2 7.3 9.5 14.7 16.1 22.5 23.8 
Rep-3 7.3 9.6 14.8 16.2 22.5 23.8 
Rep-4 7.4 9.7 14.9 16.4 22.6 23.9 
Rep-5 7.4 9.7 15.1 16.5 22.6 23.9 
Rep-6 7.4 9.8 15.2 16.6 22.7 24.0 
Rep-7 7.5 9.9 15.4 16.8 22.7 24.0 
Rep-8 7.5 9.9 15.5 17.0 22.7 24.1 
Rep-9 7.6 10.0 15.6 17.1 22.8 24.2 
Rep-10 7.6 10.1 15.8 17.2 22.8 24.2 
Rep-11 7.6 10.1 15.9 17.3 22.8 24.3 
Rep-12 7.6 10.2 16.0 17.3 22.8 24.3 
Rep-13 7.7 10.2 16.1 17.4 22.9 24.3 
Rep-14 7.7 10.3 16.2 17.4 22.9 24.3 
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Table 66. LC-UV method extension: peak area 
Mixed 
Standard 
Results 
IMP GMP AMP CMP UMP TMP 
Rep-1 638138 982334 1119976 593685 770011 1843228 
Rep-2 640022 986420 1127234 597848 773187 1855738 
Rep-3 636447 981626 1120259 592765 769603 1842289 
Rep-4 645569 993141 1133985 597917 779022 1866522 
Rep-5 632147 975974 1111935 585924 766264 1838637 
Rep-6 624578 962047 1095944 573769 753739 1809489 
Rep-7 653286 1006752 1145159 600617 790462 1892580 
Rep-8 637618 981851 1116001 588061 773469 1854067 
Rep-9 630436 967112 1099008 580259 758997 1821988 
Rep-10 621475 959689 1090717 574672 752423 1806074 
Rep-11 630009 967348 1109294 583220 761399 1825315 
Rep-12 638728 983285 1128934 591601 771544 1856610 
Rep-13 637092 980414 1117724 587872 769926 1842529 
Rep-14 616894 946592 1084900 572612 743720 1779084 
 
 
Table 67. LC-UV method extension: CMP linearity 
Standard Concentration Peak Area 
Number (ng mL-1) Expt-1 Expt-2 Expt-3 
1 30.40 3068 2764 2951 
2 75.99 7950 6901 6208 
3 151.98 15870 15743 14559 
4 303.97 33905 33426 30072 
5 790.32 91542 89617 87619 
6 1641.44 185087 194640 191435 
7 4012.40 469266 479866 477601 
8 8207.19 953511 983051 973409 
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Table 68. LC-UV method extension: UMP linearity 
Standard Concentration Peak Area 
Number (ng mL-1) Expt-1 Expt-2 Expt-3 
1 29.9 3287 2762 3068 
2 74.7 8295 7248 6433 
3 149.5 17528 17060 15393 
4 299.0 37265 35897 33386 
5 777.4 102256 96457 95696 
6 1614.6 212913 210417 207391 
7 3946.7 526514 520532 521321 
8 8072.9 1079162 1071946 1065016 
 
Table 69. LC-UV method extension: GMP linearity 
Standard Concentration Peak Area 
Number (ng mL-1) Expt-1 Expt-2 Expt-3 
1 30.1 3139 3356 2685 
2 75.3 9279 7244 4161 
3 150.6 19241 17251 12724 
4 301.3 41543 39812 32870 
5 783.3 114857 106351 108758 
6 1626.8 243900 238192 225350 
7 3976.6 609095 584126 579317 
8 8133.9 1248954 1236241 1254776 
 
Table 70. LC-UV method extension: IMP linearity 
Standard Concentration Peak Area 
Number (ng mL-1) Expt-1 Expt-2 Expt-3 
1 30.3 3310 3044 3486 
2 75.7 9418 7958 6443 
3 151.4 18290 18569 16915 
4 302.8 42722 40371 36493 
5 787.2 121191 112168 111833 
6 1634.9 253892 246719 245055 
7 3996.5 630236 619282 617073 
8 8174.6 1303341 1272772 1274573 
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Table 71. LC-UV method extension: AMP linearity 
Standard Concentration Peak Area 
Number (ng mL-1) Expt-1 Expt-2 Expt-3 
1 30.1 3935 2695 3429 
2 75.2 10245 8343 6771 
3 150.4 20433 20009 17738 
4 300.8 44687 43798 38795 
5 782.0 146449 120017 119155 
6 1624.1 266211 263989 259700 
7 3969.9 685088 661717 656761 
8 8120.4 1377034 1364391 1359536 
 
Table 72. LC-UV method extension: TMP linearity 
Standard Concentration Peak Area 
Number (ng mL-1) Expt-1 Expt-2 Expt-3 
1 30.3 4236 2818 4052 
2 75.6 10261 8306 8029 
3 151.3 20669 19434 18994 
4 302.6 44382 43441 39653 
5 786.7 124543 114412 116256 
6 1633.8 255504 252406 250776 
7 3993.8 635068 631412 631464 
8 8169.2 1301278 1294196 1286217 
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Table 79. LC-UV method extension: bias (NIST1849a CRM results) 
Sample 
Results (mg hg
-1
) 
CMP UMP GMP AMP 
NIST 1849a day one, rep-1 27.60 13.00 14.93 10.71 
NIST 1849a day one, rep-2 28.68 12.88 15.71 11.15 
NIST 1849a day two, rep-1 26.99 13.16 14.25 10.08 
NIST 1849a day two, rep-2 27.66 13.17 14.76 10.45 
NIST 1849a day three, rep-1 25.97 12.02 14.55 10.52 
NIST 1849a day three, rep-2 26.26 12.77 14.34 10.28 
NIST 1849a day four, rep-1 27.37 13.12 14.64 10.33 
NIST 1849a day four, rep-2 27.41 13.10 14.35 10.30 
NIST 1849a day five, rep-1 30.06 12.00 15.43 11.31 
NIST 1849a day five, rep-1 28.56 11.56 15.29 11.25 
NIST 1849a day six, rep-1 29.77 11.54 15.40 11.44 
NIST 1849a day six, rep-2 29.34 11.80 15.15 11.24 
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APPENDIX IV: TPAN ANALYSIS RAW DATA 
Table 86. TPAN chromatography: resolution 
Mixed 
Standard 
Results 
Cyd Urd 5mCyd Ino Guo Ado 8BrGuo 
Rep-1 0.0 6.3 8.1 8.3 2.6 12.8 9.5 
Rep-2 0.0 6.4 8.3 7.7 2.6 12.7 9.5 
Rep-3 0.0 6.2 7.7 9.1 2.7 12.8 9.1 
Rep-4 0.0 6.0 7.5 9.4 2.8 12.6 9.0 
Rep-5 0.0 6.1 7.5 9.4 2.8 12.8 9.1 
Rep-6 0.0 6.0 7.5 9.5 2.7 12.8 8.9 
Rep-7 0.0 6.1 7.5 9.5 2.7 12.7 8.9 
Rep-8 0.0 6.1 7.5 9.5 2.8 12.4 8.9 
Rep-9 0.0 6.0 7.5 9.5 2.8 12.7 9.0 
Rep-10 0.0 6.0 7.4 9.5 2.7 12.5 9.0 
Rep-11 0.0 6.0 7.5 9.4 2.7 12.4 8.9 
Rep-12 0.0 6.0 7.5 9.4 2.8 12.5 8.9 
Rep-13 0.0 6.0 7.4 9.3 2.7 12.3 8.9 
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Table 87. TPAN method: retention factor 
Mixed 
Standard 
Results 
Cyd Urd 5mCyd Ino Guo Ado 8BrGuo 
Rep-1 1.5 2.4 3.8 5.1 5.3 6.5 7.6 
Rep-2 1.6 2.4 4.0 5.1 5.4 6.5 7.7 
Rep-3 1.4 2.2 3.6 5.0 5.2 6.3 7.4 
Rep-4–5 1.4 2.2 3.5 4.9 5.1 6.3 7.3 
Rep-6–7 1.4 2.2 3.4 4.9 5.1 6.3 7.3 
Rep-8–9 1.4 2.2 3.5 4.9 5.1 6.3 7.3 
Rep-10–12 1.4 2.2 3.5 4.9 5.2 6.3 7.3 
Rep-13 1.4 2.2 3.5 4.9 5.2 6.3 7.4 
 
 
Table 88. TPAN method: theoretical plates 
Mixed 
Standard 
Results 
Cyd Urd 5mCyd Ino Guo Ado 8BrGuo 
Rep-1 6672 7887 8519 70604 89268 96811 56826 
Rep-2 6701 7989 8647 74783 94298 93766 56620 
Rep-3 6786 7712 8223 61494 83362 98738 62705 
Rep-4 6398 7587 8148 52520 78441 94140 61317 
Rep-5 6664 7551 8056 53554 80348 98512 62110 
Rep-6 6582 7612 8067 50148 79176 98374 61100 
Rep-7 6577 7697 8151 50714 79199 96656 60978 
Rep-8 6685 7677 8181 52691 75328 94129 61109 
Rep-9 6429 7626 8173 53735 80204 97516 60310 
Rep-10 6600 7481 8071 55531 79830 94802 60606 
Rep-11 6309 7476 8134 54349 80597 92142 59610 
Rep-12 6442 7603 8132 55589 81436 91610 58672 
Rep-13 6570 7552 8005 55645 78695 91755 59102 
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Table 89. TPAN method: tailing factor 
Mixed 
Standard 
Results 
Cyd Urd 5mCyd Ino Guo Ado 8BrGuo 
Rep-1 1.2 1.1 1.0 1.1 1.1 1.2 1.1 
Rep-2–5 1.2 1.1 1.0 1.1 1.2 1.2 1.1 
Rep-6 1.2 1.2 1.0 1.1 1.2 1.2 1.2 
Rep-7 1.2 1.1 1.0 1.1 1.2 1.2 1.1 
Rep-8 1.2 1.1 1.0 1.1 1.1 1.2 1.1 
Rep-9 1.2 1.2 1.0 1.2 1.2 1.2 1.1 
Rep-10 1.2 1.1 1.0 1.1 1.1 1.2 1.1 
Rep-11 1.2 1.1 1.0 1.1 1.2 1.2 1.1 
Rep-12 1.2 1.2 1.0 1.1 1.2 1.2 1.1 
Rep-13 1.2 1.1 1.0 1.1 1.1 1.2 1.1 
 
 
Table 90. TPAN method: retention time 
Mixed 
Standard 
Results 
Cyd Urd 5mCyd Ino Guo Ado 8BrGuo 
Rep-1 5.5 7.4 10.6 13.4 13.9 16.4 18.9 
Rep-2 5.6 7.6 10.9 13.5 14.0 16.5 19.1 
Rep-3 5.3 7.1 10.1 13.1 13.6 16.2 18.4 
Rep-4 5.2 7.0 9.8 12.9 13.5 16.0 18.3 
Rep-5 5.2 7.0 9.8 12.9 13.5 16.1 18.3 
Rep-6 5.2 6.9 9.7 12.9 13.5 16.0 18.2 
Rep-7–9 5.2 7.0 9.8 12.9 13.5 16.0 18.3 
Rep-10 5.3 7.0 9.9 13.0 13.5 16.1 18.3 
Rep-11 5.3 7.0 9.9 13.0 13.6 16.1 18.3 
Rep-12 5.3 7.0 9.9 13.0 13.6 16.1 18.4 
Rep-13 5.3 7.1 9.9 13.0 13.6 16.1 18.4 
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Table 91. TPAN method: peak area 
Mixed 
Standard 
Results 
Cyd Urd 5mCyd Ino Guo Ado 8BrGuo 
Rep-1 101975 136868 94477 107797 130840 184237 177727 
Rep-2 105768 141774 98055 111589 135530 190849 183974 
Rep-3 105551 142184 97903 111931 135823 191183 184517 
Rep-4 100819 135980 93473 107415 130514 184413 177853 
Rep-5 101162 136223 93597 107182 130006 183118 176836 
Rep-6 102232 137473 94690 108501 131816 186241 180033 
Rep-7 101667 136607 94439 107596 130516 183946 177581 
Rep-8 103696 139471 96106 109759 133043 187420 181116 
Rep-9 103636 139555 96139 109670 132891 187400 180905 
Rep-10 100363 134937 93228 106175 128751 181702 176011 
Rep-11 106120 142754 98189 112251 136077 192060 186263 
Rep-12 112602 151446 104781 119170 144577 203855 197927 
Rep-13 103396 138942 95438 109222 132363 186623 181340 
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Table 92. TPAN raw data: winter herd milk (rep-1) 
Samplea,b 
Enzyme 
Treatment 
Results (mg dL-1) 
Cyd Urd Guo Ado 
Day 0 
A 1.29 14.43 0.08 0.00 
B 2.82 50.99 0.88 0.74 
C 2.97 51.05 1.25 1.09 
D 3.23 55.29 2.22 1.72 
Day 0.25 
A 0.94 9.67 0.07 0.00 
B 1.33 17.05 0.36 0.36 
C 1.34 17.81 0.70 0.61 
D 1.52 18.76 0.98 0.77 
Day 1 
A 0.84 12.31 0.14 0.00 
B 4.07 31.72 1.24 0.84 
C 4.29 31.81 1.64 1.16 
D 4.42 35.87 2.31 1.80 
Day 2 
A 0.55 14.69 0.22 0.14 
B 4.76 22.61 0.81 0.85 
C 4.99 23.04 1.11 1.19 
D 5.03 24.92 1.74 1.95 
Day 3 
A 0.46 10.09 0.13 0.14 
B 4.46 16.11 0.58 1.26 
C 4.55 16.41 0.73 1.28 
D 4.58 17.79 1.31 1.90 
Day 5 
A 0.32 5.40 0.00 0.05 
B 3.33 5.72 0.17 0.94 
C 3.46 5.87 0.39 1.13 
D 3.48 6.08 0.60 1.33 
Day 10 
A 0.16 0.82 0.00 0.03 
B 1.89 0.91 0.07 0.69 
C 1.90 0.92 0.15 0.75 
D 1.94 0.99 0.18 0.84 
Day 20 
A 0.13 0.29 0.00 0.04 
B 1.07 0.33 0.00 0.28 
C 1.13 0.35 0.08 0.35 
D 1.14 0.38 0.09 0.37 
Day30 A 0.13 0.22 0.00 0.03 
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B 0.75 0.24 0.00 0.13 
C 0.81 0.26 0.06 0.18 
D 0.81 0.27 0.07 0.20 
a
 Milk/colostrum samples from 7 cows pooled at each sampling time. 
b
 Sampling time in days post-partum. 
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Table 93. TPAN raw data: winter herd milk (rep-2) 
Samplea,b 
Enzyme 
Treatment 
Results (mg dL-1) 
Cyd Urd Guo Ado 
Day 0 
A 1.31 13.87 0.09 0.00 
B 2.76 47.49 0.88 0.80 
C 2.89 50.04 1.31 1.17 
D 3.07 57.39 2.58 1.81 
Day 0.25 
A 1.00 9.75 0.07 0.00 
B 1.25 15.52 0.35 0.37 
C 1.27 16.65 0.65 0.61 
D 1.53 17.28 1.01 0.72 
Day 1 
A 0.87 12.03 0.15 0.00 
B 4.01 30.46 1.30 0.76 
C 4.06 31.85 1.64 1.26 
D 4.11 33.58 2.30 1.68 
Day 2 
A 0.65 14.81 0.24 0.17 
B 4.66 21.54 0.78 0.87 
C 4.92 22.44 1.06 1.19 
D 5.03 23.82 1.78 1.83 
Day 3 
A 0.53 10.78 0.16 0.19 
B 4.40 15.62 0.55 0.97 
C 4.47 15.81 0.75 1.23 
D 4.67 17.29 1.41 1.82 
Day 5 
A 0.41 5.12 0.00 0.07 
B 3.30 5.50 0.16 0.92 
C 3.39 5.53 0.41 1.09 
D 3.40 5.73 0.56 1.22 
Day 10 
A 0.23 0.76 0.00 0.03 
B 1.84 0.86 0.07 0.64 
C 1.97 0.92 0.19 0.71 
D 1.98 0.94 0.20 0.74 
Day 20 
A 0.19 0.34 0.00 0.04 
B 1.13 0.34 0.00 0.24 
C 1.17 0.35 0.08 0.27 
D 1.19 0.41 0.11 0.30 
Day30 A 0.16 0.18 0.00 0.03 
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B 0.76 0.23 0.00 0.10 
C 0.82 0.25 0.07 0.12 
D 0.83 0.26 0.08 0.14 
a
 Milk/colostrum samples from 7 cows pooled at each sampling time. 
b
 Sampling time in days post-partum. 
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Table 94. TPAN raw data: summer herd milk (rep-1) 
Samplea,b 
Enzyme 
Treatment 
Results (mg dL-1) 
Cyd Urd Guo Ado 
Day 0 
A 0.61 13.36 0.66 0.00 
B 0.94 13.64 0.71 0.00 
C 1.05 13.75 1.02 0.25 
D 1.10 13.89 1.11 0.31 
Day 0.25 
A 0.86 6.76 0.51 0.00 
B 1.04 6.88 0.55 0.00 
C 1.11 7.24 0.81 0.21 
D 1.18 7.43 0.85 0.24 
Day 1 
A 1.26 10.21 0.63 0.00 
B 3.05 11.20 0.73 0.00 
C 3.23 11.40 1.00 0.24 
D 3.58 12.91 1.33 0.33 
Day 2 
A 0.82 9.56 0.69 0.00 
B 3.48 9.67 0.75 0.25 
C 3.61 9.92 0.89 0.32 
D 3.61 10.27 1.13 0.43 
Day 3 
A 1.59 5.53 0.32 0.00 
B 3.15 6.54 0.42 0.50 
C 3.29 6.97 0.53 0.59 
D 3.32 7.11 0.66 0.71 
Day 5 
A 0.27 2.23 0.11 0.00 
B 2.26 2.33 0.18 0.52 
C 2.43 2.44 0.26 0.58 
D 2.47 2.52 0.29 0.65 
Day 10 
A 0.15 0.74 0.00 0.00 
B 1.17 0.77 0.00 0.29 
C 1.22 0.84 0.10 0.32 
D 1.29 0.85 0.12 0.37 
Day 20 
A 0.17 0.44 0.00 0.00 
B 0.86 0.45 0.00 0.11 
C 0.86 0.47 0.00 0.12 
D 0.89 0.49 0.00 0.14 
Day30 A 0.15 0.31 0.00 0.00 
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B 0.57 0.32 0.00 0.00 
C 0.57 0.33 0.00 0.00 
D 0.60 0.34 0.00 0.08 
a
 Milk/colostrum samples from 7 cows pooled at each sampling time. 
b
 Sampling time in days post-partum. 
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Table 95. TPAN raw data: summer herd milk (rep-2) 
Samplea,b 
Enzyme 
Treatment 
Results (mg dL-1) 
Cyd Urd Guo Ado 
Day 0 
A 0.67 11.37 0.56 0.00 
B 1.05 11.66 0.61 0.00 
C 1.15 11.67 0.93 0.25 
D 1.17 11.77 1.00 0.31 
Day 0.25 
A 0.90 6.91 0.50 0.00 
B 0.96 6.99 0.54 0.00 
C 1.05 7.44 0.76 0.20 
D 1.10 7.71 0.79 0.22 
Day 1 
A 1.38 9.78 0.57 0.00 
B 3.14 10.87 0.64 0.00 
C 3.27 11.20 0.94 0.14 
D 3.72 13.03 1.31 0.20 
Day 2 
A 0.96 9.59 0.84 0.00 
B 3.34 9.67 0.90 0.21 
C 3.46 9.93 1.01 0.28 
D 3.46 10.40 1.27 0.37 
Day 3 
A 1.66 4.96 0.35 0.00 
B 2.95 5.69 0.43 0.65 
C 3.06 5.95 0.54 0.73 
D 3.09 6.08 0.63 0.84 
Day 5 
A 0.23 2.27 0.00 0.00 
B 2.15 2.37 0.07 0.53 
C 2.39 2.51 0.15 0.58 
D 2.50 2.61 0.17 0.66 
Day 10 
A 0.13 0.75 0.00 0.00 
B 1.09 0.78 0.00 0.34 
C 1.12 0.83 0.10 0.37 
D 1.16 0.83 0.11 0.40 
Day 20 
A 0.17 0.28 0.00 0.00 
B 0.91 0.29 0.00 0.09 
C 0.91 0.31 0.00 0.10 
D 0.95 0.32 0.00 0.12 
Day30 A 0.15 0.32 0.00 0.00 
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B 0.50 0.32 0.00 0.00 
C 0.51 0.33 0.00 0.00 
D 0.53 0.34 0.00 0.08 
a
 Milk/colostrum samples from 7 cows pooled at each sampling time. 
b
 Sampling time in days post-partum. 
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Table 96. TPAN raw data: bovine, caprine, ovine milk (rep-1) 
Sample 
Enzyme 
Treatment 
Results (mg dL-1) 
Cyd Urd Guo Ado 
Bovinea 
A 0.20 0.44 0.00 0.00 
B 1.03 0.59 0.00 0.00 
C 1.04 0.60 0.00 0.11 
D 1.06 0.62 0.10 0.14 
Caprinea 
A 0.39 2.70 0.00 0.00 
B 1.23 11.64 2.58 0.62 
C 1.42 12.03 2.99 0.81 
D 1.59 14.29 7.09 1.72 
Ovineb 
A 0.54 3.42 0.16 0.00 
B 1.96 48.41 1.94 3.24 
C 2.04 49.43 2.25 3.48 
D 2.29 75.28 8.56 7.44 
a
 Pooled samples taken from silos prior to manufacturing. 
b
 Pooled sample taken from research herd. 
 
Table 97. TPAN raw data: bovine, caprine, ovine milk (rep-2) 
Sample 
Enzyme 
Treatment 
Results (mg dL-1) 
Cyd Urd Guo Ado 
Bovinea 
A 0.24 0.49 0.00 0.00 
B 1.02 0.58 0.00 0.00 
C 1.07 0.63 0.00 0.13 
D 1.08 0.64 0.13 0.15 
Caprinea 
A 0.37 2.83 0.00 0.00 
B 1.28 12.05 2.77 0.68 
C 1.39 12.12 2.97 0.78 
D 1.57 14.78 7.09 1.66 
Ovineb 
A 0.56 3.80 0.16 0.00 
B 1.89 50.31 1.93 3.23 
C 2.06 51.37 2.33 3.69 
D 2.28 74.54 8.56 7.40 
a
 Pooled samples taken from silos prior to manufacturing. 
b
 Pooled sample taken from research herd. 
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APPENDIX V: LS-MS METHOD RAW DATA 
Table 98. LC-MS method: bias (AOAC 2011.20 results) 
Sample 
Result (mg hg-1) 
CMP UMP GMP IMP AMP 
Bovine milk-based IF rep-1 12.6 4.3 1.6 0.0 3.2 
Bovine milk-based IF rep-2 13.0 4.1 1.7 0.0 3.5 
Bovine milk-based IF rep-3 11.8 4.2 1.5 0.0 3.1 
Bovine milk-based IF rep-4 11.7 4.2 1.5 0.0 3.0 
Bovine milk-based IF rep-5 12.2 3.8 1.6 0.0 3.3 
Bovine milk-based IF rep-6 12.6 3.8 1.6 0.0 3.3 
Bovine milk-based IF rep-7 12.7 4.2 1.5 0.0 3.3 
Bovine milk-based IF rep-8 13.0 4.1 1.8 0.0 3.5 
Bovine milk-based IF rep-9 11.9 4.2 1.6 0.0 3.1 
Bovine milk-based IF rep-10 11.9 4.2 1.6 0.0 3.1 
Bovine milk-based IF rep-11 11.7 3.7 1.6 0.0 3.2 
Bovine milk-based IF rep-12 12.8 3.7 1.6 0.0 3.3 
 
Table 99. LC-MS method: bias (LC-MS method results) 
Sample 
Result (mg hg-1) 
CMP UMP GMP IMP AMP 
Bovine milk-based IF rep-1 13.3 4.2 1.6 0.0 3.6 
Bovine milk-based IF rep-2 13.2 4.2 1.6 0.0 3.5 
Bovine milk-based IF rep-3 12.9 4.1 1.6 0.0 3.5 
Bovine milk-based IF rep-4 12.8 4.2 1.6 0.0 3.6 
Bovine milk-based IF rep-5 12.7 3.8 1.7 0.0 3.6 
Bovine milk-based IF rep-6 12.4 4.0 1.6 0.0 3.6 
Bovine milk-based IF rep-7 13.4 4.2 1.6 0.0 3.6 
Bovine milk-based IF rep-8 13.5 3.9 1.6 0.0 3.9 
Bovine milk-based IF rep-9 12.6 4.2 1.6 0.0 3.6 
Bovine milk-based IF rep-10 12.5 4.3 1.6 0.0 3.5 
Bovine milk-based IF rep-11 12.7 3.9 1.6 0.0 3.6 
Bovine milk-based IF rep-12 12.3 4.2 1.6 0.0 3.7 
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0
.0
2
 
1
.2
7
 
0
.5
2
 
9
.7
8
 
C
y
d
 
0
.6
2
 
0
.1
0
 
0
.0
1
 
1
.0
9
 
0
.0
9
 
0
.8
3
 
S
a
m
p
le
 
IF
 p
o
w
d
e
r 
p
/h
 b
o
v
in
e
 m
ilk
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
p
/h
 s
o
y
-b
a
s
e
d
 
In
fa
n
t 
e
le
m
e
n
ta
l 
p
o
w
d
e
r 
IF
 P
o
w
d
e
r 
b
o
v
in
e
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ilk
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
s
o
y
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
c
a
p
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n
e
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a
s
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T
a
b
le
 1
1
5
. 
L
C
-M
S
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e
th
o
d
: 
re
c
o
v
e
ry
 (
5
0
%
 s
p
ik
e
d
 s
a
m
p
le
) 
R
e
s
u
lt
s
 (
m
g
 h
g
-1
) 
A
M
P
 
7
.6
6
 
2
.2
0
 
1
.7
6
 
4
.8
7
 
1
.9
9
 
4
.1
2
 
p
/h
 =
 p
a
rt
ia
lly
 h
y
d
ro
ly
s
e
d
 
IM
P
 
1
.1
5
 
0
.9
6
 
1
.0
8
 
0
.9
8
 
0
.9
2
 
1
.3
3
 
G
M
P
 
3
.1
1
 
1
.4
1
 
1
.0
0
 
2
.4
7
 
1
.2
7
 
1
.2
6
 
U
M
P
 
7
.5
8
 
1
.8
1
 
1
.6
7
 
5
.3
6
 
1
.7
0
 
7
.7
0
 
C
M
P
 
1
4
.7
3
 
4
.8
9
 
4
.8
6
 
1
5
.6
5
 
4
.8
6
 
7
.7
8
 
A
d
o
 
1
.2
5
 
2
.1
7
 
1
.2
5
 
1
.4
8
 
2
.2
8
 
1
.2
1
 
In
o
 
1
.0
0
 
0
.9
4
 
1
.0
0
 
1
.2
5
 
1
.0
9
 
7
.7
3
 
G
u
o
 
1
.2
1
 
1
.6
9
 
1
.1
6
 
1
.4
0
 
1
.5
9
 
1
.6
3
 
U
rd
 
2
.4
5
 
1
.7
1
 
1
.1
9
 
2
.2
4
 
1
.3
8
 
1
0
.9
5
 
C
y
d
 
1
.6
4
 
1
.1
3
 
1
.0
3
 
2
.0
3
 
1
.1
8
 
1
.8
0
 
S
a
m
p
le
 
IF
 p
o
w
d
e
r 
p
/h
 b
o
v
in
e
 m
ilk
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
p
/h
 s
o
y
-b
a
s
e
d
 
In
fa
n
t 
e
le
m
e
n
ta
l 
p
o
w
d
e
r 
IF
 P
o
w
d
e
r 
b
o
v
in
e
 m
ilk
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
s
o
y
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
c
a
p
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n
e
 m
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T
a
b
le
 1
1
6
. 
L
C
-M
S
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e
th
o
d
: 
re
c
o
v
e
ry
 (
1
5
0
%
 s
p
ik
e
d
 s
a
m
p
le
) 
R
e
s
u
lt
s
 (
m
g
 h
g
-1
) 
A
M
P
 
1
0
.8
8
 
5
.8
5
 
5
.2
2
 
8
.3
2
 
5
.5
4
 
7
.9
5
 
p
/h
 =
 p
a
rt
ia
lly
 h
y
d
ro
ly
s
e
d
 
IM
P
 
3
.6
4
 
3
.3
4
 
3
.6
3
 
3
.4
5
 
3
.2
3
 
3
.4
6
 
G
M
P
 
5
.2
0
 
3
.4
0
 
3
.0
7
 
4
.3
9
 
3
.2
1
 
3
.1
5
 
U
M
P
 
1
1
.8
5
 
5
.4
3
 
5
.7
1
 
9
.0
6
 
5
.4
3
 
1
1
.4
0
 
C
M
P
 
2
3
.4
2
 
1
3
.8
9
 
1
3
.6
7
 
2
5
.2
4
 
1
3
.7
2
 
1
6
.5
4
 
A
d
o
 
3
.5
9
 
4
.5
4
 
3
.5
8
 
3
.6
9
 
4
.5
8
 
3
.7
0
 
In
o
 
2
.7
9
 
3
.0
7
 
2
.9
3
 
3
.0
3
 
3
.0
0
 
1
0
.2
7
 
G
u
o
 
3
.4
2
 
3
.9
6
 
3
.2
7
 
3
.5
3
 
3
.9
5
 
3
.8
8
 
U
rd
 
5
.1
9
 
3
.9
8
 
3
.5
3
 
4
.6
0
 
3
.7
3
 
1
4
.1
7
 
C
y
d
 
3
.4
1
 
3
.2
2
 
3
.0
3
 
4
.0
1
 
3
.0
9
 
3
.8
1
 
S
a
m
p
le
 
IF
 p
o
w
d
e
r 
p
/h
 b
o
v
in
e
 m
ilk
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
p
/h
 s
o
y
-b
a
s
e
d
 
In
fa
n
t 
e
le
m
e
n
ta
l 
p
o
w
d
e
r 
IF
 P
o
w
d
e
r 
b
o
v
in
e
 m
ilk
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
s
o
y
-b
a
s
e
d
 
IF
 P
o
w
d
e
r 
c
a
p
ri
n
e
 m
ilk
-b
a
s
e
d
 
